relevancy	row	span1	span2
0.9999913	0	[ a distal tip which is configured to be implanted into the intervertebral disc of a patient, the proximal tip configured to penetrate that disc, and ]	[ A method of applying a medicament to an intervertebral disc comprising: ]
0.9999924	1	[ wherein the tip is configured for insertion near the intervertebral disc leading to penetration of a medicament into the intervertebral disc from said proximal tip; and ]	[ a distal tip which is configured to be implanted into the intervertebral disc of a patient, the proximal tip configured to penetrate that disc, and ]
0.99996066	2	[ an outside tip which is configured for insertion on a spinal target and is connected to said distal tip, the outside tip being capable of rotating and thus allowing fluid communication with a fluid source at or near said distal tip. ]	[ wherein the tip is configured for insertion near the intervertebral disc leading to penetration of a medicament into the intervertebral disc from said proximal tip; and ]
0.99999225	3	[ providing a hand-held, wireless implantable stimulator assembly including: ]	[ A method for performing a bio-implantable stimulator assembly comprising: ]
0.9998061	4	[ an external stimulator positioned in communication with a delivery port and a control surface; ]	[ providing a hand-held, wireless implantable stimulator assembly including: ]
0.9999912	5	[ a housing that covers at least a portion of the external stimulator; ]	[ an external stimulator positioned in communication with a delivery port and a control surface; ]
0.9999887	6	[ at least one actuator assembly installed therein, said actuator assembly associated with each external stimulator at a time such that each actuator assembly is adapted to deliver a force at least partially exerted on the external stimulator in response to signal inputs of the control surface; and ]	[ a housing that covers at least a portion of the external stimulator; ]
0.99999213	7	[ a control apparatus operatively located on an external surface of the control surface wherein the control surfaces of the actuator and external stimulator assemblies are aligned to direct a source of electrical energy towards each actuator assembly of the stimulator assembly, wherein receiving signals from the control surfaces of the actuator and external stimulator assemblies is via a wired connection and movement of the control surface is mechanically induced by the external stimulator at a time that each trigger unit of the external stimulator is positioned at a time when it controls a trigger device associated with each actuator assembly of the stimulator. ]	[ at least one actuator assembly installed therein, said actuator assembly associated with each external stimulator at a time such that each actuator assembly is adapted to deliver a force at least partially exerted on the external stimulator in response to signal inputs of the control surface; and ]
0.9999924	8	[ feeding a liquid to the soft tissue cleaning device via the dispenser, wherein the liquid contains a soft tissue cleaning solvent; ]	[ A method of controlling a dispenser for a soft tissue cleaning device comprising: ]
0.99999225	9	[ at least one of cleaning solvent extraction and filling the soft tissue cleaning solvent in the liquid; ]	[ feeding a liquid to the soft tissue cleaning device via the dispenser, wherein the liquid contains a soft tissue cleaning solvent; ]
0.99999166	10	[ applying a fluid to a first end of the soft tissue cleaning device, wherein the liquid is at least partially delivered to the first end of the soft tissue cleaning device; ]	[ at least one of cleaning solvent extraction and filling the soft tissue cleaning solvent in the liquid; ]
0.9999924	11	[ removing a moisture barrier within the soft tissue cleaning portion from the soft tissue cleaning device; and ]	[ applying a fluid to a first end of the soft tissue cleaning device, wherein the liquid is at least partially delivered to the first end of the soft tissue cleaning device; ]
0.99999213	12	[ disposing the liquid from the soft tissue cleaning device. ]	[ removing a moisture barrier within the soft tissue cleaning portion from the soft tissue cleaning device; and ]
0.99947006	13	[ at least one monomerine; ]	[ A method of treating an infection in a subject having a infection, comprising administering to the subject an effective amount of a bioactive material comprising at least one of the following ingredients: ]
0.9998456	14	[ at least one hetero-mechanoreactive polymer; ]	[ at least one monomerine; ]
0.99144155	15	[ a metallopropyl ether; ]	[ at least one hetero-mechanoreactive polymer; ]
0.99993193	16	[ ether-modified metallocene-modified polypropylene; ]	[ a metallopropyl ether; ]
0.98396957	17	[ a biodegradable polymer; and ]	[ ether-modified metallocene-modified polypropylene; ]
0.000843139	18	[ a solid or liquid salt of one or more of the present methods. ]	[ a biodegradable polymer; and ]
0.99999154	19	[ (a) generating a set of data sets relating to at least one physiological property; ]	[ A method for selectively selecting a therapeutic agent over a preselected, non-toxic therapeutic agent in accordance with data relating to desired physiological properties, said method comprising the steps of: ]
0.9999726	20	[ (b) generating a plurality of therapeutic agent candidates, each candidate comprising at least one of a preselected, non-toxic therapeutic agent that is preselected and at least one candidate representative of an activity or property of said preselected,non-toxic therapeutic agent, and ]	[ (a) generating a set of data sets relating to at least one physiological property; ]
0.99999225	21	[ the plurality of therapeutic agent candidates are correlated to one another based at least in part on one or more properties of said preselected,non-toxic therapeutic agent; and ]	[ (b) generating a plurality of therapeutic agent candidates, each candidate comprising at least one of a preselected, non-toxic therapeutic agent that is preselected and at least one candidate representative of an activity or property of said preselected,non-toxic therapeutic agent, and ]
0.99999225	22	[ (c) generating data correlated to said data sets in accordance with data relating to the values of selected a physiological property for said at least one candidate representative of the activity or property of said preselected,non-toxic therapeutic agent. ]	[ the plurality of therapeutic agent candidates are correlated to one another based at least in part on one or more properties of said preselected,non-toxic therapeutic agent; and ]
0.997262	23	[ a housing; ]	[ A gaming implement comprising: ]
0.99947816	24	[ a main body pivotable in a rotational state about a central axis with respect to the housing, the main body comprising: ]	[ a housing; ]
0.9999876	25	[ a first end adapted to and vertically anchor the main body onto a table; ]	[ a main body pivotable in a rotational state about a central axis with respect to the housing, the main body comprising: ]
0.9999924	26	[ a second end adapted to and horizontally anchor the main body onto a wall; ]	[ a first end adapted to and vertically anchor the main body onto a table; ]
0.9972613	27	[ a rotatable shaft pivotable between a vertical positioning position and a horizontal positioning position, the rotatable shaft comprising: ]	[ a second end adapted to and horizontally anchor the main body onto a wall; ]
0.99351007	28	[ a first aperture extending from the central axis; ]	[ a rotatable shaft pivotable between a vertical positioning position and a horizontal positioning position, the rotatable shaft comprising: ]
0.9999887	29	[ a second aperture at an end of the first aperture; and ]	[ a first aperture extending from the central axis; ]
0.9999651	30	[ a third aperture adapted to be radially engaged with a body of the table and radially extended from the central axis or horizontally disposed away from the central axis with respect to the main body; ]	[ a second aperture at an end of the first aperture; and ]
0.99980766	31	[ a rotary control member that changes an amount of rotation relative to the main body of the main body, the control member including: ]	[ a third aperture adapted to be radially engaged with a body of the table and radially extended from the central axis or horizontally disposed away from the central axis with respect to the main body; ]
0.9994661	32	[ a first rotatable control signal control member that is fixedly mounted along the second aperture; and ]	[ a rotary control member that changes an amount of rotation relative to the main body of the main body, the control member including: ]
0.99999225	33	[ a second rotatable control signal control member that is movable from the first rotatable control signal control member to the second rotatable control signal control member; ]	[ a first rotatable control signal control member that is fixedly mounted along the second aperture; and ]
0.0018501705	34	[ wherein the second rotation of the shaft is adjustable to approximately two rotation increments from the first rotation. ]	[ a second rotatable control signal control member that is movable from the first rotatable control signal control member to the second rotatable control signal control member; ]
0.9996786	35	[ a first implantation medical system comprising at least one first implantation unit for delivering an instrument to an individual; ]	[ A system for delivering a treatment to a particular subject comprising: ]
0.99999225	36	[ at least one second implantation medical system configured to be associated with one or both of the first and second implantation units at a particular location on at least one individual to be treated; and ]	[ a first implantation medical system comprising at least one first implantation unit for delivering an instrument to an individual; ]
0.99999225	37	[ a computing device coupled at least in part to one or both of the first and second implantation medical systems for executing computations to derive real-time medical status data of each a first and a second implantation unit wherein execution of the computations results in the delivery of the first and second implantation units at the particular subject. ]	[ at least one second implantation medical system configured to be associated with one or both of the first and second implantation units at a particular location on at least one individual to be treated; and ]
0.9999918	38	[ comparing a medical image obtained based on electrocardiograms (ECG) with an electroclinical image of the site to determine a difference between the electroclinical image and the medical image; ]	[ A method for acquiring and communicating an electroclinical image of a site of a tumor, the method comprising the steps of: ]
0.99999094	39	[ determining an anatomical position of a tumor based on a location of the medical image in at least one location on a patient hand of the patient; ]	[ comparing a medical image obtained based on electrocardiograms (ECG) with an electroclinical image of the site to determine a difference between the electroclinical image and the medical image; ]
0.9999919	40	[ contacting a sensing device configured to apply an electrical signals to the tumor associated with the anatomical position; ]	[ determining an anatomical position of a tumor based on a location of the medical image in at least one location on a patient hand of the patient; ]
0.999757	41	[ delivering an electrical load to at least one electrode for electric stimulation; and ]	[ contacting a sensing device configured to apply an electrical signals to the tumor associated with the anatomical position; ]
0.99999213	42	[ selecting a portion corresponding to an selected location from the at least one electrode based on an output of the at least one electrode when the anatomical position of the tumor during a time interval between ECG and electrical stimulation is at least 50% different from the anatomical position during a time interval before the electrical stimulation and the electrical load is applied to the tumor in the tumor at an electric threshold, wherein an excitation potential is set at a threshold in a region not substantially adjacent to the selected location. ]	[ delivering an electrical load to at least one electrode for electric stimulation; and ]
0.99868125	43	[ one or two peptides of pyridoyl-L-terminal glycolysine phosphatase-15 (PT2), ]	[ A method for treating coronary heart disease comprising administering to an individual a compound selected from the group consisting of the following: ]
0.9999924	44	[ one or two peptides comprising one or more peptides of pyridozolylglycolysine phosphatase-A (PTB), ]	[ one or two peptides of pyridoyl-L-terminal glycolysine phosphatase-15 (PT2), ]
0.99999106	45	[ one or more peptides comprising the amino acid sequence of serotonergic transporter, and ]	[ one or two peptides comprising one or more peptides of pyridozolylglycolysine phosphatase-A (PTB), ]
0.99999225	46	[ one or more peptides comprising the amino acid sequence of a ligand for a serotonergic receptor. ]	[ one or more peptides comprising the amino acid sequence of serotonergic transporter, and ]
0.99999046	47	[ wherein said seed contains a lignin content of 8 to 29% by weight of the carrier, ]	[ A seed of the family Crop Vercaceae, including thresamates, mixtures one or more of the seed and the carrier, and ]
0.99999213	48	[ said seed having a seed protein amount of 5.1 to 7.6% by weight of the carrier, ]	[ wherein said seed contains a lignin content of 8 to 29% by weight of the carrier, ]
0.99996877	49	[ all of a seed in the seed collection in such a quantity that all seeds in the collection are to be harvested under identical conditions. ]	[ said seed having a seed protein amount of 5.1 to 7.6% by weight of the carrier, ]
0.99994636	50	[ a fragrance, the composition comprising one or more lip thickening agents, an active substance on the surface of the component, or a blend of both; wherein the component optionally contains an active substance which when attached to the component induces a lactic acid discharge resulting in a skin irritation condition when applied to the component. ]	[ A non-toxic skin care composition with a number of components selected from the group consisting of a water-soluble lubricant, a natural butter oil, a lip balm, a fragrance, a hair oil, and ]
0.9962585	51	[ a base member; ]	[ A golf club head comprising: ]
0.99999094	52	[ a sole member included within the base member, wherein: ]	[ a base member; ]
0.99999154	53	[ the sole member is slidably coupled to the base member and is a non-ovally-shaped body; ]	[ a sole member included within the base member, wherein: ]
0.9999913	54	[ the sole member and base member including a plurality of sidewalls formed between a central region and a periphery thereof; ]	[ the sole member is slidably coupled to the base member and is a non-ovally-shaped body; ]
0.99999225	55	[ the center region of each of the sidewalls is sized to substantially overlap the central region of the sole member and is within an interiorly circumferential region of the top edge of the center region relative to the bottom of the sole member; and ]	[ the sole member and base member including a plurality of sidewalls formed between a central region and a periphery thereof; ]
0.99999225	56	[ wherein the top edge of the central region of each side of each of the sidewalls is generally larger than the bottom of the sole member and greater than the bottom side of the sole member. ]	[ the center region of each of the sidewalls is sized to substantially overlap the central region of the sole member and is within an interiorly circumferential region of the top edge of the center region relative to the bottom of the sole member; and ]
0.99534035	57	[ (a) obtaining, for an individual, a clinical diagnosis of the individual from an imaging medical instrument and an external system, wherein the imaging instrument comprises a scanning section in the tissue of the individual and an image acquiring section in the image acquiring section to obtain a plurality of diagnostic imaging images, wherein the image acquiring section includes an adjustable portion sized and configured that can be extended to any position for scanning the imaging section, comprising a plurality of detecting region position sensors configured to sense each of a plurality of different regions in the imaging section and a plurality of target region position sensors configured to sense the locations of the detection region and the target region; ]	[ A method for identifying and selecting a vaccine suitable for use in a mammal, comprising: ]
0.9999924	58	[ (b) receiving a diagnosis of the individual from the imaging medical instrument and the external system; ]	[ (a) obtaining, for an individual, a clinical diagnosis of the individual from an imaging medical instrument and an external system, wherein the imaging instrument comprises a scanning section in the tissue of the individual and an image acquiring section in the image acquiring section to obtain a plurality of diagnostic imaging images, wherein the image acquiring section includes an adjustable portion sized and configured that can be extended to any position for scanning the imaging section, comprising a plurality of detecting region position sensors configured to sense each of a plurality of different regions in the imaging section and a plurality of target region position sensors configured to sense the locations of the detection region and the target region; ]
0.99998605	59	[ (c) comparing the diagnostic imaging images for the diagnosis to at least one other diagnostic image; ]	[ (b) receiving a diagnosis of the individual from the imaging medical instrument and the external system; ]
0.9999924	60	[ (d) assigning a predicted likelihood value to the diagnostic imaging images for the diagnosis based on a classification on at least one criterion for classification of the diagnostic imaging images by a selected classifier for the classification of the diagnostic imaging images; and ]	[ (c) comparing the diagnostic imaging images for the diagnosis to at least one other diagnostic image; ]
0.99998903	61	[ (e) selecting, based on the predicted likelihood value, a vaccine having sufficient predictability to eliminate substantial risk of transmission of infectious disease (IDD) and/or disease symptoms or associated other pathological parameters through the target region to the animal or other species of the individual. ]	[ (d) assigning a predicted likelihood value to the diagnostic imaging images for the diagnosis based on a classification on at least one criterion for classification of the diagnostic imaging images by a selected classifier for the classification of the diagnostic imaging images; and ]
0.99999034	62	[ associating the endpoints with one another and comprising the following steps: ]	[ A method for determining the spatial position of two endpoints of an apparatus, the method comprising: ]
0.9999882	63	[ locating a first endpoint and a second endpoint on a first plane, respectively, and ]	[ associating the endpoints with one another and comprising the following steps: ]
0.9999881	64	[ positioning each to receive an apparatus positioned on the first plane; ]	[ locating a first endpoint and a second endpoint on a first plane, respectively, and ]
0.9999913	65	[ detecting whether the respective apparatus can be moved in a direction perpendicular to the first plane as desired; ]	[ positioning each to receive an apparatus positioned on the first plane; ]
0.99997556	66	[ determining a position of the apparatus; and ]	[ detecting whether the respective apparatus can be moved in a direction perpendicular to the first plane as desired; ]
0.99979323	67	[ adjusting a position of two other endpoints; ]	[ determining a position of the apparatus; and ]
0.99997556	68	[ determining whether the apparatus moves in the direction specified after contacting a first endpoint with a detector based on the position of a second platform disposed over the apparatus, ]	[ adjusting a position of two other endpoints; ]
0.009655633	69	[ wherein each subsequent step may be performed by at least two different machines. ]	[ determining whether the apparatus moves in the direction specified after contacting a first endpoint with a detector based on the position of a second platform disposed over the apparatus, ]
0.99996257	70	[ a handle for each individual hand of the apparatus, ]	[ An open-hand training apparatus, comprising: ]
0.9993749	71	[ a base portion configured to be slidably supported near the handle, ]	[ a handle for each individual hand of the apparatus, ]
0.9876423	72	[ a plurality of rings and a plurality of straps provided at first such that the hand being trained through each of the rings falls to the ground beneath the rings, and ]	[ a base portion configured to be slidably supported near the handle, ]
0.99999094	73	[ a rotatable surface provided around a lower portion of each of the rings, ]	[ a plurality of rings and a plurality of straps provided at first such that the hand being trained through each of the rings falls to the ground beneath the rings, and ]
0.99999046	74	[ wherein the individual hand being trained is further configured to be inserted into the rotatable surface of one of the rings and at least one of the straps of the respective one of the rings. ]	[ a rotatable surface provided around a lower portion of each of the rings, ]
0.014015006	75	[ the method comprising: ]	[ A method for providing a patient with an environment characterized by a plurality of personal objects within the patient, in which the personal objects extend from a first to a second surface, the plurality of personal objects including at least one of a front body and a back body, a front and back side; ]
0.066358216	76	[ moving a central device located between the first and second surfaces from a first position configured to receive a patient for use as a patient being, using a plurality of portable devices arranged in at least one of said front and back surface regions, toward a second position of receiving the patient and in the first position wherein the central device is provided with a plurality of means for controlling a dynamic flow of flow. ]	[ the method comprising: ]
0.9986307	77	[ providing a combination of sodium nitrosopurine and potassium nitrosopurine. ]	[ A method for treating a pulmonary embolism in a patient or an embolic fluid with an alkaline nitro acid or an acid of natural gas comprising: ]
0.9999919	78	[ a) the process of contacting a compound with the signaling pathway; and ]	[ A method of evaluating the ability of a compound to affect a signaling pathway which comprises: ]
0.999992	79	[ b) a determination of whether a response is consistent with the reaction between the compound and at least one analyte, the analyte being capable of binding to one or more specific sites of the signaling pathway. ]	[ a) the process of contacting a compound with the signaling pathway; and ]
0.99999213	80	[ wherein the composition is a solid formulation having a range of water solubility, i.e., n of the total molar weight of the peptide-protein conjugate, p of the total molar weight of the peptide-protein conjugate, 10 of the total molar weight of the peptide-protein conjugate, and ]	[ A composition comprising a peptide-protein conjugate having the following configuration: ]
0.9999908	81	[ m of the total molar weight of the formulation having a water solubility of less than about 9 wt. % by weight. ]	[ wherein the composition is a solid formulation having a range of water solubility, i.e., n of the total molar weight of the peptide-protein conjugate, p of the total molar weight of the peptide-protein conjugate, 10 of the total molar weight of the peptide-protein conjugate, and ]
0.9999901	82	[ determining at least one clinical biomarker for a substance to be identified in the subject; ]	[ A method of identifying a subject that may receive a treatment or is exposed to a substance having an elevated potential for causing metabolic disease in an individual, the method comprising: ]
0.9999882	83	[ identifying a candidate subject that is at a risk of developing metabolic disease under conditions of at least one of exposure to the substance, metabolic disease of the substance, or both exposure and metabolic disease; and ]	[ determining at least one clinical biomarker for a substance to be identified in the subject; ]
0.9999924	84	[ identifying, at the treatment site and at the site of the suspected metabolism, a first compound selected from the compound database and combinations thereof that can drive the activity of the agent as determined by the assay or mixture selected from the mixture databases and that can cause development of metabolic disease of the substance or metabolic disease of the substance. ]	[ identifying a candidate subject that is at a risk of developing metabolic disease under conditions of at least one of exposure to the substance, metabolic disease of the substance, or both exposure and metabolic disease; and ]
0.9999858	85	[ said pair of legs each having a supporting body component disposed therein provided thereon with at least one pair of elongated metal grooves extending longitudinal and substantially parallel to said connecting section; ]	[ A pair of legs comprising: ]
0.99999034	86	[ said pair of legs comprising: ]	[ said pair of legs each having a supporting body component disposed therein provided thereon with at least one pair of elongated metal grooves extending longitudinal and substantially parallel to said connecting section; ]
0.0023398197	87	[ at least one first elongated metal groove comprising, ]	[ said pair of legs comprising: ]
0.9996264	88	[ a first metal wire extending therethrough; ]	[ at least one first elongated metal groove comprising, ]
0.9999881	89	[ at least one second elongated metal groove comprising, <|span|>A first elongated metal wire extending between said first groove and said connecting section when said connecting section has not been attached to said at least one pair of grooves; and ]	[ a first metal wire extending therethrough; ]
0.99999225	90	[ a second metal wire extending between said first groove and said connecting section when said connecting section is attached there thereto. ]	[ at least one second elongated metal groove comprising, <|span|>A first elongated metal wire extending between said first groove and said connecting section when said connecting section has not been attached to said at least one pair of grooves; and ]
0.99947184	91	[ a flexible base member having a first end and a second end and a rearward portion terminating in a first foldable member, the first foldable member attached to the flexibly base member; ]	[ A bag comprising: ]
0.99999225	92	[ a flexible strap adapted to attach to the first foldable member, the flexible strap having at least one flexible fabric material threaded through the at least one flexible fabric material whereupon the flexible strap is stretched out to the length of the flexible base member and, on bending towards the rearward portion, is fixed within the flexibly base member, the second foldable member extended away from the flexibly base member, the second foldable member providing a locking device adapted to the locking device for unlocking the flexible strap, thereby the bag is locked into a closed shape; and ]	[ a flexible base member having a first end and a second end and a rearward portion terminating in a first foldable member, the first foldable member attached to the flexibly base member; ]
0.99999225	93	[ a sleeve, pivotally attached to the distal end of the flexibly base member at a first end, the sleeve extending outside the first foldable member and through the distal end of the first foldable member, the strap, generally lying inside the distal end of the flexibly base member, ]	[ a flexible strap adapted to attach to the first foldable member, the flexible strap having at least one flexible fabric material threaded through the at least one flexible fabric material whereupon the flexible strap is stretched out to the length of the flexible base member and, on bending towards the rearward portion, is fixed within the flexibly base member, the second foldable member extended away from the flexibly base member, the second foldable member providing a locking device adapted to the locking device for unlocking the flexible strap, thereby the bag is locked into a closed shape; and ]
0.9999913	94	[ wherein at least one of the first and second foldable members has a folded position and a unfolded position. ]	[ a sleeve, pivotally attached to the distal end of the flexibly base member at a first end, the sleeve extending outside the first foldable member and through the distal end of the first foldable member, the strap, generally lying inside the distal end of the flexibly base member, ]
0.99727964	95	[ applying a solubilizer to a liquid mixture and a mixture of compounds in which about 2%, about 44% and about 72% by weight of the mixture of compounds is a water-soluble form; ]	[ A method for generating a liquid composition by using aqueous composition, comprising the steps of: ]
0.9999906	96	[ compressing the liquid mixture; ]	[ applying a solubilizer to a liquid mixture and a mixture of compounds in which about 2%, about 44% and about 72% by weight of the mixture of compounds is a water-soluble form; ]
0.9999074	97	[ compressing the solubilizer to obtain a mixture of heavy, light and medium solubilizers having the following properties: ]	[ compressing the liquid mixture; ]
0.99999225	98	[ heavy the solubilizer has an approximate amount of water of about 0.5, ]	[ compressing the solubilizer to obtain a mixture of heavy, light and medium solubilizers having the following properties: ]
0.99999225	99	[ medium the solubilizer has about 0.077 mole % of that concentration of natural gas per mole % of the solvent; and ]	[ heavy the solubilizer has an approximate amount of water of about 0.5, ]
0.99999225	100	[ light the solubilizer has approximately 5 mole % of that concentration of natural gas per mole % of the solvent, as measured using the modified method having fewer weight units and using a formula of 6.29 mole % water per mole % and containing hydrogen, oxygen and oxygen atoms; and ]	[ medium the solubilizer has about 0.077 mole % of that concentration of natural gas per mole % of the solvent; and ]
0.99999225	101	[ selecting light and heavy solubilizers based on the weight units and for obtaining a solution of water and solubilizer for use in applications to which water is soluble. ]	[ light the solubilizer has approximately 5 mole % of that concentration of natural gas per mole % of the solvent, as measured using the modified method having fewer weight units and using a formula of 6.29 mole % water per mole % and containing hydrogen, oxygen and oxygen atoms; and ]
0.999835	102	[ tracking positions of a first individual and a second individual according to an estimate of a patient's anatomy, and ]	[ A method of providing guidance to a patient during a treatment session, comprising: ]
0.99999225	103	[ correlating said estimates of said first and second individuals with an estimated position of a medication administration position in a patient's drug database; ]	[ tracking positions of a first individual and a second individual according to an estimate of a patient's anatomy, and ]
0.9999647	104	[ in response to a request at a control server from said control server to acquire a medication order of a medication, based on a list of first, second, and ]	[ correlating said estimates of said first and second individuals with an estimated position of a medication administration position in a patient's drug database; ]
0.999992	105	[ third medications specified in the medication order, determining, during a database table acquisition operation in response to a control server request, by at least one processor, the availability of first medications and second medications for said first individual at the medication delivery position determined by the estimate of the patient's anatomy; ]	[ in response to a request at a control server from said control server to acquire a medication order of a medication, based on a list of first, second, and ]
0.9999924	106	[ adding to, or removing from, the medication delivery position said second individuals; ]	[ third medications specified in the medication order, determining, during a database table acquisition operation in response to a control server request, by at least one processor, the availability of first medications and second medications for said first individual at the medication delivery position determined by the estimate of the patient's anatomy; ]
0.99999225	107	[ searching said drug database for a second individual with a position corresponding to the medication delivery position determined by the estimator of the patient's anatomy as to determine whether said second individual is available; wherein said searching further comprises comparing said estimator of the patient's anatomy to the estimated position at the medication delivery position determined by said estimate of said patient's anatomy, which, when added or removed, determines an availability of a second individual for said second individual; and ]	[ adding to, or removing from, the medication delivery position said second individuals; ]
0.9999924	108	[ granting permission to select another drug for said second individual if another medication is available for the first individual. ]	[ searching said drug database for a second individual with a position corresponding to the medication delivery position determined by the estimator of the patient's anatomy as to determine whether said second individual is available; wherein said searching further comprises comparing said estimator of the patient's anatomy to the estimated position at the medication delivery position determined by said estimate of said patient's anatomy, which, when added or removed, determines an availability of a second individual for said second individual; and ]
0.9972512	109	[ a first support structure; and ]	[ An assembly for collecting debris, the assembly consisting essentially of: ]
0.99997723	110	[ a second support structure positioned adjacent to said first support structure and used to support a receptacle for debris collected by said receptacle, ]	[ a first support structure; and ]
0.9999893	111	[ wherein each of said first and second support structures comprises an anchor being rotatable about an axis when disposed at an upper end thereof such that said lower end of said first support structure and said upper end thereof pivot substantially all of their axis away from the axis of the anchor and such and such. ]	[ a second support structure positioned adjacent to said first support structure and used to support a receptacle for debris collected by said receptacle, ]
0.9954334	112	[ a) an anode for emitting light into a body, the light emitted through an anode comprising a first material; ]	[ An optical system for measuring a body shape, the optical system comprising: ]
0.9999205	113	[ b) a cornea with an anode material; ]	[ a) an anode for emitting light into a body, the light emitted through an anode comprising a first material; ]
0.99999154	114	[ c) an implant for providing the anode with an optical surface for the anode material; and ]	[ b) a cornea with an anode material; ]
0.99993706	115	[ the implant comprises circuitry for: ]	[ c) an implant for providing the anode with an optical surface for the anode material; and ]
2.850247e-05	116	[ 1) detecting when an image of a shape of the anhydric acid is formed in the body with the anode, and ]	[ the implant comprises circuitry for: ]
0.9998248	117	[ 2) outputting a signal generated by the detection to be the image; and ]	[ 1) detecting when an image of a shape of the anhydric acid is formed in the body with the anode, and ]
0.013984676	118	[ 3) measuring the anhydric acid in the body with the optical system. ]	[ 2) outputting a signal generated by the detection to be the image; and ]
0.9999913	119	[ a generally plane-shaped cutting rod having a first end for engaging the cutting implement; ]	[ A tool for guiding the cutting edge of a cutting implement, comprising: ]
0.9999906	120	[ a plurality of first guides attached to and extending along the cutting handle and each end of the rod, wherein the guide has a first dimension with respect to a plane to permit the rod to be directed from a lower plane to a top plane by sliding into the guide and removing the guide from the cutting implement and retaining the first guide; ]	[ a generally plane-shaped cutting rod having a first end for engaging the cutting implement; ]
0.999992	121	[ a second guide provided at and extending along the cutting handle and having a second dimension that is larger than the first dimension; ]	[ a plurality of first guides attached to and extending along the cutting handle and each end of the rod, wherein the guide has a first dimension with respect to a plane to permit the rod to be directed from a lower plane to a top plane by sliding into the guide and removing the guide from the cutting implement and retaining the first guide; ]
0.99999213	122	[ a third guide extending proximally from the cutting rod to the cutting handle; and ]	[ a second guide provided at and extending along the cutting handle and having a second dimension that is larger than the first dimension; ]
0.9999697	123	[ a base wire that is secured to the cutting handle; ]	[ a third guide extending proximally from the cutting rod to the cutting handle; and ]
0.9999646	124	[ wherein the guide is adapted to be inserted into each of an inwardly extending portion of the cutting handle when the cutting rod is slid by the second guide and extending axially forward for extending through an axis through which the rod is to be steered, and ]	[ a base wire that is secured to the cutting handle; ]
0.99995196	125	[ wherein the first and third guides are electrically parallel and are cooperably releasably connected. ]	[ wherein the guide is adapted to be inserted into each of an inwardly extending portion of the cutting handle when the cutting rod is slid by the second guide and extending axially forward for extending through an axis through which the rod is to be steered, and ]
0.0005745586	126	[ transmitting signals including an antenna to a patient; ]	[ A method of detecting an oral infection comprising: ]
0.99998	127	[ processing the signals to detect an activity level in the patient; ]	[ transmitting signals including an antenna to a patient; ]
0.999992	128	[ calculating the activity level based on sensing at least two distinct signals included in the signals transmitted through sensors each other, such that (i) the calculated activity level depends on the distinct signals and (ii) the detected activity level is greater than a threshold activity level on the basis of detecting at least the two distinct signals, and ]	[ processing the signals to detect an activity level in the patient; ]
0.99999213	129	[ determining if the determined activity level is above the threshold for a disease that causes an event. ]	[ calculating the activity level based on sensing at least two distinct signals included in the signals transmitted through sensors each other, such that (i) the calculated activity level depends on the distinct signals and (ii) the detected activity level is greater than a threshold activity level on the basis of detecting at least the two distinct signals, and ]
0.009471307	130	[ a) a body and an end supporting member comprising a first surface, a second surface, and ]	[ A hair dryer comprising: ]
0.99994934	131	[ a middle surface, wherein the first and second surfaces are joined together to form an adjustable length through which a length of hair can be received; ]	[ a) a body and an end supporting member comprising a first surface, a second surface, and ]
0.0004426999	132	[ b) a tubular receptacle; ]	[ a middle surface, wherein the first and second surfaces are joined together to form an adjustable length through which a length of hair can be received; ]
0.9999902	133	[ c) an active surface arranged to receive the tubular receptacle and the active surface configured to provide a plurality of areas of access to tubular materials; ]	[ b) a tubular receptacle; ]
0.99956423	134	[ d) at least one retaining member; ]	[ c) an active surface arranged to receive the tubular receptacle and the active surface configured to provide a plurality of areas of access to tubular materials; ]
0.99980706	135	[ e) a plurality of tabs interposed between the body and the tubular receptacle and arranged to retain the body and the tubular receptacle when the holding member is located proximal to the middle surface opposite to the first surface where the end of the tubular receptacle is positioned; ]	[ d) at least one retaining member; ]
0.9999902	136	[ f) wherein the holding member comprises at least two sealing members and a holding portion which moves relative to the body while the body is being adjusted to the second side. ]	[ e) a plurality of tabs interposed between the body and the tubular receptacle and arranged to retain the body and the tubular receptacle when the holding member is located proximal to the middle surface opposite to the first surface where the end of the tubular receptacle is positioned; ]
0.999992	137	[ a top surface and a bottom surface extending a distance between the top surface and the first member and the adapter, the piece comprising a first curved member and an elongated member having a hollow portion therethrough, the adapter including a mounting plate including three curved projections and a slot, the mountable outer sleeve having opposed ends, each projecting inwardly, the bottom surface of each projection extending through the slot as well as being at least partially perpendicular to the bottom surface via the mounting plate of the adapter, wherein the adapter includes a first fastener including a first coupling member and a connection member. ]	[ A planar sleeve assembly with a planar inner sleeve disposed on a first material and a first planar outer sleeve, the outer sleeve including a first member and a slot at one end of the inner sleeve, the sleeve assembly comprising an opening, an adapter fitted in the opening, and ]
0.99995303	138	[ culturing the tumor cell in a high pressure fluid environment comprising a plurality of fluid paths; ]	[ A method for the extraction of tumor cancer cell growth factors from polypeptides extracted from a tumor cell, the method comprising: ]
0.99998677	139	[ contacting the tumor cell with a growth factor extraction solution containing a selected plurality of growth factors to obtain the growth factor extracted from the tumor cell; and ]	[ culturing the tumor cell in a high pressure fluid environment comprising a plurality of fluid paths; ]
0.99999213	140	[ separating the cancer cell from the extracted growth factor to obtain a selected tumor cell with a tumor cell growthfactor specific removal amount. ]	[ contacting the tumor cell with a growth factor extraction solution containing a selected plurality of growth factors to obtain the growth factor extracted from the tumor cell; and ]
0.99999213	141	[ determining three or more histological levels of an organ or tissue; ]	[ A method for establishing a level of an organ or tissue comprising: ]
0.9999924	142	[ measuring one or more histological levels of the organ or tissue; ]	[ determining three or more histological levels of an organ or tissue; ]
0.99984145	143	[ determining an intensity of blood flow on a percutaneous or surgical path; ]	[ measuring one or more histological levels of the organ or tissue; ]
0.999992	144	[ if the intensity of blood flow is less than the three or more histological levels of the organ or tissue, selecting a one of the three or more histological levels of the organ or tissue with an intensity difference ratio of at least 5: ]	[ determining an intensity of blood flow on a percutaneous or surgical path; ]
0.99999213	145	[ 1 within one hour of determining the intensity of blood flow; and ]	[ if the intensity of blood flow is less than the three or more histological levels of the organ or tissue, selecting a one of the three or more histological levels of the organ or tissue with an intensity difference ratio of at least 5: ]
0.9999919	146	[ if the intensity of blood flow is greater than the three or more histological levels of the organ or tissue, initiating a surgical procedure. ]	[ 1 within one hour of determining the intensity of blood flow; and ]
0.99997294	147	[ a walkinger that is adapted to move from a first position to a second position, the first position comprising a first and a second foot positions, such that the robot is moved horizontally in the first foot position toward a first foot of a wearer of the robot; ]	[ A robot, comprising: ]
0.99998593	148	[ a driving device adjacent to the first foot position; ]	[ a walkinger that is adapted to move from a first position to a second position, the first position comprising a first and a second foot positions, such that the robot is moved horizontally in the first foot position toward a first foot of a wearer of the robot; ]
0.9996928	149	[ a drive driver movably mounted within the walkinger; ]	[ a driving device adjacent to the first foot position; ]
0.99985147	150	[ a first wheel mounted on the driving device; ]	[ a drive driver movably mounted within the walkinger; ]
0.9999876	151	[ a second wheel mounted on the second wheel; and ]	[ a first wheel mounted on the driving device; ]
0.9999646	152	[ a speed knob positioned adjacent to the first wheel, whereby a movement of the speed knob can be manipulated to cause the walkinger to: ]	[ a second wheel mounted on the second wheel; and ]
0.9999919	153	[ (a) move from a first of a first and second of the first and second foot positions, using the first position to move past the first foot position in time to turn off the speed knob; and ]	[ a speed knob positioned adjacent to the first wheel, whereby a movement of the speed knob can be manipulated to cause the walkinger to: ]
0.99999225	154	[ (b) move from a second of the first and second of the first and second foot positions to a third of the first and second foot positions. ]	[ (a) move from a first of a first and second of the first and second foot positions, using the first position to move past the first foot position in time to turn off the speed knob; and ]
0.9975647	155	[ a first communication channel and a second communication channel; ]	[ An apparatus for controlling a virtual game service, comprising: ]
0.99999106	156	[ a selection rule configured to determine whether to allow a first user to select a movement in front of a third party user in the first communication channel; and ]	[ a first communication channel and a second communication channel; ]
0.9999906	157	[ a first movement rule specifying that the thirdparty user will be in a position where information of one or more games of interest being played can be changed by the first user; ]	[ a selection rule configured to determine whether to allow a first user to select a movement in front of a third party user in the first communication channel; and ]
0.99999225	158	[ an update function configured to update a time of a change made to the data of one or more games of interest to a predetermined time of an event that is not associated with the first user so as to allow the thirdparty user to select the movement and to have the movement have occurred in time; ]	[ a first movement rule specifying that the thirdparty user will be in a position where information of one or more games of interest being played can be changed by the first user; ]
0.9999893	159	[ wherein the step of the selection rule determines whether the timing of the movement is a constant, the selection is controlled, the operation of the selection rule and the update function is executed by a virtual machine, the first communication channel and the second communication channel are disconnected from each other, and ]	[ an update function configured to update a time of a change made to the data of one or more games of interest to a predetermined time of an event that is not associated with the first user so as to allow the thirdparty user to select the movement and to have the movement have occurred in time; ]
0.99999213	160	[ the selection rules cause the virtual machine to indicate whether the plurality of games of interest of the selection is available or not by way of the first movement rule and the update function. ]	[ wherein the step of the selection rule determines whether the timing of the movement is a constant, the selection is controlled, the operation of the selection rule and the update function is executed by a virtual machine, the first communication channel and the second communication channel are disconnected from each other, and ]
0.99406356	161	[ an objective lens, wherein the objective lens comprises a semiconductor lens and an electrical substrate layer, and ]	[ An endoscope or microscope for applying a transgenic microscope comprising: ]
0.9999876	162	[ wherein the electronic substrate layer is selected from the group consisting of silicon, silicon with a metal, zinc and bayer semiconductor material, and ]	[ an objective lens, wherein the objective lens comprises a semiconductor lens and an electrical substrate layer, and ]
0.9998977	163	[ wherein at least part of the substrate layer has a positive voltage impedance connected to a positive energy source; and ]	[ wherein the electronic substrate layer is selected from the group consisting of silicon, silicon with a metal, zinc and bayer semiconductor material, and ]
0.9998908	164	[ an optical lens, wherein the optical lens comprises a planar lens lens disposed between the objective lens and the electronic substrate layer. ]	[ wherein at least part of the substrate layer has a positive voltage impedance connected to a positive energy source; and ]
0.9998952	165	[ (i) delivering a continuous infusion pulse, comprising at least one arterial wave, to a patient; ]	[ An implantable cardiac resuscitation method for treating blood vessel obstruction, comprising the steps of: ]
0.9999914	166	[ (ii) directing a sequence of continuous intracardiac pulses to the patient; ]	[ (i) delivering a continuous infusion pulse, comprising at least one arterial wave, to a patient; ]
0.9999682	167	[ (iii) gradually increasing a first pulse pressure within a first chamber of the heart until the first pulse pressure reaches an atmosuppressible threshold pressure whereby a ventricular pulse is less than a first cardiac pulse and a myocardial pulse is greater than a second one of the first two cardiac pulses; and ]	[ (ii) directing a sequence of continuous intracardiac pulses to the patient; ]
0.99999225	168	[ (iv) gradually decreasing a second pulse pressure within the first chamber to a ventricular pulse lower then the first atmosuppressible threshold pressure. ]	[ (iii) gradually increasing a first pulse pressure within a first chamber of the heart until the first pulse pressure reaches an atmosuppressible threshold pressure whereby a ventricular pulse is less than a first cardiac pulse and a myocardial pulse is greater than a second one of the first two cardiac pulses; and ]
0.02731157	169	[ a shaft; ]	[ A catheter assembly comprising: ]
0.99991417	170	[ a shaft sleeve; and ]	[ a shaft; ]
0.3820845	171	[ a head assembly, each part of said head assembly being an elongate rod including a proximal end and a distal end, said distal end includes at least one needle having an anvil shaped part adapted to rotate about a longitudinal axis of said first end; ]	[ a shaft sleeve; and ]
0.99999213	172	[ further comprising an intermingling of a shaft and a tailpiece on at least a portion of said shaft, said head assembly being sized so that when said head assembly is removed from a catheter, said shaft sleeve engages said at least one needle; and ]	[ a head assembly, each part of said head assembly being an elongate rod including a proximal end and a distal end, said distal end includes at least one needle having an anvil shaped part adapted to rotate about a longitudinal axis of said first end; ]
0.99999225	173	[ wherein said helical structure of said shaft engages at least a portion of said tailpiece to enable rotation of said helical structure of said shaft said helical structure defining a shaft member in and out of contact with said helical structure between the at least one needle to rotate about a longitudinal axis of the shaft. ]	[ further comprising an intermingling of a shaft and a tailpiece on at least a portion of said shaft, said head assembly being sized so that when said head assembly is removed from a catheter, said shaft sleeve engages said at least one needle; and ]
0.9923382	174	[ providing a first support pole having first and second ends that are connected at first and second ends; ]	[ A method for enabling a human to walk on a surface comprising: ]
0.9999924	175	[ providing a second support pole having first and second ends that are connected at first and second ends; ]	[ providing a first support pole having first and second ends that are connected at first and second ends; ]
0.999992	176	[ positioning a first weight, intermediate between the first and second support poles, towards the first end of the first support pole and a second weight intermediate between the first support pole and the second support pole; ]	[ providing a second support pole having first and second ends that are connected at first and second ends; ]
0.99999225	177	[ providing a second weight, intermediate between the second and first weights, towards the second end of the second support pole and a plurality of weights, the plurality of weights arranged vertically and each including an upper portion over a lower portion and a lower shoulder from which side they are separated, being separated by a gap that extends between the upper and lower portions of the weights in the vertical members of the plurality of weights, the lower shoulder being spaced apart a distance that is greater than the distance for a human foot. ]	[ positioning a first weight, intermediate between the first and second support poles, towards the first end of the first support pole and a second weight intermediate between the first support pole and the second support pole; ]
0.9201715	178	[ a structure comprising an upper material and a plurality of lower portions; and ]	[ A flexible polymer fabric, comprising: ]
0.0010142719	179	[ a layer comprising an ink-extraction polymer and an absorbent element having a porous, thermoplastic core, wherein the ink-extraction polymer comprises the following materials selected from the group consisting of polyvinylpyrrolidone, a poly(vinylpyrrolidone tridacene), and ]	[ a structure comprising an upper material and a plurality of lower portions; and ]
0.999479	180	[ polyvinyl acetate. ]	[ a layer comprising an ink-extraction polymer and an absorbent element having a porous, thermoplastic core, wherein the ink-extraction polymer comprises the following materials selected from the group consisting of polyvinylpyrrolidone, a poly(vinylpyrrolidone tridacene), and ]
0.022397067	181	[ a) contacting a first article with a first liquid containing an artificial solid at a concentration greater than 5 micrograms/mL of a selected synthetic flavonizing agent, wherein the water is in amounts different than the levels in the water of the selected synthetic flavonizing agent, ]	[ A method, comprising: ]
0.99999225	182	[ b) exposing the first article to a second article that is a polymer, the polymer having at least a portion of the at least a portion of the selected synthetic flavonizing agent, ]	[ a) contacting a first article with a first liquid containing an artificial solid at a concentration greater than 5 micrograms/mL of a selected synthetic flavonizing agent, wherein the water is in amounts different than the levels in the water of the selected synthetic flavonizing agent, ]
0.99999213	183	[ c) maintaining the second article for a time sufficient to enable the polymer of the second article to be recognized by the first article at a later contact time that is later in time than when the second article was exposed to the hybrid when not exposed to the first article, ]	[ b) exposing the first article to a second article that is a polymer, the polymer having at least a portion of the at least a portion of the selected synthetic flavonizing agent, ]
0.99999225	184	[ d) drying the polymer of the second article by dissolving the polymer by one or more of freezing, pressure washing, vapor drying, and ]	[ c) maintaining the second article for a time sufficient to enable the polymer of the second article to be recognized by the first article at a later contact time that is later in time than when the second article was exposed to the hybrid when not exposed to the first article, ]
0.99999225	185	[ heat dissolving when the polymer of the second article is dried by its own decomposition, and ]	[ d) drying the polymer of the second article by dissolving the polymer by one or more of freezing, pressure washing, vapor drying, and ]
0.9999889	186	[ e) contacting the second article with a second liquid containing a second artificial solid at a concentration greater than 5 micrograms/mL of the selected synthetic flavonizing agent when the second article has at least a portion of the selected synthetic flavonizing agent. ]	[ heat dissolving when the polymer of the second article is dried by its own decomposition, and ]
0.9997025	187	[ providing a treatment vessel comprising a reservoir of anhydrous anionic esters having a reduced coefficient of refraction, wherein: ]	[ A method for reducing the amount of acetate, acetate ester, acetic acid and ethanol from liquid drinking-water comprising: ]
0.99998474	188	[ the treatment vessel is designed to contain the liquid having an average concentration of at least about 130 to about 210 mole % of alcohol and at least about 35 mole % of acetate, ]	[ providing a treatment vessel comprising a reservoir of anhydrous anionic esters having a reduced coefficient of refraction, wherein: ]
0.99998796	189	[ wherein the treated drinking-water has a content of at least about 0.5 mole % of alcohol, and ]	[ the treatment vessel is designed to contain the liquid having an average concentration of at least about 130 to about 210 mole % of alcohol and at least about 35 mole % of acetate, ]
0.9997025	190	[ wherein at least about 5 mole % of theacetate is substituted with acetic acid and a third ester wherein at least about 5 mole % of acetate is not substituted with acetic acid and at least about 5 mole % of the acetic acid is selected from the group consisting of acetate, phenyl acetate and propyl acetate; ]	[ wherein the treated drinking-water has a content of at least about 0.5 mole % of alcohol, and ]
0.99777055	191	[ the treatment vessel further comprises a reservoir of a first acid, a second acid different from the first acid, the first acid having a low concentration of acetate, and ]	[ wherein at least about 5 mole % of theacetate is substituted with acetic acid and a third ester wherein at least about 5 mole % of acetate is not substituted with acetic acid and at least about 5 mole % of the acetic acid is selected from the group consisting of acetate, phenyl acetate and propyl acetate; ]
0.99999213	192	[ the second acid having a high concentration of acetic acid. ]	[ the treatment vessel further comprises a reservoir of a first acid, a second acid different from the first acid, the first acid having a low concentration of acetate, and ]
0.99999166	193	[ a carrier for conveying said media; ]	[ A container for conveying a media having a variety of components, comprising: ]
0.99975854	194	[ said carrier having a primary support having a plurality of pivot pivotally connected to each other, wherein the primary support is secured to a bottom of a main container holding the vehicle of said container; ]	[ a carrier for conveying said media; ]
0.9999894	195	[ said carrier having inner wheels pivotally connected to an outer wheel of said carrier to generate torque; ]	[ said carrier having a primary support having a plurality of pivot pivotally connected to each other, wherein the primary support is secured to a bottom of a main container holding the vehicle of said container; ]
0.99781847	196	[ a plurality of hub rotatably connected to said primary support that rotates through a hub shaft that is supported in said housing before rotation of said belt; ]	[ said carrier having inner wheels pivotally connected to an outer wheel of said carrier to generate torque; ]
0.99998987	197	[ a plurality of spring-loaded members rotatably connected to said distal wheel of said carrier having an axis to rotate said belt; ]	[ a plurality of hub rotatably connected to said primary support that rotates through a hub shaft that is supported in said housing before rotation of said belt; ]
0.9999819	198	[ a plurality of resilient pads rotatably connectable to said outer wheel of said carrier that is pivotally connected to each other and provided with a plurality of mounting holes for mounting of said peripheral supports for the plurality of hubs; and ]	[ a plurality of spring-loaded members rotatably connected to said distal wheel of said carrier having an axis to rotate said belt; ]
0.9999902	199	[ a plurality of elastic pads; wherein said core of said belt is generally of a length greater than a weight of said plurality of plurality of inner wheels and and wherein said center of gravity of said belt is centered about said plurality of pivot pivot pivotally connected hub edges. ]	[ a plurality of resilient pads rotatably connectable to said outer wheel of said carrier that is pivotally connected to each other and provided with a plurality of mounting holes for mounting of said peripheral supports for the plurality of hubs; and ]
0.999355	200	[ a) the amino acid sequence selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, and ]	[ An oral composition comprising a peptide comprising: ]
0.99994457	201	[ SEQ ID NO: 4; and ]	[ a) the amino acid sequence selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, and ]
0.99530363	202	[ b) an amino acid sequence having at least 95% identity to the amino acid sequence selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, and ]	[ SEQ ID NO: 4; and ]
0.99990535	203	[ SEQ ID NO: 4. ]	[ b) an amino acid sequence having at least 95% identity to the amino acid sequence selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, and ]
0.9999763	204	[ a. disposing the fiber substrate within an elongate substrate having a first surface and a second face, the elongate substrate comprising a first polymer wall adapted for contacting a surface of a polymer matrix, the polymer matrix comprising a second polymer wall of the same cross-linked polymer material as the first polymer wall, wherein the first material is polymerically bonded to the second polymer wall and the second material is copolymerically bonded to the first polymer wall; ]	[ A method of manufacturing a fiber substrate, comprising: ]
0.9999908	205	[ b. introducing a fiber-forming medium into the elongate substrate within a flow of the fiber-forming medium into the polymer-matrix formation at a time and place prior to the fiber-forming medium introducing the fiber-forming medium into the polymer-matrix formation; and ]	[ a. disposing the fiber substrate within an elongate substrate having a first surface and a second face, the elongate substrate comprising a first polymer wall adapted for contacting a surface of a polymer matrix, the polymer matrix comprising a second polymer wall of the same cross-linked polymer material as the first polymer wall, wherein the first material is polymerically bonded to the second polymer wall and the second material is copolymerically bonded to the first polymer wall; ]
0.9999924	206	[ c. distancing the fiber-forming medium from the elongate substrate when the fiber-forming medium becomes exhausted, ]	[ b. introducing a fiber-forming medium into the elongate substrate within a flow of the fiber-forming medium into the polymer-matrix formation at a time and place prior to the fiber-forming medium introducing the fiber-forming medium into the polymer-matrix formation; and ]
0.9735411	207	[ wherein a portion of the material of the polymer-matrix form becomes an impurity by cross-linking itself around the portion, thereby raising the polymer-matrix material. ]	[ c. distancing the fiber-forming medium from the elongate substrate when the fiber-forming medium becomes exhausted, ]
0.1721427	208	[ analyzing a biologic function to determine a function parameter; ]	[ A method comprising: ]
0.9999919	209	[ correlating the function parameter with a physical state; and ]	[ analyzing a biologic function to determine a function parameter; ]
0.9999914	210	[ generating a function parameter value based on the analyzed biologic function. ]	[ correlating the function parameter with a physical state; and ]
0.99433184	211	[ a tray comprising a tray rim and a rear end, the tray including: ]	[ A self-applying tape dispenser, comprising: ]
0.9844275	212	[ a base with a base rim defining an open opening, the base including a hole corresponding to the open opening, the hole including a base portion disposed within the tubular inner shell and an inner wall, the base portion including a wall portion defining a convex face disposed within of the hollow interior of the inner shell, the convex face adjacent the hollow interior of the inner shell; ]	[ a tray comprising a tray rim and a rear end, the tray including: ]
0.99684346	213	[ a removable recess having a width of at least 0.3 inches and a height of up to 24 inches and configured to receive one or more elongate inner tubular arms, the recess further having at least one channel defined over the width of the recess, the channel having a width longer than the thickness of the recess and configured to move generally up and down on the recess, the channel in a longitudinal direction of the recess; ]	[ a base with a base rim defining an open opening, the base including a hole corresponding to the open opening, the hole including a base portion disposed within the tubular inner shell and an inner wall, the base portion including a wall portion defining a convex face disposed within of the hollow interior of the inner shell, the convex face adjacent the hollow interior of the inner shell; ]
0.99887556	214	[ at least one removable tape dispensing lumen extending throughout the base for receiving one or more tape dispensing lumen members disposed within the base portion, the at least one lumen extending along a length of the at least one lumen; and ]	[ a removable recess having a width of at least 0.3 inches and a height of up to 24 inches and configured to receive one or more elongate inner tubular arms, the recess further having at least one channel defined over the width of the recess, the channel having a width longer than the thickness of the recess and configured to move generally up and down on the recess, the channel in a longitudinal direction of the recess; ]
0.99999225	215	[ a plurality of thin film film transducers disposed circumferentially across the recess and spaced apart between the at least one lumen and one of the tape dispensing lumen portions, each said transducer having a diameter smaller than the width of the recess and and disposed within the tape dispensing lumen such that a direct intersection between the tissue of the tape in the tape dispensing lumen portion and the tissue of the tubular inner shell in the base portion moves a portion of the tape in the duct, the one or more tape dispensing lumen members are capable of being placed within the recess and receiving a first dose of the self-applying tape during one or more sets of applications so as to present a plurality of thin film film transducers for self-applying tape to the tissue of the patient. ]	[ at least one removable tape dispensing lumen extending throughout the base for receiving one or more tape dispensing lumen members disposed within the base portion, the at least one lumen extending along a length of the at least one lumen; and ]
0.9689746	216	[ a processor; and ]	[ A system for identifying a type of an agent, comprising: ]
0.99724483	217	[ a memory configured to analyze at least one parameter in the agent, wherein the processor receives information from a remote data acquisition system that has acquired said agent; ]	[ a processor; and ]
0.99999213	218	[ the processor further configured to further analyze said at least one parameter by: ]	[ a memory configured to analyze at least one parameter in the agent, wherein the processor receives information from a remote data acquisition system that has acquired said agent; ]
0.99416524	219	[ receiving a state of said agent from said remote data acquisition system; and ]	[ the processor further configured to further analyze said at least one parameter by: ]
0.9999924	220	[ analyzing from said state of said agent a data set of characteristics comprising a common phenotype of said agent. ]	[ receiving a state of said agent from said remote data acquisition system; and ]
0.9999893	221	[ isolating an output of the water pump associated with a sensor, the output from said sensor having a first variable level and a second variable level; ]	[ A method of regulating water-contacting activity of a water pump, the method comprising: ]
0.99999	222	[ measuring at least two energy peaks in the first variable level and at least two energy peaks in the second variable level; and ]	[ isolating an output of the water pump associated with a sensor, the output from said sensor having a first variable level and a second variable level; ]
0.9999924	223	[ determining after at least one of the data points in the first or second variable level is above the predetermined value, regulating water-contacting activity of the water pump based on a corresponding measurement of the at least two energy peaks. ]	[ measuring at least two energy peaks in the first variable level and at least two energy peaks in the second variable level; and ]
0.9998933	224	[ allowing a tubular polyhedron form that defines an internal chamber having a closed position, wherein said polyhedron is the structure of a mammalian urine, to receive at least one internal container; ]	[ A method of obtaining a urine volume profile, comprising: ]
0.99999213	225	[ permitting fluid flow, from said internal container, to said fluid containing the said polyhedron, through said interior chamber, and ]	[ allowing a tubular polyhedron form that defines an internal chamber having a closed position, wherein said polyhedron is the structure of a mammalian urine, to receive at least one internal container; ]
0.99613744	226	[ to the internal compartment being associated therewith; ]	[ permitting fluid flow, from said internal container, to said fluid containing the said polyhedron, through said interior chamber, and ]
0.99997663	227	[ for each interior compartment associated with a corresponding external compartment, permitting fluid flow to said interior compartment through said interior container through said interior compartment and towards said, external compartment through said and said interior chamber or into said at least one external container; ]	[ to the internal compartment being associated therewith; ]
0.99999225	228	[ for each interior compartment associated with at least one external compartment, permitting fluid flow to said at least one external compartment through said at least one external container; and ]	[ for each interior compartment associated with a corresponding external compartment, permitting fluid flow to said interior compartment through said interior container through said interior compartment and towards said, external compartment through said and said interior chamber or into said at least one external container; ]
0.99646074	229	[ obtaining a volume profile at each tubular polyhedron form, wherein said volume profiles are obtained in association with the use of a patient's urine. ]	[ for each interior compartment associated with at least one external compartment, permitting fluid flow to said at least one external compartment through said at least one external container; and ]
0.99999225	230	[ (a) contacting said prostate cells with a therapeutically effective amount of an antibody or antigen-binding fragment thereof that specifically binds to prostate cell-derived growth factor, or a fragment thereof that specifically binding to prostate cell-derived growth factor; and ]	[ A method for delivering a therapeutically effective amount of monoclonal antibody or antigen-binding fragment thereof to prostate cells, wherein said method comprises the steps of: ]
0.99999225	231	[ (b) subjecting said prostate cells to at least one test solution consisting of 95% protein by weight of an amount of said cancer-derived growth factor in the test solution that is sufficient to induce a proliferation of said prostate cells, and ]	[ (a) contacting said prostate cells with a therapeutically effective amount of an antibody or antigen-binding fragment thereof that specifically binds to prostate cell-derived growth factor, or a fragment thereof that specifically binding to prostate cell-derived growth factor; and ]
0.99999213	232	[ wherein said cancer-derived growth factor is not a monoclonal antibody or antigen-binding fragment thereof. ]	[ (b) subjecting said prostate cells to at least one test solution consisting of 95% protein by weight of an amount of said cancer-derived growth factor in the test solution that is sufficient to induce a proliferation of said prostate cells, and ]
0.99455464	233	[ a patient support provided with a support assembly on a proximal and a distal portion of the patient support; and ]	[ A patient care system for use by a patient, such system comprising: ]
0.99999213	234	[ a patient support system located at a first position on the proximal portion of the support assembly, ]	[ a patient support provided with a support assembly on a proximal and a distal portion of the patient support; and ]
0.99998915	235	[ wherein the patient support system includes a first and a second member disposed about a single annular circumferential surface disposed around at least a first portion of a length of the first member, and ]	[ a patient support system located at a first position on the proximal portion of the support assembly, ]
0.99979585	236	[ wherein a second member lying on a bottom is connected to the first member and a longitudinally extending groove is provided extending from substantially below the length of the first member, the groove having an width that is larger than a width of the first member, and ]	[ wherein the patient support system includes a first and a second member disposed about a single annular circumferential surface disposed around at least a first portion of a length of the first member, and ]
0.99956924	237	[ wherein the wide strip is electrically insulated from the continuous longitudinal magnetic boundary surrounding the single annular circumferential surface at a center of the groove. ]	[ wherein a second member lying on a bottom is connected to the first member and a longitudinally extending groove is provided extending from substantially below the length of the first member, the groove having an width that is larger than a width of the first member, and ]
0.99998975	238	[ determining a baseline state of a mouse; ]	[ A method for improving health of a mouse comprising: ]
0.999992	239	[ determining a physiological status of the mouse; ]	[ determining a baseline state of a mouse; ]
0.99999225	240	[ selecting a stimulus for the mouse based on the baseline state and the physiological status; ]	[ determining a physiological status of the mouse; ]
0.99999225	241	[ determining a stimulus for a second condition as a function of the baseline state and the physiological status; and ]	[ selecting a stimulus for the mouse based on the baseline state and the physiological status; ]
0.99957687	242	[ adjusting one or more parameter parameters selected from the group consisting of stimulus type, modality, and ]	[ determining a stimulus for a second condition as a function of the baseline state and the physiological status; and ]
0.99992335	243	[ stimulation energy range based on the determination of the baseline state, the physiological state, and ]	[ adjusting one or more parameter parameters selected from the group consisting of stimulus type, modality, and ]
0.9997383	244	[ the stimulus for the second condition. ]	[ stimulation energy range based on the determination of the baseline state, the physiological state, and ]
0.9949928	245	[ receiving a signal from a biological system, the biological system including a heart and a liver; ]	[ A method for a bio-mechanical device, the method comprising: ]
0.99999225	246	[ determining an average heart rhythm of the biological system from the received signal; ]	[ receiving a signal from a biological system, the biological system including a heart and a liver; ]
0.9999924	247	[ computing the average heart rhythm of each biological system with a predetermined set of factors including a physical characteristic, a heart rate, a speed of respiratory cycles of the biological system; ]	[ determining an average heart rhythm of the biological system from the received signal; ]
0.9999924	248	[ determining a current heart rhythm within the biological system based on the average heart rhythm of the biological system, wherein generating the current heart rhythm is an algorithm that generates a set of components comprising at least one of a first component, a second component, and ]	[ computing the average heart rhythm of each biological system with a predetermined set of factors including a physical characteristic, a heart rate, a speed of respiratory cycles of the biological system; ]
0.99996984	249	[ a third component; ]	[ determining a current heart rhythm within the biological system based on the average heart rhythm of the biological system, wherein generating the current heart rhythm is an algorithm that generates a set of components comprising at least one of a first component, a second component, and ]
0.00022177535	250	[ comparing the current heart rhythm to a preset period to maintain a preset mean heart rhythm including no changes from the preset period; and ]	[ a third component; ]
0.99999225	251	[ changing the preset mean heart rhythm to an intermediate heart rhythm based on the calculated mean heart rhythm. ]	[ comparing the current heart rhythm to a preset period to maintain a preset mean heart rhythm including no changes from the preset period; and ]
0.99985325	252	[ a) providing an in situ tissue perfusion device comprising at least one tissue, said in situ tissue perfusion device comprising ionically charged hydrophobic solid metal particles which are injected, and ]	[ A method of treating tissue, comprising: ]
0.9999783	253	[ wherein the solid metallic particles are separated from an exterior material of the in situ tissue, the solid metallic particles being bonded with a nonfissile fiber-based liquid contact; ]	[ a) providing an in situ tissue perfusion device comprising at least one tissue, said in situ tissue perfusion device comprising ionically charged hydrophobic solid metal particles which are injected, and ]
0.99859446	254	[ b) contacting the electrically charged liquid particle with a solid material; ]	[ wherein the solid metallic particles are separated from an exterior material of the in situ tissue, the solid metallic particles being bonded with a nonfissile fiber-based liquid contact; ]
0.9999869	255	[ c) allowing the electrically charged liquid to flow along a fluid communication channel; ]	[ b) contacting the electrically charged liquid particle with a solid material; ]
0.99957925	256	[ d) a mechanical pressure of said substantially electrically charged solid metal particles is operative, and ]	[ c) allowing the electrically charged liquid to flow along a fluid communication channel; ]
0.9999902	257	[ the surface of the solid metal particles is pressed against a surface of one or more tissue at least partially within the in situ tissue; ]	[ d) a mechanical pressure of said substantially electrically charged solid metal particles is operative, and ]
0.99998236	258	[ e) a tension of said electrically charged electrically charged solid metallic particles is operative, wherein a resistance of the electrically charged solid metal particles in said tension is between about 40&#xb0; cm&#xb0; in between; and ]	[ the surface of the solid metal particles is pressed against a surface of one or more tissue at least partially within the in situ tissue; ]
0.99971527	259	[ f) wherein less than 20% of the electrical charges generated within the in situ tissue are activated, and ]	[ e) a tension of said electrically charged electrically charged solid metallic particles is operative, wherein a resistance of the electrically charged solid metal particles in said tension is between about 40&#xb0; cm&#xb0; in between; and ]
0.99975306	260	[ wherein during the step in n=15-20 of said step d) said tension of the solid metallic particles is less than 50% when the pressure of said substantially electrically charged solid metal particles is operative. ]	[ f) wherein less than 20% of the electrical charges generated within the in situ tissue are activated, and ]
0.9999924	261	[ receiving an instruction from said second wireless controller to disable an operational mode of said at least one wireless controller; ]	[ A method for controlling at least one wireless controller having communication with a second wireless controller, said method comprising: ]
0.99999225	262	[ programming said at least one wireless controller to operate within the operational mode by processing movement information captured by an embedded unit that is within said at least one wireless controller; ]	[ receiving an instruction from said second wireless controller to disable an operational mode of said at least one wireless controller; ]
0.9999924	263	[ transmitting a power command from said at least one wireless controller to actuate the operational mode; ]	[ programming said at least one wireless controller to operate within the operational mode by processing movement information captured by an embedded unit that is within said at least one wireless controller; ]
0.9999919	264	[ disconnecting from said second wireless controller; ]	[ transmitting a power command from said at least one wireless controller to actuate the operational mode; ]
0.99999225	265	[ sending a command from said second wireless controller to activate said operational mode; ]	[ disconnecting from said second wireless controller; ]
0.9999924	266	[ turning on said second wireless controller when said power command is received; ]	[ sending a command from said second wireless controller to activate said operational mode; ]
0.9999914	267	[ communicating data to said at least one wireless controller; and ]	[ turning on said second wireless controller when said power command is received; ]
0.9999913	268	[ adjusting at least one attribute of a portion of the message processing by at least one of said wireless controllers based at least in part on the data information. ]	[ communicating data to said at least one wireless controller; and ]
0.9999914	269	[ a portion of the elongated tubular member rotatably mounted to the elongated tubular member, wherein the elongated tubular member is a cross-sectional structure and is rigidly enclosed between the tubular bore of said tubular member and the longitudinal axis of the elongated tubular member. ]	[ A vacuum-shaped catheter assembly including, in spaced apart groups, an elongated tubular member with a tubular bore, and ]
0.999977	270	[ an X-ray collection medium disposed within a container, having a size sufficient to retain X-rays emitted from the container; and ]	[ An X-ray image processing system comprising: ]
0.9999894	271	[ a detection device disposed within the container, comprising: ]	[ an X-ray collection medium disposed within a container, having a size sufficient to retain X-rays emitted from the container; and ]
0.9999893	272	[ a detection unit configured to be mounted within the container; and ]	[ a detection device disposed within the container, comprising: ]
0.99418193	273	[ an X-ray filter comprising: ]	[ a detection unit configured to be mounted within the container; and ]
0.9901474	274	[ a first layer disposed within the container in combination with the detection unit, wherein the first layer is disposed within the container in accordance with the size of the container, and ]	[ an X-ray filter comprising: ]
0.007255266	275	[ has a first depth level; and ]	[ a first layer disposed within the container in combination with the detection unit, wherein the first layer is disposed within the container in accordance with the size of the container, and ]
0.9999918	276	[ a second layer disposed within the container in combination with the detection unit, wherein the second layer has a second depth level equal to the first depth level, ]	[ has a first depth level; and ]
0.9999919	277	[ wherein the detection unit is configured to be disposed within the container in the first depth level. ]	[ a second layer disposed within the container in combination with the detection unit, wherein the second layer has a second depth level equal to the first depth level, ]
0.9999802	278	[ a tube configured to couple the catheter body to a surgical instrument; ]	[ A device for delivering a catheter structure by sliding, or at least through the sliding action of the device, a catheter body, comprising: ]
0.9999759	279	[ a catheter chamber configured to receive the catheter; and ]	[ a tube configured to couple the catheter body to a surgical instrument; ]
0.9999597	280	[ a distal end of the tube configured to engage a bone and disposed within the cavity of the catheter; ]	[ a catheter chamber configured to receive the catheter; and ]
0.9999716	281	[ wherein a distal end of the tube is sized prior to attachment of the tube therewith; ]	[ a distal end of the tube configured to engage a bone and disposed within the cavity of the catheter; ]
0.99816775	282	[ and wherein the catheter chamber is configured to contain an apparatus for releasing the catheter structure prior to the coupling of the catheter body to the surgical instrument by a sliding or sliding action. ]	[ wherein a distal end of the tube is sized prior to attachment of the tube therewith; ]
0.98789793	283	[ about 100, ]	[ A therapeutic compound, said therapeutic compound comprising: ]
0.9991536	284	[ 000 fold reduction in serum amyloid protein levels from about 35 fold change in serum amyloid content of a pre-molded reference body to about 35 fold decreased serum amyloid particle content when compared to a normal animal from about 2 to about 4 fold variation in a tau level from about 25 to 80 mg/L, and ]	[ about 100, ]
0.99999225	285	[ below about 5 fold reduction in said tau level but below blood amyloid level in about 2&#xb0; ]	[ 000 fold reduction in serum amyloid protein levels from about 35 fold change in serum amyloid content of a pre-molded reference body to about 35 fold decreased serum amyloid particle content when compared to a normal animal from about 2 to about 4 fold variation in a tau level from about 25 to 80 mg/L, and ]
0.99999154	286	[ , with a tau level less than about 15 mg/L, wherein said therapeutic compound has an effect on amyloid delivery in from about 5 to about 15% of the human animal in need thereof, said effect being due to said therapeutic compound having a high-purity amount of amyloid peptide; and ]	[ below about 5 fold reduction in said tau level but below blood amyloid level in about 2&#xb0; ]
0.998089	287	[ about 300, ]	[ , with a tau level less than about 15 mg/L, wherein said therapeutic compound has an effect on amyloid delivery in from about 5 to about 15% of the human animal in need thereof, said effect being due to said therapeutic compound having a high-purity amount of amyloid peptide; and ]
0.99924767	288	[ 000 fold reduction in said animal for at least about 20 to about 40 times the normal amount of amyloid peptide. ]	[ about 300, ]
0.98224974	289	[ measuring levels of a first variable, an alkyl phosphate at the presence of a solvent; ]	[ A process for the preparation of a cosmetic and/or lubricant, comprising the steps of: ]
0.999992	290	[ measuring levels of a precursor, a dicarboxylic acid at the presence of the solvent; ]	[ measuring levels of a first variable, an alkyl phosphate at the presence of a solvent; ]
0.9999826	291	[ extracting the cosmetic and/or lubricant from the liquid solvent resulting in the cosmetic and/or lubricant, said extracted cosmetic and/or lubricant having a chemical composition which comprises both, an alkyl phosphate as the chemical content of the compound extracted and a dicarboxylic acid as the chemical content of the compound and which is not present in the presence of the solvent; and ]	[ measuring levels of a precursor, a dicarboxylic acid at the presence of the solvent; ]
0.9999217	292	[ further excluding solvent component of the elastomeric component of the precursor, wherein the solvent component is included in the present chemical composition. ]	[ extracting the cosmetic and/or lubricant from the liquid solvent resulting in the cosmetic and/or lubricant, said extracted cosmetic and/or lubricant having a chemical composition which comprises both, an alkyl phosphate as the chemical content of the compound extracted and a dicarboxylic acid as the chemical content of the compound and which is not present in the presence of the solvent; and ]
0.9999924	293	[ removing the non-transparent article or material, or the article or material from which it is carried to which a hydrated or unsaturated pigment material is included; ]	[ A method for determining whether a hair and/or skin comprises a hydrated or unsaturated pigment material, being adapted to be put on a non-transparent article or material which is an ablationable barrier to germinate from the skin to that article or material, further comprising: ]
0.99999225	294	[ treating the article or material using a suitable hydrated or unsaturated pigment material, which to be treated is retained in a hydrated or unsaturated pigment material; ]	[ removing the non-transparent article or material, or the article or material from which it is carried to which a hydrated or unsaturated pigment material is included; ]
0.99999225	295	[ measuring or capturing the measured or captured hydrated or unsaturated pigment material; ]	[ treating the article or material using a suitable hydrated or unsaturated pigment material, which to be treated is retained in a hydrated or unsaturated pigment material; ]
0.9999924	296	[ determining whether the hydrated or unsaturated pigment material is not there within a first potential band of the first measured or captured hydrated or unsaturated pigment material in the test material having a first first surface area at a first first level of the measurement or captured fluid; and ]	[ measuring or capturing the measured or captured hydrated or unsaturated pigment material; ]
1.1660619e-05	297	[ removing the non-transparent article or material or article or material part from which the non-transparent article or material or the article or material is carried to which the non-transparent article or material is to be removed to which the non-transparent article or material or the article or material material is to be put, to which the non-transparent article or material or the article or material and its/receiving material are carried, to thereby obtain a result according to the determination. ]	[ determining whether the hydrated or unsaturated pigment material is not there within a first potential band of the first measured or captured hydrated or unsaturated pigment material in the test material having a first first surface area at a first first level of the measurement or captured fluid; and ]
0.9995105	298	[ a fiber conduit extending along a longitudinal axis generally parallel to the longitudinal axis of the tube; and ]	[ An electrosurgical tube, comprising: ]
0.9999919	299	[ a distal terminus of said fiber conduit comprising a flexible region that is separable from at least about 1% of said longitudinal axis; ]	[ a fiber conduit extending along a longitudinal axis generally parallel to the longitudinal axis of the tube; and ]
0.99999225	300	[ wherein said proximal terminus includes rigid tissue adjacent the region of said at least about 1% of the longitudinal axis; and ]	[ a distal terminus of said fiber conduit comprising a flexible region that is separable from at least about 1% of said longitudinal axis; ]
0.9999145	301	[ wherein about 1% of the region is substantially homogenous to make the region substantially uncoupled from the remainder of the region. ]	[ wherein said proximal terminus includes rigid tissue adjacent the region of said at least about 1% of the longitudinal axis; and ]
0.9979371	302	[ one or more first and two second faces; ]	[ A golf club head, comprising: ]
0.9999616	303	[ a ground plane that overlies the first faces and a face plane that overlies the second faces; and ]	[ one or more first and two second faces; ]
0.9999919	304	[ a golf ball that faces the ground plane, wherein the face plane of the ground plane faces a first portion of the four faces of the structure, and ]	[ a ground plane that overlies the first faces and a face plane that overlies the second faces; and ]
0.99999225	305	[ the golf ball has a center of gravity that is centered on the first portion of the four faces of the structure. ]	[ a golf ball that faces the ground plane, wherein the face plane of the ground plane faces a first portion of the four faces of the structure, and ]
0.9999862	306	[ -butylene-3-(1-methyl-1H-difluorophenyl)-methylene sulfonic acid)-4-chloro-3-(2, ]	[ A treatment method for a cancer of the lung for treatment of airway hyperallergy, comprising administering to a patient a composition comprising a composition comprising 2-chloro-2-n-1-(1-isopropyl-1, ]
0.9959365	307	[ 3, ]	[ -butylene-3-(1-methyl-1H-difluorophenyl)-methylene sulfonic acid)-4-chloro-3-(2, ]
0.9833097	308	[ 5-dihydro-4H-pyrrolidone)-4-chloro-1-(2-methyl-4H-difluorophenyl)-5-methylene-1-ylthiophene containing the lung, wherein the composition does not comprise: ]	[ 3, ]
0.9915093	309	[ sodium chloride; ]	[ 5-dihydro-4H-pyrrolidone)-4-chloro-1-(2-methyl-4H-difluorophenyl)-5-methylene-1-ylthiophene containing the lung, wherein the composition does not comprise: ]
0.99962366	310	[ sodium bicarbonate; or ]	[ sodium chloride; ]
0.9912186	311	[ sorbitol, ]	[ sodium bicarbonate; or ]
0.9988728	312	[ wherein administered to the patient under conditions sufficient to support disease free lung tissue for a duration of weeks to months. ]	[ sorbitol, ]
0.9991696	313	[ a body having a proximal end; a lateral portion extending outwardly from said proximal end, wherein at least part of the proximal end of the device is disposed within said lateral portion; said lateral portion comprising an anterior portion and a posterior portion; said anterior portion comprising a first protrusive portion proximate said lateral section and an anterior portion and posterior portion comprising a distal portion, a longitudinal portion, and ]	[ A device to deliver bioactive material to a subject being placed into an MRI imaging machine, comprising: ]
0.9944595	314	[ a longitudinal axis; and ]	[ a body having a proximal end; a lateral portion extending outwardly from said proximal end, wherein at least part of the proximal end of the device is disposed within said lateral portion; said lateral portion comprising an anterior portion and a posterior portion; said anterior portion comprising a first protrusive portion proximate said lateral section and an anterior portion and posterior portion comprising a distal portion, a longitudinal portion, and ]
0.9923499	315	[ a lower body having a proximal end and a distal end, wherein the distal end of the device is located outside of and above the anterior portion of the posterior portion; said lateral portion comprising a distal tip; a first portion extending from the proximal portion of the body toward the lateral portion and said proximal tip of the device; and ]	[ a longitudinal axis; and ]
0.9999908	316	[ a second portion extending from the distal portion of the body and said anterior portion of the posterior portion to the anterior portion of the posterior portion, wherein said second portion and said posterior portion are spaced apart between said anterior portion and said posterior portion in substantially an axially continuous format. ]	[ a lower body having a proximal end and a distal end, wherein the distal end of the device is located outside of and above the anterior portion of the posterior portion; said lateral portion comprising a distal tip; a first portion extending from the proximal portion of the body toward the lateral portion and said proximal tip of the device; and ]
0.9999919	317	[ wherein administering the NAM when administered in a bolus of blood was not effective as a bolus of blood. ]	[ A method of inhibiting the proliferation of TNF-&#x3b1; molecules in vitro comprising administering an effective amount of an isolated N-like amino acid molecule (NAM), selected from the group consisting of amino acids 1-11, for a period of time, measured in milliseconds, as a bolus of blood from an inflatable vessel, wherein each of the NAM has a molecular weight of less than 500, and ]
0.9980398	318	[ a shaft body having a proximal side, a distal side and two curved ends; ]	[ A golf club shaft, comprising: ]
0.99999225	319	[ at least one resilient element supporting the proximal side and the distal side of the shaft body, and ]	[ a shaft body having a proximal side, a distal side and two curved ends; ]
0.99999225	320	[ at least one cutting element located on a proximal end of the at least one resilient element along the curved ends of the shaft body; ]	[ at least one resilient element supporting the proximal side and the distal side of the shaft body, and ]
0.99999225	321	[ a distal end portion of the at least one resilient element supporting a shaft member disposed proximate the proximal end portion of the at least one resilient element, and ]	[ at least one cutting element located on a proximal end of the at least one resilient element along the curved ends of the shaft body; ]
0.99999225	322	[ a center wall portion of and extending between a proximal opening on the proximal end portion of the at least one resilient element and a distal end portion of the at least one resilient element, the proximal end portion of the at least one resilient element being configured to pivot relative to the proximal side of the shaft body when the golf club is bent; and ]	[ a distal end portion of the at least one resilient element supporting a shaft member disposed proximate the proximal end portion of the at least one resilient element, and ]
0.99999213	323	[ a hook face on the proximal end of the distal end of the proximal end portion of the at least one resilient element, and ]	[ a center wall portion of and extending between a proximal opening on the proximal end portion of the at least one resilient element and a distal end portion of the at least one resilient element, the proximal end portion of the at least one resilient element being configured to pivot relative to the proximal side of the shaft body when the golf club is bent; and ]
0.99999225	324	[ a hook head on a proximal end portion of the hook face with an opposing hook head disposed adjacent a distal surface of the hook face, wherein the hook head and the distal hole are configured to be grasped by the fingers of a user when the golf club is in a curved and extended position, the proximal side of the at least one resilient element supported by the distal side of the shaft body. ]	[ a hook face on the proximal end of the distal end of the proximal end portion of the at least one resilient element, and ]
0.9984421	325	[ a handle; ]	[ An interventional surgical blade comprising: ]
0.99971956	326	[ a handle clamp that holds a single scalpel at least partially on a scalloped portion of the handle to be turned; and ]	[ a handle; ]
0.99994147	327	[ a scalloped portion attached to the handle for contacting to an internal surface of an implant, ]	[ a handle clamp that holds a single scalpel at least partially on a scalloped portion of the handle to be turned; and ]
0.9999913	328	[ wherein the handle is connected to the scalloped portion by a proximal end, and ]	[ a scalloped portion attached to the handle for contacting to an internal surface of an implant, ]
0.9999863	329	[ the distal end is spaced from the scalloped portion by a distal end; ]	[ wherein the handle is connected to the scalloped portion by a proximal end, and ]
0.99788326	330	[ wherein at least a portion of the handle has a diameter greater than 10 feet. ]	[ the distal end is spaced from the scalloped portion by a distal end; ]
0.9999453	331	[ a sterilized liquid comprising sodium chloride; and ]	[ A liquid sterilization device comprising: ]
0.99999046	332	[ an anion agent associated with that sterilized liquid, wherein said anion agent is at least one fluorophore, wherein said sterilized liquid has elevated O 2 to total O 3 ratio (OH to total O 2 ) less than the total O 3 ratio (OH to total O ) based on mass-and/or temperature values, and ]	[ a sterilized liquid comprising sodium chloride; and ]
0.9999918	333	[ wherein a value of 5% to 60% by mass is used in the determination of the total O 3 ratio. ]	[ an anion agent associated with that sterilized liquid, wherein said anion agent is at least one fluorophore, wherein said sterilized liquid has elevated O 2 to total O 3 ratio (OH to total O 2 ) less than the total O 3 ratio (OH to total O ) based on mass-and/or temperature values, and ]
0.022494925	334	[ an antenna coupled to a transmitter provided with a receiving antenna and including at least one transmitter element for receiving signals; ]	[ A system adapted for delivering a radiofrequency energy in a range of from about 50 nanometers to about 35 nanometers and comprising: ]
0.99970573	335	[ an amplifier and transceiver in communication with said antenna; ]	[ an antenna coupled to a transmitter provided with a receiving antenna and including at least one transmitter element for receiving signals; ]
0.99875605	336	[ a control module generating a field-of-view to simulate an antenna trajectory so as to define a path through a skin of a patient which can be impacted by radiation from a radiation source; and ]	[ an amplifier and transceiver in communication with said antenna; ]
0.9999585	337	[ an image sensor or photo-detector coupled to said control module for receiving at least one of the radiation signals and based at least in part on, by using an image from said image sensor or photo-detector, determining the location of the sensor in vivo including determining the signal intensity. ]	[ a control module generating a field-of-view to simulate an antenna trajectory so as to define a path through a skin of a patient which can be impacted by radiation from a radiation source; and ]
0.99918216	338	[ a first unit having a first end and a second end, the unit having a cutting surface within a first plane at which a first end tip will cut at a first surface of a body; ]	[ A surgical tool, comprising: ]
0.99999213	339	[ a second unit having a first end and a second end, the unit having a cutting surface within a second plane above the first plane; ]	[ a first unit having a first end and a second end, the unit having a cutting surface within a first plane at which a first end tip will cut at a first surface of a body; ]
0.99999213	340	[ a first control unit supporting the cutting surface of the first unit within the first plane; ]	[ a second unit having a first end and a second end, the unit having a cutting surface within a second plane above the first plane; ]
0.99999225	341	[ a second control unit supporting the cutting surface of the second unit within the second plane below the first plane; ]	[ a first control unit supporting the cutting surface of the first unit within the first plane; ]
0.99989617	342	[ a first shaft extending from the first unit to the second end; and, ]	[ a second control unit supporting the cutting surface of the second unit within the second plane below the first plane; ]
0.99999213	343	[ a second shaft extending from the first shaft to the second end; ]	[ a first shaft extending from the first unit to the second end; and, ]
0.99997795	344	[ a first shaft holder for holding the first shaft. ]	[ a second shaft extending from the first shaft to the second end; ]
0.9966869	345	[ (a) a guidewire having a longitudinal length and including a distal end; and ]	[ A catheter implantable in peripheral tissues during or around surgery comprising: ]
0.99999034	346	[ (b) a retractably movable member having a cross-section substantially identical to the longitudinal length of the guidewire, an inner surface thereof defining a circumferential slit within which to retract a capillary for insertion; ]	[ (a) a guidewire having a longitudinal length and including a distal end; and ]
0.999987	347	[ wherein the retraction distance is defined by a linear relationship to a longitudinal axis of the distal end of the guidewire to a distal end of the retractable member. ]	[ (b) a retractably movable member having a cross-section substantially identical to the longitudinal length of the guidewire, an inner surface thereof defining a circumferential slit within which to retract a capillary for insertion; ]
0.010043793	348	[ a biocompatible liquid crystal material (LCM) wherein at least one of a plurality of plurality of substrates of the LCM are bonded respectively toward the membrane side of a tumor and are in direct contact with a plurality of plurality of lumens on and outside the tumor; and ]	[ An implantable medical device (IMD) comprising: ]
0.99997616	349	[ a biocompatible biocompatible polymer (BPC) bonded to a substrate surface, ]	[ a biocompatible liquid crystal material (LCM) wherein at least one of a plurality of plurality of substrates of the LCM are bonded respectively toward the membrane side of a tumor and are in direct contact with a plurality of plurality of lumens on and outside the tumor; and ]
0.9999913	350	[ wherein the LCM and BPC are complementary to each other and the BPC is bonded to the LCM together, ]	[ a biocompatible biocompatible polymer (BPC) bonded to a substrate surface, ]
0.9999919	351	[ wherein the LCM is biically solid and the BPC is biically dispersed. ]	[ wherein the LCM and BPC are complementary to each other and the BPC is bonded to the LCM together, ]
0.9999739	352	[ providing a plurality of threads, substantially horizontal lines defined by at least two linear fibers defining an exterior surface; ]	[ A method of coating a plurality of threads into an actuator material comprising: ]
0.002748551	353	[ defining a second channel; ]	[ providing a plurality of threads, substantially horizontal lines defined by at least two linear fibers defining an exterior surface; ]
0.99885166	354	[ forming a channel extending substantially horizontally along at least a portion of each of the linear fibers, allowing the multiple threads to pass through the channel at one or more defined distance between the channel and an exterior surface of the channel for each of the threads which may be simultaneously mounted to each of the linear fibers; ]	[ defining a second channel; ]
0.9999924	355	[ disposing the plurality of threads in a central orientation by gripping or latching one of the sections of the single linear fibers between the second channel and the exterior surface of the channel; ]	[ forming a channel extending substantially horizontally along at least a portion of each of the linear fibers, allowing the multiple threads to pass through the channel at one or more defined distance between the channel and an exterior surface of the channel for each of the threads which may be simultaneously mounted to each of the linear fibers; ]
0.99999154	356	[ defining at least one end surface in front of the central orientation, and ]	[ disposing the plurality of threads in a central orientation by gripping or latching one of the sections of the single linear fibers between the second channel and the exterior surface of the channel; ]
0.98873794	357	[ also having proximal and distal ends; and ]	[ defining at least one end surface in front of the central orientation, and ]
0.9706626	358	[ placing a thin layer of the actuator material at the end surface which is disposed under the longitudinal axis of the actuator material. ]	[ also having proximal and distal ends; and ]
0.9991579	359	[ activating a tissue treatment agent in a sample to produce a serum or plasma preparation comprising one or more of human serum mononuclear cells, the serum or plasma preparation comprising an active agent capable of activating the tissue treatment agent; and ]	[ A method for providing a therapeutic substance, the method comprising: ]
0.9999924	360	[ analyzing the plasma or serum sample to determine if the volume of activatable tissue treatment agent being activated in the sample matches a predetermined volume of activatable tissue treatment agent in human or animal tissue. ]	[ activating a tissue treatment agent in a sample to produce a serum or plasma preparation comprising one or more of human serum mononuclear cells, the serum or plasma preparation comprising an active agent capable of activating the tissue treatment agent; and ]
0.999992	361	[ an elongate endoscope body configured to include a support member; ]	[ An elongate endoscope comprising: ]
0.999992	362	[ a support member attached to the support member to determine an external reference position during use of the elongate endoscope body and having an axis of rotation substantially similar to the longitudinal axis of the elongate endoscope body and a first and second axial axes of rotation, and ]	[ an elongate endoscope body configured to include a support member; ]
0.0027186766	363	[ configured to extend to a first end of a head of a user having a head; ]	[ a support member attached to the support member to determine an external reference position during use of the elongate endoscope body and having an axis of rotation substantially similar to the longitudinal axis of the elongate endoscope body and a first and second axial axes of rotation, and ]
0.9999895	364	[ at least one positioning element between the axis of rotation and the first end of the user having a head and having a second axis of rotation substantially parallel to the first axis of rotation, the insertion of the positioning element between the axis of rotation and the first end of the user having the head positioned the elongate endoscope body is to maintain the elongate endoscope body in at least a first or second generally horizontal orientation with a third axis of rotation perpendicular to the second axis of rotation; and ]	[ configured to extend to a first end of a head of a user having a head; ]
0.9997949	365	[ at least one fixing element between the first and second axial axes of rotation, the at least one fixing element comprising an intermediate layer and a first surface extending radially outwardly from the intermediate layer and configured to connect the first and second axes of rotation. ]	[ at least one positioning element between the axis of rotation and the first end of the user having a head and having a second axis of rotation substantially parallel to the first axis of rotation, the insertion of the positioning element between the axis of rotation and the first end of the user having the head positioned the elongate endoscope body is to maintain the elongate endoscope body in at least a first or second generally horizontal orientation with a third axis of rotation perpendicular to the second axis of rotation; and ]
0.99993825	366	[ (A) a high-compact hair dye emulsifier and a polymeric emulsion thereof; and ]	[ A hair dye composition comprising: ]
0.9999566	367	[ wherein the emulsifier and emulsion is a monoglyceride or a glycolized monoglyceramide. ]	[ (A) a high-compact hair dye emulsifier and a polymeric emulsion thereof; and ]
0.9994355	368	[ a polyester C6-12-alkyl ester having a phenyl group attached to one or more substituents, at least some of the substituents having from about 15 to about 15100 carbon atoms; and ]	[ A multi-protective compound comprising: ]
0.99811965	369	[ a phyllosilicate selected from the group consisting of H, NH and SO. ]	[ a polyester C6-12-alkyl ester having a phenyl group attached to one or more substituents, at least some of the substituents having from about 15 to about 15100 carbon atoms; and ]
0.99943155	370	[ 4 and the antiretroviral agents, ]	[ A method of treating cancer of the stomach, lung and bladder of a mammal, the method comprising administering to the mammal a therapeutically effective amount of an anti-Ascorbic Acid Receptor polypeptide selected from SEQ ID NO: ]
0.9979019	371	[ wherein said anti-Ascorbic Acid Receptor polypeptide is a sequence selected from the group consisting of: ]	[ 4 and the antiretroviral agents, ]
0.9993931	372	[ SEQ ID NO: 1, 2, 3 and 4. ]	[ wherein said anti-Ascorbic Acid Receptor polypeptide is a sequence selected from the group consisting of: ]
0.99999106	373	[ , adenovirus E&#x3b1; ]	[ An isolated CD45 protein selected from the group consisting of adenovirus, adenovirus B&#x3b1; ]
0.00868244	374	[ (E&#x2212; ]	[ , adenovirus E&#x3b1; ]
0.99987984	375	[ E&#x2212; ]	[ (E&#x2212; ]
0.99972576	376	[ E&#x2b4; ]	[ E&#x2212; ]
0.98420054	377	[ ), adenovirus V&#x3b4; ]	[ E&#x2b4; ]
0.9999912	378	[ , adenovirus B&#x3b1; ]	[ ), adenovirus V&#x3b4; ]
0.99999166	379	[ , adenovirus I&#x3b1; ]	[ , adenovirus B&#x3b1; ]
0.99999166	380	[ , adenovirus C&#x3b1; ]	[ , adenovirus I&#x3b1; ]
0.99999154	381	[ , adenovirus P&#x3b1; ]	[ , adenovirus C&#x3b1; ]
0.2413653	382	[ , and ]	[ , adenovirus P&#x3b1; ]
0.015045159	383	[ HPV3&#x3b1; ]	[ , and ]
0.0015420698	384	[ , or, where an amplified adenovirus CD44 protein is provided, an isolated adenovirus CD44 protein selected from each of the group according to the following formula and comprising the amino acid sequence of SEQ ID NO: ]	[ HPV3&#x3b1; ]
0.9999832	385	[ 7, wherein the amino acid sequence of CD45 is obtained from VAPL4 of the VAPL4R5G3 (P) chain of the SEQ ID NO: ]	[ , or, where an amplified adenovirus CD44 protein is provided, an isolated adenovirus CD44 protein selected from each of the group according to the following formula and comprising the amino acid sequence of SEQ ID NO: ]
0.99987507	386	[ 7 of SEQ ID NO: ]	[ 7, wherein the amino acid sequence of CD45 is obtained from VAPL4 of the VAPL4R5G3 (P) chain of the SEQ ID NO: ]
0.99955684	387	[ 7. ]	[ 7 of SEQ ID NO: ]
0.9997627	388	[ an elongate tubular member having a proximal, a distal and a longitudinal axis, said distal end extending in a first helical direction within said proximal tubular member; and ]	[ An intravascular catheter for placement in a patient having an intervertebral disc, said catheter comprising a proximal end and a distal end, said distal end adapted to be connected with an insertion catheter having a proximal end and a distal end, said catheter comprising: ]
0.9996803	389	[ a tube located at said proximal proximal end. ]	[ an elongate tubular member having a proximal, a distal and a longitudinal axis, said distal end extending in a first helical direction within said proximal tubular member; and ]
0.9999894	390	[ (a) providing a first radiopharmaceutical molecule in a first therapeutic agent; ]	[ A method for generating a radiopharmaceutical, comprising: ]
0.99999154	391	[ (b) measuring a plasma concentration of the first therapeutic agent under controlled conditions in a physiological unit during a respiration test; ]	[ (a) providing a first radiopharmaceutical molecule in a first therapeutic agent; ]
0.999992	392	[ (c) providing a second, a different radiotracer and a different radiotracer in a second therapeutic agent, the second and second therapeutic agents being spaced, in contrast to the physiological unit, apart from and generally uncharged; ]	[ (b) measuring a plasma concentration of the first therapeutic agent under controlled conditions in a physiological unit during a respiration test; ]
0.999992	393	[ (d) moving the second radiotracer and the third radiotracer around relative to one another relative to the first radiotracer and the second radiotracer by the respiratory and/or physiological units, in order to simulate a physiologic state of blood in the first treatment agent on a therapeutic agent sensor for the first radiotracer or the second radiotracer; ]	[ (c) providing a second, a different radiotracer and a different radiotracer in a second therapeutic agent, the second and second therapeutic agents being spaced, in contrast to the physiological unit, apart from and generally uncharged; ]
0.99999225	394	[ (e) moving the second and third therapeutic agents around relative to one another relative to the one another; and ]	[ (d) moving the second radiotracer and the third radiotracer around relative to one another relative to the first radiotracer and the second radiotracer by the respiratory and/or physiological units, in order to simulate a physiologic state of blood in the first treatment agent on a therapeutic agent sensor for the first radiotracer or the second radiotracer; ]
0.99996424	395	[ (f) measuring plasma concentration under non-controlled conditions and determining a concentration of the respective second and third therapeutically active rifampin monomer in the second and third therapeutically active rifampin monomers, respectively. ]	[ (e) moving the second and third therapeutic agents around relative to one another relative to the one another; and ]
0.0046421257	396	[ (e) LQF10H2a12C(R)W(R, &#x2014; ]	[ An isolated polypeptide selected from the group consisting of the following: ]
0.022605445	397	[ OH&#x2014; ]	[ (e) LQF10H2a12C(R)W(R, &#x2014; ]
0.98043734	398	[ O)N(R) where 0 = &#x2014; ]	[ OH&#x2014; ]
0.99915457	399	[ CON(R)W(R, &#x2014; ]	[ O)N(R) where 0 = &#x2014; ]
0.9839246	400	[ OH&#x2014; ]	[ CON(R)W(R, &#x2014; ]
0.018778281	401	[ O)R; and ]	[ OH&#x2014; ]
0.00023281622	402	[ (f) a polypeptide comprising an amino acid sequence; ]	[ O)R; and ]
0.999913	403	[ wherein (g) is an amino acid sequence selected from the group consisting of: (i) an amino acid sequence of SEQ ID NOS: 56, 56 or 65; or (ii) a amino acid sequence selected from those having identical amino acid content of 1 to 14 nucleotides whose length is less than 10, wherein said sequences each are: ]	[ (f) a polypeptide comprising an amino acid sequence; ]
0.99944836	404	[ (i) DQWYQWXIJWLQVHGWT&#x2003; ]	[ wherein (g) is an amino acid sequence selected from the group consisting of: (i) an amino acid sequence of SEQ ID NOS: 56, 56 or 65; or (ii) a amino acid sequence selected from those having identical amino acid content of 1 to 14 nucleotides whose length is less than 10, wherein said sequences each are: ]
0.010469165	405	[ O&#x2003; ]	[ (i) DQWYQWXIJWLQVHGWT&#x2003; ]
0.9967134	406	[ Y&#x2003; ]	[ O&#x2003; ]
0.99728906	407	[ Z. ]	[ Y&#x2003; ]
0.99970156	408	[ an isolated cell expressing a transgenic tumor-stimulating activity programmed to initiate tumor migration and to recognize the promoter of the transgenic tumor-stimulating activity and transfer the promoter thereof into an endothelial cell after introduction of tumor antigen into the isolated cell, wherein the endogenous promoter of the transgene is selected from the group consisting of nucleotides 1-16 of SEQ ID NO: ]	[ A method of preventing a tumor from metastasizing from an isolated prostate cell, comprising: ]
0.9999622	409	[ 1, 17-32 of SEQ ID NO: ]	[ an isolated cell expressing a transgenic tumor-stimulating activity programmed to initiate tumor migration and to recognize the promoter of the transgenic tumor-stimulating activity and transfer the promoter thereof into an endothelial cell after introduction of tumor antigen into the isolated cell, wherein the endogenous promoter of the transgene is selected from the group consisting of nucleotides 1-16 of SEQ ID NO: ]
0.9999914	410	[ 1, 33-40 of SEQ ID NO: ]	[ 1, 17-32 of SEQ ID NO: ]
0.9999918	411	[ 1, 41-84 of SEQ ID NO: ]	[ 1, 33-40 of SEQ ID NO: ]
0.93671846	412	[ 1, and ]	[ 1, 41-84 of SEQ ID NO: ]
0.009540564	413	[ 85-144 of SEQ ID NO: ]	[ 1, and ]
0.9934063	414	[ 1; or, wherein the isolated cell is a tumor-tumor that does not express the endogenous promoter, and ]	[ 85-144 of SEQ ID NO: ]
0.9998196	415	[ the transgene is operably linked to one of the genes encoded by SEQ ID NO: ]	[ 1; or, wherein the isolated cell is a tumor-tumor that does not express the endogenous promoter, and ]
0.9965328	416	[ 1; and ]	[ the transgene is operably linked to one of the genes encoded by SEQ ID NO: ]
0.99146277	417	[ expression of the endogenous promoter (the transgene being operably linked to one or more of the genes selected from to 19) produces a cell that does not have metastaticigenic cancer. ]	[ 1; and ]
0.9999888	418	[ a steeringwheel and a front brake coupled to the drive portion of the seat, wherein the front brake includes a drive shaft; ]	[ A portable multi-energy sports car comprising: a seat, a drive portion, a front wheel lock and a rear wheel lock, the drive portion being mounted to an exterior surface of the seat; ]
0.9999846	419	[ a rear wheel engaging member adapted to engage with one or more rear wheels of the drive portion, and ]	[ a steeringwheel and a front brake coupled to the drive portion of the seat, wherein the front brake includes a drive shaft; ]
0.991793	420	[ wherein the driver is seated in an elevated position on a lower part of the vehicle, and ]	[ a rear wheel engaging member adapted to engage with one or more rear wheels of the drive portion, and ]
0.9904502	421	[ the rear brake includes a push-through engaging zone at a corner of the rear brake engaging member; and ]	[ wherein the driver is seated in an elevated position on a lower part of the vehicle, and ]
0.99998033	422	[ a safety locking member which includes two locking members arranged on opposing rear side walls of the safety locking member, whereby one or more rear brake surfaces are locked together with respect to the other rear brake surface by a push-through force created by the steeringwheel, the driving wheel and the front brake. ]	[ the rear brake includes a push-through engaging zone at a corner of the rear brake engaging member; and ]
0.9996505	423	[ a medical bag; ]	[ A medical support device, comprising: ]
0.0077889743	424	[ a grip assembly, the grip assembly comprising a central portion, a peripheral portion, and ]	[ a medical bag; ]
0.9999919	425	[ a pair of retractable members disposed opposite each other at opposing ends thereof, wherein the peripheral portion comprises a first flexible member of an array of first and second materialized members which are substantially shaped to match respective shapes and sizes of first and second fingers of a user when the grip assembly is inserted into a patient's hand; and ]	[ a grip assembly, the grip assembly comprising a central portion, a peripheral portion, and ]
0.561215	426	[ wherein: ]	[ a pair of retractable members disposed opposite each other at opposing ends thereof, wherein the peripheral portion comprises a first flexible member of an array of first and second materialized members which are substantially shaped to match respective shapes and sizes of first and second fingers of a user when the grip assembly is inserted into a patient's hand; and ]
0.100492105	427	[ the first flexible member does not extend to the first end of the grip assembly at the peripheral portion; ]	[ wherein: ]
0.999992	428	[ the grip assembly is disposed on an upper end of an abdominal portion, the grip assembly being releasably coupled proximally to the distal end of the abdominal portion. ]	[ the first flexible member does not extend to the first end of the grip assembly at the peripheral portion; ]
0.99999154	429	[ providing an MR apparatus; ]	[ A method of designing a magnetic resonance (MR) apparatus, said method comprising the steps of: ]
0.9999914	430	[ measuring a magnetic resonance (MR)-value of an ultrasound wave being received in a region that is outside of the MR apparatus; ]	[ providing an MR apparatus; ]
0.9999918	431	[ determining that the direction in which the signal is being received is not coincident with a common magnetic resonance (MR) axis; ]	[ measuring a magnetic resonance (MR)-value of an ultrasound wave being received in a region that is outside of the MR apparatus; ]
0.99999225	432	[ if the direction in which the signal is being received is not coincident with the MR axis, identifying a reference point along the MR axes formed by the common MR axis; ]	[ determining that the direction in which the signal is being received is not coincident with a common magnetic resonance (MR) axis; ]
0.99999213	433	[ modifying an MR-vector corresponding to one of the signals in order to correct for deviations from the common MR-axis to create a corresponding M-vector, wherein at least one variant of the M-vector is generated only if a common deviation of the signal within a specified direction of the common MR axis within a longitudinal area being modified is smaller than a total deviation in a predetermined direction of the common MR-axis during an MR-operation that is performed with the MR apparatus; ]	[ if the direction in which the signal is being received is not coincident with the MR axis, identifying a reference point along the MR axes formed by the common MR axis; ]
0.99999213	434	[ modifying a calibration vector associated with the M-vector based on a plurality of the signals in order to cause a calibration of a M-vector; ]	[ modifying an MR-vector corresponding to one of the signals in order to correct for deviations from the common MR-axis to create a corresponding M-vector, wherein at least one variant of the M-vector is generated only if a common deviation of the signal within a specified direction of the common MR axis within a longitudinal area being modified is smaller than a total deviation in a predetermined direction of the common MR-axis during an MR-operation that is performed with the MR apparatus; ]
0.9987947	435	[ determining that the signal is being received within said predetermined direction of the MR axis in the MR-operation; and ]	[ modifying a calibration vector associated with the M-vector based on a plurality of the signals in order to cause a calibration of a M-vector; ]
0.99390393	436	[ defining a data path for selecting a plurality of locations using the M-vector. ]	[ determining that the signal is being received within said predetermined direction of the MR axis in the MR-operation; and ]
0.9999919	437	[ wherein the game input device is in communication with the processor, the game input device includes: ]	[ A computer comprising a processor running a game and a game input device, ]
0.99992824	438	[ a housing configured to receive a game system component and the game system component including a first interface portion and a second interface portion, the first interface portion configured to be connected to an input device to receive a input therein, and ]	[ wherein the game input device is in communication with the processor, the game input device includes: ]
0.999992	439	[ at least one controller integrated into and operable to control the first interface portion; and ]	[ a housing configured to receive a game system component and the game system component including a first interface portion and a second interface portion, the first interface portion configured to be connected to an input device to receive a input therein, and ]
0.9972006	440	[ a plurality of controller components, each of the plurality of controller components operating in a corresponding controller mode in the processor, ]	[ at least one controller integrated into and operable to control the first interface portion; and ]
0.99570113	441	[ wherein an input device includes first and second input ports, each of the first and second input ports associated with the first and second input ports that are configured to allow each respective first and second input port to receive multiple different inputs from each other, as well as to present multiple of each first and second input port in a combination via an output port, ]	[ a plurality of controller components, each of the plurality of controller components operating in a corresponding controller mode in the processor, ]
0.9999883	442	[ wherein the output port includes instructions to communicate a first graphical icon to a first user, and ]	[ wherein an input device includes first and second input ports, each of the first and second input ports associated with the first and second input ports that are configured to allow each respective first and second input port to receive multiple different inputs from each other, as well as to present multiple of each first and second input port in a combination via an output port, ]
0.9999907	443	[ the first graphical icon appears in at least one display of the processor to distinguish one-tenth of multiple of the plurality of controller components from other processors of the processor and to distinguish different types of game input from one another, ]	[ wherein the output port includes instructions to communicate a first graphical icon to a first user, and ]
0.9999887	444	[ wherein a first game input component is added to the input device. ]	[ the first graphical icon appears in at least one display of the processor to distinguish one-tenth of multiple of the plurality of controller components from other processors of the processor and to distinguish different types of game input from one another, ]
0.9858394	445	[ a first sensor unit including a first conductive layer; and, ]	[ An electrical interconnection circuit comprising: ]
0.99999213	446	[ a second sensor unit including a second conductive layer with alternating a first conductive layer and a second conductive layer, ]	[ a first sensor unit including a first conductive layer; and, ]
0.99984074	447	[ wherein an air gap formed between the first and second conductive layers is defined by a first conductive layer, an air gap formed between the second and third conductive layers is defined by a second conductive layer coupled up with the first conductive layer, and ]	[ a second sensor unit including a second conductive layer with alternating a first conductive layer and a second conductive layer, ]
0.99999213	448	[ a gap formed between the first and third conductive layers is defined by an intermediate layer of an insulating material configured for insulation. ]	[ wherein an air gap formed between the first and second conductive layers is defined by a first conductive layer, an air gap formed between the second and third conductive layers is defined by a second conductive layer coupled up with the first conductive layer, and ]
0.99996746	449	[ wherein the salt comprising the potassium chloride has a total mass ratio between chloride of 14.5 and chloride of 18.5 to an average of about 18.6; ]	[ A method for the direct preparation of a pharmaceutically acceptable salt of potassium chloride or a salt comprising the pharmaceutically acceptable salt, wherein the method comprises the steps of, receiving a liquid sample of potassium chloride; ]
0.99999225	450	[ wherein the salt comprising the potassium chloride has a concentration of chloride of about 17.0 wt %; and ]	[ wherein the salt comprising the potassium chloride has a total mass ratio between chloride of 14.5 and chloride of 18.5 to an average of about 18.6; ]
0.99999106	451	[ wherein the salt comprising the potassium chloride is the standard salt. ]	[ wherein the salt comprising the potassium chloride has a concentration of chloride of about 17.0 wt %; and ]
0.99999225	452	[ i) sequestering a mammalian polypeptide comprising antigen binding domain region of a human monomer together with an antigen comprising a nucleic acid having at least one of one of the phosphatase, tyrosine kinase, Lysine kinase, an antibody binding domain region of a human monomer and an amino acid sequence selected from the group consisting of SEQ ID NO: ]	[ A method for identifying an antibody that binds to a human polypeptide comprising antigen binding domain region of at least one phosphatase, a first and second GPCR domains having at least 3 different GPCRs, a tyrosine kinase and a Lysine kinase, wherein said method further comprises: ]
0.9973568	453	[ 13, 34 or SEQ ID NO: ]	[ i) sequestering a mammalian polypeptide comprising antigen binding domain region of a human monomer together with an antigen comprising a nucleic acid having at least one of one of the phosphatase, tyrosine kinase, Lysine kinase, an antibody binding domain region of a human monomer and an amino acid sequence selected from the group consisting of SEQ ID NO: ]
0.99985373	454	[ 39.; ]	[ 13, 34 or SEQ ID NO: ]
0.9894085	455	[ ii) detecting hybridization of the extracted polypeptide of said method. ]	[ 39.; ]
0.9993426	456	[ 2 or SEQ ID NO: ]	[ A multi-electrode method of treating a disorder involving electrically-active polypeptides consisting essentially of SEQ ID NO: ]
0.999603	457	[ 3, wherein the therapy comprises a reduction in immune response to the abnormal polypeptide resulting from a reduction in at least one of the polypeptide's electro-potential or PPRI. ]	[ 2 or SEQ ID NO: ]
0.9999907	458	[ a pair of surgical implements carried by a patient; ]	[ One or more combinations of surgical tools including at least one of: ]
0.9984785	459	[ a plunger apparatus loaded with a mixture of a liquid delivery fluid and a pharmaceutically acceptable fluid; ]	[ a pair of surgical implements carried by a patient; ]
0.9999924	460	[ at least one piston operable to rotatably drive the mixture of the liquid delivery fluid and the pharmaceutically acceptable fluid in the plunger apparatus; and ]	[ a plunger apparatus loaded with a mixture of a liquid delivery fluid and a pharmaceutically acceptable fluid; ]
0.99998593	461	[ at least one pump operable to expel the mixture of fluid and the pharmaceutical ingredients produced by mixing the pharmaceutical ingredients comprising pharmaceutical ingredients supplied by a dispensing device, ]	[ at least one piston operable to rotatably drive the mixture of the liquid delivery fluid and the pharmaceutically acceptable fluid in the plunger apparatus; and ]
0.9984806	462	[ wherein said at least one piston comprises a piston base portion, wherein the piston base portion is rotatably supported by a first support and a two-part base pivotable relative to the second support to move between a stationary position and a moving position. ]	[ at least one pump operable to expel the mixture of fluid and the pharmaceutical ingredients produced by mixing the pharmaceutical ingredients comprising pharmaceutical ingredients supplied by a dispensing device, ]
0.9999113	463	[ a housing that encloses a first core and a plurality of first coil channels such that a first coil is disposed in each of the first coil channels and a second coil is disposed in each of the first coil channels, wherein the two coils are bonded to each other via a bonding material in the first core; ]	[ A magnetic coil assembly that comprises a plurality of coils, of an ultrasonic coil having a coil section, comprising: ]
0.99999225	464	[ a first coil assembly comprising a first core and first plurality of first coil channels spaced apart from each other and arranged such that a second coil is disposed in the first coils channel each of which has a different diameter; and ]	[ a housing that encloses a first core and a plurality of first coil channels such that a first coil is disposed in each of the first coil channels and a second coil is disposed in each of the first coil channels, wherein the two coils are bonded to each other via a bonding material in the first core; ]
0.99999225	465	[ a second coil assembly comprising a second core and a second plurality of second coil channels spaced apart from each other and arranged such that a second coil is disposed in the first coils channel each of which has a different diameter such that the diameter of a gap in a magnetic field between the two coils from the first core is a minimum. ]	[ a first coil assembly comprising a first core and first plurality of first coil channels spaced apart from each other and arranged such that a second coil is disposed in the first coils channel each of which has a different diameter; and ]
0.99999225	466	[ wherein one of predetermined user properties of the input device is changed during the user-migration sequence, and ]	[ A method for establishing a user-migration sequence between an input user and an input device to be operated on, the information storing a state of operation of the input device in accordance with a particular user of the input device, ]
0.9999924	467	[ wherein the information is stored in a memory having user-migration sequences associated therewith and which include the user-migration sequences, wherein each each of the information stores at least one set of user-migration sequence information associated with at least one of the plurality of user profiles. ]	[ wherein one of predetermined user properties of the input device is changed during the user-migration sequence, and ]
0.99987876	468	[ a housing for holding at least a first set of cards and for storing at least a second set of cards; ]	[ A game apparatus for receiving input, the apparatus comprising: ]
0.00065043883	469	[ a processor receiving the input and displaying first message content on a display; ]	[ a housing for holding at least a first set of cards and for storing at least a second set of cards; ]
0.99999225	470	[ a processor receiving input on a controller, the controller including at least one actionable button, at least one of the first message content and at least one of the input being displayed to a user on a display; and ]	[ a processor receiving the input and displaying first message content on a display; ]
0.99999225	471	[ a sensing device receiving signals from the first message content and the received input, the sensing device detecting a physical position of a handle of a player who is handling the first set of cards from the display. ]	[ a processor receiving input on a controller, the controller including at least one actionable button, at least one of the first message content and at least one of the input being displayed to a user on a display; and ]
0.97718656	472	[ moving a probe image through a field of view in a first image region, a second image region and a third image region; ]	[ An electrical imaging method for measuring an axial position of a plurality of magnetic element locations on a skin surface of a patient, the method including: ]
0.99999166	473	[ detecting a magnitude of a displacement or orientation angle of a portion of the object in the first image region; ]	[ moving a probe image through a field of view in a first image region, a second image region and a third image region; ]
0.99999225	474	[ correlating the magnitude of the displacement or orientation angle of the portion of the object to detection of a movement or orientation of a portion of the object within the second image region and the third image region from the first image region to a second information region comprising magnetic and molecular material; and ]	[ detecting a magnitude of a displacement or orientation angle of a portion of the object in the first image region; ]
0.99999225	475	[ using the second information region to determine a degree of an axial aberration of the surface by utilizing the magnetic and molecular material associated with the second information region. ]	[ correlating the magnitude of the displacement or orientation angle of the portion of the object to detection of a movement or orientation of a portion of the object within the second image region and the third image region from the first image region to a second information region comprising magnetic and molecular material; and ]
0.9999826	476	[ a flexible needle having a distal end configured to implant a needle into an external body of a patient, at least one portion of the needle configured to be implanted at said at least one input point and detachably positioned on a distal end of an elastically deformable medical cylinder, wherein the variable length of the flexible needle is configured to prevent pressure in the elastic body of the medical cylinder from the constant distal length of the needle from causing bending of the medical cylinder; ]	[ A drug delivery apparatus having an interface configured to be on at least one user-specific input point thereof, the medication delivery apparatus including: ]
0.9999893	477	[ a pressure sensor for measuring a force experienced by the elastic body on which the flexible needle is implanted, in the region occupied by the dynamic strain, the pressure sensor also including a rotatable valve configured to dispense an effective amount of fluid along the length of the needle; ]	[ a flexible needle having a distal end configured to implant a needle into an external body of a patient, at least one portion of the needle configured to be implanted at said at least one input point and detachably positioned on a distal end of an elastically deformable medical cylinder, wherein the variable length of the flexible needle is configured to prevent pressure in the elastic body of the medical cylinder from the constant distal length of the needle from causing bending of the medical cylinder; ]
0.0001223181	478	[ a non-transitory computer program stored on a non-transitory data system, the non-transitory computer program comprising instructions that cause a drive unit of the drug delivery apparatus to: ]	[ a pressure sensor for measuring a force experienced by the elastic body on which the flexible needle is implanted, in the region occupied by the dynamic strain, the pressure sensor also including a rotatable valve configured to dispense an effective amount of fluid along the length of the needle; ]
0.0015622795	479	[ move the at least one portion of the needle throughout an axis across a range of changes in both the direction of the elastic substance in the elastic body and the longitudinal direction along the fluid volume in a manner that minimizes bending of the elastic body; and ]	[ a non-transitory computer program stored on a non-transitory data system, the non-transitory computer program comprising instructions that cause a drive unit of the drug delivery apparatus to: ]
0.9999924	480	[ calculate a ratio between the minimum pressure experienced on the elastic substance within the elastic body within the range of changes that provides the effective amount of fluid for a constant distal needle of the flexible needle. ]	[ move the at least one portion of the needle throughout an axis across a range of changes in both the direction of the elastic substance in the elastic body and the longitudinal direction along the fluid volume in a manner that minimizes bending of the elastic body; and ]
0.9961928	481	[ (a) contacting a natural cell with acid phosphatase (AP) which is coupled to a complexed H&#x2032; ]	[ A method of extracting or making a compound in a dosage form that mimics the activity of an analog of an amino-acid, the method comprising the steps of: ]
0.99999166	482	[ -hydropyranosyl chain (hAPC) coupled to an amino acid, wherein the composition of said h APC is prepared by contacting a pharmaceutically acceptable salt of HAPC with a salt of an organic product and then in this manner preventing acid phosphatase (AP) from responding to the H&#x2032; ]	[ (a) contacting a natural cell with acid phosphatase (AP) which is coupled to a complexed H&#x2032; ]
0.9999862	483	[ -hydropyranosyl chain; ]	[ -hydropyranosyl chain (hAPC) coupled to an amino acid, wherein the composition of said h APC is prepared by contacting a pharmaceutically acceptable salt of HAPC with a salt of an organic product and then in this manner preventing acid phosphatase (AP) from responding to the H&#x2032; ]
0.00020787198	484	[ (b) obtaining a monoclonal antibody that specifically binds to hAPC and that specifically binds to an (a)+3 to 5 bond, wherein said monoclonal antibody is specifically associated with an (a)+3 to 5 bond. ]	[ -hydropyranosyl chain; ]
0.0004937179	485	[ receiving on a digital storage memory, at a server computer, a request for a change of a physical location of an input device; ]	[ A method of controlling a machine, comprising: ]
0.9859428	486	[ associating at least three items of data into one digital store based on at least a general location and a selected destination; ]	[ receiving on a digital storage memory, at a server computer, a request for a change of a physical location of an input device; ]
0.9918819	487	[ setting a particular value of a physical identifier. ]	[ associating at least three items of data into one digital store based on at least a general location and a selected destination; ]
0.99996257	488	[ a dispensing chamber on an outer surface of a substantially cylindrical unit; ]	[ A dispensing device comprising: ]
0.99998593	489	[ the dispensing device includes: ]	[ a dispensing chamber on an outer surface of a substantially cylindrical unit; ]
0.99998355	490	[ first and second portions each being joined with members located in a longitudinal direction of the dispensing chamber; ]	[ the dispensing device includes: ]
0.9999896	491	[ the first portion of the dispensing device having a top surface and a bottom surface; ]	[ first and second portions each being joined with members located in a longitudinal direction of the dispensing chamber; ]
0.99999225	492	[ the second portion of the dispensing device having a top surface and a bottom surface; ]	[ the first portion of the dispensing device having a top surface and a bottom surface; ]
0.9999608	493	[ an outer wall which is at least partially free of the dispensing chamber; and ]	[ the second portion of the dispensing device having a top surface and a bottom surface; ]
0.99998915	494	[ a plurality of connecting strips extending from the outer wall to both the top surface and sides of the body of the dispensing device; ]	[ an outer wall which is at least partially free of the dispensing chamber; and ]
0.9999894	495	[ wherein each of said plurality of connecting strips has a respective hole; ]	[ a plurality of connecting strips extending from the outer wall to both the top surface and sides of the body of the dispensing device; ]
0.999992	496	[ wherein said plurality of connecting strips comprise a plurality of hollow pins which receive a plurality of the connected strips into each of the holes for applying the plurality of members to the plurality of holes in the outer wall which is at least partially free from the casing. ]	[ wherein each of said plurality of connecting strips has a respective hole; ]
0.9972466	497	[ 5a-d)whereinR1, ]	[ A method of extracting a composition from a compound of the general formula (&#x2014; ]
0.986267	498	[ R 2 and R 3 are each independently N, selected from the group consisting of C, O, ]	[ 5a-d)whereinR1, ]
0.99896896	499	[ S and F, ]	[ R 2 and R 3 are each independently N, selected from the group consisting of C, O, ]
0.023448952	500	[ &#x2014; ]	[ S and F, ]
0.99260193	501	[ Y or &#x2014; ]	[ &#x2014; ]
0.002227688	502	[ /(R1, ]	[ Y or &#x2014; ]
0.0019385474	503	[ R2&#x2014; ]	[ /(R1, ]
0.0010112177	504	[ 1) or (Rn, ]	[ R2&#x2014; ]
0.0008245618	505	[ &#x2014; ]	[ 1) or (Rn, ]
0.018328855	506	[ Rb)(Rr)wherein R1 is 0, 1, 2, 3, 4 or 5 or (F1, ]	[ &#x2014; ]
0.991602	507	[ F2), ]	[ Rb)(Rr)wherein R1 is 0, 1, 2, 3, 4 or 5 or (F1, ]
0.99977535	508	[ F, ]	[ F2), ]
0.99904186	509	[ Rb and R1 and F are each independently N or Q, A, L or S. ]	[ F, ]
0.0020232822	510	[ (a) a polypeptide having an amino acid sequence having at least 40% identity to one or more amino acids represented by SEQ ID NO: ]	[ A method for selectively reducing the levels of: ]
0.99998844	511	[ 105, wherein at least 30% of the amino acid sequence is different than a corresponding amino acid in SEQ ID NO: ]	[ (a) a polypeptide having an amino acid sequence having at least 40% identity to one or more amino acids represented by SEQ ID NO: ]
0.9999778	512	[ 105 or SEQ ID NO: ]	[ 105, wherein at least 30% of the amino acid sequence is different than a corresponding amino acid in SEQ ID NO: ]
0.99977154	513	[ 105-2; and ]	[ 105 or SEQ ID NO: ]
0.00019927147	514	[ (b) a polypeptide having an amino acid sequence adjacent to SEQ ID NO: ]	[ 105-2; and ]
0.9988017	515	[ 105. ]	[ (b) a polypeptide having an amino acid sequence adjacent to SEQ ID NO: ]
0.98584753	516	[ detecting fluid velocity for the fluid of a fluid system contained at a first location in the fluid system, wherein the first location is in a flow direction corresponding to fluid fluid travel path of the fluid from a fluid source in the flow direction to a fluid recipient at a second location outside the flow direction in a fluid delivery path of the fluid system; ]	[ A method comprising: ]
0.99998724	517	[ forming a differential volume sensor with a plurality of electrodes in the fluid delivery path; and ]	[ detecting fluid velocity for the fluid of a fluid system contained at a first location in the fluid system, wherein the first location is in a flow direction corresponding to fluid fluid travel path of the fluid from a fluid source in the flow direction to a fluid recipient at a second location outside the flow direction in a fluid delivery path of the fluid system; ]
0.99999225	518	[ detecting the spatial pattern of the differential volume sensor based on a first set of first parameters and a second set of first parameters, the first set of first parameters including fluid velocity detected by detecting the radial velocity of the fluid of the first location relative to one of the second locations. ]	[ forming a differential volume sensor with a plurality of electrodes in the fluid delivery path; and ]
0.9910216	519	[ a mobile platform having an interior; ]	[ A mobile transport system, comprising: ]
0.99996436	520	[ an anchor connected to the platform in a distal end of the platform; ]	[ a mobile platform having an interior; ]
0.9998975	521	[ an actuating unit configured to actuate the anchor in a direction in which the anchor is driven by gravity; and ]	[ an anchor connected to the platform in a distal end of the platform; ]
0.9998424	522	[ a suspension plate positioned between the anchor and the platform and secured to the mobile platform; ]	[ an actuating unit configured to actuate the anchor in a direction in which the anchor is driven by gravity; and ]
0.99999225	523	[ the anchor and suspension plate being adapted to couple to one another so that the suspension plate provides the mobile platform with a maximum diameter, such that the platform is constrained by a constraint line connected to the suspension plate. ]	[ a suspension plate positioned between the anchor and the platform and secured to the mobile platform; ]
0.99992025	524	[ an insulative body coupled to a carrier in a catheter assembly; ]	[ A system utilizing a catheter comprising: ]
0.99999166	525	[ an electrical circuit coupled to the insulative body; ]	[ an insulative body coupled to a carrier in a catheter assembly; ]
0.99999213	526	[ a memory including information describing a state of the insulative body; and ]	[ an electrical circuit coupled to the insulative body; ]
0.99999213	527	[ an electrical switch coupled to the memory allowing the switch to be selectively opened or closed to communicate information describing the state of the insulative body with the carrier when the switch is selected to become a closed switch, wherein the switch resides in the memory and is selectively activated during operation to contact the memory and allow the memory to communicate the information. ]	[ a memory including information describing a state of the insulative body; and ]
0.9999839	528	[ forming a ring piece having a proximal portion and a distal portion, wherein an inner rim of the ring piece extends away from the proximal portion on an inner surface of the ring piece and an outer rim of the ring piece extends toward the distal portion, the outer rim configured to engage the engaging surface of the inner surface of the inner surface of the ring piece to align the engaging surface on the inner surface to form an engaging ring; and ]	[ A method for the manufacturing of metal rods, wherein each metallic rod has an inner surface having a thickness and a periphery thereof including an engaging surface, the outer surface of the inner surface having a thickness, the method comprising: ]
0.99999213	529	[ forming a channel having a proximal end and a distal end, wherein the distal end defines an opening wherein the inner rim contacts the outer rim so as to couple the contacting surface of the inner surface to the engaging surface. ]	[ forming a ring piece having a proximal portion and a distal portion, wherein an inner rim of the ring piece extends away from the proximal portion on an inner surface of the ring piece and an outer rim of the ring piece extends toward the distal portion, the outer rim configured to engage the engaging surface of the inner surface of the inner surface of the ring piece to align the engaging surface on the inner surface to form an engaging ring; and ]
0.99997103	530	[ a laser energy transducer configured to transmit excitation laser energy in a waveform including an excitation frequency at a laser transducer frequency offset from a target excitation frequency as the beam enters the bone; and ]	[ An apparatus for detecting an ultrasound beam entering a patient's bone, the apparatus comprising: ]
0.9999924	531	[ a resonator configured to generate a frequency response to the excitation laser energy in the waveform transmitted energy from the excitation laser energy within a range of approximately 10-200 kHz, wherein a frequency response obtained from the laser energy transducer is determined by a function of the excitation frequency and the target excitation frequency, ]	[ a laser energy transducer configured to transmit excitation laser energy in a waveform including an excitation frequency at a laser transducer frequency offset from a target excitation frequency as the beam enters the bone; and ]
0.999992	532	[ wherein a first function of the frequency response is a function of an excitation frequency measured in the waveform and a frequency of excitation frequency measured at said laser transducer. while the resonator are offset by about 10 times from the target wavelength in the excitation frequency. ]	[ a resonator configured to generate a frequency response to the excitation laser energy in the waveform transmitted energy from the excitation laser energy within a range of approximately 10-200 kHz, wherein a frequency response obtained from the laser energy transducer is determined by a function of the excitation frequency and the target excitation frequency, ]
0.005032502	533	[ a) storing, in a storage device, a user profile of a user as an active user identifier; ]	[ A method comprising: ]
0.9999893	534	[ b) establishing a first reference on the user when the user profiles stored separately for one or more users are in interaction with one another; ]	[ a) storing, in a storage device, a user profile of a user as an active user identifier; ]
0.99999213	535	[ c) establishing a second reference on the user when the user profiles are associated with the first reference; ]	[ b) establishing a first reference on the user when the user profiles stored separately for one or more users are in interaction with one another; ]
0.99998593	536	[ d) activating, via a server, a first application on the storage device in cooperation with the first reference, the first application being a notification application in cooperation with the second reference; ]	[ c) establishing a second reference on the user when the user profiles are associated with the first reference; ]
0.9999571	537	[ e) monitoring when one or more of the application signatures in a signature space corresponding to a first application signature are in communication with the first application signature while the signature space corresponds to only the user currently initiating the message; and ]	[ d) activating, via a server, a first application on the storage device in cooperation with the first reference, the first application being a notification application in cooperation with the second reference; ]
0.99999225	538	[ f) detecting a status of the application signatures in the signature space when one or more of the signature space corresponding to a second application signature is not in communication with the first application signature. ]	[ e) monitoring when one or more of the application signatures in a signature space corresponding to a first application signature are in communication with the first application signature while the signature space corresponds to only the user currently initiating the message; and ]
0.9990428	539	[ a non-woven bent structure adapted to provide a length of the procedure; and ]	[ A needle-in-lancet system for use in a surgical procedure, the system comprising: ]
0.99999094	540	[ a cannula having a proximal end and a distal end, the cannula including a guidewire operatively coupling the guidewire to the cannula, the guidewire with a length of the non-woven bent structure, whereinthe guidewire comprises a first guidewire having a length of 3 mm or less and a second guidewire having a length of 0.90 or greater and a guidewire material configured to be wound about different areas of the guidewire by pressure against human skin. ]	[ a non-woven bent structure adapted to provide a length of the procedure; and ]
0.9962722	541	[ a first bioactive peptide (A) wherein said first bioactive peptide (A) is represented by the structure NEP-S1HZ-(PDZ)-Y-RNSQRRY, and ]	[ A method of treating a patient who has cancer, the method comprising administering to the patient in need thereof a composition comprising: ]
0.99999225	542	[ wherein said first bioactive peptide (A) interacts with the tumor cells and binds to said prostate. ]	[ a first bioactive peptide (A) wherein said first bioactive peptide (A) is represented by the structure NEP-S1HZ-(PDZ)-Y-RNSQRRY, and ]
0.9950599	543	[ an aperture for receiving an eye socket, the aperture having a first end and a second end; ]	[ A surgical apparatus comprising: ]
0.99984705	544	[ a surgical collar having first and second ends and generally located substantially perpendicular to the first end of the surgical collar, the first and second ends being substantially parallel to one another; ]	[ an aperture for receiving an eye socket, the aperture having a first end and a second end; ]
0.99999225	545	[ a first insertion member inserted substantially perpendicular to the first end of the surgical collar; ]	[ a surgical collar having first and second ends and generally located substantially perpendicular to the first end of the surgical collar, the first and second ends being substantially parallel to one another; ]
0.999992	546	[ a second insertion member inserted substantially parallel to that of the first insertion member and substantially located remotely from the first insertion member and substantially adjacent to the second insertion member; and ]	[ a first insertion member inserted substantially perpendicular to the first end of the surgical collar; ]
0.99861455	547	[ a mechanism for facilitating movement of the surgical collar relative to the surgical collar. ]	[ a second insertion member inserted substantially parallel to that of the first insertion member and substantially located remotely from the first insertion member and substantially adjacent to the second insertion member; and ]
0.9997117	548	[ a gate provided on the detector to receive an input from the sensor and send a control signal to the valve, wherein the control signal includes a plurality of pulses that are configured to be transmitted through the detector wire at different directions. ]	[ A control device for a pharmaceutical delivery system for delivering a compound to a target tissue, comprising: a light source for illuminating the target tissue; an electron beam detector for detecting an electron beam generated by the light source; a sensor and an input for receiving an input signal; a detector having a first and a second electrode, the detector receiving a signal from the input signal generated by the input signal; a detector wire connected to the first and the second electrode to form an electrical connection between the first and the second electrode; and ]
0.9954438	549	[ a protective emulsion; ]	[ A non-pore sterilizing liquid for sterilizing a surgical instrument comprising: ]
0.99932706	550	[ at least one sterilizing agent; and ]	[ a protective emulsion; ]
0.9996636	551	[ at least one surfactant, wherein the microbicidal surfactant comprises a first polymeric stabilizing polymer isolated from an azine polymers which are not aryl polymers of the following N-butylamino carbons bonded to non-alkyl residues and are selected at least from the group consisting of poly(methylsulphate), hydrocolloid and styrene; ]	[ at least one sterilizing agent; and ]
0.99999166	552	[ wherein the microbicidal surfactant is present in an amount of from about 0.01% to about 30% by weight; and ]	[ at least one surfactant, wherein the microbicidal surfactant comprises a first polymeric stabilizing polymer isolated from an azine polymers which are not aryl polymers of the following N-butylamino carbons bonded to non-alkyl residues and are selected at least from the group consisting of poly(methylsulphate), hydrocolloid and styrene; ]
0.9999924	553	[ wherein the microbicidal surfactant is present in an amount of from about 0.001% to about 2% by weight. ]	[ wherein the microbicidal surfactant is present in an amount of from about 0.01% to about 30% by weight; and ]
0.99391645	554	[ an acoustic energy source that emits acoustic energy in a first direction; ]	[ An automated therapy apparatus comprising: ]
0.99998546	555	[ a first resonator coupled to said acoustic energy source for generating a first resonance oscillation frequency for a first type of energy that is excitated by an electric field between a first region in the body of an individual in a body environment and a second region in a body environment; and ]	[ an acoustic energy source that emits acoustic energy in a first direction; ]
0.999992	556	[ a compressor that compresses said first resonance oscillation frequency to receive a first frequency and generate an alternating frequency, said first transmission frequency being substantially the same as said first frequency. ]	[ a first resonator coupled to said acoustic energy source for generating a first resonance oscillation frequency for a first type of energy that is excitated by an electric field between a first region in the body of an individual in a body environment and a second region in a body environment; and ]
0.99999213	557	[ wherein the biofluid is of a desired composition, such that an amount of said biological product delivers a sufficient volume of said biological product to promote retention of a pharmaceutical composition within a space suitable for implantation near the surface of the biotechnic product. ]	[ A method for delivering a biotechnological product comprising administering a biological product within a biofluid-vibrating body member, which body member is composed of a non-invasive fluid interface, and ]
0.99982566	558	[ a web processing platform configured to send or receive a message; ]	[ A computer-implemented system for delivering, at a web-based online service, a message to one or more sites on a network, comprising: ]
0.9996687	559	[ means for using the message; ]	[ a web processing platform configured to send or receive a message; ]
0.998497	560	[ communications data providing information identifying one or more sites on the network to receive a message from the web processing platform, the messages being delivered to one or more sites on the network; and, ]	[ means for using the message; ]
0.99999225	561	[ a server configured to receive the messages from the web processing platform and to send the messages to the one or more sites, the server further providing an ability to define messages that can be delivered to the one or more sites on the network directly using the message. ]	[ communications data providing information identifying one or more sites on the network to receive a message from the web processing platform, the messages being delivered to one or more sites on the network; and, ]
0.99995553	562	[ a fluid source for supplying to the biological fluid wherein the biological fluid is in fluid communication with the fluid source and defines a fluid-free area where at least one of it and other fluids in the biological fluid within a fluid-free area are able to contact the fluid source; ]	[ An apparatus for measuring a concentration of a chemical or organic compound in a biological fluid, comprising: ]
0.9999907	563	[ a temperature detector for measuring a temperature of the fluid source; and ]	[ a fluid source for supplying to the biological fluid wherein the biological fluid is in fluid communication with the fluid source and defines a fluid-free area where at least one of it and other fluids in the biological fluid within a fluid-free area are able to contact the fluid source; ]
0.99997497	564	[ a data processor for identifying the chemical or organic compound to be measured from the temperature/ temperature detector pair, wherein the data processor separates the chemical or organic compound from a reference chemical or organic compound. ]	[ a temperature detector for measuring a temperature of the fluid source; and ]
0.9976071	565	[ a rotor of a lower portion; ]	[ A rotary dial instrument comprising: ]
0.9959395	566	[ a shaft including a rotary shaft portion and a movable arm; ]	[ a rotor of a lower portion; ]
0.9999908	567	[ a drive assembly engaging a shaft portion of the rotating arm and coupled to the movable arm; ]	[ a shaft including a rotary shaft portion and a movable arm; ]
0.99788	568	[ a magnet operatively coupled to a shaft drive coupling and rotatable between an actuating position and a retracted position; ]	[ a drive assembly engaging a shaft portion of the rotating arm and coupled to the movable arm; ]
0.99994874	569	[ a finger engaging device on the magnet for engaging an adjacent finger in a predetermined position when the magnet is in the actuating position, and ]	[ a magnet operatively coupled to a shaft drive coupling and rotatable between an actuating position and a retracted position; ]
0.006433913	570	[ then gradually retracting the motor; and ]	[ a finger engaging device on the magnet for engaging an adjacent finger in a predetermined position when the magnet is in the actuating position, and ]
0.004195467	571	[ a switch associated with the drive assembly, said switch being operable independently of the magnet. ]	[ then gradually retracting the motor; and ]
0.99999225	572	[ (a) obtaining first data representative of a curvature of the patient's bone along a curved surface of the diseased and progressive vertebrae, and ]	[ A method of correcting a diseased bone in a patient having a diseased and progressive vertebrae comprising the steps of: ]
0.99999225	573	[ providing second data representative of the curvature of the patient's bone along the curved surface of the diseased and progressive vertebrae; ]	[ (a) obtaining first data representative of a curvature of the patient's bone along a curved surface of the diseased and progressive vertebrae, and ]
0.9999609	574	[ (b) assessing the first data and the second data to detect a tissue abnormality, wherein the second data and the first data have correlated data within time, and ]	[ providing second data representative of the curvature of the patient's bone along the curved surface of the diseased and progressive vertebrae; ]
0.99999154	575	[ wherein the first data and the second data match and only be misidentified by the diseased bone; ]	[ (b) assessing the first data and the second data to detect a tissue abnormality, wherein the second data and the first data have correlated data within time, and ]
0.99862194	576	[ (c) determining whether the tissue abnormality is from a cochlea in a patient whose cochlea changes substantially to a first pattern as compared to corresponding patterns of the other two vertebrae; and ]	[ wherein the first data and the second data match and only be misidentified by the diseased bone; ]
0.9999865	577	[ (d) correcting the cochlea of the patient so as to improve or stabilize the patient's condition when corrected by modifying the second data in accordance with a condition of the patient prior to presenting the second data. ]	[ (c) determining whether the tissue abnormality is from a cochlea in a patient whose cochlea changes substantially to a first pattern as compared to corresponding patterns of the other two vertebrae; and ]
0.99822634	578	[ emitting a signal through an external earpiece to a patient. ]	[ A method of use-as-an-apparatus for diagnosing patient-related conditions of a patient, the method comprising: ]
0.99987864	579	[ administering to the subject a humanized antibody or pro-humanized antibody that specifically binds epitope 535; or a pharmaceutically acceptable salt thereof, to specifically block V&#x3b1; ]	[ A method for the treatment of or prevention of an immune disorder in a subject in need thereof, the method comprising: ]
0.9789373	580	[ , ]	[ administering to the subject a humanized antibody or pro-humanized antibody that specifically binds epitope 535; or a pharmaceutically acceptable salt thereof, to specifically block V&#x3b1; ]
0.99554646	581	[ 1-adrenergic receptor A31 (V&#x3b1; ]	[ , ]
0.9875267	582	[ , ]	[ 1-adrenergic receptor A31 (V&#x3b1; ]
0.006017025	583	[ 1-ADRA31) activity as compared to an untreated receptor, wherein the humanized antibody or pro-humanized antibody does not specifically bind V&#x3b1; ]	[ , ]
0.99856395	584	[ -1, ]	[ 1-ADRA31) activity as compared to an untreated receptor, wherein the humanized antibody or pro-humanized antibody does not specifically bind V&#x3b1; ]
0.9971374	585	[ 1, ]	[ -1, ]
0.993216	586	[ 2, ]	[ 1, ]
0.96610427	587	[ 4- ADRA31: ]	[ 2, ]
0.9798007	588	[ 4, ]	[ 4- ADRA31: ]
0.9914038	589	[ 4-DIMR&#x2014; ]	[ 4, ]
0.9844862	590	[ 6, ]	[ 4-DIMR&#x2014; ]
0.9941339	591	[ 9-adrenergic receptor A32 (V&#x3b1; ]	[ 6, ]
0.9855326	592	[ , ]	[ 9-adrenergic receptor A32 (V&#x3b1; ]
0.98915625	593	[ ADRA32) activity, or the polypeptide of type 1- A1-(at least some) or type 1- ADRAR&#x2014; ]	[ , ]
0.9968828	594	[ 17. ]	[ ADRA32) activity, or the polypeptide of type 1- A1-(at least some) or type 1- ADRAR&#x2014; ]
0.9997683	595	[ contacting the agent with a peptide composition consisting of a polypeptide, optionally substituted with one or more amino acid substitutions, wherein said amino acid substitutions are selected from the group consisting of: ]	[ A method for enhancing the efficacy of therapy, based on a composition comprising an agent, comprising: ]
0.9993388	596	[ a linear amino acid sequence having at least 95% residue number homology with SEQ ID NO: 1. ]	[ contacting the agent with a peptide composition consisting of a polypeptide, optionally substituted with one or more amino acid substitutions, wherein said amino acid substitutions are selected from the group consisting of: ]
0.994886	597	[ a frame adapted to maintain an obturator member for monitoring axial measurement of a position relative to a lateral axis to be measured through a length of the body of the subject, the frame comprising: ]	[ A system for measuring bone thickness, comprising: ]
0.99987984	598	[ a first portion having a proximal end defining a proximal length of the frame and a distal end; ]	[ a frame adapted to maintain an obturator member for monitoring axial measurement of a position relative to a lateral axis to be measured through a length of the body of the subject, the frame comprising: ]
0.99999166	599	[ a second portion of the frame having a proximal length, the second portion of the frame further defining a circumferential area; and ]	[ a first portion having a proximal end defining a proximal length of the frame and a distal end; ]
0.99999106	600	[ a third portion of the frame having a further circumferential area defined by a portion of the circumferential area aligned with a portion of the head of the subject, a diameter of the circumferential area and an arrangement at the circumferential area that holds a rod, and ]	[ a second portion of the frame having a proximal length, the second portion of the frame further defining a circumferential area; and ]
0.9999882	601	[ that is at least 20% larger in size than the second portion and the third portion of the frame, wherein the rod is attached to the distal end of the first portion. ]	[ a third portion of the frame having a further circumferential area defined by a portion of the circumferential area aligned with a portion of the head of the subject, a diameter of the circumferential area and an arrangement at the circumferential area that holds a rod, and ]
0.9996573	602	[ a distal end member adapted to direct an ophthalmic agent through a fixation catheter, the fixation catheter attached to a mainframe that can be moved about the fixation catheter body; ]	[ A catheter comprising: ]
0.9999913	603	[ a fixation member adapted to move about a patient, the fixation member having a first member; ]	[ a distal end member adapted to direct an ophthalmic agent through a fixation catheter, the fixation catheter attached to a mainframe that can be moved about the fixation catheter body; ]
0.99999225	604	[ a second member disposed adjacent to the first member, the second member in contact with the fixation member, wherein a gap in a surface of the second member is adapted to receive a needle; and ]	[ a fixation member adapted to move about a patient, the fixation member having a first member; ]
0.9999912	605	[ a drive structure configured to drive the fixation member between a first position and a second position, ]	[ a second member disposed adjacent to the first member, the second member in contact with the fixation member, wherein a gap in a surface of the second member is adapted to receive a needle; and ]
0.99999154	606	[ wherein the first position includes a first position where the second member is in contact with the fixation member and a second position where the second member is not in contact with the fixation member and no needle can be coupled therewith, and ]	[ a drive structure configured to drive the fixation member between a first position and a second position, ]
0.99999225	607	[ a position to a limit of the second member where no further needle can be coupled, ]	[ wherein the first position includes a first position where the second member is in contact with the fixation member and a second position where the second member is not in contact with the fixation member and no needle can be coupled therewith, and ]
0.99996614	608	[ wherein the second member is not adapted to fix a screw attached to the fixation member. ]	[ a position to a limit of the second member where no further needle can be coupled, ]
0.9973527	609	[ a) a display provided with at least one video monitor for displaying a video of an area undergoing treatment and user input for selecting an adjustment of a degree of treatment to be taken, ]	[ A patient monitoring apparatus comprising: ]
0.99999213	610	[ wherein an area undergoing treatment is indicated by a image of the area undergoing treatment on the video video monitor and a patient is indicated by the image of the patient on the video monitor and the effect on the patient being selected on the video display of displaying on the video screen thereon at least one other control to be applied via the video monitor when a change in a patient's value results in the patient being treated in at least one of less than 50% with the condition and more than 50% with the condition, and ]	[ a) a display provided with at least one video monitor for displaying a video of an area undergoing treatment and user input for selecting an adjustment of a degree of treatment to be taken, ]
0.99999213	611	[ when a change in an amount to be applied to the amount is defined as being beyond the degree of treatment of the patient, the control is applied by the user input to the video monitor and the change in amount in excess of the degree of treatment, is displayed on the video display on the display to designate in the video the change in amount in absolute value to be executed on the video monitor and thereby to limit the amount of the change in amount on the video monitor to a treatment program which includes the degree of treatment being taken. ]	[ wherein an area undergoing treatment is indicated by a image of the area undergoing treatment on the video video monitor and a patient is indicated by the image of the patient on the video monitor and the effect on the patient being selected on the video display of displaying on the video screen thereon at least one other control to be applied via the video monitor when a change in a patient's value results in the patient being treated in at least one of less than 50% with the condition and more than 50% with the condition, and ]
0.9986725	612	[ providing a blood sample comprising a first composition stored in at least one tissue region, wherein the first composition comprises a second composition which is a combination of the first and second compositions; ]	[ A method for treating a medical condition, comprising: ]
0.9991916	613	[ introducing the first-bio-initiated diffusion-free polypeptide polymer of the set forth peptide combinations comprising the first-bio-initiated diffusion-free polypeptide polymer (GPO). ]	[ providing a blood sample comprising a first composition stored in at least one tissue region, wherein the first composition comprises a second composition which is a combination of the first and second compositions; ]
0.99999225	614	[ (a) delivering to a blood sample, a therapeutically effective amount of an endothelin receptor amino acid that is a substituted humanization of a first humanization that encodes a peptide selected from the group consisting of: ]	[ A method for making a humanized therapy and control therapy for the delivery of a therapeutically effective amount of an endothelin receptor to human blood, said method comprising: ]
0.9997806	615	[ (i) the amino acid sequence of SEQ ID NO: 1; and ]	[ (a) delivering to a blood sample, a therapeutically effective amount of an endothelin receptor amino acid that is a substituted humanization of a first humanization that encodes a peptide selected from the group consisting of: ]
0.99991465	616	[ (ii) the amino acid sequence for a pharmaceutically acceptable salt and one or more substituted hydroxyacyl sequences; and ]	[ (i) the amino acid sequence of SEQ ID NO: 1; and ]
0.9866132	617	[ (b) measuring at least a portion of the blood sample in response to said delivery, wherein said measuring comprises: ]	[ (ii) the amino acid sequence for a pharmaceutically acceptable salt and one or more substituted hydroxyacyl sequences; and ]
0.9999901	618	[ i. measuring at least a portion of the tissue in the blood sample; ]	[ (b) measuring at least a portion of the blood sample in response to said delivery, wherein said measuring comprises: ]
0.999992	619	[ ii. measuring at least a portion of the drug-soluble serum in the blood sample; ]	[ i. measuring at least a portion of the tissue in the blood sample; ]
0.9999685	620	[ iii. measuring at least a portion of a soluble polypeptide that exists in-gel in the plasma of a subject to be treated, wherein said soluble polypeptide or, a polymerization molecule from said soluble polypeptide, and ]	[ ii. measuring at least a portion of the drug-soluble serum in the blood sample; ]
0.99998665	621	[ said polymerized polypeptide can be detected in a ratio from about 0 to a concentration of 0.000001-0.00005 gm/kg/day. ]	[ iii. measuring at least a portion of a soluble polypeptide that exists in-gel in the plasma of a subject to be treated, wherein said soluble polypeptide or, a polymerization molecule from said soluble polypeptide, and ]
0.029748728	622	[ an adjuvant, specifically one of esters or surfactants comprising the following compounds: ]	[ A composition comprising a composition including: ]
0.9987872	623	[ sulfamic acid, ]	[ an adjuvant, specifically one of esters or surfactants comprising the following compounds: ]
0.9997942	624	[ amylenol, ]	[ sulfamic acid, ]
0.9955983	625	[ hydroxypropylcarbamate, ]	[ amylenol, ]
0.9939619	626	[ an ester, or surfactant; and ]	[ hydroxypropylcarbamate, ]
0.99860364	627	[ one or more stabilizers. ]	[ an ester, or surfactant; and ]
0.9959961	628	[ an elongated member having a first end and a second end, the first end having an x-axis and a pierce direction; ]	[ A device for a non-destructive therapeutic treatment on a blood vessel wall, comprising: ]
0.9998299	629	[ an imaging apparatus adapted to be mounted on the first end; ]	[ an elongated member having a first end and a second end, the first end having an x-axis and a pierce direction; ]
0.99997866	630	[ a control circuit coupled to the imaging apparatus, the control circuit configured to change a position of the x-axis relative to the pierce direction in a predetermined position; ]	[ an imaging apparatus adapted to be mounted on the first end; ]
0.99998987	631	[ an imaging part disposed between the first and second ends of the elongated member, the imaging part including a first cavity for receiving a venous pressure agent, an optical element and an imaging assembly, the imaging assembly being formed by a layer having a plurality of layers spaced apart as a plane on the x-axis, the optical part of the imaging assembly being attached to the optical element of the imaging member for rotating the piece around the x-axis depending on a position of a x-axis penetration detection zone and rotating a cover with the imaging assembly to mount the imaging assembly at the x-axis penetration detection zone; and ]	[ a control circuit coupled to the imaging apparatus, the control circuit configured to change a position of the x-axis relative to the pierce direction in a predetermined position; ]
0.999966	632	[ a treatment controller configured to change a position of the x-axis penetration detection zone according to the changed location of the x-axis penetration detection zone. ]	[ an imaging part disposed between the first and second ends of the elongated member, the imaging part including a first cavity for receiving a venous pressure agent, an optical element and an imaging assembly, the imaging assembly being formed by a layer having a plurality of layers spaced apart as a plane on the x-axis, the optical part of the imaging assembly being attached to the optical element of the imaging member for rotating the piece around the x-axis depending on a position of a x-axis penetration detection zone and rotating a cover with the imaging assembly to mount the imaging assembly at the x-axis penetration detection zone; and ]
0.9998908	633	[ 2 or a fragment thereof, wherein the fragment comprises the amino acid sequence identified in SEQ ID NO: 2 of SEQ ID Number 2. ]	[ An isolated nucleic acid molecule encoding a peptide comprising the sequence of SEQ ID NO: ]
0.9999856	634	[ administration of a gossypol (0.1 to 7.0 g/day) to a subject in need thereof having dysbiosis of the gastrointestinal tract, wherein the gossypol is administration by orally receiving an effective amount of gossypol administered; ]	[ A method of treating a gastrointestinal disorder, comprising: ]
0.9999908	635	[ an oral fluid formulation comprising gossypol prior to being administered to the subject in need thereof, wherein the oral fluid formulation is encapsulated in a polymeric foam, and ]	[ administration of a gossypol (0.1 to 7.0 g/day) to a subject in need thereof having dysbiosis of the gastrointestinal tract, wherein the gossypol is administration by orally receiving an effective amount of gossypol administered; ]
0.9999895	636	[ wherein the material is arranged in a first layer of the polymeric foam adjacent to a second layer of the polymeric foam; ]	[ an oral fluid formulation comprising gossypol prior to being administered to the subject in need thereof, wherein the oral fluid formulation is encapsulated in a polymeric foam, and ]
0.99999225	637	[ the polymeric foam having a surface, arranged such that the surface of the polymeric foam defines an area substantially comparable to a mouth of the subject. ]	[ wherein the material is arranged in a first layer of the polymeric foam adjacent to a second layer of the polymeric foam; ]
0.00078562996	638	[ 2, ]	[ A vaccine having an effective amount of a polypeptide having a sequence that is at least 95% identical to or closely approximating the amino acid sequence of SEQ ID NO: ]
0.0049890373	639	[ wherein said vaccine is administered to a subject to assist in preventing or reducing the occurrence of a disease with severe erythroid cancer or to stimulate the development of a disease of or cancer associated with the neoplasm. ]	[ 2, ]
0.99952495	640	[ an elliptical device; ]	[ An exercise apparatus comprising: ]
0.9999918	641	[ a set-to be inserted after first and second steps in a non-linear movement via the elliptical device in a radial direction to a plurality of positions; and ]	[ an elliptical device; ]
0.9999802	642	[ a back plate fixedly arranged on the elliptical device, the back plate having a sidewall and a corner at least as long as an outer surface of the inner surface, the outer surface including a portion that becomes a cut-slip of substantially a thickness, the outer surface having a side that substantially is a parallel to the circumferential surface, the side having at least one feature, the side being a thin surface, the side having a cross-section that reflects the longitudinal velocity of the elliptical device after the first and second steps during the radial movement. ]	[ a set-to be inserted after first and second steps in a non-linear movement via the elliptical device in a radial direction to a plurality of positions; and ]
0.018561864	643	[ extracting and storing a unique identification of at least a portion of a living kidney; ]	[ The method comprising: ]
0.99999225	644	[ storing, in a remotely electronic storage device, a signature in association with the extracted portion of the live kidney or the signature in association with the signature of a patient to identify the unique identification of the at least the portion of the live kidney; ]	[ extracting and storing a unique identification of at least a portion of a living kidney; ]
0.99999213	645	[ displaying, in an interactive virtual interaction device, an instruction for the recipient to perform the step of reproducibly receiving a unique identification of the harvested portion of the live kidney with respect to a user; and ]	[ storing, in a remotely electronic storage device, a signature in association with the extracted portion of the live kidney or the signature in association with the signature of a patient to identify the unique identification of the at least the portion of the live kidney; ]
0.99999225	646	[ transmitting, on a data transmission system, the unique identification of the harvested portion of the live kidney with respect to the patient in order to reproduce a representative reproduction of the produced representative reproduction. ]	[ displaying, in an interactive virtual interaction device, an instruction for the recipient to perform the step of reproducibly receiving a unique identification of the harvested portion of the live kidney with respect to a user; and ]
0.9682077	647	[ a base, defining an outer surface; ]	[ A device comprising: ]
0.008844345	648	[ a substrate that is a thermoplastic composite or a polymer; and ]	[ a base, defining an outer surface; ]
0.99662006	649	[ a heat exchanger that heat diffuses heat generated by the material to the outer surface of the substrate from a thermal source from which a heat treatment is initiated across the inner surface of the substrate in a first direction, to the thermal source in a second direction, to the heat treatment initiated across the inner surface of the substrate in the first direction, to the thermal treatment initiated across the inner surface of the substrate at the outer surface of the substrate in the second direction, to the third direction, and ]	[ a substrate that is a thermoplastic composite or a polymer; and ]
0.9999747	650	[ to at least one of the fourth direction, ]	[ a heat exchanger that heat diffuses heat generated by the material to the outer surface of the substrate from a thermal source from which a heat treatment is initiated across the inner surface of the substrate in a first direction, to the thermal source in a second direction, to the heat treatment initiated across the inner surface of the substrate in the first direction, to the thermal treatment initiated across the inner surface of the substrate at the outer surface of the substrate in the second direction, to the third direction, and ]
0.99987614	651	[ wherein the first direction is direction away from the outer surface of the substrate, and ]	[ to at least one of the fourth direction, ]
0.9999541	652	[ the maximum temperature level of heat transferred from the thermal source to the outer surface of the substrate is greater when the thermal treatment is initiated within the first light; and ]	[ wherein the first direction is direction away from the outer surface of the substrate, and ]
0.9999919	653	[ a handle that does not extend outwardly from the first light when the device is in a first state of operation without a heat treatment having been initiated. ]	[ the maximum temperature level of heat transferred from the thermal source to the outer surface of the substrate is greater when the thermal treatment is initiated within the first light; and ]
0.99822634	654	[ 12, or 34, and ]	[ A device for administering a formulation comprising a polypeptide consisting of amino acids of SEQ ID NO: 8, 10, ]
0.97984225	655	[ a pharmaceutically acceptable carrier, wherein the polypeptide comprises the amino acid sequences arranged in the structure A&#x2212; ]	[ 12, or 34, and ]
0.9989791	656	[ SEQ ID NO: 8, 9, 10,11, 12, or ]	[ a pharmaceutically acceptable carrier, wherein the polypeptide comprises the amino acid sequences arranged in the structure A&#x2212; ]
0.99827135	657	[ 13, ]	[ SEQ ID NO: 8, 9, 10,11, 12, or ]
0.00015963025	658	[ the carrier comprises; ]	[ 13, ]
0.026084658	659	[ an active ingredient; ]	[ the carrier comprises; ]
0.98883516	660	[ a stabilizer; ]	[ an active ingredient; ]
0.9481003	661	[ and ]	[ a stabilizer; ]
0.95206094	662	[ a hydrophobic liquid; ]	[ and ]
0.9978635	663	[ wherein the stabilizer is produced by adding salt to a solution between the active ingredient and the active ingredient and solution containing the stabilizer and a non-soluble formulation; ]	[ a hydrophobic liquid; ]
0.99768865	664	[ a single application of the formulation is sufficient to generate a therapeutically effective concentration in the plural solutions, wherein the formulation exhibits an effectiveness that is greater than the therapeutically effective concentration, ]	[ wherein the stabilizer is produced by adding salt to a solution between the active ingredient and the active ingredient and solution containing the stabilizer and a non-soluble formulation; ]
0.9968184	665	[ the mixture includes each of: ]	[ a single application of the formulation is sufficient to generate a therapeutically effective concentration in the plural solutions, wherein the formulation exhibits an effectiveness that is greater than the therapeutically effective concentration, ]
0.9985184	666	[ at least one liquid contained within the liquid mixture such that when, as an end user who is applying the formulation to a skin surface, receives the formulation at a given location, the formulation is delivered to surface tissues such that the formulation applies to at least one skin surface; and ]	[ the mixture includes each of: ]
0.99999225	667	[ all or some of the polymer components in the formulation are added to the liquid mixture such that when the formulation is applied to one or more surfaces based on one or more selected application directions of at least one application motion, the formulation is effective to deliver the formulation to the selected ones of the surfaces based on the one or more selected application directions. ]	[ at least one liquid contained within the liquid mixture such that when, as an end user who is applying the formulation to a skin surface, receives the formulation at a given location, the formulation is delivered to surface tissues such that the formulation applies to at least one skin surface; and ]
0.99591523	668	[ at least one anti-inflammatory agent; ]	[ A composition comprising an effective amount of a hydrophilic polymeric carrier having a carrier surface in the range of 50-300 pH and having a polymer composition composition properties substantially matching the composite properties of polymeric materials, comprising: ]
0.99982065	669	[ an anti-sclerosis agent; ]	[ at least one anti-inflammatory agent; ]
0.9995228	670	[ a fatty acid ester; ]	[ an anti-sclerosis agent; ]
0.00858346	671	[ at least one carrier; ]	[ a fatty acid ester; ]
0.9998479	672	[ at least one fatty acid ester; ]	[ at least one carrier; ]
0.99964845	673	[ at least one carrier in solution; ]	[ at least one fatty acid ester; ]
0.9995407	674	[ at least one anti-inflammatory agent; ]	[ at least one carrier in solution; ]
0.99998736	675	[ an anti-inflammatory agent; and ]	[ at least one anti-inflammatory agent; ]
0.9974764	676	[ an active substance. ]	[ an anti-inflammatory agent; and ]
0.9837571	677	[ at least one processor; and ]	[ An implantable medical device comprising: ]
0.9996166	678	[ at least one memory including, ]	[ at least one processor; and ]
0.9944601	679	[ a program in the at least one processor defining, for monitoring and controlling the at least one processor, at least one condition for operation of the implantable medical device; ]	[ at least one memory including, ]
0.97806054	680	[ an input device, ]	[ a program in the at least one processor defining, for monitoring and controlling the at least one processor, at least one condition for operation of the implantable medical device; ]
0.9999776	681	[ wherein, upon activation of the input device, the input device records, in a memory in the at least one processor, a parameter of a physiological function of the patient for a duration of time different from activation that is different from that of the patient, and ]	[ an input device, ]
0.9999918	682	[ wherein, after recording the parameters that have been recorded in the memory, the interface of the implantable medical device is connected to a medical device provider, wherein data recorded in the memory, when transferred to the medical device provider, are indicative of the physiological function of the patient. ]	[ wherein, upon activation of the input device, the input device records, in a memory in the at least one processor, a parameter of a physiological function of the patient for a duration of time different from activation that is different from that of the patient, and ]
0.9999919	683	[ a. administering an effective amount of a drug having an effective amount of nitric oxide; and ]	[ A method for determining an effective amount of nitric oxide to be delivered to a site in a human, the method comprising: ]
0.9999906	684	[ b. monitoring a concentration of nitric oxide in fluid delivered to the site; ]	[ a. administering an effective amount of a drug having an effective amount of nitric oxide; and ]
0.0036024593	685	[ wherein the method is performed in a time sequence different from a timing corresponding to the drug administration, the treatment, and ]	[ b. monitoring a concentration of nitric oxide in fluid delivered to the site; ]
0.99912745	686	[ the monitoring. ]	[ wherein the method is performed in a time sequence different from a timing corresponding to the drug administration, the treatment, and ]
0.53596294	687	[ wherein: ]	[ A non-subcutaneous adhesive composition in the formula: ]
0.9896309	688	[ R1 and R2 are independently hydrogen, hydroxyl, halogen or sulfonononano or a natural compound; and ]	[ wherein: ]
0.9971276	689	[ R2 and R3 are selected from the group consisting of 1, 5, 25 and 40 alkyl; ]	[ R1 and R2 are independently hydrogen, hydroxyl, halogen or sulfonononano or a natural compound; and ]
0.97432953	690	[ where each R1 is the same, and ]	[ R2 and R3 are selected from the group consisting of 1, 5, 25 and 40 alkyl; ]
0.99997497	691	[ each R2 is the same if at least one of R1 and R2 is 2, 3 or 4 or one of R1 and R3 is the same and for at least one R3; ]	[ where each R1 is the same, and ]
0.9984908	692	[ wherein each R5 is an amino acid; and ]	[ each R2 is the same if at least one of R1 and R2 is 2, 3 or 4 or one of R1 and R3 is the same and for at least one R3; ]
0.9998529	693	[ wherein each R7 is H or the substituted heteroaromatic group or halo or the substituted heteroaromatic group having 1 to 4 carbon atoms or the halo; wherein the amino acid structure of all R7s is C3 or C8 or cyclic anions. ]	[ wherein each R5 is an amino acid; and ]
0.9922923	694	[ a base comprising a recess and a back surface, and ]	[ A rotatable magnetic-sealable dispensing bottle, comprising: ]
0.9999858	695	[ a cap, wherein the base is cylindrical, wherein the cap is cylindrical and wherein the recess is positioned adjacent the back surface of the cap, and ]	[ a base comprising a recess and a back surface, and ]
0.999992	696	[ wherein at least a portion of the back surface of the cap aligns with the face of the base, wherein the recess is fixed in such a manner that when the caps are placed in an inner region of the recess, the cap contacts the face of the base to generate rotational force, and ]	[ a cap, wherein the base is cylindrical, wherein the cap is cylindrical and wherein the recess is positioned adjacent the back surface of the cap, and ]
0.999992	697	[ wherein the cap extends above the face of the base and, when the caps are positioned inside the recess, the caps rest on the recess. ]	[ wherein at least a portion of the back surface of the cap aligns with the face of the base, wherein the recess is fixed in such a manner that when the caps are placed in an inner region of the recess, the cap contacts the face of the base to generate rotational force, and ]
0.9915969	698	[ (a) a) providing a target material; ]	[ A method for producing a composite polymer composite material, said method comprising: ]
0.9999914	699	[ (b) polymerizing the target material; ]	[ (a) a) providing a target material; ]
0.99999213	700	[ (c) removing the polymerization from the target material; and ]	[ (b) polymerizing the target material; ]
0.9999908	701	[ (d) directing polymerizing to a first polymerizable substrate, wherein the first polymerizable substrate has a polymerization rate proportional to the composition of the target material as measured to obtain the composite polymer. ]	[ (c) removing the polymerization from the target material; and ]
0.9999875	702	[ an agent-enabled device configured to execute the communication activity; ]	[ A method associated, by a communications provider of a communications activity, with an agent and having at least one interface via an over-the-air client configuration server of a communications services provider providing a communications activity, a device based on the agent configured to communicate the communications activity, and ]
0.999992	703	[ wherein the agent is an intranet server configured configured to accept requests of the communications activity in comparison to a user or access protocol of the intranet server stored and accessible by the communications service provider; ]	[ an agent-enabled device configured to execute the communication activity; ]
0.9999924	704	[ wherein the agent is configured to be available to a remote environment for performing the communication activity by an operative interface program that is delivered by the communications services provider to the communication services provider; and ]	[ wherein the agent is an intranet server configured configured to accept requests of the communications activity in comparison to a user or access protocol of the intranet server stored and accessible by the communications service provider; ]
0.99999213	705	[ wherein the communications service provider selects a communication activity based upon a selection result of a verification procedure provided by an operative interface program. ]	[ wherein the agent is configured to be available to a remote environment for performing the communication activity by an operative interface program that is delivered by the communications services provider to the communication services provider; and ]
0.99543023	706	[ an interior space comprising an inner chamber wherein an air-passaged fluid is disposed in the interior space, and ]	[ A device for dispensing non-invasively therapeutic fluids, the device comprising: ]
0.9970925	707	[ containing storage space for storing the non-invasively therapeutic fluids; and ]	[ an interior space comprising an inner chamber wherein an air-passaged fluid is disposed in the interior space, and ]
0.9990294	708	[ a flow port into the interior space, wherein the fluid flow is controlled by a flow device. ]	[ containing storage space for storing the non-invasively therapeutic fluids; and ]
0.9999919	709	[ using a detection system for detecting a current velocity of a drug in the body fluid, wherein the detection system includes a first detection unit configured to project a first signal that indicates a current position of the current drug from a first first position and for generating a second signal, the second signal being similar and having characteristic of a signal associated with the current drug; and ]	[ A method for determining a location of a drug in a body fluid, the method comprising: ]
0.9999924	710	[ using a storage unit to store the current velocity and a reference location of the drug when the current position and the reference location are known. ]	[ using a detection system for detecting a current velocity of a drug in the body fluid, wherein the detection system includes a first detection unit configured to project a first signal that indicates a current position of the current drug from a first first position and for generating a second signal, the second signal being similar and having characteristic of a signal associated with the current drug; and ]
0.012762943	711	[ a cylindrical shaft; ]	[ A hair control device which comprises: ]
0.9999913	712	[ a control bar connected to said cylindrical shaft and having a first end and a second end, an aperture therein, and ]	[ a cylindrical shaft; ]
0.9999913	713	[ means for passing the control bar between a first position and a second position; ]	[ a control bar connected to said cylindrical shaft and having a first end and a second end, an aperture therein, and ]
0.9999902	714	[ wherein said first end of said control bar is coupled to said first end of the cylindrical shaft and does not interfere with the placement of the control bar at a first location in the body, the first position of the control bar being used to adjust the position of the control bar at the first end of said shaft. ]	[ means for passing the control bar between a first position and a second position; ]
0.9999758	715	[ a pair of glove hands including first and second glove hands, a first glove hand being rotatably attached to a first one of the glove hands and securing second glove hands to one another, the second glovehand being rotatably attached to a first one of the glove hands and securing in a first location with the first one of the glove hands and the second glovehand when the protective glove is secured to one each direction and in position to protect an eye of a person wearing the protective glove. ]	[ A protective glove comprising: ]
0.99958056	716	[ wherein the second region is generally an elastomeric type in which a polymerization process is introduced, and ]	[ A method of transforming a gel into a material with an improved elastomeric properties, comprising the step of depositing liquid gel at a first location on a substrate in contact with a secondlocation of the substrate, from the secondlocation, which is different than the first location, to the first location, of substantially the same material, the step of depositing liquid gel to be deposited having a first and a second crystalline phase, wherein the first crystalline phase is bonded to at least one end of the material thereby for the solvent to provide one of a contact with the liquid gel at or above a contact temperature and a contact with the liquid gel at or below a contact temperature located at the first region, and ]
0.99981004	717	[ wherein a time between the contact temperature and the contact temperature located at the first region is less than about 1 and about 2 nanoseconds each. ]	[ wherein the second region is generally an elastomeric type in which a polymerization process is introduced, and ]
0.9991967	718	[ determining from a portion of the irradiated image a direction, shape, and ]	[ A method of identifying a candidate substance in an image obtained using a radiation detector, comprising: ]
0.9995726	719	[ color of a region of interest, the region of interest having a proximal end; ]	[ determining from a portion of the irradiated image a direction, shape, and ]
0.9992499	720	[ producing the image by imaging the image; ]	[ color of a region of interest, the region of interest having a proximal end; ]
0.9966017	721	[ determining a parameter analysis result based on the pixel values of the received image taken by the radiation detector for a region of interest between the proximal end of the region of interest and a second region of interest where the region of interest is opposed and perpendicular to the second region, the image having a red channel extending in the direction of the region of interest and a blue channel extending in the direction of the second region; ]	[ producing the image by imaging the image; ]
0.9999846	722	[ detecting radiation having radiation and corresponding coordinates by the radiation detector without providing visible information; ]	[ determining a parameter analysis result based on the pixel values of the received image taken by the radiation detector for a region of interest between the proximal end of the region of interest and a second region of interest where the region of interest is opposed and perpendicular to the second region, the image having a red channel extending in the direction of the region of interest and a blue channel extending in the direction of the second region; ]
0.9999715	723	[ analyzing the image to identify at least three types of at the region of interest, wherein analyzing comprises determining that the radiation has been identified based on a distance angle between the direction, shape, and ]	[ detecting radiation having radiation and corresponding coordinates by the radiation detector without providing visible information; ]
0.9999697	724	[ color of the region of interest and the second region; and ]	[ analyzing the image to identify at least three types of at the region of interest, wherein analyzing comprises determining that the radiation has been identified based on a distance angle between the direction, shape, and ]
0.9991725	725	[ displaying a portion of the image. ]	[ color of the region of interest and the second region; and ]
0.9911521	726	[ a housing; ]	[ A toy device that delivers a target for a target injection device, the device comprising: ]
0.94915015	727	[ a distal end surface; ]	[ a housing; ]
0.96051747	728	[ a plurality of projections configured to pass within said chamber with respect to said housing, said projections including an attachment point defining a first slot; ]	[ a distal end surface; ]
0.9847239	729	[ a hook; ]	[ a plurality of projections configured to pass within said chamber with respect to said housing, said projections including an attachment point defining a first slot; ]
0.99984324	730	[ a member slidably mounted to the distal end surface of said housing and including projections of the projecting member, said hook configured to extend between said projections; and ]	[ a hook; ]
0.9999919	731	[ a connector configured to fit into the distal end surface of the housing and configured to extend between said projections, said connector including a second slot defining a second opening for receiving a second projection member, said second projecting member associated with an elongated body having a first diameter and a second diameter different than by a portion of a length of said projecting member, the second projection member spaced apart from the second projecting slot of the housing. ]	[ a member slidably mounted to the distal end surface of said housing and including projections of the projecting member, said hook configured to extend between said projections; and ]
0.99932635	732	[ an elongate tube having a center portion, a distal end, and ]	[ A surgical instrument, comprising: ]
0.99999154	733	[ a peripheral portion protruding from one side of said periphery portion of said elongate tube, the peripheral portion being movably arranged with respect to the center portion to prevent a gap between the ends of said tube so as to permit the elongate tube to be inserted into a joint through a lumen of a human patient; ]	[ an elongate tube having a center portion, a distal end, and ]
0.9999896	734	[ a proximal end portion of the elongate tube; ]	[ a peripheral portion protruding from one side of said periphery portion of said elongate tube, the peripheral portion being movably arranged with respect to the center portion to prevent a gap between the ends of said tube so as to permit the elongate tube to be inserted into a joint through a lumen of a human patient; ]
0.99999154	735	[ a distal end portion of the elongate tube, the distal end portion being movably arranged with respect to the proximal end portion to permit displacement between adjacent transverse surfaces, the transverse surfaces disposed in an opening to the peripheral portion and arranged to permit a distal engagement toward the proximal end portion of the elongate tube; and ]	[ a proximal end portion of the elongate tube; ]
0.9999896	736	[ a distal portion of the elongate tube, the distal portion having a first end and a second end; and ]	[ a distal end portion of the elongate tube, the distal end portion being movably arranged with respect to the proximal end portion to permit displacement between adjacent transverse surfaces, the transverse surfaces disposed in an opening to the peripheral portion and arranged to permit a distal engagement toward the proximal end portion of the elongate tube; and ]
0.99993503	737	[ at least one needle rotatable within the distal portion. ]	[ a distal portion of the elongate tube, the distal portion having a first end and a second end; and ]
0.99995804	738	[ a clamp in elongated shape, the insertable device being adapted to be slidably coupled with an end side of a patient to mount on a medical end of an in-vivo system; an anti-tear device on a clamp side of the insertable device; an adhesive in-between the anti-tear device and the clamp, wherein the adhesive is in-compact and having a thinning effect on a medical implant insertion area of the implant, wherein the clamp is positioned on an end side of the flat frame; and ]	[ An insertion device comprising a flat, rectangular frame made of a flexible, melt-resistant adhesive, and ]
0.99999213	739	[ an absorbent support member coupled to one of the clamp and the anti-tear device and on the flat, rectangular frame, wherein the absorbent support member is positioned on a proximal side of the clamp, and ]	[ a clamp in elongated shape, the insertable device being adapted to be slidably coupled with an end side of a patient to mount on a medical end of an in-vivo system; an anti-tear device on a clamp side of the insertable device; an adhesive in-between the anti-tear device and the clamp, wherein the adhesive is in-compact and having a thinning effect on a medical implant insertion area of the implant, wherein the clamp is positioned on an end side of the flat frame; and ]
0.99999225	740	[ the clamp is positionable onto the absorbent support member. ]	[ an absorbent support member coupled to one of the clamp and the anti-tear device and on the flat, rectangular frame, wherein the absorbent support member is positioned on a proximal side of the clamp, and ]
0.999992	741	[ injecting a therapeutic treatment into the earache, the therapeutic treatment comprising a composition having at least one of an effective amount of pyridostigmine tetramide (PTT), an effective amount of fenibolin, a pharmaceutical, and ]	[ An earache treatment method for a patient having earache comprising: ]
0.9995309	742	[ non-phosphorous effective amount of citrate that comprises a salt thereof, and ]	[ injecting a therapeutic treatment into the earache, the therapeutic treatment comprising a composition having at least one of an effective amount of pyridostigmine tetramide (PTT), an effective amount of fenibolin, a pharmaceutical, and ]
0.98949695	743	[ at least one of a pharmaceutically acceptable composition and a dental care product, on a central nerve root from the site of the earache in a percutaneous delivery direction, the percutaneous delivery direction comprising from approximately 5 minutes to about 15 minutes, and ]	[ non-phosphorous effective amount of citrate that comprises a salt thereof, and ]
0.9998123	744	[ wherein the patient has a volume of a percutaneous nerve cord and is in a position in which the drug is effective to reduce the obstruction of the nerve center tissue of the patient. ]	[ at least one of a pharmaceutically acceptable composition and a dental care product, on a central nerve root from the site of the earache in a percutaneous delivery direction, the percutaneous delivery direction comprising from approximately 5 minutes to about 15 minutes, and ]
0.99999034	745	[ positioning a first component of a tissue mass against a surface of a non-invasive monitoring instrument; ]	[ A method for reducing waste of a tissue mass comprising: ]
0.99998593	746	[ advancing said first component from a first position through an aperture in said first component to a second position by rotating about a first axis, said first axis being substantially parallel to said first axis; and ]	[ positioning a first component of a tissue mass against a surface of a non-invasive monitoring instrument; ]
0.99999225	747	[ moving a sensing element from an initial position to a second position relative to said first component by pushing said sensing element against a second sensor array between said initial position and said second position without moving said first component towards said first position. ]	[ advancing said first component from a first position through an aperture in said first component to a second position by rotating about a first axis, said first axis being substantially parallel to said first axis; and ]
0.99962294	748	[ (a) a monoclonal antibody or antigen-binding fragment thereof in combination with selected of a) an acute phase, b) a phase wherein the chronic phase of the compound is utilized, c) a phase wherein the chronic phase is inactive, and ]	[ A method of treating a liver disorder, comprising administering to a subject in need thereof a therapeutically effective amount of a compound selected from the group consisting of: ]
0.99999213	749	[ d) a biological fragment of the acute phase or the phase wherein the chronic phase is inactive. ]	[ (a) a monoclonal antibody or antigen-binding fragment thereof in combination with selected of a) an acute phase, b) a phase wherein the chronic phase of the compound is utilized, c) a phase wherein the chronic phase is inactive, and ]
0.012857191	750	[ (a) providing a machine; ]	[ A method for the detection and/or treatment of a problem or condition associated with a muscle unit, comprising the steps of: ]
0.003736455	751	[ (b) acquiring image information depicting a structure or the structure's or a portion thereof of said structure and the muscular unit of the subject to be treated using image data of said structure; ]	[ (a) providing a machine; ]
0.99984944	752	[ (c) determining a muscle unit target signal indicative of an operation which is specific to the muscle unit; ]	[ (b) acquiring image information depicting a structure or the structure's or a portion thereof of said structure and the muscular unit of the subject to be treated using image data of said structure; ]
0.0027190452	753	[ (d) receiving said image information using said machine in said machine in accordance with said image data; ]	[ (c) determining a muscle unit target signal indicative of an operation which is specific to the muscle unit; ]
0.9999895	754	[ (e) determining muscle unit location information from said image data of said structure in said frame; ]	[ (d) receiving said image information using said machine in said machine in accordance with said image data; ]
0.9999924	755	[ (f) receiving muscle unit condition data from said frame for said exercise of said muscle unit; and ]	[ (e) determining muscle unit location information from said image data of said structure in said frame; ]
0.9999924	756	[ (g) producing a report for treatment of said subject based on (i) said muscle unit location information and (ii) said muscle unit condition data. ]	[ (f) receiving muscle unit condition data from said frame for said exercise of said muscle unit; and ]
0.9988299	757	[ (a) one or more medical devices, the one or more medical devices including a device holder for receiving the one or more medical devices; and ]	[ A system for supporting the delivery of biologic support to a patient's body composition comprising: ]
0.9993405	758	[ (b) a catheter; ]	[ (a) one or more medical devices, the one or more medical devices including a device holder for receiving the one or more medical devices; and ]
0.0006683856	759	[ the device holder being sized to carry and hold the device, with the device having a first end fixed with the device holder in a first position, and ]	[ (b) a catheter; ]
0.9999924	760	[ the device having a second end fixed with the device holder in another position different from the first position, where the one of the first end and the second end including a portion of the medical device; ]	[ the device holder being sized to carry and hold the device, with the device having a first end fixed with the device holder in a first position, and ]
0.9999907	761	[ wherein the device holder contains a first plurality of devices, and ]	[ the device having a second end fixed with the device holder in another position different from the first position, where the one of the first end and the second end including a portion of the medical device; ]
0.9999794	762	[ the first plurality of devices includes a plurality of implanted devices in a first location of the one or more devices. ]	[ wherein the device holder contains a first plurality of devices, and ]
0.9998692	763	[ measuring a spinal mass of a first patient to identify a region of interest wherein the plurality of electrodes in the spinal mass are located on different neural axons communicating with at least one nerve or spinal capillar, wherein a first one of the electrodes is located on a spinal nerve for receiving feedback from a user, and ]	[ A method for selecting a treatment device for a targeted site of spinal tissue comprising: ]
0.9999907	764	[ wherein a second one of the electrodes is located on an internal bone cap; ]	[ measuring a spinal mass of a first patient to identify a region of interest wherein the plurality of electrodes in the spinal mass are located on different neural axons communicating with at least one nerve or spinal capillar, wherein a first one of the electrodes is located on a spinal nerve for receiving feedback from a user, and ]
0.00037848	765	[ detecting a region of interest relating to an indication of the extent of local curvature of a first neural nerve of the first patient, and ]	[ wherein a second one of the electrodes is located on an internal bone cap; ]
0.99999225	766	[ a region of interest relating to the extent of local curvature of a second neural nerve of the first patient; ]	[ detecting a region of interest relating to an indication of the extent of local curvature of a first neural nerve of the first patient, and ]
0.9992053	767	[ determining the treatment device to be a primary treatment device; ]	[ a region of interest relating to the extent of local curvature of a second neural nerve of the first patient; ]
0.9978235	768	[ selecting a target site to treat the spinal mass in the spinal mass, wherein selecting a target site comprises: ]	[ determining the treatment device to be a primary treatment device; ]
0.999992	769	[ selecting both the first one of the electrodes and the second one of the electrodes based on an evaluation of the spinal mass relative to an initial surface of the location, and ]	[ selecting a target site to treat the spinal mass in the spinal mass, wherein selecting a target site comprises: ]
0.99999225	770	[ the degree of curvature over the surface of the spinal mass relative to the initial surface; and ]	[ selecting both the first one of the electrodes and the second one of the electrodes based on an evaluation of the spinal mass relative to an initial surface of the location, and ]
0.0021072398	771	[ deactivating the primary treatment device based on the identified region of interest. ]	[ the degree of curvature over the surface of the spinal mass relative to the initial surface; and ]
0.99999166	772	[ a main body configured to be fastened to the treatment pump system; ]	[ A gas treatment apparatus designed to be attached to a treatment pump system comprising: ]
0.99997854	773	[ a first gushing member provided between and coupled to the main body; and ]	[ a main body configured to be fastened to the treatment pump system; ]
0.9999895	774	[ a first gas diffuser comprising a high surface area gas diffactor and a plurality of first fluid communication ports, each of which is secured to a respective first fluid communication port of the high surface area gas diffactor, the main body and each of the first fluid communication ports cooperating to receive a respective first fluid through the first gushing member when the treatment pump system is attached to the treatment pump system, said first gushing member having a first axis, said first gushing member also having at least one second axis extending across the first height of the main body, ]	[ a first gushing member provided between and coupled to the main body; and ]
0.04660093	775	[ wherein: ]	[ a first gas diffuser comprising a high surface area gas diffactor and a plurality of first fluid communication ports, each of which is secured to a respective first fluid communication port of the high surface area gas diffactor, the main body and each of the first fluid communication ports cooperating to receive a respective first fluid through the first gushing member when the treatment pump system is attached to the treatment pump system, said first gushing member having a first axis, said first gushing member also having at least one second axis extending across the first height of the main body, ]
0.019434644	776	[ the first gushing member has an axis that is perpendicular to a first first length of an outer lip portion of said high surface area gas diffactor; and ]	[ wherein: ]
0.99999225	777	[ said first gushing member is configured to be movable relative to said high surface area gas diffactor to provide a first upward displacement of said first gushing member relative to said main body, wherein in vertical position the first gushing member has a reduced length of travel and said opposite axis of said first gushing member is rotatable, thereby increasing the flow pressure of the first fluid in the first gushing member to a desired level. ]	[ the first gushing member has an axis that is perpendicular to a first first length of an outer lip portion of said high surface area gas diffactor; and ]
0.99998343	778	[ a fixation sleeve having a first end attached to a bone head and a second end including a contact opening for inserting a first bone beam through the hole, wherein the first end has a size sufficient to hold a first bone beam at a first position for fixation to a first bone, and ]	[ A bone fixation system to be implanted in a leg, arm or foot of a patient, comprising: ]
0.99999213	779	[ a second end extending from the contact opening for inserting a second bone beam through the hole, wherein the second end has a size sufficient to hold a second bone beam at a second position for fixation to a second bone; and ]	[ a fixation sleeve having a first end attached to a bone head and a second end including a contact opening for inserting a first bone beam through the hole, wherein the first end has a size sufficient to hold a first bone beam at a first position for fixation to a first bone, and ]
0.99996006	780	[ at least one resilient member provided around each of the first end and the second end, the one resilient member comprising a hinge that engages with said contact opening at an outer portion of the surface of the member, said hinge having an upper surface and a lower surface opposite one another, a forward and rearward side opposite said lower surface and wherein at least one of said resilient members is affixed to a flexible surface thereby thereby interlocking said two resilient members to each other. ]	[ a second end extending from the contact opening for inserting a second bone beam through the hole, wherein the second end has a size sufficient to hold a second bone beam at a second position for fixation to a second bone; and ]
0.99996495	781	[ (a) at least one of a) a first portion of a surgical tissue segment and a second portion of the surgical tissue segment, the first portion of the surgical tissue segment having first portions of surgical tissue and the second portion of the surgical tissue segment having the non-surgical tissue, wherein the first portion of the surgical tissue segment includes: ]	[ A surgical tissue manipulation method comprising: ]
0.9999918	782	[ (1) a first portion extending from a first contact area of the non-surgical tissue; a second portion extending from a second contact area of the non-surgical tissue; and ]	[ (a) at least one of a) a first portion of a surgical tissue segment and a second portion of the surgical tissue segment, the first portion of the surgical tissue segment having first portions of surgical tissue and the second portion of the surgical tissue segment having the non-surgical tissue, wherein the first portion of the surgical tissue segment includes: ]
0.9999677	783	[ (2) a first surface thereof facing outwardly from the first portion; ]	[ (1) a first portion extending from a first contact area of the non-surgical tissue; a second portion extending from a second contact area of the non-surgical tissue; and ]
0.9954601	784	[ (b) a first pressure applied to the non-surgical tissue, wherein the first pressure is applied to the non-surgical tissue as a part of an operation; ]	[ (2) a first surface thereof facing outwardly from the first portion; ]
0.99999225	785	[ (c) at least one of a second pressure applied to the non-surgical tissue, wherein the second pressure is applied to the non-surgical tissue as a part of an operation; and ]	[ (b) a first pressure applied to the non-surgical tissue, wherein the first pressure is applied to the non-surgical tissue as a part of an operation; ]
0.9999896	786	[ (d) at least one of a first longitudinal axis of the first portion of the surgical tissue segment and a second longitudinal axis of the second portion of the surgical tissue segment. ]	[ (c) at least one of a second pressure applied to the non-surgical tissue, wherein the second pressure is applied to the non-surgical tissue as a part of an operation; and ]
0.99395543	787	[ an auxiliary shaft coupled to a first portion of a first shaft while said auxiliary handle is simultaneously coupled to a second portion of the first shaft; ]	[ An insertion and removal system for moving an implantable medical device into and out of a medical setting, said system comprising: ]
0.9999906	788	[ a plurality of flexible pieces coupled to said Aux handle and configured to be extended and retracted via said auxiliary shaft; and ]	[ an auxiliary shaft coupled to a first portion of a first shaft while said auxiliary handle is simultaneously coupled to a second portion of the first shaft; ]
0.9999862	789	[ an intermediate shaft coupled to said auxiliary shaft and a lumen extending between said auxiliary handle and said auxiliary shaft, said first shaft and said auxiliary shaft being defined by an insertion guide defining an opening therethrough that allows said apparatus to be inserted therein, ]	[ a plurality of flexible pieces coupled to said Aux handle and configured to be extended and retracted via said auxiliary shaft; and ]
0.99997663	790	[ wherein said plurality of flexible pieces extend outward from said auxiliary handle to an expandable outer region of said Aux handle. ]	[ an intermediate shaft coupled to said auxiliary shaft and a lumen extending between said auxiliary handle and said auxiliary shaft, said first shaft and said auxiliary shaft being defined by an insertion guide defining an opening therethrough that allows said apparatus to be inserted therein, ]
0.98853755	791	[ a hollow cylindrical body having a generally cylindrical shape; ]	[ A therapeutic capsule comprising: ]
0.97037256	792	[ a generally planar cavity that is sized to surround and contain a plurality of biological structures; ]	[ a hollow cylindrical body having a generally cylindrical shape; ]
0.00020883948	793	[ a sealable insert that is installed in the cylindrical body in the closed condition when the capsule is pressed against a patient; ]	[ a generally planar cavity that is sized to surround and contain a plurality of biological structures; ]
0.99922204	794	[ a closed chamber that is sized to contain a therapeutic compound selected from the group consisting of benzyl alcohol, propylene glycol, and ]	[ a sealable insert that is installed in the cylindrical body in the closed condition when the capsule is pressed against a patient; ]
0.99779534	795	[ acetone; and ]	[ a closed chamber that is sized to contain a therapeutic compound selected from the group consisting of benzyl alcohol, propylene glycol, and ]
1.14839795e-05	796	[ at least one sealing member that seals the cavity in the closed chamber when the sealable insert is installed in the closed chamber and when the sealable insert is removed from the cavity in the closed chamber; ]	[ acetone; and ]
0.9999918	797	[ wherein the capsule is in a closed and sealed state while sealed in the closed chamber. ]	[ at least one sealing member that seals the cavity in the closed chamber when the sealable insert is installed in the closed chamber and when the sealable insert is removed from the cavity in the closed chamber; ]
0.9999918	798	[ (a) providing an implantable defibrillator; ]	[ A method of producing an implantable, implantable defibrillator, the method comprising: ]
0.99986506	799	[ (b) providing a combination of material elements, said combination comprising: ]	[ (a) providing an implantable defibrillator; ]
0.99670416	800	[ (i) a blood pressure sensor, said blood pressure sensor comprising an insulating layer, ]	[ (b) providing a combination of material elements, said combination comprising: ]
0.99901855	801	[ (ii) at least one of a biocompatible liquid (C-LL) and a non-cable or non-cerine polymer coating, ]	[ (i) a blood pressure sensor, said blood pressure sensor comprising an insulating layer, ]
0.9999248	802	[ (iii) at least one of a non-polar/neutral (C-NN), the C-NN being a hydrophobic shell and with an electrochlorinated material coating, and ]	[ (ii) at least one of a biocompatible liquid (C-LL) and a non-cable or non-cerine polymer coating, ]
0.9999385	803	[ (iv) at least one of an aqueous or a media, said non-cable or non-cerine coating being adhered to at least one of said material elements, and ]	[ (iii) at least one of a non-polar/neutral (C-NN), the C-NN being a hydrophobic shell and with an electrochlorinated material coating, and ]
0.9999858	804	[ wherein said aqueous or media is a biocompatible material. ]	[ (iv) at least one of an aqueous or a media, said non-cable or non-cerine coating being adhered to at least one of said material elements, and ]
0.0008861117	805	[ an interior wall assembly; ]	[ An apparatus for providing patient assistance of an individual in need thereof, comprising: ]
0.999992	806	[ at least one arm or appendage operably coupled to the interior wall assembly, the arm being movable within the interior wall assembly, through a designated area, and ]	[ an interior wall assembly; ]
0.9999893	807	[ into a designated sub-area where it is responsive to a control on the apparatus of a first user, a second user, or both each to thereby assist the individual in need of the assistance in movement of the at least one arm to perform basic tasks of self-contained life, such as lying down, standing, standing or walking, in which one arm or appendage of the individual performs assistance without such assistance being required from an external source, in order to achieve some physical or mental outcome, which is associated with motion of movements of the at least one arm and at least one appendage. ]	[ at least one arm or appendage operably coupled to the interior wall assembly, the arm being movable within the interior wall assembly, through a designated area, and ]
0.018396175	808	[ the method comprising: ]	[ A method for automatically producing a color combination of a plurality of three-dimensional images of a skin surface, ]
0.050902184	809	[ storing the plurality of three-dimensional images in a memory; ]	[ the method comprising: ]
0.9999578	810	[ searching a plurality of image fields of each image field of the plurality of images, wherein the search is performed repeatedly during the time period for which an image is stored in the memory; ]	[ storing the plurality of three-dimensional images in a memory; ]
0.99998546	811	[ processing a first one of the image fields to determine a first predetermined value representing a first predetermined point for the color combination; ]	[ searching a plurality of image fields of each image field of the plurality of images, wherein the search is performed repeatedly during the time period for which an image is stored in the memory; ]
0.99999225	812	[ processing a second one of the image fields to determine a second predetermined value representing a second predetermined point for the color combinations on the skin surface; and ]	[ processing a first one of the image fields to determine a first predetermined value representing a first predetermined point for the color combination; ]
0.99999225	813	[ generating a color combination consisting of the first and second predetermined values corresponding to the first and second predetermined points for a second one of the image fields, the processing being in response to a query from a user; ]	[ processing a second one of the image fields to determine a second predetermined value representing a second predetermined point for the color combinations on the skin surface; and ]
0.99999213	814	[ wherein the first predetermined value is determined based on the image fields of the first image field of the first image field that include the first predetermined point, the algorithm further comprising: ]	[ generating a color combination consisting of the first and second predetermined values corresponding to the first and second predetermined points for a second one of the image fields, the processing being in response to a query from a user; ]
0.9999893	815	[ extracting a first one of a plurality of image cells into a plurality of image cells being extracted without obtaining a third one of the image field cells that corresponds to a third point; ]	[ wherein the first predetermined value is determined based on the image fields of the first image field of the first image field that include the first predetermined point, the algorithm further comprising: ]
0.99999213	816	[ extracting a second one of the plurality of image cells into a plurality of image cells being extracted without obtaining a fourth one of the image field cells that corresponds to a fourth point; ]	[ extracting a first one of a plurality of image cells into a plurality of image cells being extracted without obtaining a third one of the image field cells that corresponds to a third point; ]
0.99998593	817	[ comparing a first and a second predetermined value within the plurality of image fields; and ]	[ extracting a second one of the plurality of image cells into a plurality of image cells being extracted without obtaining a fourth one of the image field cells that corresponds to a fourth point; ]
0.9999809	818	[ assigning a negative value of the first predetermined value to a point on the skin surface at which the skin surface is covered with skin. ]	[ comparing a first and a second predetermined value within the plurality of image fields; and ]
0.9993462	819	[ a playing piece that includes a frame, a back, a base, a heel, a hook, a strap, a hand, and ]	[ A game machine comprising: ]
0.9999114	820	[ a plurality of playing members that include first, second, and ]	[ a playing piece that includes a frame, a back, a base, a heel, a hook, a strap, a hand, and ]
0.99985766	821	[ third hands each including a front,, a back, and ]	[ a plurality of playing members that include first, second, and ]
0.97539186	822	[ a body, and ]	[ third hands each including a front,, a back, and ]
0.9994931	823	[ a recess that is formed in the outer part thereof, the recess extending to the back of said playing piece by a distance such that the hand can be pulled and the front of the hand can be pulled into the front of said recess adjacent the body of the body of the playing member; and ]	[ a body, and ]
0.9999913	824	[ a movable platform at the front of the playing piece, the platform including a pivot portion that is movable to the front of the playing piece by a rotational engagement region between the front of each of the first hand and the front of each of the second hand such that the side that has been pushed through the recess is aligned with respect to the center of a centerline of the playing piece. ]	[ a recess that is formed in the outer part thereof, the recess extending to the back of said playing piece by a distance such that the hand can be pulled and the front of the hand can be pulled into the front of said recess adjacent the body of the body of the playing member; and ]
0.999992	825	[ further comprising activating the metallic element in the patient's chest for 5 to 20 minutes prior to surgery, wherein the prosthenium is placed in the patient's chest while the metallic element activates. ]	[ A method of treating a cancer, comprising inserting into a patient's chest in a manner not in fluid communication with tissue of the patient a prosthesis comprised of a first surface, an opening through an interface, one end of the interface and a second surface attached to the opening and having sufficient structure around the first surface to form a seal with the a vascular wall, wherein the prosthenium is a metallic element having predetermined composition to be activated by injection into the patient when the metallic element is placed in the patient's chest; and ]
0.99999213	826	[ a housing having a first side and a second side, the housing further comprising an image display unit operably connected to said housing and adapted to deliver a plurality of predetermined radiographic imaging spectra to said first side and said second side; ]	[ A device for providing a plurality of radiographic imaging spectra, the device comprising: ]
0.99999225	827	[ a detector operatively connected to the housing and configured to acquire at least one of the plurality of predetermined radiographic imaging spectra; and ]	[ a housing having a first side and a second side, the housing further comprising an image display unit operably connected to said housing and adapted to deliver a plurality of predetermined radiographic imaging spectra to said first side and said second side; ]
0.0027980064	828	[ a memory having one or more of data storage and a database, the memory having data, data collection, and ]	[ a detector operatively connected to the housing and configured to acquire at least one of the plurality of predetermined radiographic imaging spectra; and ]
0.99811965	829	[ a set of data, data collection routines for receiving and storing data from said detector and for processing the data. ]	[ a memory having one or more of data storage and a database, the memory having data, data collection, and ]
0.99642617	830	[ providing a print-front layer that rests on a substrate and comprises at least one color printing process; ]	[ A process for printing a printed product selected from the group including a product for use into a product holder comprising: ]
0.99999213	831	[ forming the print-front layer with a print-front process product; ]	[ providing a print-front layer that rests on a substrate and comprises at least one color printing process; ]
0.99999225	832	[ depositing at least an intermediate layer between the print-front and the the product; ]	[ forming the print-front layer with a print-front process product; ]
0.99999213	833	[ adhering the intermediate layer to the print-front layer, so as to expose the intermediate layer to a customer; ]	[ depositing at least an intermediate layer between the print-front and the the product; ]
0.99999213	834	[ applying only a print-front layer comprising only the intermediate layer after the print-front layer has been deposited to the product holder in order to generate a print-front layer image; ]	[ adhering the intermediate layer to the print-front layer, so as to expose the intermediate layer to a customer; ]
0.99999225	835	[ printing the print-front layer including the intermediate layer formed above the print-front layer in a vertical position, so as to expose the intermediate layer to only at least a portion of the customer during the printing process; ]	[ applying only a print-front layer comprising only the intermediate layer after the print-front layer has been deposited to the product holder in order to generate a print-front layer image; ]
0.99999225	836	[ applying a layer of a third color that has an opposite color pattern to the pattern selected for the print-front layer except a portion of the surface area of a side of the customer that is exposed; ]	[ printing the print-front layer including the intermediate layer formed above the print-front layer in a vertical position, so as to expose the intermediate layer to only at least a portion of the customer during the printing process; ]
0.99999225	837	[ allowing the third color to radiate toward the side of the customer after the end of the printing process; ]	[ applying a layer of a third color that has an opposite color pattern to the pattern selected for the print-front layer except a portion of the surface area of a side of the customer that is exposed; ]
0.9999758	838	[ sealing the print-front layer in a sealed position and depositing only the intermediate layer in the print-front layer to eliminate its interference with the printing process, but permitting a portion of the intermediate layer to radiate during printing when the intermediate layer is in the sealed form; ]	[ allowing the third color to radiate toward the side of the customer after the end of the printing process; ]
0.98381066	839	[ preparing a plastic package having a printed product portion selected from the group of printed products, the plastic package having at least one cover disposed between the printed product portion and the cover. ]	[ sealing the print-front layer in a sealed position and depositing only the intermediate layer in the print-front layer to eliminate its interference with the printing process, but permitting a portion of the intermediate layer to radiate during printing when the intermediate layer is in the sealed form; ]
0.99915636	840	[ a container having an inside and an outside; ]	[ A non-disposable, compact bag for carrying goods, wherein the bag comprises: ]
0.99995434	841	[ a main body extending from the inside to the exterior of the container, wherein the main body extends through an exterior of the compartment into the inside of the container in a first direction and defines a first cavity; and ]	[ a container having an inside and an outside; ]
0.9999763	842	[ a first coupling, separated from the main body and having a distal end, having a first aperture, wherein the first coupling has a second aperture, and ]	[ a main body extending from the inside to the exterior of the container, wherein the main body extends through an exterior of the compartment into the inside of the container in a first direction and defines a first cavity; and ]
0.9999845	843	[ wherein the second aperture lies within a plane perpendicular to the first aperture and defines a second cavity extending from the second cavity to the exterior of the second bundle, and ]	[ a first coupling, separated from the main body and having a distal end, having a first aperture, wherein the first coupling has a second aperture, and ]
0.004237571	844	[ an optional extension extending from at least one end of the optional extension to at least one end of the container; and ]	[ wherein the second aperture lies within a plane perpendicular to the first aperture and defines a second cavity extending from the second cavity to the exterior of the second bundle, and ]
0.99999225	845	[ wherein the main body and the optional extension define an interior, wherein the free surface of the main body and the optional extension includes a cutting edge when the main body is supported on an adjacent pocket of the container. ]	[ an optional extension extending from at least one end of the optional extension to at least one end of the container; and ]
0.99917704	846	[ providing an instrument that comprises: a plurality of blades disposed distally of a body rod, wherein each blade has proximal and distal ends, and ]	[ A method for use in a method of cutting the bone over a gingival area of a vertebral body, the method comprising: ]
0.9999907	847	[ the blades further comprise a blade tip extendable from the body rod to form a wound on the gingival area of the vertebral body, and ]	[ providing an instrument that comprises: a plurality of blades disposed distally of a body rod, wherein each blade has proximal and distal ends, and ]
0.999992	848	[ a blade comprising a plurality of cutting members comprising a cutting tool that is adapted to permit cuts through the gingival surface of the cervical vertebra for delivery of an amount of medication that is imperceptible relative to the gingival area of the vertebral body when the use of the instrument is performed. ]	[ the blades further comprise a blade tip extendable from the body rod to form a wound on the gingival area of the vertebral body, and ]
0.9894866	849	[ a first surface; ]	[ A golf club head comprising: ]
0.99994767	850	[ a second surface defining an outer surface area, the outer surface area comprising: ]	[ a first surface; ]
0.023104977	851	[ a first solidified material comprising (i) a first composition and (ii) a first polymer, and ]	[ a second surface defining an outer surface area, the outer surface area comprising: ]
0.9999914	852	[ (iii) a second polymer which differs from (i) and other polymerized material used in the first solidified material in at least one of it being non-ionic, non-polymerized, non-solvent, non-mixture of a molar ratio by formula (A): ]	[ a first solidified material comprising (i) a first composition and (ii) a first polymer, and ]
0.97305197	853	[ wherein r, k, m, n, p, and ]	[ (iii) a second polymer which differs from (i) and other polymerized material used in the first solidified material in at least one of it being non-ionic, non-polymerized, non-solvent, non-mixture of a molar ratio by formula (A): ]
0.9969494	854	[ q are the same or different. ]	[ wherein r, k, m, n, p, and ]
0.9996612	855	[ (a) a polypeptide sequence having a first amino acid from SEQ ID NOS: ]	[ A synthetic protein comprising: ]
0.9999862	856	[ 16 and a second, substitutable sequence from SEQ ID NOS: ]	[ (a) a polypeptide sequence having a first amino acid from SEQ ID NOS: ]
0.9996985	857	[ 22, wherein the first amino acid is under the control of a heterocyclic group and the second amino acid is under the control of a heteroaryl group; and ]	[ 16 and a second, substitutable sequence from SEQ ID NOS: ]
0.99998796	858	[ (b) a ligand to reduce the formation of an interfering polypeptide upon binding to said polypeptide sequence on an immune cell, wherein the ligand, if present in the amount required to decrease their activation, has an effectiveness of activating the immune cells against said heterocyclic group and the heteroaryl group. ]	[ 22, wherein the first amino acid is under the control of a heterocyclic group and the second amino acid is under the control of a heteroaryl group; and ]
0.002761719	859	[ a substantially tubular enclosure having an interior wall defining a first compartment with open interior and allowing access to at least one first chamber for holding a contents stored therein; and ]	[ A mobile device to be assembled with a vehicle, comprising: ]
0.99999225	860	[ a second substantially tubular enclosure which comprises at least one rigid flexible support wall being spaced from the first and second walls, the support walls defining at least one entrance port into the interior into which an opening is made through the support walls with the opening of the first compartment containing one or more contents when the enclosure is in a closed configuration allowing flow of first contents into another compartment; ]	[ a substantially tubular enclosure having an interior wall defining a first compartment with open interior and allowing access to at least one first chamber for holding a contents stored therein; and ]
0.99999225	861	[ wherein when a door is placed into the second enclosure with the vehicle, the at least one support wall has been moved into position in the second enclosure and the opening is made through the support walls with the opening of the opening of the first compartment is directly positioned in the first compartment when the first compartment is opened in the closed configuration and at least a portion of the passage for transporting the first items is located in a cavity located between the first compartment and the first support wall. ]	[ a second substantially tubular enclosure which comprises at least one rigid flexible support wall being spaced from the first and second walls, the support walls defining at least one entrance port into the interior into which an opening is made through the support walls with the opening of the first compartment containing one or more contents when the enclosure is in a closed configuration allowing flow of first contents into another compartment; ]
0.00018527449	862	[ an interface comprising: ]	[ A method, comprising the steps of: ]
0.015495425	863	[ an insert; ]	[ an interface comprising: ]
0.9999877	864	[ an insertion tip disposed relative to the insert, the insertion tip forming an engagement portion with the insert; ]	[ an insert; ]
0.9999857	865	[ a clamp coupled with the insert, the clamp adapted to retain the insert while being moved along a linear axis; and ]	[ an insertion tip disposed relative to the insert, the insertion tip forming an engagement portion with the insert; ]
0.9983259	866	[ a slide locking device configured to move the insertion tip along the insertion axis, wherein sliding the slide locking device is non-transparent or non-circular. ]	[ a clamp coupled with the insert, the clamp adapted to retain the insert while being moved along a linear axis; and ]
0.9750761	867	[ imaging the human body to detect a set of biological features and to generate imaging data representing the set of biological features; ]	[ A method that comprises: ]
0.99999154	868	[ capturing imaging data representing a set of image-based biaminas of the human body in a live image, or from a digital image captured in a live image, and ]	[ imaging the human body to detect a set of biological features and to generate imaging data representing the set of biological features; ]
0.99999225	869	[ wherein identifying a second set of image-based biaminas in the live image is substantially simultaneous with or after the capturing of the imaging data representing the set of image-based biaminas, the second set of biaminas having less spatial structure than the corresponding first set of biaminas; ]	[ capturing imaging data representing a set of image-based biaminas of the human body in a live image, or from a digital image captured in a live image, and ]
0.9999918	870	[ detecting a specific position and orientation of a first biological feature for a volume containing an area in the human body with the image data of the live image and using the acquired imaging data to detect at least one biological feature that is associated with the at least one biological feature detected as the first biological feature using the specific position and orientation; and ]	[ wherein identifying a second set of image-based biaminas in the live image is substantially simultaneous with or after the capturing of the imaging data representing the set of image-based biaminas, the second set of biaminas having less spatial structure than the corresponding first set of biaminas; ]
0.99999225	871	[ displaying a sequence of imaging data representing the volume with the at least one biological feature based on that detection. ]	[ detecting a specific position and orientation of a first biological feature for a volume containing an area in the human body with the image data of the live image and using the acquired imaging data to detect at least one biological feature that is associated with the at least one biological feature detected as the first biological feature using the specific position and orientation; and ]
0.0007128905	872	[ a lumen having a longitudinal axis; ]	[ A non-metallic fiber comprising: ]
0.010362034	873	[ a material having a diametrically opposite elongate profile, having a first cross sectional dimension (D) and a second cross sectional dimension (G), the diameter of the first cross sectional dimension being greater than the diameter of the second cross sectional dimension; and ]	[ a lumen having a longitudinal axis; ]
0.99704796	874	[ a compound that is bonded to the lumen and defines a space between the lumen and the material; ]	[ a material having a diametrically opposite elongate profile, having a first cross sectional dimension (D) and a second cross sectional dimension (G), the diameter of the first cross sectional dimension being greater than the diameter of the second cross sectional dimension; and ]
0.9973901	875	[ wherein the material of the non-metallic fiber comprises a semi-soluble polymer, as to in part, the non-metallic fiber has a high water absorption value. ]	[ a compound that is bonded to the lumen and defines a space between the lumen and the material; ]
0.99921	876	[ or a pharmaceutically acceptable salt thereof, or H or N-oxide under conditions wherewith H or N-oxide is available in said compound. ]	[ A compound of formula (I): ]
0.99999106	877	[ (a) contacting the cancer cells with two antibody products, and <|span|>/or at least one antigen present in said antibody products as an isolated or purified compound; and ]	[ A method for the identification and removal of cancer cells in a mammal, comprising the steps of: ]
0.99999213	878	[ (b) detecting anti-CAM antibody activity from said cancer cells in vitro based on a fluorescence characteristic of said antibody product, wherein (i) the cancer cells are tissue cancer cell lines having a presence in said mammal or an appearance of staining in said mammalian cell lines; and ]	[ (a) contacting the cancer cells with two antibody products, and <|span|>/or at least one antigen present in said antibody products as an isolated or purified compound; and ]
0.99999225	879	[ (ii) the presence of anti-CAM antibody activity indicates that the cancer cells have cancer cells that have cell-mediated immunity. ]	[ (b) detecting anti-CAM antibody activity from said cancer cells in vitro based on a fluorescence characteristic of said antibody product, wherein (i) the cancer cells are tissue cancer cell lines having a presence in said mammal or an appearance of staining in said mammalian cell lines; and ]
0.0010425627	880	[ a) inserting a tongue to expand a fluid channel across a fluid channel having a first edge and a second edge; ]	[ A method suitable for manufacturing dental treatments for a patient to be treated, the method comprising: ]
0.99998784	881	[ b) inserting a treatment area comprising a first channel and a second channel, wherein a first end of a first channel is aligned with a first edge of the second channel and the second end of a first channel is aligned with a second edge of the second channel; ]	[ a) inserting a tongue to expand a fluid channel across a fluid channel having a first edge and a second edge; ]
0.99999106	882	[ c) placing a first shape guide insertable between the first channel and the second channel such that a first channel edge passes through at least part of the first channel; ]	[ b) inserting a treatment area comprising a first channel and a second channel, wherein a first end of a first channel is aligned with a first edge of the second channel and the second end of a first channel is aligned with a second edge of the second channel; ]
0.9999924	883	[ d) inserting a treatment area comprising a second channel and a second edge such that a second channel edge passes through at least part of the second channel; ]	[ c) placing a first shape guide insertable between the first channel and the second channel such that a first channel edge passes through at least part of the first channel; ]
0.99947494	884	[ e) passing the first shape guide through a patient and into a cavity; and ]	[ d) inserting a treatment area comprising a second channel and a second edge such that a second channel edge passes through at least part of the second channel; ]
0.99999213	885	[ f) applying pressure to the user to expand the tongue using the tongue to expand the fluid channel through the cavity as directed by the second shape guide and to the treatment area, and ]	[ e) passing the first shape guide through a patient and into a cavity; and ]
0.99999225	886	[ to expand the dentition, wherein the pressure is applied in the second direction to the treatment area. ]	[ f) applying pressure to the user to expand the tongue using the tongue to expand the fluid channel through the cavity as directed by the second shape guide and to the treatment area, and ]
0.99999106	887	[ a) positioning an article of footwear within a surface of a living entity, the item of footwear comprising at least one device to control movement of the item of footwear; ]	[ A method for an article of footwear comprising the steps of: ]
0.9999924	888	[ b) introducing an item of footwear into a chamber of the living entity; ]	[ a) positioning an article of footwear within a surface of a living entity, the item of footwear comprising at least one device to control movement of the item of footwear; ]
0.99999225	889	[ c) the item of footwear being used by one or more entities the chamber to conduct a surgical procedure; ]	[ b) introducing an item of footwear into a chamber of the living entity; ]
0.9999907	890	[ d) the chambers having at least one barrier surrounding the chamber, wherein the at least one barrier is used to restrict access to portions of the chamber during the surgical procedure, wherein access is by at least one instrument or device adapted to move the device during the surgical procedure; and ]	[ c) the item of footwear being used by one or more entities the chamber to conduct a surgical procedure; ]
0.99999225	891	[ e) the and barrier closing off an area of the living entity during the surgical procedure, the barrier being designed so as to prevent advancement of tissue over those portions of the living entity that permit access to the chamber during the surgical procedure. ]	[ d) the chambers having at least one barrier surrounding the chamber, wherein the at least one barrier is used to restrict access to portions of the chamber during the surgical procedure, wherein access is by at least one instrument or device adapted to move the device during the surgical procedure; and ]
0.9999912	892	[ registering the device with at least one of a plurality of different devices; ]	[ A non-transitory computer-readable storage medium storing a method for determining a level of risk for a device from a plurality of devices having different diagnostic inputs, the method comprising: ]
0.99999034	893	[ receiving a first diagnostic input from the device on a first device coupled to the at least one of the plurality of different devices; ]	[ registering the device with at least one of a plurality of different devices; ]
0.9999924	894	[ identifying a degree of medical dependence of the device of the plurality of different devices from the first diagnostic input; ]	[ receiving a first diagnostic input from the device on a first device coupled to the at least one of the plurality of different devices; ]
0.99999225	895	[ comparing values of the device of the plurality of different devices to a threshold threshold; ]	[ identifying a degree of medical dependence of the device of the plurality of different devices from the first diagnostic input; ]
0.99998426	896	[ depending on the degree of medical dependence of the device, determining that the device has an estimated level of risk; ]	[ comparing values of the device of the plurality of different devices to a threshold threshold; ]
0.99999225	897	[ when determining a level of risk for the device, calculating a maximum risk value for that device; ]	[ depending on the degree of medical dependence of the device, determining that the device has an estimated level of risk; ]
0.9997968	898	[ receiving a second diagnostic input from the device on a second device; ]	[ when determining a level of risk for the device, calculating a maximum risk value for that device; ]
0.99999225	899	[ identifying a degree of medical dependence of the device of the plurality of different devices from the second diagnostic input; and ]	[ receiving a second diagnostic input from the device on a second device; ]
0.99999225	900	[ based on an identification result from the first diagnostic input and the second diagnostic input, calculating estimated level of risk for the device based on the degree of medical dependence of the device as a function of distance between the device and the estimated level of risk and a degree of medical dependence of the device as a function of distance between the device and the corresponding specified threshold set according to the threshold threshold; ]	[ identifying a degree of medical dependence of the device of the plurality of different devices from the second diagnostic input; and ]
0.9999924	901	[ wherein the non-transitory computer readable medium includes at least one step to calculate the level of risk based on the determined degree of medical dependence. ]	[ based on an identification result from the first diagnostic input and the second diagnostic input, calculating estimated level of risk for the device based on the degree of medical dependence of the device as a function of distance between the device and the estimated level of risk and a degree of medical dependence of the device as a function of distance between the device and the corresponding specified threshold set according to the threshold threshold; ]
0.99999213	902	[ aback side tip region, wherein said front portion from which the object of interest moves varies between a front surface thereof and a back surface thereof, wherein the front side tip portion is shaped to have a reduced surface top and rear surface; ]	[ A method for reducing an object of interest in an observation sequence by a moving object having a front side and a rear side, said method comprising an interaction with a front portion of the object of interest, said front portion including a front side tip, including a front side tip portion, a front side area, and ]
0.99999106	903	[ wherein a force on said object of interest applies a force therebetween, and ]	[ aback side tip region, wherein said front portion from which the object of interest moves varies between a front surface thereof and a back surface thereof, wherein the front side tip portion is shaped to have a reduced surface top and rear surface; ]
0.9999902	904	[ at least two of the front side regions of the object of interest extend through the front surface of the front portion, the back surface for contact with an object of interest disposed at the rear side of the object of interest, during the interaction with the front portion prior to the object of interest moving from a front to a back position, wherein the force applied on said object of interest by the force applied on said front portion of the object of interest at the front portion determines when or if or when or when the force is applied to the object of interest. ]	[ wherein a force on said object of interest applies a force therebetween, and ]
0.999764	905	[ a housing, an open end of the housing defining into which an occlusion to be placed by the device is inserted; ]	[ A device for providing intravascular delivery of blood to a patient such as a catheter, the device comprising: ]
0.99722373	906	[ a guide hole formed in the housing; and ]	[ a housing, an open end of the housing defining into which an occlusion to be placed by the device is inserted; ]
0.9993455	907	[ a conduit formed in the housing, said conduit having a first length and a second length, the first length being wider than the second length and the second length being wider than the first length. ]	[ a guide hole formed in the housing; and ]
0.99917656	908	[ an elongate tubular tubular member having a longitudinal axis and a distal end; ]	[ A stent comprising: ]
0.99998915	909	[ a stiffener within said tubular member, wherein said stiffener and said elongate tubular member are attached by one or more fastening components to each other and extend to the outer sidewall of said tubular member; and ]	[ an elongate tubular tubular member having a longitudinal axis and a distal end; ]
0.9986443	910	[ a tubular shell having a rigid main body and a tubular port therethrough, wherein the main body is attached to the rigid tubular member and the tubular port is attached to the rigid tubular member. ]	[ a stiffener within said tubular member, wherein said stiffener and said elongate tubular member are attached by one or more fastening components to each other and extend to the outer sidewall of said tubular member; and ]
0.9997018	911	[ wherein the at least one pharmaceutically acceptable carrier is obtained from the group consisting of aliphatic hydrocarbon extracts, cyclic hydrocarbons, cyclopropane compounds, cyclopropane derivatives, hydrocarbons, solvents and alcohols. ]	[ A computer-implemented method of promoting the initiation of growth in a mammal using at least one pharmaceutical formulation comprising at least a portion of an agent active in the presence of the at least one pharmaceutical formulation, wherein the at least one pharmaceutical formulation is selected from the group of compounds which are synergistic with a pharmaceutical formula and combinations thereof, and ]
0.98895884	912	[ a wireless electronic controller having a screen; ]	[ A system for a patient to reduce and/or terminate exercise and training-related sleep cycles with care, comprising: ]
0.99984884	913	[ a memory storing a programming program that is executable by the controller to control a mode of operation of the controller; ]	[ a wireless electronic controller having a screen; ]
0.99703085	914	[ an electronic controller that is operable to activate and deactivate a power source adapted to transmit a first signal as to whether the power source is available, whether the power source does not exist and optionally, a pattern of timing; and ]	[ a memory storing a programming program that is executable by the controller to control a mode of operation of the controller; ]
0.99999225	915	[ an instruction memory housing storing instruction instructions that are executable by the controller to the electronic controller and configured to at the same time activate the power source and deactivate the power source, a pattern of timing comprising at least one of: ]	[ an electronic controller that is operable to activate and deactivate a power source adapted to transmit a first signal as to whether the power source is available, whether the power source does not exist and optionally, a pattern of timing; and ]
0.998511	916	[ using the light source supplied by the power source, ]	[ an instruction memory housing storing instruction instructions that are executable by the controller to the electronic controller and configured to at the same time activate the power source and deactivate the power source, a pattern of timing comprising at least one of: ]
0.99998546	917	[ using a bed, ]	[ using the light source supplied by the power source, ]
0.99999094	918	[ using a table and/or bed surfaces of the bed, ]	[ using a bed, ]
0.99998856	919	[ using a mattress, and ]	[ using a table and/or bed surfaces of the bed, ]
0.9999895	920	[ using a bedside surface of the mattress. ]	[ using a mattress, and ]
0.99930966	921	[ receiving the object; ]	[ A method of presenting to a subject at least one of an animated object and a body, the method comprising: ]
0.99869126	922	[ moving the subject in the environment, based on a predetermined motion vector; ]	[ receiving the object; ]
0.9999919	923	[ recording the subject moving, at selected times; ]	[ moving the subject in the environment, based on a predetermined motion vector; ]
0.9999052	924	[ receiving additional motion information indicative of moving in a portion of an actual body; and ]	[ recording the subject moving, at selected times; ]
0.999992	925	[ combining the additional motion information from the captured subject with a plurality of motion data points from a display device to generate motion data corresponding to the captured object based on a first motion vector and a second motion vector, wherein the motion data indicates wherein the subject moves in an area that is indicated by the plurality of motion data points, and ]	[ receiving additional motion information indicative of moving in a portion of an actual body; and ]
0.99999225	926	[ wherein the location of points corresponding to multiple motion positions corresponding to different motion directions are mapped to a central axis defined by the first and second motion vectors. ]	[ combining the additional motion information from the captured subject with a plurality of motion data points from a display device to generate motion data corresponding to the captured object based on a first motion vector and a second motion vector, wherein the motion data indicates wherein the subject moves in an area that is indicated by the plurality of motion data points, and ]
0.99985564	927	[ a lens having the form of a continuous, tubular lens; ]	[ A non-contacting lens apparatus for use in surgical photography, comprising: ]
0.9999107	928	[ a housing extending from said lens, providing contact with at least a portion of a first interior surface of the lens and configured for receiving a tool; and ]	[ a lens having the form of a continuous, tubular lens; ]
0.99997914	929	[ defining means along a center line of said housing to define a surface that can be selectively used as a tool-for-hand, said surface being adjacent said lens as a surface with a curvature that increases to an entire minimum width of said surface from which a substantially fixed focal point of said lens can be fixed, wherein the substantially fixed focal point is configured so that when said convex surface of said lens is engaged with the curved surface of a first surface, said curvature becomes flat, and ]	[ a housing extending from said lens, providing contact with at least a portion of a first interior surface of the lens and configured for receiving a tool; and ]
0.9999888	930	[ when said convex surface contacts the curvature of the curved surface, said convex surface of the lens does not, along most of the surface, have a distal end such that said lens cannot contact the first interior surface of the lens. ]	[ defining means along a center line of said housing to define a surface that can be selectively used as a tool-for-hand, said surface being adjacent said lens as a surface with a curvature that increases to an entire minimum width of said surface from which a substantially fixed focal point of said lens can be fixed, wherein the substantially fixed focal point is configured so that when said convex surface of said lens is engaged with the curved surface of a first surface, said curvature becomes flat, and ]
0.9999912	931	[ setting a first set of predetermined test electrodes on the lens or, in a lens region, on the surface surface of the lens and inserting said electrodes from the lens region under the cornea and into at least one of the cornea and the lens, wherein at least a portion of the test electrode in-frame has a predetermined conductivity for retaining and releasing photoreceptor; and ]	[ A method for treating a lesion which is present under the cornea of a lens or which is on an corneal surface of the lens or which is protruding under a surface surface of the lens or which exhibits a condition related to a failure of the lens or the cornea to retain a photoreceptor, comprising: ]
0.9999924	932	[ setting an automatic sensor for detecting an amount of excitation of an endogenous light component of the lenses or the cornea using said test electrodes, wherein the automated sensor is configured to enable monitoring of the amount of excitation that the test electrodes retain or release by said sensors, and ]	[ setting a first set of predetermined test electrodes on the lens or, in a lens region, on the surface surface of the lens and inserting said electrodes from the lens region under the cornea and into at least one of the cornea and the lens, wherein at least a portion of the test electrode in-frame has a predetermined conductivity for retaining and releasing photoreceptor; and ]
0.99999213	933	[ wherein the use of said automated sensor is enabled to provide a digital signal indicative of a size of said excitation. ]	[ setting an automatic sensor for detecting an amount of excitation of an endogenous light component of the lenses or the cornea using said test electrodes, wherein the automated sensor is configured to enable monitoring of the amount of excitation that the test electrodes retain or release by said sensors, and ]
0.9981659	934	[ a lid including a distal end and having an attachment region on a bottom portion, said lid extends outwardly from a bottom edge of said lid. ]	[ A tubular container having: ]
0.9997851	935	[ wherein the patient is a male or female medical patient. ]	[ A method for determining whether a patient has osteosarcoma in a subject having a first diagnosis of osteosarcoma in the subject, the method comprising the step of an automated dental mapping method, ]
0.98651904	936	[ an elliptic body having a distal end; ]	[ A catheter comprising: ]
0.9999918	937	[ an inwardly elongated hollow conduit having a distal end extending as far as a lumen therethrough and adapted to receive a portion of an arm of a leg or a foot or the foot of a user, the lumen defining a hollow cavity having a diameter greater than the diameter of the outer end of the elliptic body, the outer end of the cavity defining a lumen passage adapted to pass through the outer end of the elliptic body for receiving a subject of non-contrast optical imaging; ]	[ an elliptic body having a distal end; ]
0.999992	938	[ an imaging device arranged at least partially along the outer end of the cavity so as to have a long axis directed substantially parallel to the long axis of the elliptic body; and ]	[ an inwardly elongated hollow conduit having a distal end extending as far as a lumen therethrough and adapted to receive a portion of an arm of a leg or a foot or the foot of a user, the lumen defining a hollow cavity having a diameter greater than the diameter of the outer end of the elliptic body, the outer end of the cavity defining a lumen passage adapted to pass through the outer end of the elliptic body for receiving a subject of non-contrast optical imaging; ]
0.9999919	939	[ an image pickup device disposed at a distal end of the outer end of the cavity along the axis of the imaging device. ]	[ an imaging device arranged at least partially along the outer end of the cavity so as to have a long axis directed substantially parallel to the long axis of the elliptic body; and ]
0.9999784	940	[ said wall of the bone part comprising an exterior surface, the exterior surface including a central chamber, wherein the inner surface of the wall is within the central chamber; ]	[ A method of treating a wound, the method comprising administering to a patient an effective amount of x-ray radiation when administered to a bone or joint in a first location comprising delivering the bone or joint to a distal location, wherein the distal location further comprises a bone part having a reduced thickness, wherein the reduced thickness is greater than its respective thickness to cause injury to the bone of the bone portion at the proximal end thereof, a bone part comprising an inside surface, the distal location containing the bone part of the bone that delivers the x-ray radiation and a wall in an interior region less than a wall of the bone part, the hole formed in the bone part of the bone, the wall being reduced than the wall of the bone part, wherein the bone part of the bone has a single outer corner, ]
0.999992	941	[ a plurality of fibers protruding from the exterior surface of the wall without contacting the central chamber of the interior region. ]	[ said wall of the bone part comprising an exterior surface, the exterior surface including a central chamber, wherein the inner surface of the wall is within the central chamber; ]
0.9457675	942	[ a shape-shifting surface; ]	[ A bag comprising: ]
0.9999918	943	[ a base defining a first opening at the shape-shifting surface, the base having one end extending from the shape-shifting surface, the plurality of dimensions allowing for a maximum dimension of the cavity to be in fluid communication with the surface based on the dimension of the base and a respective volume of weight of the bag being in fluid communication with the shape-shifting surface; ]	[ a shape-shifting surface; ]
0.99999225	944	[ a door extending along the shape-shifting surface from the first opening; ]	[ a base defining a first opening at the shape-shifting surface, the base having one end extending from the shape-shifting surface, the plurality of dimensions allowing for a maximum dimension of the cavity to be in fluid communication with the surface based on the dimension of the base and a respective volume of weight of the bag being in fluid communication with the shape-shifting surface; ]
0.9999639	945	[ an optical system located within the first opening, the optical system projecting light therefrom; ]	[ a door extending along the shape-shifting surface from the first opening; ]
0.12312051	946	[ a light detecting unit arranged on said base, the reflecting surface of the light detecting unit being located on an opposite side of the shape-shifting surface, the light detecting unit being arranged within the plurality of dimensions, the reflection surface of light determining the angle of reflection of the light towards the shape-shifting surface; and ]	[ an optical system located within the first opening, the optical system projecting light therefrom; ]
0.9999896	947	[ a housing positioned within the shape-shifting surface in close proximity to said optical system, the housing defining a cavity having a first dimensions that permit insertion and removal of the optical system, the housing having a second dimension that allows a substantially the same fluid communication between the housing and the optical system as those between the housing and surface of the shape-shifting surface. ]	[ a light detecting unit arranged on said base, the reflecting surface of the light detecting unit being located on an opposite side of the shape-shifting surface, the light detecting unit being arranged within the plurality of dimensions, the reflection surface of light determining the angle of reflection of the light towards the shape-shifting surface; and ]
0.9999908	948	[ the inner cover is substantially conical and includes a plurality of lumen openings through which fluid may flow; and ]	[ An optical fiber for a catheter, comprising an elongate tubular member having front and rear ends, an expanded outer surface and an inner cover, wherein: ]
0.60316384	949	[ the optical fiber comprises a tubular connector having a first end with a first elongate extension member slidably connected within the base section and a second end having a second elongate extension member spaced substantially between the first and second ends defining a circumferential groove; ]	[ the inner cover is substantially conical and includes a plurality of lumen openings through which fluid may flow; and ]
0.999992	950	[ wherein the circumferential groove is substantially longitudinally extending, the first and second ends being spaced apart by a distance smaller than a horizontal distance between the first and second ends, and ]	[ the optical fiber comprises a tubular connector having a first end with a first elongate extension member slidably connected within the base section and a second end having a second elongate extension member spaced substantially between the first and second ends defining a circumferential groove; ]
0.9682261	951	[ the inner cover formed by a non-circular elastic material, as the outer cover, overlaps at least one of the longitudinal and longitudinal outer surfaces; and ]	[ wherein the circumferential groove is substantially longitudinally extending, the first and second ends being spaced apart by a distance smaller than a horizontal distance between the first and second ends, and ]
0.99065804	952	[ the elongated extension member positioned in the circumferential groove creates a substantially radial guide surface extending radially outwardly from one of the rear ends. ]	[ the inner cover formed by a non-circular elastic material, as the outer cover, overlaps at least one of the longitudinal and longitudinal outer surfaces; and ]
0.9943613	953	[ a body having a proximal end and a distal end; ]	[ A medical implant structure comprising: ]
0.9974704	954	[ an internal tubular body cavity extending within the body cavity between its adjacent ends; ]	[ a body having a proximal end and a distal end; ]
0.9887666	955	[ at least one first contact member coupled to a proximal side of the body; ]	[ an internal tubular body cavity extending within the body cavity between its adjacent ends; ]
0.99999225	956	[ at least one second contact member coupled to a distal side of the body; and ]	[ at least one first contact member coupled to a proximal side of the body; ]
0.9999908	957	[ a base having a perimeter, wherein at least one of the first, second and third contacts is coupled together to define a pocket in the second contact member. ]	[ at least one second contact member coupled to a distal side of the body; and ]
0.9999745	958	[ providing a skateboard with a skateboard body comprising a seat, support arms, and ]	[ A method of providing an extended-use workout to a user of a skateboard, said method comprising a step of: ]
0.99996555	959	[ an overhead-mounted pole assembly, said overhead-mounted pole assembly having a first end portion and a second end portion, said first and second end portions being formed in a skateboard body with an upper portion, a bottom portion, and ]	[ providing a skateboard with a skateboard body comprising a seat, support arms, and ]
0.99999225	960	[ an upper portion, said first end portion and said second end portion being configured for contacting a surface of the skateboard body to be lifted or pedaled, ]	[ an overhead-mounted pole assembly, said overhead-mounted pole assembly having a first end portion and a second end portion, said first and second end portions being formed in a skateboard body with an upper portion, a bottom portion, and ]
0.99999106	961	[ providing a plurality of legs including one end and the other end, said legs terminating in one or more leg shaft assemblies that detachably couple to said skateboard body in said skateboard body and one or more wheels respectively that are coupled to to one or more of said legs, said one or more wheels of said leg shaft assemblies being coupled to said legs, said one or more wheels of the leg shaft assemblies having a plurality of holes respectively connected to said leg shaft assemblies, ]	[ an upper portion, said first end portion and said second end portion being configured for contacting a surface of the skateboard body to be lifted or pedaled, ]
0.99999213	962	[ and extending from said lower portion of the skateboard to a pad for resting within said skateboard body, ]	[ providing a plurality of legs including one end and the other end, said legs terminating in one or more leg shaft assemblies that detachably couple to said skateboard body in said skateboard body and one or more wheels respectively that are coupled to to one or more of said legs, said one or more wheels of said leg shaft assemblies being coupled to said legs, said one or more wheels of the leg shaft assemblies having a plurality of holes respectively connected to said leg shaft assemblies, ]
0.99986434	963	[ providing a skate wheel comprising a skate, a first surface and a second surface, the first surface and the second surface, wherein at least a portion of said first surface and at least a portion of said second surface are selectively coated with a compound for imparting contact-forming properties to said skate wheel, wherein a layer of said compound may be introduced into the skate wheel through said openings and wherein said layers of said compound are formed on said surface of said skate wheel by the applying of a pressure to an existing surface of said skate wheel to remove said sealing and move said layers of the compound to a region where contact-forming properties are enhanced. ]	[ and extending from said lower portion of the skateboard to a pad for resting within said skateboard body, ]
0.9999739	964	[ providing a main space (12), having a plurality of aisles between which items are positioned; ]	[ A method for controlling operation of a plurality of aisles of a multi-function container, comprising: ]
0.9999906	965	[ connecting the main space (12) to a motor (14/15) to increase a starting position for the main space (12), a driving mechanism (16) coupled to a motor (14/15), and ]	[ providing a main space (12), having a plurality of aisles between which items are positioned; ]
0.9999919	966	[ a drive shaft (38) with a first end (14) for the main space (12) and a second (16) end connector (22). ]	[ connecting the main space (12) to a motor (14/15) to increase a starting position for the main space (12), a driving mechanism (16) coupled to a motor (14/15), and ]
0.9999918	967	[ (a) contacting the ocular vision enhancing agent with the patient at an eye being treated by an ophthalmic vision enhancing agent and wherein (i) the eye being treated is in a non-optimal state and (ii) the patient is receiving treatment using an ophthalmic vision enhancing agent that has a time window that is larger than a critical window; and ]	[ A method for enhancing an ophthalmic vision comprising administering to a patient under management of a visual system management process (SPM) practitioner an ophthalmic vision enhancing agent, the method comprising: ]
0.9999671	968	[ (b) delivering a carrier to the target eye. ]	[ (a) contacting the ocular vision enhancing agent with the patient at an eye being treated by an ophthalmic vision enhancing agent and wherein (i) the eye being treated is in a non-optimal state and (ii) the patient is receiving treatment using an ophthalmic vision enhancing agent that has a time window that is larger than a critical window; and ]
0.99574274	969	[ a rigid outer cover having upper edges and a lower edge; ]	[ A pair of surgical hooks consisting of: ]
0.9999418	970	[ a lumen extending across the lower edge of the cover, the lumen having a length which has an initial width and an initial depth suitable to receive an implant; and ]	[ a rigid outer cover having upper edges and a lower edge; ]
0.9999833	971	[ an elongate insert attached to at least a portion of the surface of at least a part of the upper edge of the elongate cover and including: ]	[ a lumen extending across the lower edge of the cover, the lumen having a length which has an initial width and an initial depth suitable to receive an implant; and ]
0.99999154	972	[ a first end affixed to an end of the elongate insert; and ]	[ an elongate insert attached to at least a portion of the surface of at least a part of the upper edge of the elongate cover and including: ]
0.9998074	973	[ a second end attached to outside surface of the cover; ]	[ a first end affixed to an end of the elongate insert; and ]
0.9994567	974	[ wherein the insert is arranged substantially concentrically with the middle of the elongate insert wherein the lower edge of the cover is generally perpendicular to the inner length of the lumen. ]	[ a second end attached to outside surface of the cover; ]
0.99988127	975	[ 10 or to construct a chimeric human cell expressing and comprising a nucleic acid. ]	[ A method of treating a patient in need of such treatment comprising administering a therapeutically effective amount of a nucleic acid having the sequence encoded as SEQ ID NO: ]
0.9999924	976	[ applying first said tissue-rehabilitation treatment to the bone surface, the first said tissue-rehabilitation treatment comprising: ]	[ A method of applying a tissue-rehabilitation treatment to a bone surface of a subject, said method comprising: ]
0.9999875	977	[ placing, in contact with a bone surface of the subject, tissue-responsive material; and ]	[ applying first said tissue-rehabilitation treatment to the bone surface, the first said tissue-rehabilitation treatment comprising: ]
0.9999919	978	[ applying a substantially mechanical force on the tissue-responsive material. ]	[ placing, in contact with a bone surface of the subject, tissue-responsive material; and ]
0.9986099	979	[ (1) obtaining a signal corresponding to time-domain visual information; ]	[ A method of deriving an image quality parameter that is associated with a quality of a visual scene comprising: ]
0.9999852	980	[ (2) acquiring visual data comprising visible light and an ambient light; ]	[ (1) obtaining a signal corresponding to time-domain visual information; ]
0.999992	981	[ (3) making an adjustment to a quality of the visual scene based at least partially on the visible light obtained prior to and within the time-domain visual information; and ]	[ (2) acquiring visual data comprising visible light and an ambient light; ]
0.99999225	982	[ (4) adjusting the quality of the visual scene based at least partially on the adjustment to the quality of the visual scene and the time-domain visual information. ]	[ (3) making an adjustment to a quality of the visual scene based at least partially on the visible light obtained prior to and within the time-domain visual information; and ]
0.99640584	983	[ acyl-CoA buffer; ]	[ A pharmaceutical composition comprising: ]
0.009489427	984	[ &#x3b5; ]	[ acyl-CoA buffer; ]
0.99670106	985	[ 4&#x3b7; ]	[ &#x3b5; ]
0.00029979777	986	[ carbon-oxygen bonds; ]	[ 4&#x3b7; ]
0.0025123917	987	[ &#x3b4; ]	[ carbon-oxygen bonds; ]
0.99889934	988	[ 1 &#x3b8; ]	[ &#x3b4; ]
0.9997211	989	[ -alkoxy&#x3b8; ]	[ 1 &#x3b8; ]
0.9989791	990	[ -sulfonate; ]	[ -alkoxy&#x3b8; ]
0.019304745	991	[ &#x3b4; ]	[ -sulfonate; ]
0.99889934	992	[ 1 &#x3b8; ]	[ &#x3b4; ]
0.021939125	993	[ -alkoxy-sulfonate; and ]	[ 1 &#x3b8; ]
0.014405415	994	[ &#x3b5; ]	[ -alkoxy-sulfonate; and ]
0.0077735824	995	[ 6-methacrylic acid copolymer; ]	[ &#x3b5; ]
0.007796499	996	[ wherein the individual has not been given multiple doses of a polypeptide of formula I: ]	[ 6-methacrylic acid copolymer; ]
0.0007299557	997	[ X-Y-Z-1 , ]	[ wherein the individual has not been given multiple doses of a polypeptide of formula I: ]
0.9992016	998	[ YI-Z-O-O&#x2003; ]	[ X-Y-Z-1 , ]
0.9919864	999	[ (Nth) = &#x2003; ]	[ YI-Z-O-O&#x2003; ]
0.99975985	1000	[ O: (Nth)m -nN- N1 -dwherein N1 is 0 or 1 and the nth residue of said &#x2003; ]	[ (Nth) = &#x2003; ]
0.0014081527	1001	[ O; ]	[ O: (Nth)m -nN- N1 -dwherein N1 is 0 or 1 and the nth residue of said &#x2003; ]
0.009027716	1002	[ 1 is from 15 to 27 and the d is from 7 to 12, ]	[ O; ]
0.00015703459	1003	[ wherein a quantity of said acyl-CoA buffer is not more than about &#x3b5; ; ]	[ 1 is from 15 to 27 and the d is from 7 to 12, ]
0.018450323	1004	[ 3; ]	[ wherein a quantity of said acyl-CoA buffer is not more than about &#x3b5; ; ]
0.0006091452	1005	[ wherein the composition comprises an A&#x2014; ]	[ 3; ]
0.9764613	1006	[ &#x2003; ]	[ wherein the composition comprises an A&#x2014; ]
0.9990521	1007	[ &#x2003; ]	[ &#x2003; ]
0.0025829622	1008	[ O; ]	[ &#x2003; ]
0.0009820828	1009	[ wherein the composition is not a polypeptide having a cyclic acid. ]	[ O; ]
0.9999603	1010	[ establishing a contact space in a proximal terminal of the vessels; ]	[ A method for preventing fluid drainage from the inner part of a distal region of vessels, the method comprising: ]
0.9999919	1011	[ removing a surface of a membrane from the contact space, the membrane composed of a gel-like material having a first core and an outer periphery, the inner part of the vessels located proximal to the contact space, wherein the outer periphery of the gel-like material has a temperature of about 60&#xb0; C. to about 800&#xb0; C.; ]	[ establishing a contact space in a proximal terminal of the vessels; ]
0.99998415	1012	[ preparing the outer surface of the membrane for a contact with a fluid; and ]	[ removing a surface of a membrane from the contact space, the membrane composed of a gel-like material having a first core and an outer periphery, the inner part of the vessels located proximal to the contact space, wherein the outer periphery of the gel-like material has a temperature of about 60&#xb0; C. to about 800&#xb0; C.; ]
0.9984231	1013	[ activating the contact about a first contact point in the contact space. ]	[ preparing the outer surface of the membrane for a contact with a fluid; and ]
0.9999207	1014	[ (a) wherein the polypeptide comprises: ]	[ A method for providing in vivo expression of a Cephalostatic and a Subcutaneous Adenosine Thrase or the combination thereof, which is a polypeptide comprising: ]
0.99989593	1015	[ 2) a polypeptide consisting essentially of the sequence of SEQ ID NO: 1. ]	[ (a) wherein the polypeptide comprises: ]
0.99738175	1016	[ (a) attaching a non-obtrusive tether to a body part of a patient; ]	[ A method of delivering a cancer chemotherapy, that operates via a delivery device and the delivery device sends the cancer chemotherapy along a path through a body, comprising the steps of: ]
0.9999367	1017	[ (b) feeding an effective amount of the cancer chemotherapy through the tether; ]	[ (a) attaching a non-obtrusive tether to a body part of a patient; ]
0.99999213	1018	[ (c) driving the cancer chemotherapy along the path with the cutting device; ]	[ (b) feeding an effective amount of the cancer chemotherapy through the tether; ]
0.9999907	1019	[ (d) cutting through the cancer through the body; ]	[ (c) driving the cancer chemotherapy along the path with the cutting device; ]
0.99998987	1020	[ (e) receiving the cancer treatment from the tumor; and, ]	[ (d) cutting through the cancer through the body; ]
0.9999918	1021	[ (f) delivering the cancer chemotherapy to or through the body, the cancer treatment being delivered along a predetermined path by the delivery device. ]	[ (e) receiving the cancer treatment from the tumor; and, ]
0.99997973	1022	[ placing a tube in a stent; ]	[ A method of altering the fluid delivery environment in a stent, comprising: ]
0.9999782	1023	[ receiving an amount of stent fluid through a stent; ]	[ placing a tube in a stent; ]
0.9999914	1024	[ determining the volume of the stent fluid into which the Stent fluid has been displaced and whether the displaced volume of the stent fluid is larger than its volume in the stent; ]	[ receiving an amount of stent fluid through a stent; ]
0.99999225	1025	[ adjusting the diameter of the stent fluid so an amount of stent fluid passed through the stent fluid remains within the stent fluid space; and ]	[ determining the volume of the stent fluid into which the Stent fluid has been displaced and whether the displaced volume of the stent fluid is larger than its volume in the stent; ]
0.9999883	1026	[ providing an adjustable stent. ]	[ adjusting the diameter of the stent fluid so an amount of stent fluid passed through the stent fluid remains within the stent fluid space; and ]
0.016722584	1027	[ a first portion having an inlet and an outlet; ]	[ A device for measuring a height and a width of a living body, comprising: ]
0.99997413	1028	[ a second portion attached to the first portion; ]	[ a first portion having an inlet and an outlet; ]
0.97322595	1029	[ a force transducer having opposite boreings configured for conveying a force to the living body; ]	[ a second portion attached to the first portion; ]
0.0025948526	1030	[ a first assembly comprising a first rigid member having radially outwardly extending longitudinal and radially inwardly deformed axial axis; ]	[ a force transducer having opposite boreings configured for conveying a force to the living body; ]
0.99999225	1031	[ a second assembly including a second rigid member having radially outwardly extending longitudinal and radially inwardly deformed axial axis, wherein the second rigid member has an arcuate surface that extends radially outwardly from the first rigid member, and ]	[ a first assembly comprising a first rigid member having radially outwardly extending longitudinal and radially inwardly deformed axial axis; ]
0.99999225	1032	[ wherein the arcuate surface of the second rigid member extends radially outwardly from the first rigid member; and ]	[ a second assembly including a second rigid member having radially outwardly extending longitudinal and radially inwardly deformed axial axis, wherein the second rigid member has an arcuate surface that extends radially outwardly from the first rigid member, and ]
0.00013773642	1033	[ a pair of sensors arranged at both the inlet and outlet location. ]	[ wherein the arcuate surface of the second rigid member extends radially outwardly from the first rigid member; and ]
0.9999914	1034	[ a proximal end adapted to be contained within the vessel, the tube from which the insert is introduced being made from an elongate stem having a distal portion adapted to be releasable from the body of the tube and having a fastener comprising a seal forming an opening for insertion into the vessel along the insertion, ]	[ An elongate insert for insertion into a vessel in a limb of a vertebral body, comprising: ]
0.9999924	1035	[ a distal end adapted to be pushed through an outer surface of the vessel along a passage through the spine, at least a portion of the distal portion having a longitudinal direction of substantially normal for the body of the tube and to be pushed through by the body of the tube whereby the elongate stem comprises a longitudinal axis disposed relative to distal-end of the distal end, a distal end axis being positioned in the longitudinal direction of the distal-end, ]	[ a proximal end adapted to be contained within the vessel, the tube from which the insert is introduced being made from an elongate stem having a distal portion adapted to be releasable from the body of the tube and having a fastener comprising a seal forming an opening for insertion into the vessel along the insertion, ]
0.9999895	1036	[ at least a portion of the distal portion being extended along a length of the tube as the proximal end is pushed through, the extension of the flange along the length of the tube providing lateral support for the distal end axis. ]	[ a distal end adapted to be pushed through an outer surface of the vessel along a passage through the spine, at least a portion of the distal portion having a longitudinal direction of substantially normal for the body of the tube and to be pushed through by the body of the tube whereby the elongate stem comprises a longitudinal axis disposed relative to distal-end of the distal end, a distal end axis being positioned in the longitudinal direction of the distal-end, ]
0.99426514	1037	[ providing a first rod assembly including first and second shafts with complementary attachment means, and ]	[ A method for positioning a golf club head, comprising: ]
0.99998415	1038	[ a plurality of slots formed in the sidewall of each of the first and second shafts; ]	[ providing a first rod assembly including first and second shafts with complementary attachment means, and ]
0.98138005	1039	[ cutting a shaft portion in the first rod assembly; ]	[ a plurality of slots formed in the sidewall of each of the first and second shafts; ]
0.99999225	1040	[ inserting at least one insertion element in one of the at least one slots of the first rod assembly; ]	[ cutting a shaft portion in the first rod assembly; ]
0.99999213	1041	[ drilling a hole in the shaft portion before the at least one insertion element is inserted into the target hole in the rod, wherein the rod assembly and the hole are substantially along the same axis when the rod assembly is positioned; and ]	[ inserting at least one insertion element in one of the at least one slots of the first rod assembly; ]
0.9999924	1042	[ cutting a notch in the second body portion of the first rod assembly to seal a bore in either of the shaft portions and a hole of the shaft portion after the rod assembly has been positioned. ]	[ drilling a hole in the shaft portion before the at least one insertion element is inserted into the target hole in the rod, wherein the rod assembly and the hole are substantially along the same axis when the rod assembly is positioned; and ]
0.9999583	1043	[ a fluid chamber supporting a fluid containing protein, the fluid chamber including a sidewall; ]	[ An apparatus for measuring a level of protein within a fluid in a medical environment, the apparatus comprising: ]
0.9999565	1044	[ a first pump assembly configured to deliver water through a first water filter of the fluid chamber through a first coupling member, a first tubular membrane coupled to the first coupling member, and ]	[ a fluid chamber supporting a fluid containing protein, the fluid chamber including a sidewall; ]
0.9999764	1045	[ a first inlet for receiving fluid from a first fluid receiving device, the first inlet supporting a first water filter; and ]	[ a first pump assembly configured to deliver water through a first water filter of the fluid chamber through a first coupling member, a first tubular membrane coupled to the first coupling member, and ]
0.99993813	1046	[ a second pump assembly configured to deliver water through a second water filter of the fluid chamber through a second coupling member, a second tubular membrane coupled to the second coupling member, and ]	[ a first inlet for receiving fluid from a first fluid receiving device, the first inlet supporting a first water filter; and ]
0.9999603	1047	[ a second inlet for receiving fluid from a second fluid receiving device, the second inlet supporting a second water filter; ]	[ a second pump assembly configured to deliver water through a second water filter of the fluid chamber through a second coupling member, a second tubular membrane coupled to the second coupling member, and ]
0.9999865	1048	[ the first and second inlets being positioned at different angles relative to their locations along the sidewall to provide pressure in the fluid in fluid communication between the first and second inlets and with respect to respective water at the inlets during a first fluid transfer through the first water filter and a second fluid transfer through the second water filter, to hold the level of protein within fluid communication with the through channels and to isolate the presence of protein in the fluid provided in the fluid of the fluid chamber. ]	[ a second inlet for receiving fluid from a second fluid receiving device, the second inlet supporting a second water filter; ]
0.9838096	1049	[ an implantable device and a blood flow controving device; ]	[ A system for generating therapeutic delivery data for a subject having a chronic pain comprising: ]
0.0023174775	1050	[ at least one input communication device; ]	[ an implantable device and a blood flow controving device; ]
0.9967728	1051	[ an input device configured to receive an input; and ]	[ at least one input communication device; ]
0.9983449	1052	[ a controller coupled to the network of the implantable device and connected to the input, the controller configured to provide control signals to the blood flow controving device regarding flow of blood to the subject, based on at least one of a plurality of parameters included in the input, the plurality of parameter values being from 10 to 70&#xb0; ]	[ an input device configured to receive an input; and ]
0.00054946134	1053	[ mP2. ]	[ a controller coupled to the network of the implantable device and connected to the input, the controller configured to provide control signals to the blood flow controving device regarding flow of blood to the subject, based on at least one of a plurality of parameters included in the input, the plurality of parameter values being from 10 to 70&#xb0; ]
0.9993455	1054	[ a support structure configured to be implanted in a body portion of a patient; and ]	[ An implantable medical device comprising: ]
0.99994457	1055	[ a conductive material connected to and operative to the support structure, the conductive material comprising an elastic protein and a layer of conductive fibers having longitudinal dimension corresponding with the longitudinal axis of the flexible biocompatible fiber material. ]	[ a support structure configured to be implanted in a body portion of a patient; and ]
0.96048117	1056	[ a core; ]	[ A golf club head comprising: ]
0.998697	1057	[ an outer shell; and ]	[ a core; ]
0.991549	1058	[ a face; ]	[ an outer shell; and ]
0.99998176	1059	[ wherein the face includes: ]	[ a face; ]
0.008738108	1060	[ a first defining part; and ]	[ wherein the face includes: ]
0.99999225	1061	[ a second defining part located opposite to the first defining part. ]	[ a first defining part; and ]
0.99985087	1062	[ providing a pharmaceutical composition selected from the group consisting of a pharmaceutical composition comprising an antithrombin compound and a pharmaceutical composition containing an effective amount of a diaphragm antithrombin compound; and ]	[ A method for selecting in vitro method of delivering a pharmaceutical composition to an animal, wherein the method comprises: ]
0.9971944	1063	[ delivering at least one agent to an animal in need thereof. ]	[ providing a pharmaceutical composition selected from the group consisting of a pharmaceutical composition comprising an antithrombin compound and a pharmaceutical composition containing an effective amount of a diaphragm antithrombin compound; and ]
0.99999046	1064	[ an anti-coagulant pump adapted to receive a coagulant medication in a first portion of the applicator device, wherein the anti-coagulant pump is operable to apply the coagulant medication from the first portion to a first location in the patient; ]	[ An applicator device for administering an anticoagulant to a patient, comprising: ]
0.99999225	1065	[ an anti-coagulant delivery device adapted to receive the anticoagulant in the first portion, wherein the anti-coagulant delivery device is operable to deliver the anticoagulant to the first location; ]	[ an anti-coagulant pump adapted to receive a coagulant medication in a first portion of the applicator device, wherein the anti-coagulant pump is operable to apply the coagulant medication from the first portion to a first location in the patient; ]
0.9999894	1066	[ at least one delivery channel through which the anti Coagulant Mixture comes from the anti-coagulant pump; ]	[ an anti-coagulant delivery device adapted to receive the anticoagulant in the first portion, wherein the anti-coagulant delivery device is operable to deliver the anticoagulant to the first location; ]
0.9999918	1067	[ positioning and pushing an applicator handle into a position to fit the delivery channel, wherein the applicator handle is moved through the at least one delivery channel and is positioned within the at least one delivery channel, wherein the pushing of the applicator handle is configured to support the pusher tool within the dispenser; and ]	[ at least one delivery channel through which the anti Coagulant Mixture comes from the anti-coagulant pump; ]
0.99999225	1068	[ deploying the medication into the patient via the at least one delivery channel. ]	[ positioning and pushing an applicator handle into a position to fit the delivery channel, wherein the applicator handle is moved through the at least one delivery channel and is positioned within the at least one delivery channel, wherein the pushing of the applicator handle is configured to support the pusher tool within the dispenser; and ]
0.9966607	1069	[ providing a first first chamber comprising a ventricle; ]	[ A method for treating a heart condition in a persons, comprising a method for determining whether to implant first or second aortic endothelial grafts in a patient, the method comprising: ]
0.99974805	1070	[ providing a first bifurcated patient planor having a first side, ]	[ providing a first first chamber comprising a ventricle; ]
0.99999213	1071	[ providing a first bifurcated arterial support system having a first arm, ]	[ providing a first bifurcated patient planor having a first side, ]
0.9999176	1072	[ contacting a first of the first ventricles with at least one of said first aortic endothelial grafts formed in at least said first chamber, ]	[ providing a first bifurcated arterial support system having a first arm, ]
0.99999225	1073	[ moving said first bifurcated patient planor away from the first ventricle, ]	[ contacting a first of the first ventricles with at least one of said first aortic endothelial grafts formed in at least said first chamber, ]
0.99999225	1074	[ moving said first bifurcated arterial support system away from the first chamber to an adjacent chamber, and ]	[ moving said first bifurcated patient planor away from the first ventricle, ]
0.9994867	1075	[ contacting a second patient planor having a second side, ]	[ moving said first bifurcated arterial support system away from the first chamber to an adjacent chamber, and ]
0.99999213	1076	[ moving said second bifurcated patient planor away from the second chamber, and ]	[ contacting a second patient planor having a second side, ]
0.999992	1077	[ contacting said second patient planor having a second arm, ]	[ moving said second bifurcated patient planor away from the second chamber, and ]
0.99999225	1078	[ moving said second bifurcated patient planor away from the second chamber, ]	[ contacting said second patient planor having a second arm, ]
0.99999213	1079	[ moving said second bifurcated artery, said arterial support system, and ]	[ moving said second bifurcated patient planor away from the second chamber, ]
0.9996929	1080	[ a first transverse channel of a continuous blood supply between the at least 2 the first ventricle and the second artery to the patients patient planor after the step of contacting said first ventricle with the at least 1 of the first ventricle and the second artery in the first ventricle is completed. ]	[ moving said second bifurcated artery, said arterial support system, and ]
0.9879309	1081	[ providing a surgical needle delivery channel and an implant insertion channel, wherein the insertion channel is adapted to receive the surgical needle delivery channel, the channel being defined by a proximal end located when the surgical needle delivery channel is slidably received with the implant insertion channel and a distal end located in a common carrier, wherein the proximal end of the insertion channel is adapted to have a distal end portion positioned at an end of the needle delivery channel; ]	[ A method of implanting an endocardial graft, comprising: ]
0.99999225	1082	[ delivering the surgical needle to a patient through said insertion channel through said proximal end of the insertion channel; ]	[ providing a surgical needle delivery channel and an implant insertion channel, wherein the insertion channel is adapted to receive the surgical needle delivery channel, the channel being defined by a proximal end located when the surgical needle delivery channel is slidably received with the implant insertion channel and a distal end located in a common carrier, wherein the proximal end of the insertion channel is adapted to have a distal end portion positioned at an end of the needle delivery channel; ]
0.9999043	1083	[ implanting the implant into the patient. ]	[ delivering the surgical needle to a patient through said insertion channel through said proximal end of the insertion channel; ]
0.013838038	1084	[ a plurality of teeth having a first end with a first bore through which the teeth are movable in an opposite direction from each other, a second end with a first bore through which the teeth are movable in an opposite direction from each other, and ]	[ A pet collar that can be affixed to a pet and comprises: ]
0.99999225	1085	[ a third end with a second bore through which the teeth are movable in an opposite direction to one another, a guide for receiving a neck of the second tooth; ]	[ a plurality of teeth having a first end with a first bore through which the teeth are movable in an opposite direction from each other, a second end with a first bore through which the teeth are movable in an opposite direction from each other, and ]
0.99999213	1086	[ an arcuate rod through which said teeth moves and is disposed and is electrically connected to the guide, said arcuate rod comprising an upward-facing barrel portion which is adapted to be attached to the neck of the second tooth during movement of the teeth; ]	[ a third end with a second bore through which the teeth are movable in an opposite direction to one another, a guide for receiving a neck of the second tooth; ]
0.99999154	1087	[ at least one first head including a head cover which is electrically connected to the arcuate rod; and ]	[ an arcuate rod through which said teeth moves and is disposed and is electrically connected to the guide, said arcuate rod comprising an upward-facing barrel portion which is adapted to be attached to the neck of the second tooth during movement of the teeth; ]
0.99999166	1088	[ at least one second head. ]	[ at least one first head including a head cover which is electrically connected to the arcuate rod; and ]
0.9979996	1089	[ 7. ]	[ A method of treating or preventing a risk of eye disorders, comprising administering a therapeutically effective amount of one or more cationic polycarbonates of polymeric composition, wherein said one or more cationic polycarbonates of polymeric composition at least partially polypeptide comprising the amino acid sequence and residues 31-62 of SEQ ID NO: ]
0.99998033	1090	[ a pair of actuators that extends into said knee joint, each of said actuators having a longitudinally extendable central opening having a longitudinal axis; ]	[ A system for determining a degree of stiffness of a knee joint between said centerline of a joint and a lateral surface of a leg that is partially defined by said joint, comprising: ]
0.99994266	1091	[ a first actuator having a first openable hole configured to permit movement of said first opening in a direction away from a predefined centerline, said first actuator having a first closed hole for engagement with said first openable hole; ]	[ a pair of actuators that extends into said knee joint, each of said actuators having a longitudinally extendable central opening having a longitudinal axis; ]
0.99999225	1092	[ a second actuator having a second openable hole configured to permit movement of said second opening in a direction away from said predefined centerline, said second actuator having a second closed hole for engagement with said second openable hole; ]	[ a first actuator having a first openable hole configured to permit movement of said first opening in a direction away from a predefined centerline, said first actuator having a first closed hole for engagement with said first openable hole; ]
0.999889	1093	[ a plurality of actuators mounted on said feet of a human patient; ]	[ a second actuator having a second openable hole configured to permit movement of said second opening in a direction away from said predefined centerline, said second actuator having a second closed hole for engagement with said second openable hole; ]
0.9996488	1094	[ a processor that identifies a height of said knee joint between said centerline and said lateral surface of said leg from a position of said first opening to the position of said second opening for a first angle that substantially corresponds and is within said predetermined second angle; ]	[ a plurality of actuators mounted on said feet of a human patient; ]
0.99999046	1095	[ a processor that generates first data representing a displacement of said first actuator along said centerline to a first direction such that said first actuator exhibits a first range of flexibility among said plurality of actuators; ]	[ a processor that identifies a height of said knee joint between said centerline and said lateral surface of said leg from a position of said first opening to the position of said second opening for a first angle that substantially corresponds and is within said predetermined second angle; ]
0.99999225	1096	[ a processor that generates second data representing a determination of a stiffness of said knee joint based at least in part on said first data and at least in part on said second data to determine at least a first stiffness of said knee joint between said centerline and said lateral surface of said leg, said first stiffness and said second stiffness being dependent on the position of said first actuator along said centerline and the angle of said first openable or closed hole; ]	[ a processor that generates first data representing a displacement of said first actuator along said centerline to a first direction such that said first actuator exhibits a first range of flexibility among said plurality of actuators; ]
0.99999225	1097	[ a display that displays the determined relative position of said knee joint between said centerline and said lateral surface of said leg as a line; and ]	[ a processor that generates second data representing a determination of a stiffness of said knee joint based at least in part on said first data and at least in part on said second data to determine at least a first stiffness of said knee joint between said centerline and said lateral surface of said leg, said first stiffness and said second stiffness being dependent on the position of said first actuator along said centerline and the angle of said first openable or closed hole; ]
0.999992	1098	[ a controller for directing in real time said processor, said processor and said display to execute processing for determining a said stiffness of said knee joint by comparing those third dimensional representations of said joint. ]	[ a display that displays the determined relative position of said knee joint between said centerline and said lateral surface of said leg as a line; and ]
0.9936427	1099	[ a housing having a side face in which a cap is provided; ]	[ An infant cleaning device comprising: ]
0.9982834	1100	[ a base section with an opening in an upper surface of said base section, said opening adapted to receive and retain an infant in a cleaning manner to be provided therethrough, said housing having a bottom; ]	[ a housing having a side face in which a cap is provided; ]
0.99999154	1101	[ a hose, generally linear in length and extending over, such a portion of the base section to wherein a portion of the base section is extended in a plane extending through the airway, said hose is adapted to attach to a cap section of and retractably receive a cap of a head of an infant, the hose having an inner wall defining a bore; and ]	[ a base section with an opening in an upper surface of said base section, said opening adapted to receive and retain an infant in a cleaning manner to be provided therethrough, said housing having a bottom; ]
0.99999166	1102	[ an elongate cap section adapted to receive, expel, and ]	[ a hose, generally linear in length and extending over, such a portion of the base section to wherein a portion of the base section is extended in a plane extending through the airway, said hose is adapted to attach to a cap section of and retractably receive a cap of a head of an infant, the hose having an inner wall defining a bore; and ]
0.9995435	1103	[ removably retain an infant's cap to a cap surface opposite to to use when the infant is placed on, or carried by, the hose. ]	[ an elongate cap section adapted to receive, expel, and ]
0.9937388	1104	[ receiving, from a device; ]	[ An improved method for determining an activity level of a user device, comprising: ]
0.99970764	1105	[ determining an information performance level based on input to the device; and ]	[ receiving, from a device; ]
0.9999924	1106	[ determining an activity level based on the information performance level. ]	[ determining an information performance level based on input to the device; and ]
0.99116397	1107	[ (a) generating three-dimensional structural data via a three dimensional processing system by: ]	[ A process for dispensing a substantially pure, transparent container, comprising; ]
0.9999913	1108	[ (i) applying at least two predetermined three-dimensional processes to target materials in a material that includes the structural data defining the transparent container; ]	[ (a) generating three-dimensional structural data via a three dimensional processing system by: ]
0.999992	1109	[ (ii) measuring the weight of each of the plurality of material components in each of the material to be changed as a function of a change on a dimension of the transparent container; <|span|>(iii) determining the difference between the weight of each of the plurality of material components compared to the weight of each of the materials in the material to be changed and a desired weight value; and ]	[ (i) applying at least two predetermined three-dimensional processes to target materials in a material that includes the structural data defining the transparent container; ]
0.99998975	1110	[ (iv) specifying and predicting a product, wherein a predetermined product is defined where each of the plurality of material components is selected from the materials that are in a product, resulting in a product including a substance that has a uniform shape between such materials in a product; and ]	[ (ii) measuring the weight of each of the plurality of material components in each of the material to be changed as a function of a change on a dimension of the transparent container; <|span|>(iii) determining the difference between the weight of each of the plurality of material components compared to the weight of each of the materials in the material to be changed and a desired weight value; and ]
0.9999888	1111	[ (b) delivering the product in the transparent container by removing the solid material components from a material that includes the structural data required to provide a translucent surface and inserting the partially transparent material components in an opaque container that has a volume of at least 1ml to at least 1 L to form a container containing the product, wherein the volume is smaller than a volume of the container. ]	[ (iv) specifying and predicting a product, wherein a predetermined product is defined where each of the plurality of material components is selected from the materials that are in a product, resulting in a product including a substance that has a uniform shape between such materials in a product; and ]
0.9934202	1112	[ a matrix comprising: ]	[ A pet food for a rat, comprising: ]
0.9999018	1113	[ at least one starch residue matrix comprising at least 13 starch molecules and at least 30 moisture-containing carbohydrates; ]	[ a matrix comprising: ]
0.99999166	1114	[ at least one transgenic maize plant wherein said transgenic plant contains the insulin-like growth factor II receptor (IGF-II rRNA) and an antibody or antigen binding fragment thereof that binds to the IGF-II rRNA, wherein said at least one starch residue matrix contains one or more soluble sugar components and has a total weight distribution of 4-30 g/100 ml when presented in food, and ]	[ at least one starch residue matrix comprising at least 13 starch molecules and at least 30 moisture-containing carbohydrates; ]
0.99999225	1115	[ wherein said at least one starch residue matrix is derived from a first transgenic corn plant having less than 2 times its level of CO2 extraction and a second transgenic corn plant having less than 100 times its level of CO2 extraction. ]	[ at least one transgenic maize plant wherein said transgenic plant contains the insulin-like growth factor II receptor (IGF-II rRNA) and an antibody or antigen binding fragment thereof that binds to the IGF-II rRNA, wherein said at least one starch residue matrix contains one or more soluble sugar components and has a total weight distribution of 4-30 g/100 ml when presented in food, and ]
1.5059808e-05	1116	[ administering to a subject in need thereof a composition containing a monoclonal antibody, said monoclonal antibody recognized by a natural complementarity index (NAI) value that is equal to five or more; and ]	[ A method of treating an enlarged peripheral optic vein; comprising the steps of: ]
0.999992	1117	[ administering to a subject in need thereof an effective amount from 1 to 4 mg of the isolated monoclonal antibody. ]	[ administering to a subject in need thereof a composition containing a monoclonal antibody, said monoclonal antibody recognized by a natural complementarity index (NAI) value that is equal to five or more; and ]
0.005494069	1118	[ a housing having a front face and a rear face, wherein the front face is fixed to the rear face, the rear face is provided with a pair of opposed faces defining a cavity, the faces each provided with a pair of flexible contact surfaces, the contacts provided with two different axial axis portions and two generally cylindrical surfaces extending from one of the opposing faces, a length of at least five nanometers extending between the ends of the axial axes, and, for a predetermined distance, the axial axes, said cavity of the housing being configured to pass through the contact surfaces of said two different axial axes; ]	[ A medical device for operating a diagnostic object located in a user's brain, comprising: ]
0.9972172	1119	[ a first actuator member in fluid communication with the cavity of the housing, said first actuator member having an external dimension of approximately one-third to approximately one-seventh of the internal dimension of the housing; and ]	[ a housing having a front face and a rear face, wherein the front face is fixed to the rear face, the rear face is provided with a pair of opposed faces defining a cavity, the faces each provided with a pair of flexible contact surfaces, the contacts provided with two different axial axis portions and two generally cylindrical surfaces extending from one of the opposing faces, a length of at least five nanometers extending between the ends of the axial axes, and, for a predetermined distance, the axial axes, said cavity of the housing being configured to pass through the contact surfaces of said two different axial axes; ]
0.9999924	1120	[ a second actuator member in fluid communication with said cavity, said second actuator member having an external dimension of approximately one-third to approximately one-seventh of the internal dimension of the housing, said second actuator member configured to receive and be released from said cavity by the actuator member. ]	[ a first actuator member in fluid communication with the cavity of the housing, said first actuator member having an external dimension of approximately one-third to approximately one-seventh of the internal dimension of the housing; and ]
0.99990237	1121	[ (a) a first and a second acoustic transducer, the first and second acoustic transducer providing acoustic information, wherein the acoustic information is generated by a plurality of ultrasound transducers, ]	[ An automatic ultrasound system, comprising: ]
0.9999919	1122	[ (b) an output port that receives acoustic information output from the plurality of ultrasound transducers to generate a corresponding acoustic signal, wherein the output port is at least partially transparent on a first surface of the output port, and ]	[ (a) a first and a second acoustic transducer, the first and second acoustic transducer providing acoustic information, wherein the acoustic information is generated by a plurality of ultrasound transducers, ]
0.99993575	1123	[ (c) a microphone which receives the acoustic signal with respect to a first acoustic area with a first microphone and with respect to an adjacent first acoustic area with a second microphone, ]	[ (b) an output port that receives acoustic information output from the plurality of ultrasound transducers to generate a corresponding acoustic signal, wherein the output port is at least partially transparent on a first surface of the output port, and ]
0.9999913	1124	[ wherein the first and the second acoustic transducers generate the acoustic information and the microphone generates the result of receiving the acoustic signal, ]	[ (c) a microphone which receives the acoustic signal with respect to a first acoustic area with a first microphone and with respect to an adjacent first acoustic area with a second microphone, ]
0.9999721	1125	[ wherein the microphone is made of a shape fitting material structured to fit around the first acoustic area and in a shape sufficient to transmit with integrity sound in the first acoustic area. ]	[ wherein the first and the second acoustic transducers generate the acoustic information and the microphone generates the result of receiving the acoustic signal, ]
0.99998736	1126	[ 3-pentanediol) as a suspension in water, the composition defining a concentration of said N(3, ]	[ A composition for use as a liquid treatment solution for treatment of an eye of a patient, the composition comprising 0.01 to 1.0 M of N(3, ]
0.99999213	1127	[ 3-pentanediol) in the concentration range of 0.01 to 1.0 M which is representative of a recommended amount of said N(3, ]	[ 3-pentanediol) as a suspension in water, the composition defining a concentration of said N(3, ]
0.9999864	1128	[ 3-pentanediol) as a therapeutic action agent to treat an eye in need thereof. ]	[ 3-pentanediol) in the concentration range of 0.01 to 1.0 M which is representative of a recommended amount of said N(3, ]
0.0016884065	1129	[ a first compound of formula (I): ]	[ A pharmaceutical composition, comprising: ]
0.9999908	1130	[ a second compound of formula (II): ]	[ a first compound of formula (I): ]
0.9969127	1131	[ and a pharmaceutically acceptable carrier. ]	[ a second compound of formula (II): ]
0.9999919	1132	[ 2, wherein the antibody is effective in binding to the amino acid sequence of SEQ ID NO: ]	[ A method for treating an inflammatory state comprising administering to a human patient via a nasopharyngeal stream of fluids free of other fluids on a day-to-day basis a therapeutically effective amount of an anti-Leangin (NPS) antibody-binding domain I which comprises the amino acid sequence of SEQ ID NO: ]
0.99777573	1133	[ 2, and ]	[ 2, wherein the antibody is effective in binding to the amino acid sequence of SEQ ID NO: ]
0.94699377	1134	[ effective in treatment of the inflammatory state. ]	[ 2, and ]
0.00048472156	1135	[ a. providing a first connector structure comprising first and second housing elements, a first pair of connectors being provided at the first pair of connectors, a second connector element having a first housing element having a second housing element. ]	[ A method for fabricating a fiber optic filter, the method comprising: ]
0.99983215	1136	[ cytologically-active sample; ]	[ An apparatus for testing a candidate for prostate cancer cells, comprising: ]
0.99999225	1137	[ an analyte-protease complex, wherein a lysosomal analyte in the cytologically-active sample is activated and thereby capable of dissolving from the cytologically-active sample the protease complex, and ]	[ cytologically-active sample; ]
0.9999919	1138	[ wherein the analyte-protease complex is selectively activated by a first or second protease that specifically activates said analyte-protease complex after a first or second dose of an agent which inhibits or inhibits the activation of said analyte-protease complex; and ]	[ an analyte-protease complex, wherein a lysosomal analyte in the cytologically-active sample is activated and thereby capable of dissolving from the cytologically-active sample the protease complex, and ]
0.99998176	1139	[ a buffer for ensuring that the protease complex and the active sample are separated at the start of testing; ]	[ wherein the analyte-protease complex is selectively activated by a first or second protease that specifically activates said analyte-protease complex after a first or second dose of an agent which inhibits or inhibits the activation of said analyte-protease complex; and ]
0.99999213	1140	[ wherein the analyte-protease complex does not receive any therapy in the presence of the buffer. ]	[ a buffer for ensuring that the protease complex and the active sample are separated at the start of testing; ]
0.9998872	1141	[ generating an ultrasonic transducer for delivering light through a target object through at least one of the modules; ]	[ A method for use in an implant having an optical fiber array comprising optical fiber modules from a plurality of optical fiber modules comprising a plurality of modules each configured as an individual member of an array including a plurality of individual modules, said method comprising: ]
0.99999213	1142	[ positioning one of the modules in a first position wherein a reference beam is directed to the target object; ]	[ generating an ultrasonic transducer for delivering light through a target object through at least one of the modules; ]
0.9999924	1143	[ positioning one of the modules in a second position wherein a second reference beam substantially extends outwardly of a normal surface of the target object when the of the reference beam is directed from the reference beam, wherein said reference beam differs from the first reference beam according to a distance between the of the reference beam and the reference surface; and ]	[ positioning one of the modules in a first position wherein a reference beam is directed to the target object; ]
0.99286795	1144	[ monitoring the distance. ]	[ positioning one of the modules in a second position wherein a second reference beam substantially extends outwardly of a normal surface of the target object when the of the reference beam is directed from the reference beam, wherein said reference beam differs from the first reference beam according to a distance between the of the reference beam and the reference surface; and ]
0.9988524	1145	[ providing a gas element or gas conduit; ]	[ A process for testing a chemical compounds in water and gas, the process comprising: ]
0.999992	1146	[ injecting, by said gas device or gas conduit, a stream of gas into said gas element or gas conduit, wherein said gas is selected from the mixture of water, fire, and ]	[ providing a gas element or gas conduit; ]
0.99996996	1147	[ smoke; ]	[ injecting, by said gas device or gas conduit, a stream of gas into said gas element or gas conduit, wherein said gas is selected from the mixture of water, fire, and ]
0.97735137	1148	[ injecting, by said gas element or gas conduit into gases provided within said water supply; and ]	[ smoke; ]
0.999992	1149	[ monitoring changes in pressures among the various gases in said gas flow by the gas element or said gas conduit, wherein the pressures to which gas molecules or gas molecules and gas molecules are injected into water and gas and water by said gas can be influenced by variables of the environment such as temperature, pressure, temperature variation or humidity, and ]	[ injecting, by said gas element or gas conduit into gases provided within said water supply; and ]
0.9996805	1150	[ wherein said air sample and gas sampling is carried out by an air source. ]	[ monitoring changes in pressures among the various gases in said gas flow by the gas element or said gas conduit, wherein the pressures to which gas molecules or gas molecules and gas molecules are injected into water and gas and water by said gas can be influenced by variables of the environment such as temperature, pressure, temperature variation or humidity, and ]
0.99997723	1151	[ (a) obtaining a cat, wherein it has blood cell migration, the blood cell migration comprising a blood cell migration pattern of at least 3 components, wherein each component is distinct from the corresponding component of the blood cell migration but represents at least one of an auto-migration trend and a vascular morphologic characteristic of the blood cell migration and comprises a proximal component adapted to contact proximal bone, a distal component adapted to contact underlying bone, a distal lumen extending transversely from the proximal component and having an axial displacement greater than about 10&#xb0; ]	[ A method for determining the level of resistance to growth factor activity in a cat, the method comprising: ]
0.99995506	1152	[ m and at least one of the proximal and distal components having at least 1 degree of freedom within the axial displacement; ]	[ (a) obtaining a cat, wherein it has blood cell migration, the blood cell migration comprising a blood cell migration pattern of at least 3 components, wherein each component is distinct from the corresponding component of the blood cell migration but represents at least one of an auto-migration trend and a vascular morphologic characteristic of the blood cell migration and comprises a proximal component adapted to contact proximal bone, a distal component adapted to contact underlying bone, a distal lumen extending transversely from the proximal component and having an axial displacement greater than about 10&#xb0; ]
2.2724867e-05	1153	[ (b) contacting at least one of blood cells, bone, bone marrow and tissue within the cat with a specific type of growth factor, wherein the specific type of growth factor consists of the growth factor activity gene (GEFA) being a DNA sequence encoding a growth factor activity gene (GAGF7) subunit; ]	[ m and at least one of the proximal and distal components having at least 1 degree of freedom within the axial displacement; ]
0.00048114863	1154	[ (c) detecting at least one degree of freedom in the axial displacement between the distal lumen and the proximal lumen to which the tissue has been directly electrically connected, wherein each degree of freedom is at least about 1 degree of freedom; and ]	[ (b) contacting at least one of blood cells, bone, bone marrow and tissue within the cat with a specific type of growth factor, wherein the specific type of growth factor consists of the growth factor activity gene (GEFA) being a DNA sequence encoding a growth factor activity gene (GAGF7) subunit; ]
0.9924096	1155	[ (d) calculating the level of resistance to growth factor activity in the cat. ]	[ (c) detecting at least one degree of freedom in the axial displacement between the distal lumen and the proximal lumen to which the tissue has been directly electrically connected, wherein each degree of freedom is at least about 1 degree of freedom; and ]
0.9999511	1156	[ sensor elements and the delivery system for delivery of diagnostic information to said sensor elements into blood-forming tissue of the syndrome; ]	[ An implantable device for diagnosing the presence of a condition in a patient having a syndrome, the tissue condition being characterized generally by a lack of complementarity between tissue layers of the patient, said device comprising: ]
0.0038793415	1157	[ a battery; and ]	[ sensor elements and the delivery system for delivery of diagnostic information to said sensor elements into blood-forming tissue of the syndrome; ]
0.9992048	1158	[ an electrocardiogram (ECG) sensor coupled to the delivery system and comprising circuitry, said circuitry for receiving a signal and, in response to signal processing by said circuitry, emitting a battery pulse therefrom; and ]	[ a battery; and ]
0.003534265	1159	[ the electrode at one of the, and ]	[ an electrocardiogram (ECG) sensor coupled to the delivery system and comprising circuitry, said circuitry for receiving a signal and, in response to signal processing by said circuitry, emitting a battery pulse therefrom; and ]
0.0006011084	1160	[ substantially the identical, anatomical layer of the patient defining said syndrome, configured to be worn proximate the onset of occurrence of theosis to generate an electrical signal representative of physiological condition in the patient. ]	[ the electrode at one of the, and ]
0.99997485	1161	[ a container for holding the medication; ]	[ A apparatus for preparing a medication label for an indication of the concentration and concentration range of an agent, the apparatus comprising: ]
0.9999914	1162	[ an infusing device which infuses the medication into the container; ]	[ a container for holding the medication; ]
0.9999919	1163	[ a label reading device which reads the label of the medication held in the container; ]	[ an infusing device which infuses the medication into the container; ]
0.999992	1164	[ a container opening device which contains the medication in a container therein; ]	[ a label reading device which reads the label of the medication held in the container; ]
0.9999902	1165	[ means to remove the medication from the container upon read by the label reading device, ]	[ a container opening device which contains the medication in a container therein; ]
0.9999881	1166	[ wherein said opening device is provided on a side of an applicator and adapted to accommodate a container containing medication such that the container can be opened by applying light to the applicator to release the medication from the container; and ]	[ means to remove the medication from the container upon read by the label reading device, ]
0.9999912	1167	[ a seal means that seals the container opening device and means to support the container holding an indication of the dosage of the medication, said seal means being further adapted to place the container over the opening device thereby retaining a pressure on the container during fluid opening. ]	[ wherein said opening device is provided on a side of an applicator and adapted to accommodate a container containing medication such that the container can be opened by applying light to the applicator to release the medication from the container; and ]
0.99881566	1168	[ R3 and R4 is at least one optionally substituted or unsubstituted alkyl group with one or more substituents selected from the group consisting of H, CH, &#x2014; ]	[ A method for producing a compound of the formula (I), whereinR1 and R2 are each independently CH2, S, OR2, or SOH; ]
0.99528533	1169	[ O, &#x2014; ]	[ R3 and R4 is at least one optionally substituted or unsubstituted alkyl group with one or more substituents selected from the group consisting of H, CH, &#x2014; ]
0.9968677	1170	[ R, &#x2014; ]	[ O, &#x2014; ]
0.99743205	1171	[ NH, &#x2014; ]	[ R, &#x2014; ]
0.994253	1172	[ S(O)D, LR, &#xb7; ]	[ NH, &#x2014; ]
0.9998853	1173	[ cycloalkyl, &#xb7; ]	[ S(O)D, LR, &#xb7; ]
0.98955554	1174	[ heteroaryl, O, and ]	[ cycloalkyl, &#xb7; ]
0.99926263	1175	[ ethoxyalkyl, ]	[ heteroaryl, O, and ]
0.981388	1176	[ R5 is CH, &#x2014; ]	[ ethoxyalkyl, ]
0.99736136	1177	[ C(O)R1, C(O)R2, or C(O)R3 and R6, R7, and ]	[ R5 is CH, &#x2014; ]
0.9998523	1178	[ R8 are each C(O) or LOR1 and R9 and R10 are each independently CH, S or C(O)R2, and ]	[ C(O)R1, C(O)R2, or C(O)R3 and R6, R7, and ]
0.9988317	1179	[ R11, R12, and ]	[ R8 are each C(O) or LOR1 and R9 and R10 are each independently CH, S or C(O)R2, and ]
0.9989518	1180	[ R13 are each C(O)R3, C(O)R4, C(O)R5, or a mixture thereof. ]	[ R11, R12, and ]
0.99618906	1181	[ /&#x394; ]	[ A method to treat a lung, the method comprising administering to an individual suffering from asthma containing one or more abnormal cells that produce epitopes designated by their number and a first antibody sequence consisting of G-Arg&#x394; ]
0.99999	1182	[ /&#x394; ]	[ /&#x394; ]
0.99999	1183	[ /&#x394; ]	[ /&#x394; ]
0.00014355168	1184	[ (SEQ ID NO: ]	[ /&#x394; ]
0.9997825	1185	[ 4) and a second antibody sequence consisting of A-Arg&#x394; ]	[ (SEQ ID NO: ]
0.003520876	1186	[ /&#x394; ]	[ 4) and a second antibody sequence consisting of A-Arg&#x394; ]
0.99999	1187	[ /&#x394; ]	[ /&#x394; ]
0.99999	1188	[ /&#x394; ]	[ /&#x394; ]
0.00014355168	1189	[ (SEQ ID NO: ]	[ /&#x394; ]
0.9978023	1190	[ 5) and an enzyme, wherein said enzyme is activated. ]	[ (SEQ ID NO: ]
0.999992	1191	[ forming a first portion of a prosthesis in a second position in the medical tool, the method comprising: ]	[ A method for selectively positioning an inflatable body in a first position in a medical tool on an upright frame, forming a first medical instrument, and ]
0.9999001	1192	[ positioning the inflatable body in the first position; ]	[ forming a first portion of a prosthesis in a second position in the medical tool, the method comprising: ]
0.999992	1193	[ positioning a second medical instrument on a first axis with the inflatable body; ]	[ positioning the inflatable body in the first position; ]
0.9999924	1194	[ positioning a first portion of a prosthesis on at least one of the first medical instrument and the first portion of the inflatable body; and ]	[ positioning a second medical instrument on a first axis with the inflatable body; ]
0.9999924	1195	[ positioning the second portion of the prosthesis on at least one of the first medical instrument and the second portion of the inflatable device in the second position so that the second portion of the prosthesis is in contact with the first portion of the prosthesis, the first portion of the inflatable device and the first portion of the prosthesis having a height along the first line of the first portion of the prosthesis extending along the first portion of the prosthesis. ]	[ positioning a first portion of a prosthesis on at least one of the first medical instrument and the first portion of the inflatable body; and ]
0.9999578	1196	[ collecting medical data including a plurality of physiological signals collected at a plurality of locations along at least one of a longitudinal and a radial axis of said medical device; and ]	[ A method for operating a medical device, comprising: ]
0.9996488	1197	[ detecting a medical condition of a patient using a processing device, ]	[ collecting medical data including a plurality of physiological signals collected at a plurality of locations along at least one of a longitudinal and a radial axis of said medical device; and ]
0.99842346	1198	[ wherein said processing device further includes a display, ]	[ detecting a medical condition of a patient using a processing device, ]
0.9999906	1199	[ wherein said display includes pixel information capable of being defined by the patient and a user associated with said processing device, ]	[ wherein said processing device further includes a display, ]
0.9999924	1200	[ wherein said processing device retrieves the pixel information from said display using a processor, ]	[ wherein said display includes pixel information capable of being defined by the patient and a user associated with said processing device, ]
0.99999225	1201	[ wherein said processing device generates the pixel information using data within a signal data warehouse, and ]	[ wherein said processing device retrieves the pixel information from said display using a processor, ]
0.9999924	1202	[ wherein when said processing device receives the pixel information, said processing device changes a first parameter associated with the received pixel information to a second parameter associated with the plurality of physiological signals based on the detector detected of the detected condition by a processor, and ]	[ wherein said processing device generates the pixel information using data within a signal data warehouse, and ]
0.9999924	1203	[ wherein said first parameter and said second parameter of said processing device provide a user an indication, the user accessing said signal data warehouse to obtain a predetermined value associated with the received pixel information. ]	[ wherein when said processing device receives the pixel information, said processing device changes a first parameter associated with the received pixel information to a second parameter associated with the plurality of physiological signals based on the detector detected of the detected condition by a processor, and ]
0.9999881	1204	[ providing a balloon having a diameter; ]	[ A method for using a balloon in an injection of an immunogenic composition or implantable bone graft to maintain viability, said method comprising: ]
0.9999893	1205	[ establishing a valve assembly in said balloon and at least one valve that moves an end of a spring in a direction opposing an end of the valve assembly, said valve assembly allowing an injection of said immunogenic composition or implantable bone graft; and ]	[ providing a balloon having a diameter; ]
0.99999213	1206	[ moving said valve assembly to at least one position towards and away from said respective end of the spring such that contact between said valves is maintained by said spring when said insulin is in fluid contact with said interior of said implantable bone graft, wherein said balloon and said valve assembly are held at one position by holding said valve assembly with the at least one valve; and ]	[ establishing a valve assembly in said balloon and at least one valve that moves an end of a spring in a direction opposing an end of the valve assembly, said valve assembly allowing an injection of said immunogenic composition or implantable bone graft; and ]
0.9999924	1207	[ moving said spring to the at least one position to maintain the implantable bone graft in a tissue-independent tissue with said implantable bone graft in fluid contact with said interior of said implantable bone graft the spring being supported by the inner portion of said balloon. ]	[ moving said valve assembly to at least one position towards and away from said respective end of the spring such that contact between said valves is maintained by said spring when said insulin is in fluid contact with said interior of said implantable bone graft, wherein said balloon and said valve assembly are held at one position by holding said valve assembly with the at least one valve; and ]
0.072120644	1208	[ an inside passage; ]	[ A device comprising: ]
0.9999918	1209	[ an interior, including an interior entrance channel formed a main wall of the inside passage, and ]	[ an inside passage; ]
0.9999918	1210	[ a distal end on which an insertion point for introducing the insertion point through the interior entrance channel is formed; ]	[ an interior, including an interior entrance channel formed a main wall of the inside passage, and ]
0.9981957	1211	[ wherein an elastomeric seal is provided around the inside opening; ]	[ a distal end on which an insertion point for introducing the insertion point through the interior entrance channel is formed; ]
0.9738854	1212	[ wherein said insert point is placed, at least substantially, in the interior interior entry channel; ]	[ wherein an elastomeric seal is provided around the inside opening; ]
0.99999094	1213	[ wherein a second element connects said outer opening and said interior entrance channel, and ]	[ wherein said insert point is placed, at least substantially, in the interior interior entry channel; ]
0.97653776	1214	[ wherein the inside passage is constructed from an epoxy layer. ]	[ wherein a second element connects said outer opening and said interior entrance channel, and ]
0.9943117	1215	[ an electric field producing device configured to generate an electric field; and ]	[ A treatment device for a subject or a living being, comprising: ]
0.9999558	1216	[ an implantable element in communication with said subject or living being, such that said implantable element covers an inner surface of said subject or living being, wherein said electric field generating device comprises: <|span|>a. a first field generator extending from at least a portion of a head of said subject or living being, and ]	[ an electric field producing device configured to generate an electric field; and ]
0.9999875	1217	[ configured to generate electric field in a first first region of said head to penetrate said head and generate an inbuilt electric field in said first first field generator to produce a first electric field therein; and ]	[ an implantable element in communication with said subject or living being, such that said implantable element covers an inner surface of said subject or living being, wherein said electric field generating device comprises: <|span|>a. a first field generator extending from at least a portion of a head of said subject or living being, and ]
0.9999893	1218	[ b. receiving components located inside said head of said subject or living being, wherein said receiving components are configured to receive a portion of an electromagnetic field generated by electromagnetic currents passed between the first field generator and said subject or living being. ]	[ configured to generate electric field in a first first region of said head to penetrate said head and generate an inbuilt electric field in said first first field generator to produce a first electric field therein; and ]
0.002508257	1219	[ a shaft configured to have a proximal end, adjacent to the proximal end of a shaft shaft that is configured to be disposed within a single drive shaft mount; ]	[ A golf-driving machine comprising: ]
0.9999838	1220	[ a core mounted within the shaft shaft which is coupled to the shaft shaft opposite the proximal end of the shaft shaft, the core comprising an outer shell that includes a lumen connecting a first end of the lumen to the core and a second end; and ]	[ a shaft configured to have a proximal end, adjacent to the proximal end of a shaft shaft that is configured to be disposed within a single drive shaft mount; ]
0.9999918	1221	[ a hook which is mounted on the core adjacent the proximal end of the shaft and wherein the hook is capable of being connected to the core through the lumen through which the hook is attached proximally to the core, wherein the hook comprises at least a first hook portion and at least a second hook portion, wherein at least the first hook portion is connected to the first hook portion by the lumen; ]	[ a core mounted within the shaft shaft which is coupled to the shaft shaft opposite the proximal end of the shaft shaft, the core comprising an outer shell that includes a lumen connecting a first end of the lumen to the core and a second end; and ]
0.999907	1222	[ an obturator pivotally mounted within the inner walls of a lower surface portion of the shaft shaft and pivotably coupled to the core as the obturator extends in front of the shaft shaft; and ]	[ a hook which is mounted on the core adjacent the proximal end of the shaft and wherein the hook is capable of being connected to the core through the lumen through which the hook is attached proximally to the core, wherein the hook comprises at least a first hook portion and at least a second hook portion, wherein at least the first hook portion is connected to the first hook portion by the lumen; ]
0.99999225	1223	[ a spring coupled to the obturator to allow the obturator to pivot the obturator. ]	[ an obturator pivotally mounted within the inner walls of a lower surface portion of the shaft shaft and pivotably coupled to the core as the obturator extends in front of the shaft shaft; and ]
0.9999701	1224	[ generating a first database query for each person, the first database query in the form of a multidimensional database query, wherein each multidimensional database query comprises a plurality of columns corresponding to each person that are structured to determine which of at least a sample of person details will be found in at least a portion of the plurality of data sets; ]	[ A computer-implemented method for managing data and/or metadata of a plurality of people, comprising: ]
0.999992	1225	[ generating a second database query for each of the plurality of people, the second database query in the form of a multidimensional database query, wherein each multidimensional database query comprises a plurality of columns corresponding to each person that are structured to determine which of at least a sample of person details will be found in at least a portion of the plurality of data sets; ]	[ generating a first database query for each person, the first database query in the form of a multidimensional database query, wherein each multidimensional database query comprises a plurality of columns corresponding to each person that are structured to determine which of at least a sample of person details will be found in at least a portion of the plurality of data sets; ]
0.99999225	1226	[ processing the first database query and the second database query with a processing processor to achieve processing control for the multi-dimensional database query; and ]	[ generating a second database query for each of the plurality of people, the second database query in the form of a multidimensional database query, wherein each multidimensional database query comprises a plurality of columns corresponding to each person that are structured to determine which of at least a sample of person details will be found in at least a portion of the plurality of data sets; ]
0.99999225	1227	[ performing the processing of the multidimensional database query by processing information derived from the step of generating the first database query, calculating the sample of person details, comparing the sample of person details to the selected sample of person details, processing the at least a portion of each of the sample of person details, and ]	[ processing the first database query and the second database query with a processing processor to achieve processing control for the multi-dimensional database query; and ]
0.99999213	1228	[ predicting at least one person characteristic of each of the selected sample of person details. ]	[ performing the processing of the multidimensional database query by processing information derived from the step of generating the first database query, calculating the sample of person details, comparing the sample of person details to the selected sample of person details, processing the at least a portion of each of the sample of person details, and ]
0.0074354215	1229	[ a pharmaceutically acceptable pharmaceutically acceptable active ingredient; and ]	[ A composition comprising: ]
0.999482	1230	[ at least one pharmaceutically acceptable buffer; ]	[ a pharmaceutically acceptable pharmaceutically acceptable active ingredient; and ]
0.019492276	1231	[ wherein the combined contents of the active ingredients of wherein the combined contents of the active ingredients of are at least about 30% weight of the inactive ingredient. ]	[ at least one pharmaceutically acceptable buffer; ]
0.00052048976	1232	[ providing an insheathable substrate comprising: ]	[ A method for delivering oral liquid under pressure, comprising: ]
0.01144825	1233	[ a first, at least partially closed, flange with first and second convex, elliptical recesses therein positioned on opposite sides of the first convex recess and each comprising a second curved member and an opposite sidewall disposed opposite the first convex recess; ]	[ providing an insheathable substrate comprising: ]
0.99999166	1234	[ the first convex recess comprising an opening sized and configured such that the inward orientation of the first convex recess about a central axis of the first convex recess in a first planar plane of the sidewall is substantially the same and the inward orientation of the first convex recess to be substantially perpendicular to surface planar plane of the sidewall in a second planar plane of the sidewall is substantially the same; and ]	[ a first, at least partially closed, flange with first and second convex, elliptical recesses therein positioned on opposite sides of the first convex recess and each comprising a second curved member and an opposite sidewall disposed opposite the first convex recess; ]
0.00041539318	1235	[ at least one fluid outlet in fluid communication with at least one fluid drain; and ]	[ the first convex recess comprising an opening sized and configured such that the inward orientation of the first convex recess about a central axis of the first convex recess in a first planar plane of the sidewall is substantially the same and the inward orientation of the first convex recess to be substantially perpendicular to surface planar plane of the sidewall in a second planar plane of the sidewall is substantially the same; and ]
0.99999213	1236	[ placing a vacuum in fluid communication with said at least one fluid outlet; ]	[ at least one fluid outlet in fluid communication with at least one fluid drain; and ]
0.99999213	1237	[ placing between said at least one fluid outlet and said at least one cavity, a hollow vessel formed from a solid substance wherein the hollow vessel extends in a direction of convection; and ]	[ placing a vacuum in fluid communication with said at least one fluid outlet; ]
0.99993455	1238	[ providing at least one annular liner in fluid communication with said fluid drain. ]	[ placing between said at least one fluid outlet and said at least one cavity, a hollow vessel formed from a solid substance wherein the hollow vessel extends in a direction of convection; and ]
0.9993285	1239	[ 25. ]	[ An isolated viral polypeptide comprising the amino acid sequence of SEQ ID NO: ]
0.99999106	1240	[ a tooth cleaning unit including: ]	[ A tooth cleaning system comprising: ]
0.9999907	1241	[ a tooth cleaning surface; ]	[ a tooth cleaning unit including: ]
0.99999225	1242	[ a tooth filling station disposed on the tooth cleaning surface; ]	[ a tooth cleaning surface; ]
0.99999213	1243	[ a tooth cleaning filling slot disposed within the tooth filling station; and ]	[ a tooth filling station disposed on the tooth cleaning surface; ]
0.9999907	1244	[ a tooth cleaning filling rod to be used for filling cavity and/or fragment content of the cavity, ]	[ a tooth cleaning filling slot disposed within the tooth filling station; and ]
0.99998987	1245	[ a first roller mounted on the tooth cleaning surface, the first roller being mounted on the tooth fill station and partially projecting from the tooth filling station, ]	[ a tooth cleaning filling rod to be used for filling cavity and/or fragment content of the cavity, ]
0.999992	1246	[ a second roller mounted on a side opposite to the tooth filling station, the second roller being mounted to the tooth filling station partially projecting from the tooth filling slot, and ]	[ a first roller mounted on the tooth cleaning surface, the first roller being mounted on the tooth fill station and partially projecting from the tooth filling station, ]
0.99999213	1247	[ having substantially the same longitudinal movement to move the tooth filling station from a first position in which access to the tooth filling station is restricted to an object to be filled with at least in part through a portion of the side facing toward the tooth filling station and partially covering the portion of the side that faces toward the tooth filling station so that the portion of the side facing towards the tooth filling station is a fully accessible side of the tooth filling station such that the tooth filling station can be grasped and then cleaned by a user. ]	[ a second roller mounted on a side opposite to the tooth filling station, the second roller being mounted to the tooth filling station partially projecting from the tooth filling slot, and ]
0.9999205	1248	[ a pump body having a bore; ]	[ A pump comprising: ]
0.9999896	1249	[ a first nozzle portion adjacent the feed rail of the pump body and having an inner layer including a first thermoplastic polymer and the thermoplastic polymer provides a first heating point for a first temperature selected from a range from about 0-40&#xb0; C.; ]	[ a pump body having a bore; ]
0.99999225	1250	[ a second nozzle portion adjacent the feed rail of the pump body including a first thermoplastic polymer adjacent the first nozzle portion, the second thermoplastic polymer provided at a first angle from the first angle and insulated from being heated by the first heat point based, generally, upon the first heat point; and ]	[ a first nozzle portion adjacent the feed rail of the pump body and having an inner layer including a first thermoplastic polymer and the thermoplastic polymer provides a first heating point for a first temperature selected from a range from about 0-40&#xb0; C.; ]
0.99999225	1251	[ a top layer adjacent the second nozzle portion providing a second thermoplastic polymer not substantially heated by the first thermoplastic polymer. ]	[ a second nozzle portion adjacent the feed rail of the pump body including a first thermoplastic polymer adjacent the first nozzle portion, the second thermoplastic polymer provided at a first angle from the first angle and insulated from being heated by the first heat point based, generally, upon the first heat point; and ]
0.99999225	1252	[ wherein the transcutaneous prosthesis further comprises a gingival cavity formed in the central region of the gingival tissue and in the proximal portion thereof between the proximal and distal ends of the elongated catheter proximal side thereof and the proximal section of the catheter in both the proximal side and the distal side. ]	[ A transcutaneous prosthesis comprising an elongated catheter having a proximal end and a distal end and a lumen therethrough; wherein the transcutaneous prosthesis is configured to be implanted in a femoral or femoral-aromatic prosthesis; and ]
0.9999912	1253	[ an interposed, curved or recessed end that extends from a lumen extending vertically from a first end of a syringe-cabinetry unit and an end of the syringe-cabinetry unit, the interposed, curved or recessed end having a body volume that is less than a width of the first end of the syringe-cabinetry unit; ]	[ An endoscopic surgical apparatus for use in a syringe-cabinetry system, comprising: ]
0.99999225	1254	[ a first end component having a first end interface with the interposed, curved or recessed end, the first end component defined to expand with respect to the same portion of the syringe-cabinetry unit that may be connected to the first end of the interposed, curved or recessed end; and ]	[ an interposed, curved or recessed end that extends from a lumen extending vertically from a first end of a syringe-cabinetry unit and an end of the syringe-cabinetry unit, the interposed, curved or recessed end having a body volume that is less than a width of the first end of the syringe-cabinetry unit; ]
0.9999919	1255	[ a second component having a second end interface with the substantially recessed and expanded portion of the end of the syringe-cabinetry unit, the second device having a substantially larger volume, and ]	[ a first end component having a first end interface with the interposed, curved or recessed end, the first end component defined to expand with respect to the same portion of the syringe-cabinetry unit that may be connected to the first end of the interposed, curved or recessed end; and ]
0.99998903	1256	[ also smaller than the first component of the interposed, curved or recessed end. ]	[ a second component having a second end interface with the substantially recessed and expanded portion of the end of the syringe-cabinetry unit, the second device having a substantially larger volume, and ]
0.9992779	1257	[ 5-(Nn-H)(3-hydroxypropyl)glucosamine or a pharmaceutically acceptable salt thereof, ]	[ A composition of a pharmaceutically acceptable salt or ester having only one pharmaceutically acceptable substituent having at least 95% identity to the formulawherein R is the C1 to C30 hydrogen amino acid aliphatic cyclic phenyl ring or a pharmaceutically acceptable salt thereof, where the phenyl amino acid is optionally substituted by 3-3, ]
0.9357401	1258	[ where n comprises 2-3, ]	[ 5-(Nn-H)(3-hydroxypropyl)glucosamine or a pharmaceutically acceptable salt thereof, ]
0.999038	1259	[ 6-8, ]	[ where n comprises 2-3, ]
0.9999752	1260	[ 9-11 or 4, ]	[ 6-8, ]
0.9998863	1261	[ 6-8 is 5 or less, and ]	[ 9-11 or 4, ]
0.9757296	1262	[ the pharmaceutically acceptable substituent is a pharmaceutically acceptable trifluoromethyl hydrocarbon salt thereof. ]	[ 6-8 is 5 or less, and ]
0.99716115	1263	[ (1) inserting; ]	[ A method for performing an electrosurgical procedure for a surgical device, comprising the steps of: ]
0.9803473	1264	[ (2) providing an electrostatic potential differential electrode, said electrode being within an interior cavity that is configured to receive an energy source that is operative for applying the electrosurgical procedure; and ]	[ (1) inserting; ]
0.99999166	1265	[ (3) applying a vibration from said electric potential differential electrode to a device to be surgically repaired. ]	[ (2) providing an electrostatic potential differential electrode, said electrode being within an interior cavity that is configured to receive an energy source that is operative for applying the electrosurgical procedure; and ]
0.9865263	1266	[ a substantially cylindrical body; ]	[ A blood-receiving apparatus, comprising: ]
0.99997866	1267	[ a blood input conduit connected to an end of said cylindrical body; ]	[ a substantially cylindrical body; ]
0.9999521	1268	[ end-span-tape and end-span-string connected to and spaced from said substantially cylindrical body, said end-span-tape and end-span-strand respectively comprising a plurality of tissue struts and said end-span-tape and end-span-string being fixedly coupled into a longitudinal axis thereof; and ]	[ a blood input conduit connected to an end of said cylindrical body; ]
0.9999908	1269	[ a fastener fixed to and positioned in and adjacent the base of said substantially cylindrical body, ]	[ end-span-tape and end-span-string connected to and spaced from said substantially cylindrical body, said end-span-tape and end-span-strand respectively comprising a plurality of tissue struts and said end-span-tape and end-span-string being fixedly coupled into a longitudinal axis thereof; and ]
0.99998903	1270	[ wherein each of said tissue struts and said end-span-tape are configured for supporting and positioning an end of a blood supply conduit for fluid through said substantially cylindrical body at a location corresponding to a blood supply conduit outlet on the axis of said end-span-tape, and ]	[ a fastener fixed to and positioned in and adjacent the base of said substantially cylindrical body, ]
0.9999893	1271	[ wherein said substantially cylindrical body is substantially rigid. ]	[ wherein each of said tissue struts and said end-span-tape are configured for supporting and positioning an end of a blood supply conduit for fluid through said substantially cylindrical body at a location corresponding to a blood supply conduit outlet on the axis of said end-span-tape, and ]
0.9805381	1272	[ a housing having a first end, a second opening made in the housing and extending between the first and second ends, and ]	[ for providing a fastener for a container, comprising: ]
0.99994576	1273	[ an outlet for receiving a container, the housing comprising a first portion and a second portion with opposing apertures spaced from the first end when the housing is placed in a closed position, ]	[ a housing having a first end, a second opening made in the housing and extending between the first and second ends, and ]
0.99995947	1274	[ the interior of the first portion defining at least one apertured area; ]	[ an outlet for receiving a container, the housing comprising a first portion and a second portion with opposing apertures spaced from the first end when the housing is placed in a closed position, ]
0.047318902	1275	[ a wall configured to receive a part of the opening formed in the housing and the outside of the housing when the housing is in the closed position; ]	[ the interior of the first portion defining at least one apertured area; ]
0.9917857	1276	[ an interior having an open top and a bottom, the interior defining an air permeable space in a bottom near the bottom; thereby forming a chamber in the interior, whereinan opening to the opening within the interior forms a top surface to the interior, and ]	[ a wall configured to receive a part of the opening formed in the housing and the outside of the housing when the housing is in the closed position; ]
0.9999181	1277	[ the opening extends downwardly from the top surface. ]	[ an interior having an open top and a bottom, the interior defining an air permeable space in a bottom near the bottom; thereby forming a chamber in the interior, whereinan opening to the opening within the interior forms a top surface to the interior, and ]
0.99943155	1278	[ a limb support section including at least one pivotable branch extending therefrom, movable in a horizontal direction around at least one of the pivotable branches which includes a first branch in connection with a proximal end and a second branch in connection with a distal end; ]	[ A device to attach an insertable device to a leg prosthesis, the device comprising: ]
0.9999902	1279	[ a fastener engagement section configured to engage at least one fastener of the second branch, ]	[ a limb support section including at least one pivotable branch extending therefrom, movable in a horizontal direction around at least one of the pivotable branches which includes a first branch in connection with a proximal end and a second branch in connection with a distal end; ]
0.9999919	1280	[ wherein each of the first and second branches includes a first body portion having a flat surface defined for movement and a second body portion having a flat surface defined for movement and a cross section defined between the respective flat surfaces for the actuation of the at least one fastener. ]	[ a fastener engagement section configured to engage at least one fastener of the second branch, ]
0.9976164	1281	[ dispense said composition in a container including at least one cover, wherein the cover is at least partly transparent; and ]	[ A method for a medicament including a powder composition, comprising: ]
0.99974126	1282	[ transport said container onto a cutting portion of the cutting device to slice the medicament. ]	[ dispense said composition in a container including at least one cover, wherein the cover is at least partly transparent; and ]
0.99989986	1283	[ obtaining a patient's teeth by one of a suction machine with a suction outlet provided and an incision in a surgical area of the patient's mouth on a skin-surface; ]	[ A method of providing a dental seal comprising: ]
0.99999154	1284	[ placing said suction outlet and surgical area in communication with a source of incontinence created by a catheter, wherein said source is a single unit; ]	[ obtaining a patient's teeth by one of a suction machine with a suction outlet provided and an incision in a surgical area of the patient's mouth on a skin-surface; ]
0.99999213	1285	[ extracting said patient's body fluids, wherein said extracted body fluids are filtered through said suction outlet or through said incision; ]	[ placing said suction outlet and surgical area in communication with a source of incontinence created by a catheter, wherein said source is a single unit; ]
0.99982977	1286	[ inserting at least one oral cavity member therein associated with an incision of said patient's mouth or at least one mouthpiece in contact with the excised surface of the teeth by a person performing a procedure in said surgical area, wherein at least one oral cavity member are of a thin material comprising a bioretin or a biodegradable material and wherein said at least one mouthpiece also comprise a thin material. ]	[ extracting said patient's body fluids, wherein said extracted body fluids are filtered through said suction outlet or through said incision; ]
0.99100983	1287	[ an implantable arm extending in length therefrom in a generally continuous and substantially flat plane; ]	[ Apparatus for the assembly and manipulation of a body load, comprising: ]
0.999992	1288	[ a substantially circular elongated shaft extending in length therefrom in a generally flat plane; ]	[ an implantable arm extending in length therefrom in a generally continuous and substantially flat plane; ]
0.9904399	1289	[ a gripping element inserted into the implantable arm and being supported by the implantable arm in a substantially continuous at least partially open position; and ]	[ a substantially circular elongated shaft extending in length therefrom in a generally flat plane; ]
0.99985325	1290	[ a strap connected to the arm and defining a slot extending in a central dimension thereon along its length; whereinthe strap extends downwardly from the strap when the device is in said generally open position, and, ]	[ a gripping element inserted into the implantable arm and being supported by the implantable arm in a substantially continuous at least partially open position; and ]
0.99998736	1291	[ the slot extends in a generally perpendicular direction at its width between the body load and the gripping element. ]	[ a strap connected to the arm and defining a slot extending in a central dimension thereon along its length; whereinthe strap extends downwardly from the strap when the device is in said generally open position, and, ]
0.9923145	1292	[ a base member havinga mid portion extending substantially outwards and having a front end and an inner surface; ]	[ A skin pad covering comprising: ]
0.99998677	1293	[ three opposite longitudinal ends extending outwardly from said base member; and ]	[ a base member havinga mid portion extending substantially outwards and having a front end and an inner surface; ]
0.008631238	1294	[ a first edge adapted to surround and penetrate skin when in the retracted orientation; and ]	[ three opposite longitudinal ends extending outwardly from said base member; and ]
0.99999213	1295	[ a second distal end of said top portion adapted to protrude from skin when said base member is in the retracted orientation; ]	[ a first edge adapted to surround and penetrate skin when in the retracted orientation; and ]
0.9999918	1296	[ a pivot that pivots said base member between an extended and retracted position to further include said third distal end of said top portion along a first longitudinal axis at an approximate location where said second distal end of said top portion travels in a plane cross. of said distal end of said top portion. ]	[ a second distal end of said top portion adapted to protrude from skin when said base member is in the retracted orientation; ]
0.99997866	1297	[ administering to the patient an effective amount of an antibody, having the following: ]	[ A method of treating a patient suffering from an immune rejection, comprising; ]
0.99979	1298	[ an antibody binding site having an N-terminus and an associated amino acid sequence, a C-terminal heteroatom, and ]	[ administering to the patient an effective amount of an antibody, having the following: ]
0.99999166	1299	[ an associated G-terminal heteroatom; and ]	[ an antibody binding site having an N-terminus and an associated amino acid sequence, a C-terminal heteroatom, and ]
0.99492824	1300	[ a protein that binds to a polypeptide comprising a amino acid sequence of SEQ ID NO: 14 or a fragment thereof selected from proteins comprising the amino acid sequence of SEQ ID NO: 14, or protein fragments thereof, having that amino acid sequence. ]	[ an associated G-terminal heteroatom; and ]
0.0057453164	1301	[ a handle having a front facing portion, a rear facing portion and an upper end; ]	[ A lancing device comprising: ]
0.9999672	1302	[ two elongated portions elongated between adjacent opposite side edges toward said front facing portion and spaced such that the length. ]	[ a handle having a front facing portion, a rear facing portion and an upper end; ]
0.9999918	1303	[ a non-functional tooth piece having at least one lateral groove which extends through the non-functional tooth piece to a location at a lower lip of a dental/perforation device; ]	[ A dental/perforation device, comprising: ]
0.99999225	1304	[ a spring secured to the non-functional tooth piece to generate a force in an axial direction in which a tooth can be formed in the non-functional tooth piece, the spring extending along a lateral first length of the non-functional tooth piece including wherein the tooth can be formed in the non-functional tooth piece by, in a first direction between the first outer surface of the tooth and a second side surface of a tooth having at least one edge portion, engaging portions and both surfaces thereof, and ]	[ a non-functional tooth piece having at least one lateral groove which extends through the non-functional tooth piece to a location at a lower lip of a dental/perforation device; ]
0.99999225	1305	[ wherein the tooth can be formed in the non-functional tooth piece by any edge to which an end of the tooth can be inserted; and ]	[ a spring secured to the non-functional tooth piece to generate a force in an axial direction in which a tooth can be formed in the non-functional tooth piece, the spring extending along a lateral first length of the non-functional tooth piece including wherein the tooth can be formed in the non-functional tooth piece by, in a first direction between the first outer surface of the tooth and a second side surface of a tooth having at least one edge portion, engaging portions and both surfaces thereof, and ]
0.99999046	1306	[ a second non-functional tooth piece secured to the non-functional tooth piece such that the second non-functional tooth piece extends from the second outer surface of the tooth to the second side surface and the second non-functional tooth piece engages with any plurality of other non-functional teeth in the dental/perforation device. ]	[ wherein the tooth can be formed in the non-functional tooth piece by any edge to which an end of the tooth can be inserted; and ]
0.9999716	1307	[ a. a system apparatus including a game terminal; and ]	[ A game system comprising: ]
0.99999213	1308	[ b. a processor configured to execute software on the system apparatus, in a game in which a player loses, said processor comprising: ]	[ a. a system apparatus including a game terminal; and ]
0.0085324785	1309	[ (a) circuitry configured to retrieve a first result from a first search command signal, ]	[ b. a processor configured to execute software on the system apparatus, in a game in which a player loses, said processor comprising: ]
0.999992	1310	[ (b) circuitry configured to derive a second result from said first search command signal, ]	[ (a) circuitry configured to retrieve a first result from a first search command signal, ]
0.99999154	1311	[ (c) circuitry configured to receive the returned first result and said first results, and ]	[ (b) circuitry configured to derive a second result from said first search command signal, ]
0.9999924	1312	[ (d) circuitry configured to generate a second result based at least in part on said received first results and based at least in part on said retrieved first results. ]	[ (c) circuitry configured to receive the returned first result and said first results, and ]
0.013898378	1313	[ a frame assembly; ]	[ An exercise equipment, comprising: ]
0.99999	1314	[ a seat frame attached to said frame assembly, and ]	[ a frame assembly; ]
0.9999908	1315	[ having at least one upper end portion and a lower end portion, said upper end portion and said lower end portion including a plurality of hollow ribs, said upper end portion arranged proximate said frame assembly and extending away from it from said seat frame to define a compartment comprising a first open space and a second hollow cavity, said first gap, said second gap each sized and arranged to fit between said first open space and a surrounding surface, said first cavity being aligned with said second gap. ]	[ a seat frame attached to said frame assembly, and ]
0.027896902	1316	[ a shaft having a body having a plurality of connecting passages extending therealong, the shaft having a proximal end, and ]	[ A fluidary fluid pump used for delivery of a fluid from a volume of an annular hydronic delivery device to a recipient, the delivery device having a plurality of chambers each including a receiving region having a plurality of fluid channels therein, at least one of a first and a second chamber being in proximity to the receiving region, one of the remaining chambers being in contact with a top portion of the receiving region and one or more of the other chambers being exposed to outside environment, the volume comprising one or more of a liquid and air constituents, the pump comprising: ]
0.9952177	1317	[ a distal end; ]	[ a shaft having a body having a plurality of connecting passages extending therealong, the shaft having a proximal end, and ]
0.99996614	1318	[ a plurality of valves, each valve being positioned within a slot in the central portion of the shaft, wherein the one of the remaining chambers being exposed to outside environment at the distal end; ]	[ a distal end; ]
0.9999697	1319	[ an internal member supporting the tubular member including a diameter about 20 mm to 40 mm and sized the maximum volume available for delivery of the fluid comprising about 4 ml to about 6 ml, said internal member comprising an exterior surface joined to an interior surface for interlocking its presence with the exterior surface of the shaft at the distal end; ]	[ a plurality of valves, each valve being positioned within a slot in the central portion of the shaft, wherein the one of the remaining chambers being exposed to outside environment at the distal end; ]
0.9999609	1320	[ a spring coupled to the internal member; and ]	[ an internal member supporting the tubular member including a diameter about 20 mm to 40 mm and sized the maximum volume available for delivery of the fluid comprising about 4 ml to about 6 ml, said internal member comprising an exterior surface joined to an interior surface for interlocking its presence with the exterior surface of the shaft at the distal end; ]
0.9998882	1321	[ an electromagnetic force coupled to the tubular member by an external physical force. ]	[ a spring coupled to the internal member; and ]
0.9952213	1322	[ (a) analyzing a human tissue sample of an individual, wherein the human tissue sample is obtained from a patient from a plurality of sites wherein the patient is diagnosed with a primary site of the parenchymal tumor; ]	[ A method for determining a candidate in a human protein which binds to IL-10, comprising: ]
0.9999908	1323	[ (b) measuring an expression level or expression level profile of IL-10 in the human tissue sample from (a);, and ]	[ (a) analyzing a human tissue sample of an individual, wherein the human tissue sample is obtained from a patient from a plurality of sites wherein the patient is diagnosed with a primary site of the parenchymal tumor; ]
0.99998915	1324	[ (c) applying the measurement results from (b) to a candidate in a human protein having the amino acid sequence IL-10, wherein the candidate binds to IL-10. ]	[ (b) measuring an expression level or expression level profile of IL-10 in the human tissue sample from (a);, and ]
0.0067966525	1325	[ a frame; ]	[ An optical system for treating a human on an endoscope, comprising: ]
0.9996724	1326	[ an ophthalmic lens module associated with the frame, the ophthalmic lens module including a lens disposed in a transverse lens mount coupled to the endoscope, ]	[ a frame; ]
0.99987364	1327	[ at least one optic treatment element in communication with the lens; and ]	[ an ophthalmic lens module associated with the frame, the ophthalmic lens module including a lens disposed in a transverse lens mount coupled to the endoscope, ]
0.99999213	1328	[ at least one control element adapted to selectively connect one end of at least one of the at least one optic treatment elements coupled to the ophthalmic lens module to a treatment outlet in an endoscope, ]	[ at least one optic treatment element in communication with the lens; and ]
0.99999225	1329	[ wherein one optic treatment element is configured to engage the at least one control element and drive an opposing end of the at least one control element. ]	[ at least one control element adapted to selectively connect one end of at least one of the at least one optic treatment elements coupled to the ophthalmic lens module to a treatment outlet in an endoscope, ]
0.99987626	1330	[ administering to the patient inoperable doses of: (i) a human anti-CD4 antibody, or antigen binding fragment thereof that encodes a human anti-CD4 antibody; and ]	[ A method for treating an inoperative lung or breast disorder of a patient, the method comprising: ]
0.999992	1331	[ (ii) a vaccine comprising a human anti-CD46 antibody, or antigen binding fragment thereof that encodes a human anti-CD46 antibody, respectively, wherein the human anti-CD4 antibody and the human anti-CD46 antibody and antigen binding fragment thereof cross-react to form a single polypeptide and selectively inhibit the CD4-specific antibody complement to selectively inhibit the CD5-specific antibody complement. ]	[ administering to the patient inoperable doses of: (i) a human anti-CD4 antibody, or antigen binding fragment thereof that encodes a human anti-CD4 antibody; and ]
0.998988	1332	[ (a) preventing an accumulation of excess phosphorylated &#x3b3; ]	[ An isolated DNA encoding for a protein linked selectively to an insulin receptor polypeptide which has the properties of either: ]
0.9999919	1333	[ 13C-tagged protein amino acids in the plasma of a subject for which serum insulin is recommended, or (b) promoting an accumulation of surplus phosphorylated &#x3b3; ]	[ (a) preventing an accumulation of excess phosphorylated &#x3b3; ]
0.9999924	1334	[ 13C-tagged protein amino acids in the plasma of the subject; said protein-bound phosphorylated &#x3b3; ]	[ 13C-tagged protein amino acids in the plasma of a subject for which serum insulin is recommended, or (b) promoting an accumulation of surplus phosphorylated &#x3b3; ]
0.999992	1335	[ 13C-tagged protein amino acids being phosphorylated by the (a) polypeptide and not by &#x3b1; ]	[ 13C-tagged protein amino acids in the plasma of the subject; said protein-bound phosphorylated &#x3b3; ]
0.9995103	1336	[ 7Ala; and ]	[ 13C-tagged protein amino acids being phosphorylated by the (a) polypeptide and not by &#x3b1; ]
0.9993286	1337	[ in effect, allowing the excess phosphorylated &#x3b3; ]	[ 7Ala; and ]
0.9966718	1338	[ 13C-tagged protein amino acids to accumulate in the plasma of the subject. ]	[ in effect, allowing the excess phosphorylated &#x3b3; ]
0.9994759	1339	[ forming a cavity and a seal to collect waste in the cavity in one cavity and deliver space to collect waste in a second cavity in the food-receiving cavity; ]	[ A method of reducing an energy consumption of a food through a process comprising: ]
0.99996233	1340	[ contacting the first cavity with a first water-methanol mixture of a hydrophilic group and a fat-methanol mixture to form a liquid water mixture, wherein a salt group portion of the liquid water mixture, wherein the first water-methanol mixture is at least one hydrocarbon compound, and ]	[ forming a cavity and a seal to collect waste in the cavity in one cavity and deliver space to collect waste in a second cavity in the food-receiving cavity; ]
0.9999821	1341	[ wherein the second cavity is at least partially filled by vacuum; ]	[ contacting the first cavity with a first water-methanol mixture of a hydrophilic group and a fat-methanol mixture to form a liquid water mixture, wherein a salt group portion of the liquid water mixture, wherein the first water-methanol mixture is at least one hydrocarbon compound, and ]
0.9999702	1342	[ releasing the sealed first cavity of the food, said sealing of the first cavity including sealing of an opening along the dimensions of the first cavity to receive the liquid water mixture; and ]	[ wherein the second cavity is at least partially filled by vacuum; ]
0.026895313	1343	[ producing a material of a weight ratio of at least 60: ]	[ releasing the sealed first cavity of the food, said sealing of the first cavity including sealing of an opening along the dimensions of the first cavity to receive the liquid water mixture; and ]
0.9997863	1344	[ 1 to at least 30: ]	[ producing a material of a weight ratio of at least 60: ]
0.99639386	1345	[ 1. ]	[ 1 to at least 30: ]
0.99180716	1346	[ wherein any of the substituents are non-functional at least partial substituents, ]	[ A pharmaceutical composition having a pharmaceutically acceptable salt content of at least from 0.01 to about 25% by weight of a compound, the compound and its salts, esters and anions present in the composition, in a concentration effective to prevent the proliferation of B cell cancer cell line, wherein the compound in said composition has an MHC ID 4120 and is present at 7&#xb0; C. and 9&#xb0; C., ]
0.9963452	1347	[ wherein each of the compound and its salts, esters and anions have an additional hydroxyl group at an amount effective to inhibit the proliferation of B cell cancer cell line and if the hydroxyl group is absent there is a reduction in the inhibitory effect of the compound if additional hydroxyl groups are found, and ]	[ wherein any of the substituents are non-functional at least partial substituents, ]
0.99983525	1348	[ wherein the compound is not produced by a biodegradable phase. ]	[ wherein each of the compound and its salts, esters and anions have an additional hydroxyl group at an amount effective to inhibit the proliferation of B cell cancer cell line and if the hydroxyl group is absent there is a reduction in the inhibitory effect of the compound if additional hydroxyl groups are found, and ]
0.9995115	1349	[ (a) a fiber optic transmission device for use with one or more fibers of a fiber optics enclosure; ]	[ An integrated fiber-optic system comprising: ]
0.999987	1350	[ (b) a fiber optic communication device that communicates with a fiber optic transmission device to control the fiber optic transmission device, the fiber optic communication device further comprising a fiber optic sensor for detecting a position of the fiber optic transmission device; ]	[ (a) a fiber optic transmission device for use with one or more fibers of a fiber optics enclosure; ]
0.99998796	1351	[ (c) a sensor input device that is associated with at least one fiber optic sensor and at least two fiber optic storage units that store information about a location of a first fiber optic storage unit for a member of the fiber optic storage unit; ]	[ (b) a fiber optic communication device that communicates with a fiber optic transmission device to control the fiber optic transmission device, the fiber optic communication device further comprising a fiber optic sensor for detecting a position of the fiber optic transmission device; ]
0.99999213	1352	[ (d) a first controller that generates a virtual data system in response to the position of the fiber optic storage unit for the member of the fiber optic storage unit at the first fiber optic storage unit position; ]	[ (c) a sensor input device that is associated with at least one fiber optic sensor and at least two fiber optic storage units that store information about a location of a first fiber optic storage unit for a member of the fiber optic storage unit; ]
0.9999821	1353	[ (e) a control system disposed in the fiber optic enclosure for control of the fiber optic communication device and the sensor input device; and ]	[ (d) a first controller that generates a virtual data system in response to the position of the fiber optic storage unit for the member of the fiber optic storage unit at the first fiber optic storage unit position; ]
0.9999782	1354	[ (f) a control unit disposed in the fiber optic storage units that manages the data at least for a portion of an image displayed on a display portion of the fiber optic storage unit. ]	[ (e) a control system disposed in the fiber optic enclosure for control of the fiber optic communication device and the sensor input device; and ]
0.012728363	1355	[ a first casing having a second casing from which a body of said first casing is removed, wherein said apparatus further comprises a rotary movement element defined in said second casing that rotates about at least one axis; ]	[ An apparatus for performing a plurality of separate procedures, comprising: ]
0.9999913	1356	[ wherein said first and second casing are configured to receive said body from said first casing; ]	[ a first casing having a second casing from which a body of said first casing is removed, wherein said apparatus further comprises a rotary movement element defined in said second casing that rotates about at least one axis; ]
0.9999778	1357	[ wherein said body comprises a plurality of parts; ]	[ wherein said first and second casing are configured to receive said body from said first casing; ]
0.9999504	1358	[ wherein said first and second casing further comprise side walls connected to said body; ]	[ wherein said body comprises a plurality of parts; ]
0.9999889	1359	[ wherein said body includes a plurality of walls; and ]	[ wherein said first and second casing further comprise side walls connected to said body; ]
0.99972457	1360	[ wherein said casing defines two walls: ]	[ wherein said body includes a plurality of walls; and ]
0.9999373	1361	[ a first one of said walls that includes a plurality of holes; and ]	[ wherein said casing defines two walls: ]
0.9999902	1362	[ a second one of said walls that contains elongates, said fourth wall connecting at least one of the channels of said outer casing with the innermost channel of said first and second casing, respectively. ]	[ a first one of said walls that includes a plurality of holes; and ]
0.9886883	1363	[ a. providing a first polymer electrode comprising at least one second polymer electrode, wherein each of said first and second polymer electrodes comprise a first and a second non-woven, flexible layer attached of about equal thickness to a top surface; and ]	[ A method for selectively providing a multi-directional electric co-polymer comprising a polyurethane resin and a phenol, comprising: ]
0.99999213	1364	[ b. providing a heat-conducting material electrically conductive to at least one of said first polymer electrode and said heat-conducting material wherein, after said at least one second polymer electrode has been attached to at least one of said first and second polymers, said heat-conducting material has a region of highest heat conductivity outside of, and ]	[ a. providing a first polymer electrode comprising at least one second polymer electrode, wherein each of said first and second polymer electrodes comprise a first and a second non-woven, flexible layer attached of about equal thickness to a top surface; and ]
0.9999924	1365	[ within, at least one of said first and second non-woven, flexible layers when provided with a heat-conducting material having a heat conductivity over 100&#xb0; C., and, after said at least one second polymer electrode has been attached to at least one of said first and second non-woven, flexible layers, at least a portion of said from the heat-conducting material remains within said region of highest heat conductivity. ]	[ b. providing a heat-conducting material electrically conductive to at least one of said first polymer electrode and said heat-conducting material wherein, after said at least one second polymer electrode has been attached to at least one of said first and second polymers, said heat-conducting material has a region of highest heat conductivity outside of, and ]
0.9999924	1366	[ administering to the patient an effective amount of a neuroproterone peptide that is present in the neuroproterone peptide of SEQ ID NO: 15 when administered, wherein the neuroproterone peptide is not a neuroproterone peptide of SEQ ID NO: 10. ]	[ A method of treating sleep apnea in a patient of need, comprising administering to the patient an effective amount of a neuroproterone peptide that is present in the neuroproterone peptide of SEQ ID NO: 10 when administered in an amount of 1 mg to 5 mg per day for at least a first 14 days before and at least a second 14 days after the end of the first 14 days; and ]
0.021132944	1367	[ a lower end comprising a first end; ]	[ A hand prosthesis for implantation into a palm of a human patient to allow movement of the hand between elevated and lowered positions, said hand prosthesis comprising: ]
0.9999641	1368	[ a first pair of electrodes proximate to said lower end, comprising first electrodes selectively activating a first prosthesis signal, wherein the first prosthesis signal provides a first signal indicative of the reduced physical activity level of the patient in a predetermined range of decreased physiological activity; ]	[ a lower end comprising a first end; ]
0.99999213	1369	[ a second pair of electrodes proximate to said lower end, differing from the first pair of electrodes by only one electrode; ]	[ a first pair of electrodes proximate to said lower end, comprising first electrodes selectively activating a first prosthesis signal, wherein the first prosthesis signal provides a first signal indicative of the reduced physical activity level of the patient in a predetermined range of decreased physiological activity; ]
0.9999895	1370	[ a first controller coupled to said second pair of electrodes, the first controller detecting an activation of said second pair of electrodes, wherein the first and second controllers respectively control the sensitivity of said first and second pair of electrodes on a basis of activation results received from said first pair of electrodes; ]	[ a second pair of electrodes proximate to said lower end, differing from the first pair of electrodes by only one electrode; ]
0.99994886	1371	[ an electrically conductive transducer disposed proximate to said first pair of electrodes and configured to be affixed within said lower end under the skin at a location proximate to said transducer; ]	[ a first controller coupled to said second pair of electrodes, the first controller detecting an activation of said second pair of electrodes, wherein the first and second controllers respectively control the sensitivity of said first and second pair of electrodes on a basis of activation results received from said first pair of electrodes; ]
0.99995995	1372	[ which can be selectively inserted into the hand while said lower end is positioned at the predetermined range of decreased physiological activity, such that the transducer provides the first prosthesis signal while preventing stimulation of the transducer above the predetermined range of decreased physiological activity; and ]	[ an electrically conductive transducer disposed proximate to said first pair of electrodes and configured to be affixed within said lower end under the skin at a location proximate to said transducer; ]
0.9999918	1373	[ wherein the second pair of electrodes comprises second electrodes selectively activating a second prosthesis signal, while the second prosthesis signal is a tone indicating that the patient is at a reduced physical activity level. ]	[ which can be selectively inserted into the hand while said lower end is positioned at the predetermined range of decreased physiological activity, such that the transducer provides the first prosthesis signal while preventing stimulation of the transducer above the predetermined range of decreased physiological activity; and ]
0.9991928	1374	[ a radiation beam having a radio frequency (RF) energy that is greater than about 9.8 gigahertz (Ge/R) over a range within approximately about 10 nm; ]	[ A radiation therapeutic system comprising: ]
0.9999882	1375	[ at least one radio deflection chamber configured to include at least one attenuation plate coupled to a portion of the radiation beam; ]	[ a radiation beam having a radio frequency (RF) energy that is greater than about 9.8 gigahertz (Ge/R) over a range within approximately about 10 nm; ]
0.99988616	1376	[ first and second radiating elements, each radiating element including a center wave-type signal detecting element and a RF signal processing element configured to detect radio waves received by each element; and ]	[ at least one radio deflection chamber configured to include at least one attenuation plate coupled to a portion of the radiation beam; ]
0.99968064	1377	[ a multi-band irradiation unit for emitting the energy and generating at least a first and a second radiopaque element. ]	[ first and second radiating elements, each radiating element including a center wave-type signal detecting element and a RF signal processing element configured to detect radio waves received by each element; and ]
0.9946808	1378	[ a housing, as defined by an upper part of the housing and a lower part of the housing; ]	[ A disposable medical appliance for use in the management of an individual, comprising: ]
0.9999614	1379	[ an open-ended flexible hose tube extending from the upper part of the housing to a top of said housing, the housing having a left side and a right side, the housing having a closed upper portion having a tip and an open upper portion having a tip, the bottom of the housing being free of one end; and ]	[ a housing, as defined by an upper part of the housing and a lower part of the housing; ]
0.999992	1380	[ two or more flexible hose tubes adapted to support a hose in fluid communication with an internal fluid and being operably adapted to be connected to said housing; and ]	[ an open-ended flexible hose tube extending from the upper part of the housing to a top of said housing, the housing having a left side and a right side, the housing having a closed upper portion having a tip and an open upper portion having a tip, the bottom of the housing being free of one end; and ]
0.9999914	1381	[ wherein when a patient contacts the hose the medicament becomes mixed along one end of said hose tube with said personal liquid. ]	[ two or more flexible hose tubes adapted to support a hose in fluid communication with an internal fluid and being operably adapted to be connected to said housing; and ]
0.9999906	1382	[ the one rotating member including an apex surface having an opposite surface surface area than the second surface of the elastic member. ]	[ An apparatus for removing a body, the apparatus comprising: at least one elastic member disposed around at least one object to be moved relative to the apparatus and spaced apart with respect to the body to receive an object therefrom, the elastic member having surface surface area and a size; a rotating member having a first surface of substantially perpendicular length, the at least one rotating member being adapted to rotate about a center of rotation with respect to a rotational axis of the rotating member with respect to the body; and ]
0.99995136	1383	[ multiple prosthetic units, each comprising a proximal end and a distal end; and ]	[ A prosthesis, comprising: ]
0.99999166	1384	[ an implantable prosthesis in an extracorporeal body member, wherein that implantable prosthesis is configured to extend from the proximal end of said multiple prosthetic units proximal to the distal end of each multiple prosthetic unit, the implanting devices being of a type which is not different than the combinations of components that provide the prosthetic units and the implanting devices being of a size. ]	[ multiple prosthetic units, each comprising a proximal end and a distal end; and ]
0.9954171	1385	[ a liquid container; ]	[ A mobile water dispensing device, comprising: ]
0.9999888	1386	[ a water reservoir compartment located between the liquid container and the container, said reservoir compartment comprising at least two substantially separable housing members each having a interior area disposed between exterior surfaces and of substantially equal width; ]	[ a liquid container; ]
0.9999541	1387	[ wherein each housing member is configured to contact and move between a first orientation in which the interior area of said individual housing member is inwardly facing and a second orientation in which the interior area of said individual housing member is outwardly facing; and ]	[ a water reservoir compartment located between the liquid container and the container, said reservoir compartment comprising at least two substantially separable housing members each having a interior area disposed between exterior surfaces and of substantially equal width; ]
0.9999894	1388	[ a switch structure connected to the two housing members and positioned within said interior portion of each housing member and configured to selectively pivot the housing members in said respective orientations, said switch structure being configured to turn each of the two housing members in a first direction so that at least a portion of said interior area is toward the interior of the container when it is in a first orientation and subsequently to turn the individual housing member in a second direction so that the interior area of each housing member is toward the exterior side of the container when it is in said second orientation, wherein a first portion of each housing member having an upwardly projecting portion fixedly disposed about an outside surface of the interior portion of said housing member extends outwardly outward from a portion of the outlet surface of said housing member when it is in the second orientation at a generally horizontal height by the displacement of a first portion of said housing member, the second portion of each housing member having a downwardly extending portion fixedly disposed about the outside surface of the interior portion of the interior member, when it is in the second orientation, with the upwardly projecting portion of said housing member pivotally positioned within a fixed angle relative to said second orientation. ]	[ wherein each housing member is configured to contact and move between a first orientation in which the interior area of said individual housing member is inwardly facing and a second orientation in which the interior area of said individual housing member is outwardly facing; and ]
0.99460655	1389	[ a first elongated body member which terminates at the hip; ]	[ A device for use in the treatment of a joint of a user, the device comprising: ]
0.99999225	1390	[ a second elongated body member which terminates at the ankle, wherein the second elongated body member retains an axial recess on an exterior surface of the first elongated body member; ]	[ a first elongated body member which terminates at the hip; ]
0.99999225	1391	[ the second elongated body member defining a distal portion about its length, wherein the second elongated body member extends to a maximum height from the distal portion, and ]	[ a second elongated body member which terminates at the ankle, wherein the second elongated body member retains an axial recess on an exterior surface of the first elongated body member; ]
0.99999225	1392	[ wherein the distal portion is an anterior portion of the elongated body member; ]	[ the second elongated body member defining a distal portion about its length, wherein the second elongated body member extends to a maximum height from the distal portion, and ]
0.999992	1393	[ a clamp, coupled to the second elongated body member, of an elongated cross-section, wherein the clamp comprises an anterior portion which extends distally from the medial axis of the shaft of the clamp and wherein the anterior portion thereof extends distally from the lateral axis of the shaft of the clamp, and ]	[ wherein the distal portion is an anterior portion of the elongated body member; ]
0.99999166	1394	[ wherein at least one of the first and the second elongated body members is supported by a releasable pin located inside the distal portion of the second elongated body member, with the proximal portion of at least one of the first and the second elongated body members spaced from a side to which the pin is releasable, and ]	[ a clamp, coupled to the second elongated body member, of an elongated cross-section, wherein the clamp comprises an anterior portion which extends distally from the medial axis of the shaft of the clamp and wherein the anterior portion thereof extends distally from the lateral axis of the shaft of the clamp, and ]
0.9999924	1395	[ wherein a proximal end of the proximal portion of the second elongated body member is positioned proximal to a proximal edge of the longitudinal axis of the elongated body member. ]	[ wherein at least one of the first and the second elongated body members is supported by a releasable pin located inside the distal portion of the second elongated body member, with the proximal portion of at least one of the first and the second elongated body members spaced from a side to which the pin is releasable, and ]
0.99999225	1396	[ wherein the one or more medicine-carried-through-one-or-all-multiple-gauge-cells side walls form said wall side walls. ]	[ In a computer-implemented pharmaceutical delivery system comprising one or more pharmaceutical drug containers, each pharmaceutical drug container comprising at least one container side, one or more medicine-carrying side walls and at least one medicine-carried-through-one- or-all-multiple-gauge-cells side wall, wherein the first and the second wall elements forming each thereof are hollow, the medicine-carrying side walls of the first and second wall elements forming at least one wall side wall and at least one fluid-carried-through-one- or-all-multiple-gauge-cells side wall being hollow and aligned with one another, and ]
0.999992	1397	[ a first surface for receiving a portion of the food product; ]	[ An apparatus for identifying a portion of a food product comprising a protein, comprising: ]
0.99998057	1398	[ a second surface adjacent at least a portion of said first surface; ]	[ a first surface for receiving a portion of the food product; ]
0.99998987	1399	[ a sensor operatively connected to said first surface for receiving information from a first location of the sensor when the information from said first location of the sensor is received by said sensor; ]	[ a second surface adjacent at least a portion of said first surface; ]
0.9999924	1400	[ an analyzer operatively connected to said second surface for sensing said information from said first location of the sensor when the information from said first location is received by said sensor; and ]	[ a sensor operatively connected to said first surface for receiving information from a first location of the sensor when the information from said first location of the sensor is received by said sensor; ]
0.99999213	1401	[ processing unit operatively connected to said first surface for receiving and processing the information from said first location of the sensor to produce information on a portion of the food product, wherein the processing unit generates a first result of the information from said first location and outputs a second result of the information from said first location, wherein the processing unit generates a first first result with respect to the information from said first location and creates a first second result, and ]	[ an analyzer operatively connected to said second surface for sensing said information from said first location of the sensor when the information from said first location is received by said sensor; and ]
0.999992	1402	[ outputs a second first result corresponding to a second result from said first location; and ]	[ processing unit operatively connected to said first surface for receiving and processing the information from said first location of the sensor to produce information on a portion of the food product, wherein the processing unit generates a first result of the information from said first location and outputs a second result of the information from said first location, wherein the processing unit generates a first first result with respect to the information from said first location and creates a first second result, and ]
0.991398	1403	[ wherein processing unit receives a first quantity information and generates a receipt of the first quantity information if the first quantity information comprises a value that is less than a reference weight; ]	[ outputs a second first result corresponding to a second result from said first location; and ]
0.999992	1404	[ wherein processing unit outputs a first first result and a second first result, wherein the second first result which is associated on that information with a first calculation result includes a quantity information for a first quantity and a second quantity information for a second quantity, and ]	[ wherein processing unit receives a first quantity information and generates a receipt of the first quantity information if the first quantity information comprises a value that is less than a reference weight; ]
0.99999225	1405	[ wherein said second quantity information corresponding to the first quantity is linked to the second first result and the third first result; and ]	[ wherein processing unit outputs a first first result and a second first result, wherein the second first result which is associated on that information with a first calculation result includes a quantity information for a first quantity and a second quantity information for a second quantity, and ]
0.99999213	1406	[ wherein processing unit generates a second first result having a lesser value than a first evaluation result during processing according to values from said first quantity and said second quantity. ]	[ wherein said second quantity information corresponding to the first quantity is linked to the second first result and the third first result; and ]
0.9998982	1407	[ receiving a patient's genetic composition and body mass index including selected parameters of the patient at a tissue or blood culture of the patient to analyze the patient's personal characteristics, wherein the parameters of the patient including, ]	[ A system and method for treating tumor or brain cancer in a patient, comprising: ]
0.9988644	1408	[ a height and a weight, obtained from their respective data samples, of their anatomical structure; ]	[ receiving a patient's genetic composition and body mass index including selected parameters of the patient at a tissue or blood culture of the patient to analyze the patient's personal characteristics, wherein the parameters of the patient including, ]
0.9999894	1409	[ treating the patient's tumor or brain cancer through one or more selective agents, wherein the method further comprises applying the selected agents to the corresponding one or more selected anatomical features, whereby said at least selected parameters are changed and a different phenotype with respect to said a patient's anatomical structure is obtained. ]	[ a height and a weight, obtained from their respective data samples, of their anatomical structure; ]
0.9992772	1410	[ a body defining a lumen; ]	[ A medical instrument comprising: ]
0.9976217	1411	[ a pair of hands extending inwardly through said body such that said pair of hands are substantially perpendicular to each other and are positioned inwardly from the circumference of said body; ]	[ a body defining a lumen; ]
0.9999919	1412	[ a proximal end of said body being coupled to said pair of hands; ]	[ a pair of hands extending inwardly through said body such that said pair of hands are substantially perpendicular to each other and are positioned inwardly from the circumference of said body; ]
0.99999213	1413	[ an upper end of said body extending outwardly from said pair of hands and having a proximal end; ]	[ a proximal end of said body being coupled to said pair of hands; ]
0.9996507	1414	[ a pair of lower end arms; ]	[ an upper end of said body extending outwardly from said pair of hands and having a proximal end; ]
0.9999919	1415	[ at least one noncontact medical device connected to said pair of lower end arms; and ]	[ a pair of lower end arms; ]
0.9999918	1416	[ an elongate body section pivoting at a proximal pivot to the at least one noncontact medical device, wherein said at least one noncontact medical device is oriented to facilitate access and positioning of said medical instrument. ]	[ at least one noncontact medical device connected to said pair of lower end arms; and ]
0.99998784	1417	[ a movable fastening unit coupled to a first proximal end of the surgical instrument such that motion of said movable fastening unit relative to said first proximal end permits movement of said joint relative to a first supporting surface of said site; and ]	[ A surgical equipment system for assembling a surgical instrument at a site to be used for surgery, said surgical equipment system comprising: ]
0.9999924	1418	[ an actuator coupled to a second proximal end of said surgical instrument such that motion of said actuator relative to said second proximal end permits movement of said joint relative to a remote, rotating, opposing support surface of said site; wherein movement of said actuator relative to one or more supporting surfaces of a first and second supporting surface moves both said movable fastening unit and said actuator in a radial rotation direction that is radial to the corresponding distal end of said tool, and ]	[ a movable fastening unit coupled to a first proximal end of the surgical instrument such that motion of said movable fastening unit relative to said first proximal end permits movement of said joint relative to a first supporting surface of said site; and ]
0.9999919	1419	[ movement of said actuator relative to a neighboring surface causes movement of one or more moving elements in a horizontal rotation direction that is rotational to the corresponding distal end of the tool and that does not move said second supporting surface, and ]	[ an actuator coupled to a second proximal end of said surgical instrument such that motion of said actuator relative to said second proximal end permits movement of said joint relative to a remote, rotating, opposing support surface of said site; wherein movement of said actuator relative to one or more supporting surfaces of a first and second supporting surface moves both said movable fastening unit and said actuator in a radial rotation direction that is radial to the corresponding distal end of said tool, and ]
0.9999162	1420	[ wherein said first and second supporting surfaces are spaced apart such that at least to a portion of said first supports said proximal ends engage each other, wherein said support surface has a length greater than the thickness of a surgical instrument between said first and second supporting surfaces. ]	[ movement of said actuator relative to a neighboring surface causes movement of one or more moving elements in a horizontal rotation direction that is rotational to the corresponding distal end of the tool and that does not move said second supporting surface, and ]
0.98614	1421	[ a body comprising a housing; ]	[ A treatment tool, comprising or suitable for being mounted on a tool having a flexible portion, the treatment tool providing an opportunity for a surgical procedure to be performed on said flexible portion, wherein said treatment tool comprises: ]
0.98665166	1422	[ a flexible portion capable of moving to a variable pitch, wherein said flexible portion extends between an open end and closed end, and ]	[ a body comprising a housing; ]
0.99999046	1423	[ a fluidized part having an exterior defined by said flexible portion, wherein at least one first section of said flexible portion has an inner surface selected for refraction of ultrasound waves from said outside to be reflected at said fixed pitch, and ]	[ a flexible portion capable of moving to a variable pitch, wherein said flexible portion extends between an open end and closed end, and ]
0.99999225	1424	[ at least one second section of said flexible portion is configured for an optimal refractive refraction of ultrasound waves reflected from said inner surface. ]	[ a fluidized part having an exterior defined by said flexible portion, wherein at least one first section of said flexible portion has an inner surface selected for refraction of ultrasound waves from said outside to be reflected at said fixed pitch, and ]
0.99884206	1425	[ 2 to a receptor; comprising: ]	[ An apparatus for the screening for a class of proteins which bind the epitope of SEQ ID NO: ]
0.004437623	1426	[ a substrate; and ]	[ 2 to a receptor; comprising: ]
0.999183	1427	[ a receptor portion configured to bind to the epitope of SEQ ID NO: 2, wherein the receptor portion of the substrate consists solely of a peptide modified to limit the ability of the peptide to bind protein S-4 and the receptor portion comprises at least one ligand selected from the group consisting of L-carnitine, cyclo-aminobutyric acid (CAB), human SAA, human epinephrine, leucine, arginine, isoleucine, glutamine, glycine, threonine, aspartate, valine, and ]	[ a substrate; and ]
0.999992	1428	[ histidine amino acids, wherein the ligand is selected from the group consisting of the protease inhibitor class (POI) and the protease inhibitor group (POI-GATP), the receptor portion comprises the peptide modified to bind to at least 1 protein of SEQ ID NO: 2. ]	[ a receptor portion configured to bind to the epitope of SEQ ID NO: 2, wherein the receptor portion of the substrate consists solely of a peptide modified to limit the ability of the peptide to bind protein S-4 and the receptor portion comprises at least one ligand selected from the group consisting of L-carnitine, cyclo-aminobutyric acid (CAB), human SAA, human epinephrine, leucine, arginine, isoleucine, glutamine, glycine, threonine, aspartate, valine, and ]
0.98133653	1429	[ a base comprising: ]	[ An injection tool comprising, ]
0.9840566	1430	[ a tip extending along a longitudinal axis; ]	[ a base comprising: ]
0.03296384	1431	[ a guide defining a cavity defining a working channel containing a drug to be injected into a patient; ]	[ a tip extending along a longitudinal axis; ]
0.9909553	1432	[ an extension extending proximally from the tip; and ]	[ a guide defining a cavity defining a working channel containing a drug to be injected into a patient; ]
0.9999857	1433	[ a distal attachment extending at least partially outside the working channel for connecting against the extension to a plunger for causing the tip to enter the working channel to inject the drug through the implantable device into the patient, the agent being guided through the handle of the extension proximally between execution and removal of the extension to prevent the end of the extension from striking a patient during movement of the drug supply from an implantable device to a patient-specified site. ]	[ an extension extending proximally from the tip; and ]
0.99217224	1434	[ (a) a biologically active peptide of a polypeptide having amino acid residues 5-7 with a therapeutically effective amount of a pharmacologically effective amount of the peptide of ]	[ A method for providing a diagnosis in a patient having a disorder or condition, comprising treating the disorder or condition using a mixture of a therapeutically effective amount of: ]
0.9999112	1435	[ 5-7; ]	[ (a) a biologically active peptide of a polypeptide having amino acid residues 5-7 with a therapeutically effective amount of a pharmacologically effective amount of the peptide of ]
0.9991233	1436	[ (b) an exogenous receptor agonist; and ]	[ 5-7; ]
0.99960583	1437	[ (c) a pharmaceutical composition comprising an active agent and (i) at least one active peptide that binds to said RIL, and ]	[ (b) an exogenous receptor agonist; and ]
0.99976915	1438	[ (ii) at least one therapeutically effective amount of an agonist other than said biotyphen. ]	[ (c) a pharmaceutical composition comprising an active agent and (i) at least one active peptide that binds to said RIL, and ]
0.004737408	1439	[ placing and administering an effective amount of a compound of formula 1 or any mixture thereof; and ]	[ A method for enhancing a function of a tissue-restoration site of the spine in a subject, comprising: ]
0.0012757387	1440	[ subjecting the tissue-restoration site to a controlled stress therapy, wherein said tissue-restoration site is a binnifera root root of Rb-alpha; and ]	[ placing and administering an effective amount of a compound of formula 1 or any mixture thereof; and ]
0.99999213	1441	[ enhancing the strength of the binding of binnifera root tissue perimeters to the bone surface of skin. ]	[ subjecting the tissue-restoration site to a controlled stress therapy, wherein said tissue-restoration site is a binnifera root root of Rb-alpha; and ]
0.9980926	1442	[ a member having a proximal end and a distal end; ]	[ A device for cleaning a tissue, the device comprising: ]
0.99991906	1443	[ a cleaning material disposed on the member; ]	[ a member having a proximal end and a distal end; ]
0.99999034	1444	[ a pressure controller that can sense pressure differences between the distal end and the proximal end of the cleaning material; and ]	[ a cleaning material disposed on the member; ]
0.9995659	1445	[ a sensor disposed on the cleaning member; ]	[ a pressure controller that can sense pressure differences between the distal end and the proximal end of the cleaning material; and ]
0.99398994	1446	[ wherein the pressure controller detects pressure differences across at least four different chambers of the member to detect a different pressure level at each of the four chambers of the member, and ]	[ a sensor disposed on the cleaning member; ]
0.999992	1447	[ the sensor detects pressure differences for a predetermined amount of time at each of four different chambers of the member based on pressure differences experienced at each of the four different chambers at different periods of time, providing a signal indicative of the pressure level, and ]	[ wherein the pressure controller detects pressure differences across at least four different chambers of the member to detect a different pressure level at each of the four chambers of the member, and ]
0.99996424	1448	[ wherein the signal represents a change in an amount of pressure between substantially a first and a second time period. ]	[ the sensor detects pressure differences for a predetermined amount of time at each of four different chambers of the member based on pressure differences experienced at each of the four different chambers at different periods of time, providing a signal indicative of the pressure level, and ]
0.011742021	1449	[ generating, using a processor, a plurality of images, each corresponding to one of a plurality of parts of an intervertebral disc of an individual with a predetermined arrangement of joints extending therethrough; ]	[ A method of providing a therapeutic device selected from the group consisting of a surgical table comprising: ]
0.9999893	1450	[ mapping, using a processor, each image to a bone volume including a respective location relative to a corresponding joint corresponding thereto, using a processor, based on the images; ]	[ generating, using a processor, a plurality of images, each corresponding to one of a plurality of parts of an intervertebral disc of an individual with a predetermined arrangement of joints extending therethrough; ]
0.99999225	1451	[ arranging, using the processor, each image for the corresponding joint of the individual; ]	[ mapping, using a processor, each image to a bone volume including a respective location relative to a corresponding joint corresponding thereto, using a processor, based on the images; ]
0.9998826	1452	[ predicting, using the processor, a user's progress based on said locations of said images, based on the mapping by the processor; and ]	[ arranging, using the processor, each image for the corresponding joint of the individual; ]
0.9999492	1453	[ providing the patient an end result based on said prediction. ]	[ predicting, using the processor, a user's progress based on said locations of said images, based on the mapping by the processor; and ]
0.0012312757	1454	[ receiving, by a user, on a first apparatus, a multi-step configuration of commands to be executed by the first apparatus; ]	[ A method for providing an electronic display comprising: ]
0.99999225	1455	[ when the commands are associated with one or more of the steps of the multi-step configuration, the user prompts with a selection of only one of the commands indicative that at least a first one of the steps has been indicated with a prompt, wherein the prompt includes: ]	[ receiving, by a user, on a first apparatus, a multi-step configuration of commands to be executed by the first apparatus; ]
0.015584502	1456	[ <|span|> a device indication code indicating or indicating that the first apparatus is a network-based device operable to provide computing resources; and ]	[ when the commands are associated with one or more of the steps of the multi-step configuration, the user prompts with a selection of only one of the commands indicative that at least a first one of the steps has been indicated with a prompt, wherein the prompt includes: ]
0.9999876	1457	[ a first graphical user interface for displaying an information image selected by the user that corresponds to the devices of the steps of the multi-step configuration on the first apparatus; ]	[ <|span|> a device indication code indicating or indicating that the first apparatus is a network-based device operable to provide computing resources; and ]
0.9999789	1458	[ indicating when the plurality of steps has been indicated with the prompt with a confirmation prompt that comprises additional steps and that indicates that at least one of the commands associated with the first step has been confirmed with the prompt, the confirmation prompt including a third, second graphical user interface for displaying the additional steps that indicates that the at least one of the commands associated with the second step has been confirmed with the prompt; ]	[ a first graphical user interface for displaying an information image selected by the user that corresponds to the devices of the steps of the multi-step configuration on the first apparatus; ]
0.9999913	1459	[ storing the information in the first graphical user interface displayed by the confirmation prompt; ]	[ indicating when the plurality of steps has been indicated with the prompt with a confirmation prompt that comprises additional steps and that indicates that at least one of the commands associated with the first step has been confirmed with the prompt, the confirmation prompt including a third, second graphical user interface for displaying the additional steps that indicates that the at least one of the commands associated with the second step has been confirmed with the prompt; ]
0.9999894	1460	[ displaying, on the first graphical user interface, at least one information message corresponding to the additional steps; and ]	[ storing the information in the first graphical user interface displayed by the confirmation prompt; ]
0.9999713	1461	[ indicating when subsequent steps of the multi-step configuration have been indicated to the user. ]	[ displaying, on the first graphical user interface, at least one information message corresponding to the additional steps; and ]
0.999313	1462	[ a) obtaining an object from a first lung that is an axially displaced one of; an unfuilable tissue, an unfilable fluid, a living human or an unassisted non-human animal; and ]	[ A method of determining a strength of an interior wall of a lung, comprising the steps of: ]
0.9999914	1463	[ a fluid in a fluid of a lung such that the object moves within a second lung that is a fluid in the lung within a distance from a wall of the second pulmonary artery; ]	[ a) obtaining an object from a first lung that is an axially displaced one of; an unfuilable tissue, an unfilable fluid, a living human or an unassisted non-human animal; and ]
0.9992478	1464	[ b) using an optical characteristic imaging technique to measure the optical characteristic of the object so that there is a change in the optical characteristic when the object is moved, ]	[ a fluid in a fluid of a lung such that the object moves within a second lung that is a fluid in the lung within a distance from a wall of the second pulmonary artery; ]
0.9999659	1465	[ c) obtaining one or more data indicative of electrical current flow through the object along the inside of the hollow lung, the one or more data obtained by measuring the electrical current flow along the inside of the lung, such that an information about how the information is obtained, and ]	[ b) using an optical characteristic imaging technique to measure the optical characteristic of the object so that there is a change in the optical characteristic when the object is moved, ]
0.99999225	1466	[ that the electrical current flow exists of the hollow lung is present. ]	[ c) obtaining one or more data indicative of electrical current flow through the object along the inside of the hollow lung, the one or more data obtained by measuring the electrical current flow along the inside of the lung, such that an information about how the information is obtained, and ]
0.99691796	1467	[ an anchor; ]	[ A tool comprising: ]
0.9999765	1468	[ a pair of engagement elements, each said engagement element being separate from the anchor, each said engagement element having a first tip and a second tip, each said engagement element having a cross-sectional area equal to to about 2 from about 2 to about 9 inch, and ]	[ an anchor; ]
0.9999485	1469	[ at least one mounting portion for mount said anchor; ]	[ a pair of engagement elements, each said engagement element being separate from the anchor, each said engagement element having a first tip and a second tip, each said engagement element having a cross-sectional area equal to to about 2 from about 2 to about 9 inch, and ]
0.0069334814	1470	[ a springable tool holder, wherein said tool holder comprises a tool holder body, a spring actuated arm, and ]	[ at least one mounting portion for mount said anchor; ]
0.99999225	1471	[ rotatable means for moving said tool holder body relative to the outer periphery of the tool holder body, ]	[ a springable tool holder, wherein said tool holder comprises a tool holder body, a spring actuated arm, and ]
0.99999225	1472	[ wherein said tool holder body is rigidly mountable to at least one of an inner surface of a portion of the tool holder body or an outer surface of the tool holder body, wherein said mounting portion is threaded to receive a tool holder pin movable toward the outer periphery of said tool holder body and in an engageable path therebetween; ]	[ rotatable means for moving said tool holder body relative to the outer periphery of the tool holder body, ]
0.99999213	1473	[ a threaded portion secured to said threaded section of said tool holder body; and ]	[ wherein said tool holder body is rigidly mountable to at least one of an inner surface of a portion of the tool holder body or an outer surface of the tool holder body, wherein said mounting portion is threaded to receive a tool holder pin movable toward the outer periphery of said tool holder body and in an engageable path therebetween; ]
0.99999046	1474	[ a mounting member configured to be held by said threaded portion, and ]	[ a threaded portion secured to said threaded section of said tool holder body; and ]
0.99999166	1475	[ configured to retain said tool or tool holder in a predetermined position when said threaded portion is in an engageable posture within said threaded portion. ]	[ a mounting member configured to be held by said threaded portion, and ]
0.9974138	1476	[ receiving an anastomosis of a tumor with an anastomosis probe; ]	[ A method for performing an X-ray scan, comprising the steps of: ]
0.99999213	1477	[ detecting a tumor in presence of the anastomosis signal; and ]	[ receiving an anastomosis of a tumor with an anastomosis probe; ]
0.9999918	1478	[ adjusting an X-ray pulse to perform an Anastomosis &#x221b; pulse to image said tumor. ]	[ detecting a tumor in presence of the anastomosis signal; and ]
0.99999213	1479	[ a first suspension having one or more portions that are not pyrrole in cross-section and containing at least one portion cross-linked to an elastomer-containing portion from the pyrrole based substrate, wherein said elastomer-containing portion has first and second properties; ]	[ A system for making a water-soluble polymeric material by combining a pyrrole based substrate and a pyrrole based elastomer composition on a single cross-section that includes both tubular and a convex or hollow shape and that is representative of all particles in a suspension, said system comprising: ]
0.99999225	1480	[ a liquid suspension having one or more portions that are not pyrrole in cross-section and containing at least a portion cross-linked to the elastomer-containing portion formed on the cross-section comprising the both tubular and the convex or hollow shape; and ]	[ a first suspension having one or more portions that are not pyrrole in cross-section and containing at least one portion cross-linked to an elastomer-containing portion from the pyrrole based substrate, wherein said elastomer-containing portion has first and second properties; ]
0.99999225	1481	[ a second suspension having one or more portions that are not pyrrole in cross-section and containing at least a portion cross-linked to the elastomer-containing portion formed on the cross-section to form a water-soluble mixture, wherein first and second properties of said mixing substantially match first and second properties of said first suspension, and ]	[ a liquid suspension having one or more portions that are not pyrrole in cross-section and containing at least a portion cross-linked to the elastomer-containing portion formed on the cross-section comprising the both tubular and the convex or hollow shape; and ]
0.9999919	1482	[ wherein said mixing does not differ in composition from any other polymeric materials produced by melting or crystallization of the substance comprising pyrrole based substrate. ]	[ a second suspension having one or more portions that are not pyrrole in cross-section and containing at least a portion cross-linked to the elastomer-containing portion formed on the cross-section to form a water-soluble mixture, wherein first and second properties of said mixing substantially match first and second properties of said first suspension, and ]
0.9999815	1483	[ receiving at a computer a digital representation of a first cataract image containing a first set of bone landmarks, wherein the first set of bone landmarks include both a first set of points representing the first portion of the first cataract image and a second set of bone landmarks representing the second portion of the first cataract image; and ]	[ A method of creating a 3D model of a cataract in a subject comprising: ]
0.9999919	1484	[ computing a first 3D model including a first set of physical features of a subject based on the first set of points based on the second set of bone landmarks, wherein the first 3D model includes the first set of physical features of said subject in the image having the first set of point representative of at least some of the first portion of the first cataract image that is associated with selected ones of the bone landmarks representing the second portion of the first cataract image. ]	[ receiving at a computer a digital representation of a first cataract image containing a first set of bone landmarks, wherein the first set of bone landmarks include both a first set of points representing the first portion of the first cataract image and a second set of bone landmarks representing the second portion of the first cataract image; and ]
0.9999851	1485	[ a substantially continuous wall surface of non-electrode structure, the wall surface having a diameter, a length, a thickness of about 0.2 to about 1 mm to facilitate penetration of radiofrequency signals in at least the non-electroid structure, the wall surface having a surface area of about 250 to about 550 liters, ]	[ A body support for non-electrode structures, comprising: ]
0.9999914	1486	[ a plurality of support elements arranged along the wall surface, the plurality supported elements of known mass with a respective length, an average length of about 0.17 to about 0.0 nm, each of the support elements for supporting non-electrode structures being generally vertically spaced apart from each other, and ]	[ a substantially continuous wall surface of non-electrode structure, the wall surface having a diameter, a length, a thickness of about 0.2 to about 1 mm to facilitate penetration of radiofrequency signals in at least the non-electroid structure, the wall surface having a surface area of about 250 to about 550 liters, ]
0.99999154	1487	[ a base having a depth exceeding about 400 ml, that base is for supporting a portion of a non-electrode structure such that said portion of non-electrode structure extends further than the distance of the support elements in from a front toward a rear. ]	[ a plurality of support elements arranged along the wall surface, the plurality supported elements of known mass with a respective length, an average length of about 0.17 to about 0.0 nm, each of the support elements for supporting non-electrode structures being generally vertically spaced apart from each other, and ]
0.998429	1488	[ (i) a polypeptide having structure SEQ ID NO: ]	[ An isolated epitope comprising: ]
0.9958528	1489	[ 1; ]	[ (i) a polypeptide having structure SEQ ID NO: ]
0.99591124	1490	[ (ii) a polypeptide having structure SEQ ID NO: ]	[ 1; ]
0.9997749	1491	[ 1, wherein the polypeptide in combination with the non-polymerizing segment of the polymer comprises a hydrocarbon. ]	[ (ii) a polypeptide having structure SEQ ID NO: ]
0.9863885	1492	[ a. providing a compound, wherein the compound is selected from the group consisting of: ]	[ A method for making a non-naturally produced dye, comprising: ]
0.9988902	1493	[ i) a polymer; ]	[ a. providing a compound, wherein the compound is selected from the group consisting of: ]
0.9999794	1494	[ ii) a polymer or an elastomer; ]	[ i) a polymer; ]
0.9999188	1495	[ iii) a liquid; ]	[ ii) a polymer or an elastomer; ]
0.99952507	1496	[ iv) a solvate chosen from the group consisting of a solvate for use in preparing a non-naturally produced dye; ]	[ iii) a liquid; ]
0.99972504	1497	[ v) amine of 3, ]	[ iv) a solvate chosen from the group consisting of a solvate for use in preparing a non-naturally produced dye; ]
0.9824049	1498	[ 4-dimethyl-4-isoxazolyl-2-yl (I&#x2014; ]	[ v) amine of 3, ]
0.9968322	1499	[ I)diphenyl; ]	[ 4-dimethyl-4-isoxazolyl-2-yl (I&#x2014; ]
0.9985941	1500	[ vi) a salt; and ]	[ I)diphenyl; ]
0.99994195	1501	[ vii) a polymeric monomer. ]	[ vi) a salt; and ]
0.99998665	1502	[ attaching a first material to a first portion of the first container material; ]	[ A method for preparing a container material for cooking, comprising: ]
0.99999225	1503	[ attaching a second material to a second portion of the first container materials; ]	[ attaching a first material to a first portion of the first container material; ]
0.9999424	1504	[ positioning the first and second containers so that the first and second containers are aligned; and ]	[ attaching a second material to a second portion of the first container materials; ]
0.99997735	1505	[ positioning one or more materials for cooking under the one or more containers so as to permit heating of the one or more containers. ]	[ positioning the first and second containers so that the first and second containers are aligned; and ]
0.9688733	1506	[ a storage unit; ]	[ A system comprising: ]
0.9999862	1507	[ a control module operable for executing controls on said storage unit, said control module in communication with said storage unit during operation of said unit; ]	[ a storage unit; ]
0.9999627	1508	[ an access bus disposed in communication with said access unit, said access bus configured for supplying at least one of a controller component, a command component, and ]	[ a control module operable for executing controls on said storage unit, said control module in communication with said storage unit during operation of said unit; ]
0.999977	1509	[ a control component; and ]	[ an access bus disposed in communication with said access unit, said access bus configured for supplying at least one of a controller component, a command component, and ]
0.9901702	1510	[ a first control interface operable for receiving signals from said storage unit and operable for interacting with said instructions contained in electronic records in said storage unit to respond to a selection of the first control interface on the control module when a first output setting is configured on said one control interface. ]	[ a control component; and ]
0.9991111	1511	[ providing a sample; ]	[ A method for determining the presence of a ligand in a blood or plasma sample from a patient, the method comprising the steps of: ]
0.9999666	1512	[ measuring the amount of glycolipids in the sample, the measured amount of glycolipids in the sample being within one or more boundaries of a reference range; ]	[ providing a sample; ]
0.99999225	1513	[ measuring an amount of the blood or plasma sample taken by measuring the amount of glycolipids from the measured blood or plasma sample; ]	[ measuring the amount of glycolipids in the sample, the measured amount of glycolipids in the sample being within one or more boundaries of a reference range; ]
0.008327265	1514	[ producing a signal data set from the measured data set and outputting an output signal; ]	[ measuring an amount of the blood or plasma sample taken by measuring the amount of glycolipids from the measured blood or plasma sample; ]
0.9999653	1515	[ using a computer, determining based on the output signal from the computer whether a ligand is present in the sample based on the result of the step of comparing the measurement to the measurement, and ]	[ producing a signal data set from the measured data set and outputting an output signal; ]
0.99999225	1516	[ generating a data set corresponding to the presence of a ligand in the sample wherein the ligand is determined based on the analysis of the output signal. ]	[ using a computer, determining based on the output signal from the computer whether a ligand is present in the sample based on the result of the step of comparing the measurement to the measurement, and ]
0.9996444	1517	[ a) connecting a proximal end of a femoral shaft of a medical instrument to a first implantable implant and connecting a distal end of the femoral shaft to a second implantable implant, said femoral shaft comprises a bone connecting part including a proximal end that is connected to the bone connecting part and a distal end that is connected to the bone supporting part; ]	[ A method for producing a bone implant comprising the steps of: ]
0.99999213	1518	[ b) linking the distal end of said femoral shaft to a third implantable implant; ]	[ a) connecting a proximal end of a femoral shaft of a medical instrument to a first implantable implant and connecting a distal end of the femoral shaft to a second implantable implant, said femoral shaft comprises a bone connecting part including a proximal end that is connected to the bone connecting part and a distal end that is connected to the bone supporting part; ]
0.999992	1519	[ c) connecting the proximal end of the bone connecting part to the distal end of said femoral shaft when the bone connecting part of the femoral shaft is connected to said third implantable implant; ]	[ b) linking the distal end of said femoral shaft to a third implantable implant; ]
0.99999225	1520	[ d) positioning at least a portion of said distal end of the bone connecting part of the femoral shaft; ]	[ c) connecting the proximal end of the bone connecting part to the distal end of said femoral shaft when the bone connecting part of the femoral shaft is connected to said third implantable implant; ]
0.99999094	1521	[ e) connecting said proximal end of said femoral shaft to a first transverse-conical device that can receive and support the bone between the femoral shaft and a bone supporting element; and ]	[ d) positioning at least a portion of said distal end of the bone connecting part of the femoral shaft; ]
0.99999213	1522	[ f) connecting at least a portion of the bone connecting part of the femoral shaft to the bone supporting element when the proximal end of the femoral shaft is connected to said proximal end of the bone connecting part. ]	[ e) connecting said proximal end of said femoral shaft to a first transverse-conical device that can receive and support the bone between the femoral shaft and a bone supporting element; and ]
0.99980015	1523	[ an initial treatment formulation, wherein the initial treatment formulation comprises a water-soluble compound, an unsaturated, unsaturated, unsaturated, unsaturated and unsaturated-saturated, unsaturated and unsaturated monomer in a form that is capable of being applied to a surface of the patient; and ]	[ A composition for delivering a dose of a compound to a patient, comprising: ]
0.9999913	1524	[ at least one of a carrier and an adsorption medium that binds the initial treatment formulation along a lipid-coated surface. ]	[ an initial treatment formulation, wherein the initial treatment formulation comprises a water-soluble compound, an unsaturated, unsaturated, unsaturated, unsaturated and unsaturated-saturated, unsaturated and unsaturated monomer in a form that is capable of being applied to a surface of the patient; and ]
0.99999213	1525	[ an ophthalmic structure configured to conform to the support axis; ]	[ A bed assembly having a support axis relative to an ophthalmic structure, comprising: ]
0.99998915	1526	[ a wall comprising a first surface; (i) the first surface of the wall moving from a first position over the support axis to a second position having a substantially equal thickness from one end of the wall to the other end and relative to the wall; ]	[ an ophthalmic structure configured to conform to the support axis; ]
0.9999889	1527	[ (ii) the first surface of the wall configured to deform when pushed through a bed of the ophthalmic structure; and ]	[ a wall comprising a first surface; (i) the first surface of the wall moving from a first position over the support axis to a second position having a substantially equal thickness from one end of the wall to the other end and relative to the wall; ]
0.9998273	1528	[ a resilient member configured to support the first surface between the surface of the first surface and a mounting structure to prevent the mounting structure from deforming sufficiently to prevent contact between the first and second surfaces. ]	[ (ii) the first surface of the wall configured to deform when pushed through a bed of the ophthalmic structure; and ]
0.99766207	1529	[ a body of substantially homogeneous material and having a sealed surface, said body comprising a first end configured to be disposed within a substrate or body wall and a second end disposed distally of said first end; and ]	[ A self-combustible biodegradable seal for use in supplying liquid, comprising: ]
0.99998987	1530	[ a first biodegradable layer having a first biasing factor selected from the group consisting of a melting and a bending angle of the heat generated by the heat absorbing material such that a heat spread across the respective first biasing factors through said outer side of said seal to create a separation force between said first biasing factors wherein said first biodegradable layer can be used to reduce decomposition of said substrate or body wall from, or dissolve said organic material from, said liquid, and ]	[ a body of substantially homogeneous material and having a sealed surface, said body comprising a first end configured to be disposed within a substrate or body wall and a second end disposed distally of said first end; and ]
0.99999225	1531	[ wherein the first biodegradable layer further comprises a second biasing factor which depends on the temperature of the liquid. ]	[ a first biodegradable layer having a first biasing factor selected from the group consisting of a melting and a bending angle of the heat generated by the heat absorbing material such that a heat spread across the respective first biasing factors through said outer side of said seal to create a separation force between said first biasing factors wherein said first biodegradable layer can be used to reduce decomposition of said substrate or body wall from, or dissolve said organic material from, said liquid, and ]
0.99999106	1532	[ a longitudinal member having a cylindrical side being engaged with a first side of a cartridge to releasably link to said storage media carrier, the cylindrical side having a wall extending in successive channels, wherein upon impact with an object, the wall separates, and ]	[ A storage media carrier comprising: ]
0.9999659	1533	[ the wall further separates into two opposing first regions of the wall and a first second region of the wall, the first region being distinct from the first region and less than the second region and a recess at an apex connecting the wall to said cylinder, ]	[ a longitudinal member having a cylindrical side being engaged with a first side of a cartridge to releasably link to said storage media carrier, the cylindrical side having a wall extending in successive channels, wherein upon impact with an object, the wall separates, and ]
0.9999237	1534	[ wherein a diameter of the cylindrical side of the storage media carrier is less than 3 mm and the second region is less than 8 mm to provide for a storage pressure of 5 to 100 g in a vertical direction and less than 200 to 400 g in a horizontal direction, ]	[ the wall further separates into two opposing first regions of the wall and a first second region of the wall, the first region being distinct from the first region and less than the second region and a recess at an apex connecting the wall to said cylinder, ]
0.9999919	1535	[ and wherein the recessed portion is defined by a protrusion at an apex which is substantially equal to the elongate surface of one of the first and second regions, wherein the second region and the recessed portion are spaced apart by a distance of at least two decimeters from the cylindrical side of the storage media carrier. ]	[ wherein a diameter of the cylindrical side of the storage media carrier is less than 3 mm and the second region is less than 8 mm to provide for a storage pressure of 5 to 100 g in a vertical direction and less than 200 to 400 g in a horizontal direction, ]
0.9804109	1536	[ a main body; ]	[ A fluid dispensing device comprising: ]
0.9999721	1537	[ a dispensing valve which is disposed in said main body and is operable to selectively press a solid/liquid mixture, the dispensing valve being open when in a closed state and closing or locking between such closed and locked state; ]	[ a main body; ]
0.99999213	1538	[ an automatic valve holder, that is disposed in said dispensing valve and opens relative to said dispensing valve for automatically positioning or closing an inlet of the dispensing valve when said dispensing valve is in a closed mode so as to push a solid/ liquid mixture in or out of the dispensing valve; ]	[ a dispensing valve which is disposed in said main body and is operable to selectively press a solid/liquid mixture, the dispensing valve being open when in a closed state and closing or locking between such closed and locked state; ]
0.9999889	1539	[ a valve assembly configured such that the valve assembly extends from said main body through a portion of a wall of said dispensing valve towards or inside a portion of said dispensing valve external surface; and ]	[ an automatic valve holder, that is disposed in said dispensing valve and opens relative to said dispensing valve for automatically positioning or closing an inlet of the dispensing valve when said dispensing valve is in a closed mode so as to push a solid/ liquid mixture in or out of the dispensing valve; ]
0.99999213	1540	[ a device assembly that is disposed within said dispensing valve so as to extend in a transverse plane along a direction between outer and inner surfaces of said dispensing valve. ]	[ a valve assembly configured such that the valve assembly extends from said main body through a portion of a wall of said dispensing valve towards or inside a portion of said dispensing valve external surface; and ]
0.99468416	1541	[ a slot defining a path from a first end of the slot to a second end of the slot; ]	[ A medical card forming member comprising: ]
0.999972	1542	[ a hinge-end securing element located within the slot, the hinge-end securing element comprising: ]	[ a slot defining a path from a first end of the slot to a second end of the slot; ]
0.99990857	1543	[ a shaft for sliding about a first surface that receives a first of an outer surface of the slot; and ]	[ a hinge-end securing element located within the slot, the hinge-end securing element comprising: ]
0.9999871	1544	[ a slot being formed in the shaft from a second outer surface. ]	[ a shaft for sliding about a first surface that receives a first of an outer surface of the slot; and ]
0.98408806	1545	[ using magnetic resonance imaging (MRI) to examine a subject's brain, the subject having a plurality of electrodes attached to a plurality of brain regions and each electrode having an electric current path connected therewith, the plurality of electrodes arranged by a gradient of magnetic field which generates a field which extends away from the subject and towards the plurality of electrodes, and ]	[ A method comprising: ]
0.999969	1546	[ wherein only one of the plurality of electrodes can be electrically connected to a first electrode at a time; ]	[ using magnetic resonance imaging (MRI) to examine a subject's brain, the subject having a plurality of electrodes attached to a plurality of brain regions and each electrode having an electric current path connected therewith, the plurality of electrodes arranged by a gradient of magnetic field which generates a field which extends away from the subject and towards the plurality of electrodes, and ]
0.0015314223	1547	[ calculating a magnetic field waveform, which is a distribution of first and second magnetic fields that is substantially due to a change in magnetic field strength and which includes a change in magnitude of the field, and ]	[ wherein only one of the plurality of electrodes can be electrically connected to a first electrode at a time; ]
0.9999838	1548	[ calculated to reflect a measurement or process comprising said subject, by applying the magnetic field waveform to at least one of the said plurality of electrodes in a predetermined frequency range to cause said at least one of the plurality of electrodes to have a changed magnetic field strength; ]	[ calculating a magnetic field waveform, which is a distribution of first and second magnetic fields that is substantially due to a change in magnetic field strength and which includes a change in magnitude of the field, and ]
0.9999683	1549	[ providing a model representing the data regarding an object on a basis of the distribution of the first and second magnetic fields and measured data regarding the object for an object from the plurality of electrodes, the model including the parameter of volume, that is associated with at least two particular points associated with the volume, such that the object can be modeled in the subject's brain. ]	[ calculated to reflect a measurement or process comprising said subject, by applying the magnetic field waveform to at least one of the said plurality of electrodes in a predetermined frequency range to cause said at least one of the plurality of electrodes to have a changed magnetic field strength; ]
0.99945647	1550	[ SEQ ID NO: 18. ]	[ An isolated monoclonal antibody, having the binding affinity for epithelial T-helper, wherein said antibodies comprise SEQ ID NO: 13, SEQ ID NO: 14, SEQ ID NO: 15, SEQ ID NO: 16, SEQ ID NO: 17, and ]
0.99998903	1551	[ obtaining a first plurality of single-photon emission spectra, the first plurality of single-photon emission spectra provided for selecting between a first spectrum of emission formed in a first patient (8) and a second spectrum of emission formed in a second patient (10), ]	[ A single-photon emission tomography image forming method comprising the steps of: ]
0.99999166	1552	[ generating an output on the basis of each first plurality of single-photon emission spectra; ]	[ obtaining a first plurality of single-photon emission spectra, the first plurality of single-photon emission spectra provided for selecting between a first spectrum of emission formed in a first patient (8) and a second spectrum of emission formed in a second patient (10), ]
0.99999225	1553	[ for a second patient (11), forming a first plurality of coherence tomas on the basis of the first plurality of single-photon emission spectra for acquisition of first, second and third coherence tomas, wherein the output produced comprises one, another and a fourth coherence tomas; ]	[ generating an output on the basis of each first plurality of single-photon emission spectra; ]
0.9999918	1554	[ for a third patient (12), forming a second plurality of coherence tomas on the basis of the first and second plurality of single-photon emission spectra for acquisition of fourth coherence tomas, which coherence tomas contain different spectral regions, the output for each coherence toma contains the associated spectral region; and ]	[ for a second patient (11), forming a first plurality of coherence tomas on the basis of the first plurality of single-photon emission spectra for acquisition of first, second and third coherence tomas, wherein the output produced comprises one, another and a fourth coherence tomas; ]
0.99999225	1555	[ producing a single-photon emission tomography image of a second patient ( 13) with at least one coherence tomosa on the image being produced, ]	[ for a third patient (12), forming a second plurality of coherence tomas on the basis of the first and second plurality of single-photon emission spectra for acquisition of fourth coherence tomas, which coherence tomas contain different spectral regions, the output for each coherence toma contains the associated spectral region; and ]
0.9999901	1556	[ wherein the output for each coherence toma contains at least one of: ]	[ producing a single-photon emission tomography image of a second patient ( 13) with at least one coherence tomosa on the image being produced, ]
0.9999888	1557	[ a range of coherence values over a range of spectra, and ]	[ wherein the output for each coherence toma contains at least one of: ]
0.99999225	1558	[ of the spectrum spectra, wherein the range of coherence values over the spectrum spectra has been developed and defined based on the respective first plurality of single-photon emission spectra and the respective second and third plurality of single-photon emission spectra. ]	[ a range of coherence values over a range of spectra, and ]
0.99927515	1559	[ employing a radiotherapy device that acts on a primary site such as a heart; ]	[ A method of treating atrial fibrillation in a patient, the method comprising: ]
0.99945074	1560	[ placing a treatment device within the treatment site, the treatment device comprising: ]	[ employing a radiotherapy device that acts on a primary site such as a heart; ]
0.982116	1561	[ a top surface; and ]	[ placing a treatment device within the treatment site, the treatment device comprising: ]
0.9999105	1562	[ a bottom surface that is generally parallel to the top surface, wherein the top surface has a side surface coupled to a surface of the top surface, which is generally perpendicular to the surface of the top surface, ]	[ a top surface; and ]
0.00397437	1563	[ wherein the treatment device comprises a plastinated material having two sides and at least two spaced apart flanks, and ]	[ a bottom surface that is generally parallel to the top surface, wherein the top surface has a side surface coupled to a surface of the top surface, which is generally perpendicular to the surface of the top surface, ]
0.0138000995	1564	[ comprising: ]	[ wherein the treatment device comprises a plastinated material having two sides and at least two spaced apart flanks, and ]
0.084152065	1565	[ a first side; ]	[ comprising: ]
0.9999554	1566	[ at least a first angle coupled to the at least portion of the first side and with respect to a plane of the treatment site, wherein the first angled angle is greater than the second angle, and ]	[ a first side; ]
0.99996364	1567	[ wherein the first side has a shape that is curved and the plastinated surface is exposed on top of the first side, said molding having a first angle of less than about 60 degrees and a second angle of less than about 60 degrees, wherein the position of the plastinated material is at a height of a predetermined height with respect to the first angle; and ]	[ at least a first angle coupled to the at least portion of the first side and with respect to a plane of the treatment site, wherein the first angled angle is greater than the second angle, and ]
0.0039671096	1568	[ an upper surface with light material which is covered on an inner side of the second angled angle of the treatment device, ]	[ wherein the first side has a shape that is curved and the plastinated surface is exposed on top of the first side, said molding having a first angle of less than about 60 degrees and a second angle of less than about 60 degrees, wherein the position of the plastinated material is at a height of a predetermined height with respect to the first angle; and ]
0.9999305	1569	[ wherein coating is applied through a hole in the top surface of the plAST material into the space by a hollow support bar that is mounted on the first angle. ]	[ an upper surface with light material which is covered on an inner side of the second angled angle of the treatment device, ]
0.9983646	1570	[ an ultrasound device; ]	[ A control system for an automatic surgical instrument, comprising: ]
0.9999118	1571	[ an ultrasound transducer configured for transducing waves to produce an ultrasound image; ]	[ an ultrasound device; ]
0.99541265	1572	[ a processor configured to: ]	[ an ultrasound transducer configured for transducing waves to produce an ultrasound image; ]
0.99901605	1573	[ receive the transduced waves, ]	[ a processor configured to: ]
0.99999225	1574	[ provide the transduced waves to the ultrasound device, and ]	[ receive the transduced waves, ]
0.99992955	1575	[ communicate the received ultrasound images with the medical interface for display; and, ]	[ provide the transduced waves to the ultrasound device, and ]
0.99999094	1576	[ determine whether a procedure selected by a patient is to be performed on the surgical instrument based on the transmitted ultrasound images, ]	[ communicate the received ultrasound images with the medical interface for display; and, ]
0.9963218	1577	[ wherein the processor comprises: ]	[ determine whether a procedure selected by a patient is to be performed on the surgical instrument based on the transmitted ultrasound images, ]
0.9692292	1578	[ an initial control state generator configured to receive an acoustic mode of the surgical instrument and to compute an initial control state based upon the acoustic mode and a first initial control state generator time constraint being defined, and ]	[ wherein the processor comprises: ]
0.9999924	1579	[ a first initial control state generator algorithm to generate a first initial control state via the first initial controller time constraint. ]	[ an initial control state generator configured to receive an acoustic mode of the surgical instrument and to compute an initial control state based upon the acoustic mode and a first initial control state generator time constraint being defined, and ]
0.98132807	1580	[ obtaining an entire body of a patient after providing an imaging object to be imaged; ]	[ A method for creating a three-dimensional orthodontic model of an oral anatomy, comprising: ]
0.9999918	1581	[ acquiring a model of the entire body of the patient using at least one of a fluorometric image data, image data displaying an ultrasound signal, or image data displaying an X-ray signal; ]	[ obtaining an entire body of a patient after providing an imaging object to be imaged; ]
0.9998336	1582	[ detecting a motion within the entire body using the at least one of the at least one of the at least one of the at least one of the at least one of the at least one of the at least one of the at least one of the information display display; ]	[ acquiring a model of the entire body of the patient using at least one of a fluorometric image data, image data displaying an ultrasound signal, or image data displaying an X-ray signal; ]
0.9999924	1583	[ acquiring motion information using the at least one of the at least one of the at least one of the at least one of the at least one of the at least one of the information display display of the at least one of the fluorometric image data, image data displaying an ultrasound signal, or image data displaying the X-ray signal with a machine; ]	[ detecting a motion within the entire body using the at least one of the at least one of the at least one of the at least one of the at least one of the at least one of the at least one of the at least one of the information display display; ]
0.99999213	1584	[ correlating motion of a plurality of bones with motions of the at least one of the at least one of the at least one of the at least one of the at least one of the information display display of the at least one of the fluorometric image data, image data displaying the ultrasound signal, or image data displaying the X-ray signal using at least one of the machine and the motion information such that the motion of the plurality of bones is predicted by at least one algorithm at least partially independent of the motion of at least one bone; ]	[ acquiring motion information using the at least one of the at least one of the at least one of the at least one of the at least one of the at least one of the information display display of the at least one of the fluorometric image data, image data displaying an ultrasound signal, or image data displaying the X-ray signal with a machine; ]
0.9999919	1585	[ assigning the motion information and the computed position information of each of the plurality of bones to a model of the entire body; and ]	[ correlating motion of a plurality of bones with motions of the at least one of the at least one of the at least one of the at least one of the at least one of the information display display of the at least one of the fluorometric image data, image data displaying the ultrasound signal, or image data displaying the X-ray signal using at least one of the machine and the motion information such that the motion of the plurality of bones is predicted by at least one algorithm at least partially independent of the motion of at least one bone; ]
0.99999213	1586	[ determining how the orthodontic model of the entire body of the patient is impacted using the of one or more algorithms capable of correcting the motions of the plurality of bones with respect to the motion information after the computation of the computed position information with respect to the motion information. ]	[ assigning the motion information and the computed position information of each of the plurality of bones to a model of the entire body; and ]
0.00010637367	1587	[ at least one plate fixedly placed on a body surface thereof such at least one plate defining an outside diameter and at least one proximal end, and ]	[ A biased weighting system comprising: ]
0.9997024	1588	[ wherein the plate is made up of a plurality of rigid segments that are fixedly spaced from one another. ]	[ at least one plate fixedly placed on a body surface thereof such at least one plate defining an outside diameter and at least one proximal end, and ]
0.99666864	1589	[ a housing; ]	[ An energy-efficient personal vacuum cleaner, comprising: ]
0.024757588	1590	[ a first water motor and battery, said first water motor powered by anhydrally liquid; ]	[ a housing; ]
0.99999225	1591	[ a second water motor and battery, said second water motor powered by anhydrally liquid; ]	[ a first water motor and battery, said first water motor powered by anhydrally liquid; ]
0.99997616	1592	[ a first vacuum source and battery, said first vacuum source in communication with hydrogen; ]	[ a second water motor and battery, said second water motor powered by anhydrally liquid; ]
0.99999225	1593	[ a second vacuum source and battery, said second vacuum source in communication with hydrogen; ]	[ a first vacuum source and battery, said first vacuum source in communication with hydrogen; ]
0.99999213	1594	[ a third vacuum source and battery, said third vacuum source in communication with hydrogen; ]	[ a second vacuum source and battery, said second vacuum source in communication with hydrogen; ]
0.99333113	1595	[ first and second separate pressure-sensitive flow valves, said flow valves being connected to an assembly of water-intensified gaskets in at least two of the openings; and ]	[ a third vacuum source and battery, said third vacuum source in communication with hydrogen; ]
0.99380046	1596	[ a fourth, fluid-tight seal; ]	[ first and second separate pressure-sensitive flow valves, said flow valves being connected to an assembly of water-intensified gaskets in at least two of the openings; and ]
0.9988005	1597	[ said first, second and third vessels at least partially sealing at least one surface of said first, second and third vessels, wherein said first, second and third vessels contain first and second water-intensified gaskets capable of being immersed in water in said at least two openings, said gaskets being sealed closed by one or more of said seals by means of hydrogen or by means of two or more of said gaskets by means of said at least two openings having one or more liquid-extensible gaskets in contact with said at least two openings. ]	[ a fourth, fluid-tight seal; ]
0.022301389	1598	[ a) (i) introducing into cells a compound selected from the group consisting of carboxylic acid, monoglyceric acid, a modified carboxylic acid, and ]	[ A method for assessing presence of an inorganic organ having a polymeric structure comprising the steps of: ]
0.0023075128	1599	[ a compound hydrocarbon substituted with or independently of at least one of said selected functional group and polydimethylsiloxane; ]	[ a) (i) introducing into cells a compound selected from the group consisting of carboxylic acid, monoglyceric acid, a modified carboxylic acid, and ]
0.9932181	1600	[ b) (ii) contacting at least one inorganic organ of interest and cells of said cells with said compound; and ]	[ a compound hydrocarbon substituted with or independently of at least one of said selected functional group and polydimethylsiloxane; ]
0.9999906	1601	[ c) determining the presence of inorganic organ by determining whether the cell has a response characteristic of staurosporine conjugate. ]	[ b) (ii) contacting at least one inorganic organ of interest and cells of said cells with said compound; and ]
0.015648378	1602	[ a main body, said main body having an expandable member therein, adapted for expansion, including a slot defining an outlet portion, and ]	[ An apparatus for providing protection of at least one hand comprising: ]
0.999859	1603	[ a housing in fluid communication with said slot and having a chamber contained therein, the housing configured for a movement between a first fluid environment and a second fluid environment when a hand is placed on the side of the hand from said area exposed; and ]	[ a main body, said main body having an expandable member therein, adapted for expansion, including a slot defining an outlet portion, and ]
0.9993345	1604	[ an elongated shaft fastened thereto and movable from one of said liquid and semi-liquid environments, the shaft having therethrough a first protrusion, a second protrusion, and ]	[ a housing in fluid communication with said slot and having a chamber contained therein, the housing configured for a movement between a first fluid environment and a second fluid environment when a hand is placed on the side of the hand from said area exposed; and ]
0.99992836	1605	[ an end, the end having a contact and said housing being rotatable between said first and second fluid environments. ]	[ an elongated shaft fastened thereto and movable from one of said liquid and semi-liquid environments, the shaft having therethrough a first protrusion, a second protrusion, and ]
0.99824643	1606	[ a shaft having a proximal end and a distal end; ]	[ An apparatus for the manipulation of a distal end of a golf ball, comprising: ]
0.0064595803	1607	[ a rotary wheel having a rotational axis and a shaft shaft portion mounted therein; ]	[ a shaft having a proximal end and a distal end; ]
0.9999914	1608	[ a guide mounted on a distal end of the rotary wheel; and ]	[ a rotary wheel having a rotational axis and a shaft shaft portion mounted therein; ]
0.99999094	1609	[ a cover mounted on a distal end of the rod and having a distal side, wherein the cover is biased such that the cover lies on an inner surface of a ball receiving a proximal end portion of the golf ball, wherein the rotary wheel has an inner radius of curvature within its shaft shaft member portion, wherein it rotates around the outer axis of the rod shaft, and ]	[ a guide mounted on a distal end of the rotary wheel; and ]
0.99999225	1610	[ wherein the cover is biased such that the cover lies within the outer surface of the ball during movement of the golf ball. ]	[ a cover mounted on a distal end of the rod and having a distal side, wherein the cover is biased such that the cover lies on an inner surface of a ball receiving a proximal end portion of the golf ball, wherein the rotary wheel has an inner radius of curvature within its shaft shaft member portion, wherein it rotates around the outer axis of the rod shaft, and ]
0.99717987	1611	[ supplying a reference wavelength; ]	[ A method of improving the accuracy of at least one sensor in a medical apparatus comprising: ]
0.9997837	1612	[ establishing a spectral range; ]	[ supplying a reference wavelength; ]
0.9999893	1613	[ increasing the spectral range in a normal operation by changing the reference wavelength; ]	[ establishing a spectral range; ]
0.9999924	1614	[ changing one or more levels from a closed operational state to a first phase mode and from a closed operational state to a second phase mode wherein the reference wavelength is changed by changing one or more wavelengths, whereby the selected reference wavelength is maintained in the normal operation; ]	[ increasing the spectral range in a normal operation by changing the reference wavelength; ]
0.99999213	1615	[ further, providing software for operating at least one sensor, using the selected reference wavelength, and ]	[ changing one or more levels from a closed operational state to a first phase mode and from a closed operational state to a second phase mode wherein the reference wavelength is changed by changing one or more wavelengths, whereby the selected reference wavelength is maintained in the normal operation; ]
0.9964813	1616	[ using the frequency of ultrasound is changed; ]	[ further, providing software for operating at least one sensor, using the selected reference wavelength, and ]
0.9945703	1617	[ collecting at least a portion of the sensor input signals into a frequency conversion module for conversion into frequency signals; ]	[ using the frequency of ultrasound is changed; ]
0.999992	1618	[ using the frequency signals to improve a sense of frequency signal quality with at least one sensor output; or using the frequency signals for a further improvement to the overall degree of quality of the medical apparatus at least one sensor output. ]	[ collecting at least a portion of the sensor input signals into a frequency conversion module for conversion into frequency signals; ]
0.9999887	1619	[ a fluid flow sensor; ]	[ A fluid flow controller comprising: ]
0.9999919	1620	[ a control circuit, coupled with the fluid flow sensor, wherein the control circuit provides a fluid flow control signal; ]	[ a fluid flow sensor; ]
0.9999919	1621	[ a fluid channel switch input for a test fluid of the test fluid, the fluid channel switch provided operatively on a fluid distribution circuit of the fluid flow sensor; ]	[ a control circuit, coupled with the fluid flow sensor, wherein the control circuit provides a fluid flow control signal; ]
0.9999924	1622	[ a test fluid input for a test fluid of the test fluid; ]	[ a fluid channel switch input for a test fluid of the test fluid, the fluid channel switch provided operatively on a fluid distribution circuit of the fluid flow sensor; ]
0.99999225	1623	[ a test fluid switching part for switching the test fluid with a suitable test fluid; and ]	[ a test fluid input for a test fluid of the test fluid; ]
0.98992467	1624	[ a controller circuit including: ]	[ a test fluid switching part for switching the test fluid with a suitable test fluid; and ]
0.99875796	1625	[ a test circuit for receiving the control signal; ]	[ a controller circuit including: ]
0.999944	1626	[ a controller logic circuit, coupled to the fluid flow control signal connected with the test circuit of said controller circuit and to the fluid channel switch input; ]	[ a test circuit for receiving the control signal; ]
0.9999908	1627	[ a controller circuit logic circuit, coupled to the one of the controller logic circuit logic circuit and the controller circuit logic circuit, said controller circuit further including a control circuit logic circuit, connected to said controller circuit; and ]	[ a controller logic circuit, coupled to the fluid flow control signal connected with the test circuit of said controller circuit and to the fluid channel switch input; ]
0.99999213	1628	[ a third circuit switch input, operable to output an input of the control circuit to the controller circuit logic circuit further included said third circuit switch input. ]	[ a controller circuit logic circuit, coupled to the one of the controller logic circuit logic circuit and the controller circuit logic circuit, said controller circuit further including a control circuit logic circuit, connected to said controller circuit; and ]
0.9999472	1629	[ a medicament to be administered by a medicament administering device, and ]	[ In combination with a medicament composition comprising: ]
0.99999225	1630	[ a food flavoring ingredient, wherein the medicament to be administered by a medicament administering device comprises a medicament administered by said drug administering device, wherein the medicament to be administered is an inactivated aripiprazole. ]	[ a medicament to be administered by a medicament administering device, and ]
0.9998037	1631	[ an individual exhibits cancer when the individual has cancer; ]	[ A non-transitory computer readable storage medium that stores a computer-executable program for performing treatment of cancer such that: ]
0.99903154	1632	[ the computer-executable program for performing treatment of cancer comprises: ]	[ an individual exhibits cancer when the individual has cancer; ]
0.99994624	1633	[ (a) a plurality of modules using an interaction algorithm to determine a first patient interaction for each of a plurality of tumor types, the first patient interaction determining the presence of a first specific risk for the patient; and ]	[ the computer-executable program for performing treatment of cancer comprises: ]
0.99999225	1634	[ (b) modules including a set of prediction models, the prediction models used to predict a second patient interaction for a second type of cancer type from one or more patient interaction prediction models, where each prediction model includes a first one of the plurality of prediction models and a second one of the plurality of prediction models; and ]	[ (a) a plurality of modules using an interaction algorithm to determine a first patient interaction for each of a plurality of tumor types, the first patient interaction determining the presence of a first specific risk for the patient; and ]
0.99999213	1635	[ a specific selection for a model in the first patient interaction predicting the first patient interaction among the plurality of modules using the interaction algorithm. ]	[ (b) modules including a set of prediction models, the prediction models used to predict a second patient interaction for a second type of cancer type from one or more patient interaction prediction models, where each prediction model includes a first one of the plurality of prediction models and a second one of the plurality of prediction models; and ]
0.99998796	1636	[ transmitting, at a first position, a signal source associated with the subject's spine into a first fluid body cavity, wherein said signal source is configured to emit a plurality of pulse pulses at a predetermined amplitude distribution and to emit a plurality of pulses at a first predetermined frequency distribution with respect to said pulse frequency distribution; ]	[ A non-invasive method of determining a depth profile of a subject's spine, comprising: ]
0.99999225	1637	[ receiving, at a second position, a first data stream of data from the first fluid body cavity, wherein said first data stream is generated based on the reception of said first signal source; ]	[ transmitting, at a first position, a signal source associated with the subject's spine into a first fluid body cavity, wherein said signal source is configured to emit a plurality of pulse pulses at a predetermined amplitude distribution and to emit a plurality of pulses at a first predetermined frequency distribution with respect to said pulse frequency distribution; ]
0.9999918	1638	[ analyzing said first data stream for non-specific information indicative of said spine; wherein said analyzing comprises analyzing said first data stream for plurality of particular characteristics related to the presence of at least one of a first component such that the at least one at least one characteristic corresponds to at least one spine component associated with said spine. ]	[ receiving, at a second position, a first data stream of data from the first fluid body cavity, wherein said first data stream is generated based on the reception of said first signal source; ]
0.015963504	1639	[ a plurality of electrode members and an electrode cell, each of said electrode members including an electrode surface mounted to the body region, the electrode cell including a non-coastal component, the non-coastal component comprising a non-coastal cell including an outer skin cell component and an outer skin cell component extending radially outwardly from the cell, the outer skin cell component being mounted in the exterior surface of substantially impermeable housing space; ]	[ A system, comprising: ]
0.9999918	1640	[ wherein the cell is mountable on a surface of the body region; ]	[ a plurality of electrode members and an electrode cell, each of said electrode members including an electrode surface mounted to the body region, the electrode cell including a non-coastal component, the non-coastal component comprising a non-coastal cell including an outer skin cell component and an outer skin cell component extending radially outwardly from the cell, the outer skin cell component being mounted in the exterior surface of substantially impermeable housing space; ]
0.030817663	1641	[ wherein: ]	[ wherein the cell is mountable on a surface of the body region; ]
0.9539559	1642	[ the non-coastal component is mounted to the electrode cell between an outer surface of the cell and an inner surface of said inner surface of said inner surface of the cell; ]	[ wherein: ]
0.9999069	1643	[ the cell has a size and a dimensions that are smaller than the surface of the body region; ]	[ the non-coastal component is mounted to the electrode cell between an outer surface of the cell and an inner surface of said inner surface of said inner surface of the cell; ]
0.9999671	1644	[ the cell has a length substantially similar to a length of said outer skin cell component that extends from the center of said cell to an underside of a center layer of a skin surface; ]	[ the cell has a size and a dimensions that are smaller than the surface of the body region; ]
0.999972	1645	[ the cell is substantially closed inside on said inner surface and is not substantially open outside of said cells interior; ]	[ the cell has a length substantially similar to a length of said outer skin cell component that extends from the center of said cell to an underside of a center layer of a skin surface; ]
0.9999908	1646	[ the cell and the inner skin can are at least partially open; ]	[ the cell is substantially closed inside on said inner surface and is not substantially open outside of said cells interior; ]
0.9990243	1647	[ a first flexible layer is at least partially embedded within said cell, wherein said first flexible layer is arranged to contact said interior surface of said cell; and ]	[ the cell and the inner skin can are at least partially open; ]
0.017819222	1648	[ an end-to-end seal has been formed on said core. ]	[ a first flexible layer is at least partially embedded within said cell, wherein said first flexible layer is arranged to contact said interior surface of said cell; and ]
0.999992	1649	[ directed at least one water conduit for receiving the water, the method comprising the steps of: ]	[ A method for reducing the amount of water in a water supply and/or a water conduit, comprising directing at least one stream of at least one filtered water originating from a water source into a container for placement therein, and ]
0.999634	1650	[ filling the container with a water supplied by a reservoir, said reservoir having the pressure and/or size to draw a reservoir of sufficient volume into contact with the water source to place the container in contact with the water source, said volume of the container exceeding 4 &#x3bc; ]	[ directed at least one water conduit for receiving the water, the method comprising the steps of: ]
0.0024032884	1651	[ m across, said water conduits including a first conduit of selected filtration parameters, and and ]	[ filling the container with a water supplied by a reservoir, said reservoir having the pressure and/or size to draw a reservoir of sufficient volume into contact with the water source to place the container in contact with the water source, said volume of the container exceeding 4 &#x3bc; ]
0.9999924	1652	[ a second conduit of selected filtration parameters to which the water conduit is disposed, whereinsaid flow rate of the reservoir to discharge the water and the water conduit is controlled, and ]	[ m across, said water conduits including a first conduit of selected filtration parameters, and and ]
0.9999924	1653	[ in said second conduit selected by the filtration parameters; ]	[ a second conduit of selected filtration parameters to which the water conduit is disposed, whereinsaid flow rate of the reservoir to discharge the water and the water conduit is controlled, and ]
0.9999881	1654	[ supplying at least one filter to said first conduit wherein the filtered water has water level that is below the level of the reservoir; ]	[ in said second conduit selected by the filtration parameters; ]
0.99999213	1655	[ providing at least one amount of water sufficient to deliver only a specific quantity of waste at said first proximal path whereby said at least one direct channel is located such that or is substantially in contact with the level of the reservoir and which is at least partially in contact with a water-release portion upon exposure of at least a portion of said waste to the water of the reservoir, one of said selected conduit being a conduit between which the at least specific quantity of waste is disposed; and ]	[ supplying at least one filter to said first conduit wherein the filtered water has water level that is below the level of the reservoir; ]
0.99998844	1656	[ redirecting filtered water from the water source to the at least second distal path. ]	[ providing at least one amount of water sufficient to deliver only a specific quantity of waste at said first proximal path whereby said at least one direct channel is located such that or is substantially in contact with the level of the reservoir and which is at least partially in contact with a water-release portion upon exposure of at least a portion of said waste to the water of the reservoir, one of said selected conduit being a conduit between which the at least specific quantity of waste is disposed; and ]
0.9998722	1657	[ an adjustable aperture having two sides extending outwardly from the aperture, the aperture defining a main chamber having a first location adapted for fluidly containing and dispensing a sample of a patient's tissue thereto, and ]	[ A device for dispensing a medical instrument comprising: ]
0.99936086	1658	[ a second location, about which a user may stand when the accessory is mounted, adapted for holding a first part, ]	[ an adjustable aperture having two sides extending outwardly from the aperture, the aperture defining a main chamber having a first location adapted for fluidly containing and dispensing a sample of a patient's tissue thereto, and ]
0.9999796	1659	[ wherein the first and second locations allow the user to adjust the angle of angle between the first location and the second location,<|span|> wherein the adapter further comprises a shaft pivotally connected to the device and adapted to be inserted into the aperture. ]	[ a second location, about which a user may stand when the accessory is mounted, adapted for holding a first part, ]
0.99992025	1660	[ providing a proximal position positionable to a patient; ]	[ A method of positioning a patient in a sterile medical apparatus, the method comprising: ]
0.999992	1661	[ defining an intermediate position which extends proximally over the proximal position positionable via a proximal end of a hook-and-loop to attach the proximal position positionable to the patient; ]	[ providing a proximal position positionable to a patient; ]
0.9999075	1662	[ positioning a patient in a fixed and portable position in the flexible medical apparatus through one or more steps comprising placing at least a first portion of the first loop of the patient between two fixed and portable arms of the medical apparatus; and ]	[ defining an intermediate position which extends proximally over the proximal position positionable via a proximal end of a hook-and-loop to attach the proximal position positionable to the patient; ]
0.99999213	1663	[ positioning at least a second portion of the same set of the first loop of the patient between a second assembly having two distal positionable arms such that when simultaneously attached to the distal portion of the first loop of the patient, the second hand of one of the distal arm pivots to connect to the proximal end of the hook-and-loop. ]	[ positioning a patient in a fixed and portable position in the flexible medical apparatus through one or more steps comprising placing at least a first portion of the first loop of the patient between two fixed and portable arms of the medical apparatus; and ]
0.002297362	1664	[ (a) a substance having an at least one antioxidant target; ]	[ A method for reducing the likelihood of a patient developing chronic obstructive pulmonary disease, wherein the treating entity comprises: ]
0.99893004	1665	[ (b) water; ]	[ (a) a substance having an at least one antioxidant target; ]
0.9965712	1666	[ (c) the at least one antioxidant target being a mono- or diglyceride having a surface weight ratio (V1-V2) between less than and larger than (G*) which is greater than or equal to 50: ]	[ (b) water; ]
0.9990607	1667	[ 0.75, wherein G are the sum of the maximum daily consumption as measured by a human, and ]	[ (c) the at least one antioxidant target being a mono- or diglyceride having a surface weight ratio (V1-V2) between less than and larger than (G*) which is greater than or equal to 50: ]
0.99999225	1668	[ G* are the sum of the maximum daily consumption as measured by a mouse; ]	[ 0.75, wherein G are the sum of the maximum daily consumption as measured by a human, and ]
0.00066629704	1669	[ (d) the water having a percentage of total solids of a body weight (M.h.w.) of less than about 50%; and ]	[ G* are the sum of the maximum daily consumption as measured by a mouse; ]
0.9984269	1670	[ (e) the substance having the at least one antioxidant target comprising a biologically active form of the one antioxidant targeting said at least one antioxidant target and at least one monoterpenical compound. ]	[ (d) the water having a percentage of total solids of a body weight (M.h.w.) of less than about 50%; and ]
0.9985594	1671	[ administering an effective amount of a composition comprising an antibody; and ]	[ A method for promoting the development of a smooth breast prosthesis to a mature breast that contains a T-cell-derived stem cell (TSC), the method comprising: ]
0.99994934	1672	[ administering a selective TSC-stimulating component that inhibits the expression of a TSC-inducible marker, or a TSC-inducible response element (IRT) pathway mediated by the presence of the antibody, ]	[ administering an effective amount of a composition comprising an antibody; and ]
0.99999225	1673	[ wherein that antibody binds to a TSC-inducible marker, or a TSC-inducible response element (IRT) pathway mediated by the presence of the antibody, and ]	[ administering a selective TSC-stimulating component that inhibits the expression of a TSC-inducible marker, or a TSC-inducible response element (IRT) pathway mediated by the presence of the antibody, ]
0.008958743	1674	[ wherein the composition promotes the development of the smooth breast prosthesis. ]	[ wherein that antibody binds to a TSC-inducible marker, or a TSC-inducible response element (IRT) pathway mediated by the presence of the antibody, and ]
0.99995184	1675	[ sensing optical characteristics of a first portion of the tissue layer adjacent to a target sample of tissue; and ]	[ Apparatus for a method of obtaining an image of a tissue layer on a subject during an image processing operation, comprising: ]
0.99999	1676	[ reading an amount of light emitted from the tissue layer, the acquisition of light reflected from the tissue layer, the capture of light by light sensing means, the intensity of the captured light to be obtained, the amount of information present in captured light, and ]	[ sensing optical characteristics of a first portion of the tissue layer adjacent to a target sample of tissue; and ]
0.9999906	1677	[ the frequency of energy in the captured light. ]	[ reading an amount of light emitted from the tissue layer, the acquisition of light reflected from the tissue layer, the capture of light by light sensing means, the intensity of the captured light to be obtained, the amount of information present in captured light, and ]
0.9967789	1678	[ a) providing a nonionic bone graft for a bony site, wherein the selected nonionic bone graft is an anterior end portion of a rod portion extending from a distal end to a proximal end, and ]	[ An osteoarthritis treatment method, comprising: ]
0.9999908	1679	[ wherein the posterior end portion of the bony site includes a first bone region having a first number of proximal and second area types of bone forming tissue that cooperates with each other, ]	[ a) providing a nonionic bone graft for a bony site, wherein the selected nonionic bone graft is an anterior end portion of a rod portion extending from a distal end to a proximal end, and ]
0.9997576	1680	[ wherein the rod portion is disposed near the medial side of the axial bone, and ]	[ wherein the posterior end portion of the bony site includes a first bone region having a first number of proximal and second area types of bone forming tissue that cooperates with each other, ]
0.99999034	1681	[ wherein the bone graft is operable to pivot toward an axial bone shaft that is disposed at the medial side of the axial bone, ]	[ wherein the rod portion is disposed near the medial side of the axial bone, and ]
0.99983895	1682	[ wherein the proximal end portion of the bony site is located in the proximal end of the bone shaft and the first bone region has an initial size that is greater than the initial size of bone forming tissue in the posterior region. ]	[ wherein the bone graft is operable to pivot toward an axial bone shaft that is disposed at the medial side of the axial bone, ]
0.99999225	1683	[ a plurality of sensing means for sensing a plurality of spatial positions of said virtual objects, and ]	[ An apparatus for managing virtual objects having different positions and size in spatial space, comprising: ]
0.9929772	1684	[ a first signal generator for receiving said reflected signals, wherein said first signal generator generates first and second signals suitable for receiving and using by a plurality of processing units respectively in said first signal generator; each said first signal generator receiving each said signal independently; and ]	[ a plurality of sensing means for sensing a plurality of spatial positions of said virtual objects, and ]
0.99999213	1685	[ a second signal generator for generating a modified signal adapted to each said received signal by each said processing unit. ]	[ a first signal generator for receiving said reflected signals, wherein said first signal generator generates first and second signals suitable for receiving and using by a plurality of processing units respectively in said first signal generator; each said first signal generator receiving each said signal independently; and ]
0.99998033	1686	[ a plurality of image pickup sensors positioned at an object location and located at intermediate locations across a range of at least about three centimeters; ]	[ An image pickup device comprising: ]
0.9999875	1687	[ an input sensor configured to detect image information from said at least three centimeters of the subject, and ]	[ a plurality of image pickup sensors positioned at an object location and located at intermediate locations across a range of at least about three centimeters; ]
0.99998796	1688	[ to provide an image information input signal based on said image information; ]	[ an input sensor configured to detect image information from said at least three centimeters of the subject, and ]
0.999992	1689	[ a plurality of image signal processors providing a plurality of image signal signals responsive to said input signal to implement an image capture process based on said imaging information, the images reflected by the surfaces wherein all of the pixels of said image signal processors being adjacent to said object location; and ]	[ to provide an image information input signal based on said image information; ]
0.9999908	1690	[ an operator configured to recognize the images reflected by the surfaces, and ]	[ a plurality of image signal processors providing a plurality of image signal signals responsive to said input signal to implement an image capture process based on said imaging information, the images reflected by the surfaces wherein all of the pixels of said image signal processors being adjacent to said object location; and ]
0.9999615	1691	[ generate a detection signal corresponding to the recognition by the operator. ]	[ an operator configured to recognize the images reflected by the surfaces, and ]
0.999765	1692	[ means for pumping the liquid from a dispenser having at least one pump and one receptacle having a plurality of watertight compartments, the pump also including a heater for heating the liquid; ]	[ An apparatus for providing and dispensing liquid to a patient, comprising: ]
0.9709154	1693	[ a power source; ]	[ means for pumping the liquid from a dispenser having at least one pump and one receptacle having a plurality of watertight compartments, the pump also including a heater for heating the liquid; ]
0.9998698	1694	[ means for electrically connecting the pumping means to the power source; and ]	[ a power source; ]
0.99986625	1695	[ means for setting a temperature of the heated liquid; ]	[ means for electrically connecting the pumping means to the power source; and ]
0.9999864	1696	[ and a control mechanism that can determine the degree to which a pressure within a chamber of the at least one receptacle in the at least one pump is greater than a threshold pressure, wherein if the ambient pressure within the chamber of the receptacle exceeds the threshold pressure, the control mechanism deactivates the heater to expose the heated liquid to the ambient pressure within the chamber so that the patient can flow the heated liquid from at least one compartment into the other dispenser. ]	[ means for setting a temperature of the heated liquid; ]
0.99983263	1697	[ a drive shaft having longitudinal and radial axial portions; ]	[ An actuating apparatus for mechanically actuatorally providing a first action force and providing a second action force for sliding movement and a user gesture directed at an action line of a motor which is provided by a drive shaft, comprising: ]
0.9999869	1698	[ a central body connected to the drive shaft; ]	[ a drive shaft having longitudinal and radial axial portions; ]
0.9834995	1699	[ a trigger arm attached thereto; ]	[ a central body connected to the drive shaft; ]
0.99999046	1700	[ a support arm having a longitudinal axis supported by the central body and a radial axis from the axle of the trigger arm to the central body, wherein the support arm comprises a first position and a second position; and ]	[ a trigger arm attached thereto; ]
0.99999225	1701	[ a first arm including teeth positioned proximate to the radial axis opposite one another and configured for engaging at least a portion of an engagement point of the first arm against the engagement point of the central body; ]	[ a support arm having a longitudinal axis supported by the central body and a radial axis from the axle of the trigger arm to the central body, wherein the support arm comprises a first position and a second position; and ]
0.9999889	1702	[ a second arm configured to be movable between a first position and a second position; ]	[ a first arm including teeth positioned proximate to the radial axis opposite one another and configured for engaging at least a portion of an engagement point of the first arm against the engagement point of the central body; ]
0.9999784	1703	[ a non-transitory computer readable storage medium comprising an executable program stored in said computer readable storage medium for manipulating the movement of the first arm and the second arm together for motion of the action line of the motor during a sliding motion. ]	[ a second arm configured to be movable between a first position and a second position; ]
0.99999213	1704	[ generating, by the computer readable memory, a signal representing a self-proportional vibration comprising a plurality of vibrations representative of a plurality of motion parameters for being mounted on the user's body in a user's chosen position wherein the movements of the patient's hands and/or arms are reflected in the plurality of motions reflected by the plurality of motion parameters; and ]	[ A method of performing a self-proportional vibration exercise via the attachment of a non-transitory computer readable memory, on the basis of a wireless signal, from a device to be worn on a user's body and at least a portion of the data associated with the wireless signal can be read or stored as a memory, the method comprising: ]
0.9999924	1705	[ communicating, by the computer readable memory, the generated signal to a wireless data transmission device, the wireless data transmission device comprising the computing device that receives the communication signal to communicate the generated signal to the subject who is to perform the self-proportional vibration by a wireless communication system comprising a system-on-a-chip. ]	[ generating, by the computer readable memory, a signal representing a self-proportional vibration comprising a plurality of vibrations representative of a plurality of motion parameters for being mounted on the user's body in a user's chosen position wherein the movements of the patient's hands and/or arms are reflected in the plurality of motions reflected by the plurality of motion parameters; and ]
0.9999137	1706	[ i) 3 to 60 mole % of halogenated fatty acids, ]	[ A method of treating a patient suffering from a distal colon cancer that has metastasized into the patient's colon, the method comprising administering to said patient in need thereof an effective amount of an effective amount or formula of a polyol formulation comprising an alkaline polyol and a halogenated polyol, wherein the halogenated polyol represents one or more of mixtures in which each of mixtures comprises: ]
0.99999213	1707	[ ii) 2 to 120 mole % of halogenated saturated fatty acids, and ]	[ i) 3 to 60 mole % of halogenated fatty acids, ]
0.99999213	1708	[ iii) 0 to 80 mole % of halogenated mono fatty acids. ]	[ ii) 2 to 120 mole % of halogenated saturated fatty acids, and ]
0.99999166	1709	[ contacting the endocannabinoid with an endocannabinoid receptor activating agent; ]	[ A method for screening for an endocannabinoid, the method comprising the steps of: ]
0.99999225	1710	[ contacting the receptor with an endocannabinoid; and ]	[ contacting the endocannabinoid with an endocannabinoid receptor activating agent; ]
0.9994523	1711	[ detecting or measuring an induction of a drug-reactive or endogenous neurochemical pathway based on the induction of the neurochemical pathway wherein said triggering of the neurochemical pathway is mediated by an antagonist of the polypeptide of SEQ ID NO: 3. ]	[ contacting the receptor with an endocannabinoid; and ]
0.95195514	1712	[ a base; and ]	[ A sports fan equipment device, comprising: ]
0.9995671	1713	[ a mounting portion positioned between said base and said fan equipment device, ]	[ a base; and ]
0.9997869	1714	[ wherein said base has forward and aft sides facing each other; ]	[ a mounting portion positioned between said base and said fan equipment device, ]
0.9999608	1715	[ wherein an actuator member is pivotable between a first position and a second position, said actuator member having an externally mounted mounting aperture to receive said base and an integrated actuator motor mounted within, and ]	[ wherein said base has forward and aft sides facing each other; ]
0.99958426	1716	[ supported by, a non-imperial part of said base. ]	[ wherein an actuator member is pivotable between a first position and a second position, said actuator member having an externally mounted mounting aperture to receive said base and an integrated actuator motor mounted within, and ]
0.99999213	1717	[ a tubelike tissue treatment device comprising bone implants and bone implants, wherein in use said bone implants and bone implants do not comprise adjacent bone implants; ]	[ A tubelike tissue treatment system comprising: ]
0.9999882	1718	[ a first electrode configured to cause a tissue sample to be acquired based on a concentration of bioactive cells in said tissue sample, wherein said bioactive cells comprise the bioactive cells within said bone implants and including said bone insert, said tissue sampling device comprising a first housing comprising first and second housing portions that are positioned apart from one another, said first and second housing portions including an output port and a display port that is configured to display said concentration of bioactive cells in said tissue sample when said tissue sample is acquired by said electrode; and ]	[ a tubelike tissue treatment device comprising bone implants and bone implants, wherein in use said bone implants and bone implants do not comprise adjacent bone implants; ]
0.999992	1719	[ a second electrode configured to cause a first biological energy source to be attached to a first end of a first rod of said second housing portion of said implant. ]	[ a first electrode configured to cause a tissue sample to be acquired based on a concentration of bioactive cells in said tissue sample, wherein said bioactive cells comprise the bioactive cells within said bone implants and including said bone insert, said tissue sampling device comprising a first housing comprising first and second housing portions that are positioned apart from one another, said first and second housing portions including an output port and a display port that is configured to display said concentration of bioactive cells in said tissue sample when said tissue sample is acquired by said electrode; and ]
0.9957157	1720	[ providing an annulus of solid bone comprising a continuous body structure; ]	[ A method for treating a stent comprising the steps of: ]
0.99995446	1721	[ placing a head of interest into the annulus; ]	[ providing an annulus of solid bone comprising a continuous body structure; ]
0.9999924	1722	[ making a suture into the annulus of solid bone through the head of interest; ]	[ placing a head of interest into the annulus; ]
0.9999907	1723	[ placing a prosthesis in contact with the annulus of solid bone, the prosthesis comprising a stiff flexible braid and a longitudinally extended rod that has an inner surface, an outer body, an inlet, and ]	[ making a suture into the annulus of solid bone through the head of interest; ]
0.0043705045	1724	[ a conduit for receiving a tissue to be treated utilizing the stent; and ]	[ placing a prosthesis in contact with the annulus of solid bone, the prosthesis comprising a stiff flexible braid and a longitudinally extended rod that has an inner surface, an outer body, an inlet, and ]
0.015316504	1725	[ pressing the rod against the annulus of solid bone to open and close the rod in an emergency. ]	[ a conduit for receiving a tissue to be treated utilizing the stent; and ]
0.02214584	1726	[ an elongated, flexible, protein-containing polypeptide having an amino acid sequence. ]	[ A composition comprising: ]
9.3309325e-05	1727	[ (a) at least one fabric comprising a polyether chain or a polyester comprising polyether chain by carbon atom grouping; and ]	[ A method of making a plurality of elongated polymer segments, comprising: ]
0.99998724	1728	[ (b) a plurality of compartments, where each compartment has at least one elongated polymer segment made of the polyether chain or the polyester comprising polyether chain, being mounted on an inner wall of each compartment allowing tension to receive at least one of the tubular segments of a plurality of elongated polymer segments wherein the plurality of elongated polymer segments of the plurality of elongated polymer segments are adapted to be retained within each compartment when used in a closed configuration, ]	[ (a) at least one fabric comprising a polyether chain or a polyester comprising polyether chain by carbon atom grouping; and ]
0.99999213	1729	[ (i) each compartment including at least one stretch-memory material formed upon its inner surface through said elongated polymer segments, and ]	[ (b) a plurality of compartments, where each compartment has at least one elongated polymer segment made of the polyether chain or the polyester comprising polyether chain, being mounted on an inner wall of each compartment allowing tension to receive at least one of the tubular segments of a plurality of elongated polymer segments wherein the plurality of elongated polymer segments of the plurality of elongated polymer segments are adapted to be retained within each compartment when used in a closed configuration, ]
0.99999225	1730	[ (ii) the composition comprising a length of elastic fiber through which a portion of a diameter of each elongated polymer segment is stretch-memory material, such elastic portion being provided by forming the plurality of elongated polymer segments therein in tension or in a closed configuration. ]	[ (i) each compartment including at least one stretch-memory material formed upon its inner surface through said elongated polymer segments, and ]
0.9998192	1731	[ (a) a patient is placed in a subject vehicle, a first patient-to-patient maneuver is performed by a first patient in said project, ]	[ A method for improving mechanical functions in a structure of a patient, said method comprising the steps in which: ]
0.9999924	1732	[ (b) before the subject maneuver is performed, a fixation device is placed in an axial relation to and in effect the proximal end of said first patient-to-patient maneuver, and ]	[ (a) a patient is placed in a subject vehicle, a first patient-to-patient maneuver is performed by a first patient in said project, ]
0.99999225	1733	[ (c) said first patient-to-patient maneuver is made for fixed placement of said axial relative fixation device within the subject. ]	[ (b) before the subject maneuver is performed, a fixation device is placed in an axial relation to and in effect the proximal end of said first patient-to-patient maneuver, and ]
0.92100364	1734	[ wherein: ]	[ A method of providing therapeutic effectiveness and safety results to the body medicine comprising administering to a user a therapeutically effective amount, between about 1-20 percent, of a compound of formula (I)(V): ]
0.98827285	1735	[ R1 is an alkyl or alkoxy group; ]	[ wherein: ]
0.9963613	1736	[ R7 is a C1-C2 alkyl substituted with hydrogen; ]	[ R1 is an alkyl or alkoxy group; ]
0.9999311	1737	[ R8 is a C4-C5 alkyl replaced by one or more C1-C2 chain alkyl substituents; ]	[ R7 is a C1-C2 alkyl substituted with hydrogen; ]
0.9874414	1738	[ R10 has an alkyl group; ]	[ R8 is a C4-C5 alkyl replaced by one or more C1-C2 chain alkyl substituents; ]
0.99989104	1739	[ R11 has an alkyl group from the group consisting of the base of C1-C6 alkyl (cycloalkyl); and ]	[ R10 has an alkyl group; ]
0.9997675	1740	[ R12 and R13 each have a hydrogen atom. ]	[ R11 has an alkyl group from the group consisting of the base of C1-C6 alkyl (cycloalkyl); and ]
0.9999547	1741	[ a) presenting user interface elements of an IMD device to a patient using a media device for displaying an image of the IMD device; ]	[ A method for providing and operating an implantable medical device (IMD) comprising one or more electrode elements disposed on a patient's body, the method comprising: ]
0.99999213	1742	[ b) delivering the IMD device to the patient from an outside via an IMD device delivery port disposed to the patient; ]	[ a) presenting user interface elements of an IMD device to a patient using a media device for displaying an image of the IMD device; ]
0.99999213	1743	[ c) introducing the IMD device into the patient; and ]	[ b) delivering the IMD device to the patient from an outside via an IMD device delivery port disposed to the patient; ]
0.9999919	1744	[ d) imaging the IMD device in operation for the IMD device to receive an X-ray signal. ]	[ c) introducing the IMD device into the patient; and ]
0.99861956	1745	[ (a) a fragment of a monoclonal antibody which binds to said substance Y2295, wherein said fragment comprises: ]	[ A method for reducing a risk of developing a disorder or condition associated with thrombophlebitis in a patient, comprising administering to said patient a composition comprising: ]
0.99976295	1746	[ (i) a Fv antigen associated with a hemoglobin antigen, and ]	[ (a) a fragment of a monoclonal antibody which binds to said substance Y2295, wherein said fragment comprises: ]
0.99999166	1747	[ (ii) a C-terminal truncation portion of the Fv antigen, wherein the Fv antigen is selected from the group consisting of at least one of SerR5 and SerR40; and ]	[ (i) a Fv antigen associated with a hemoglobin antigen, and ]
0.99995816	1748	[ (ii) a binding fragment consisting of Fv-Cp25 of the monoclonal antibody; and ]	[ (ii) a C-terminal truncation portion of the Fv antigen, wherein the Fv antigen is selected from the group consisting of at least one of SerR5 and SerR40; and ]
0.9998921	1749	[ (b) an antisense fragment associated with a serine derivative thereof; and ]	[ (ii) a binding fragment consisting of Fv-Cp25 of the monoclonal antibody; and ]
0.9999881	1750	[ wherein the serine derivative has a T-box binding domain that has a T-box binding site, and ]	[ (b) an antisense fragment associated with a serine derivative thereof; and ]
0.9967404	1751	[ wherein the fragment of said monoclonal antibody binds to the sequence labeled by the complementarity measuring element (CMA) of said monoclonal antibody having a CMA of 1.050, and ]	[ wherein the serine derivative has a T-box binding domain that has a T-box binding site, and ]
0.9999924	1752	[ wherein the fragment of said antisense antibody binds to a sequence labeled by the CMA of about 8.00, whereinthe fragment of said monoclonal antibody has a substantially uniform immunostimulatory and anti- T-box activity in vivo and a substantially irregular immunostimulatory and anti- T-box activity in vitro. ]	[ wherein the fragment of said monoclonal antibody binds to the sequence labeled by the complementarity measuring element (CMA) of said monoclonal antibody having a CMA of 1.050, and ]
0.99977297	1753	[ at least one soluble phosphatase with a phosphatase activity of 0-5 mg urea/g of sugar per gram of free soluble phosphatase in water; ]	[ A composition for treating and preventing diabetes, comprising: ]
0.99992764	1754	[ at least one soluble polypeptide, which comprises the amino acid sequence of the SEQ ID NO: ]	[ at least one soluble phosphatase with a phosphatase activity of 0-5 mg urea/g of sugar per gram of free soluble phosphatase in water; ]
0.9992747	1755	[ 4; and ]	[ at least one soluble polypeptide, which comprises the amino acid sequence of the SEQ ID NO: ]
0.99711514	1756	[ at least one active agent, wherein said enzyme consists of (i) a homopolymerase having a diameter about 5 nm or less and having a peptide amino acid sequence; (ii) a COOH polymerase having a diameter around 2 nm or less and having a peptide amino acid sequence different than said peptide amino acid sequence of SEQ ID NO: ]	[ 4; and ]
0.9986486	1757	[ 4; and ]	[ at least one active agent, wherein said enzyme consists of (i) a homopolymerase having a diameter about 5 nm or less and having a peptide amino acid sequence; (ii) a COOH polymerase having a diameter around 2 nm or less and having a peptide amino acid sequence different than said peptide amino acid sequence of SEQ ID NO: ]
0.9859585	1758	[ (iii) a COOH oligonucleotide comprising a Tc chain, a glutamyl chain, and ]	[ 4; and ]
0.9992186	1759	[ a glutaredoxin chain, wherein the phosphatase protein is capable of activating said homopolymerase component and blocking said homopolymerase component from interacting with the soluble polypeptide. ]	[ (iii) a COOH oligonucleotide comprising a Tc chain, a glutamyl chain, and ]
0.9998512	1760	[ an hydrophilic solid comprising an oxide of sufficient intensity to contact individual cells in an intact tooth with a first substance and being available to be absorbed to form a dentin layer on tooth surfaces and resulting in an expanded dentin layer; ]	[ A disposable dental enamel composition, comprising: ]
0.983913	1761	[ a first polymer having at least one component selected from thiabignose and tungstil, wherein at least one of said at least one component comprises an acyl chain; and ]	[ an hydrophilic solid comprising an oxide of sufficient intensity to contact individual cells in an intact tooth with a first substance and being available to be absorbed to form a dentin layer on tooth surfaces and resulting in an expanded dentin layer; ]
0.95752966	1762	[ water. ]	[ a first polymer having at least one component selected from thiabignose and tungstil, wherein at least one of said at least one component comprises an acyl chain; and ]
0.9991242	1763	[ (b) an alkoxy methyl siloxane; ]	[ A composition comprising a drug comprising(a) an organic compound; ]
0.98823476	1764	[ (c) a pharmaceutically acceptable surfactant; ]	[ (b) an alkoxy methyl siloxane; ]
0.99993026	1765	[ (d) a water-soluble water-soluble polymer; and ]	[ (c) a pharmaceutically acceptable surfactant; ]
0.999897	1766	[ (e) a non-polymeric acid containing compound. ]	[ (d) a water-soluble water-soluble polymer; and ]
0.99997866	1767	[ detecting biological activity of the agent in vitro. ]	[ A method for screening a potential therapeutic agent for an anti-retinal inducible enzyme, the method comprising exposing an infected tissue to the agent, and ]
0.9998105	1768	[ a patient room; ]	[ A tool body for providing access to patient information about a patient, in a patient care facility, the patient care facility comprising: ]
0.9999887	1769	[ two patient screens associated with the patient room comprising at least two patient screens, each of the patient screens having two end panels spaced from and connected to each other, the patient screens including an inner surface and a outer surface, the inner surface being configured to apply a gripping effect to the patient to restrain a top of the patient, and ]	[ a patient room; ]
0.99998546	1770	[ the outer surface is configured to open and close; ]	[ two patient screens associated with the patient room comprising at least two patient screens, each of the patient screens having two end panels spaced from and connected to each other, the patient screens including an inner surface and a outer surface, the inner surface being configured to apply a gripping effect to the patient to restrain a top of the patient, and ]
0.020831335	1771	[ a reception panel comprising a sidewall; and ]	[ the outer surface is configured to open and close; ]
0.99999225	1772	[ at least one safety panel assembly disposed between the sidewall of the patient room and the reception panel; ]	[ a reception panel comprising a sidewall; and ]
0.016086495	1773	[ wherein, ]	[ at least one safety panel assembly disposed between the sidewall of the patient room and the reception panel; ]
0.0012768582	1774	[ the at least one safety panel assembly is configured to be fastened to at least one of the patient screens simultaneously to lock and unlock the patient by providing a locking force on each of the patient screens such that a user can manipulate the at least one safety panel and the at least one medical device on the patient bed with all of the user controls at one time when the user is not able to open each and any of the patient screens when the medical device or the scanner is closed. ]	[ wherein, ]
0.9999918	1775	[ providing a plurality of flexible pads at locations proximate a site of the interstitial cyst under operative pressure, wherein the plurality of the pads each fit into each other to be positioned within a space within the site of the interstitial cyst and the locations of the flexible pads comprise both interior and exterior material; ]	[ A method of treating an interstitial cyst, comprising; ]
0.99834585	1776	[ placing a rigid shaft into and through an opening therethrough; ]	[ providing a plurality of flexible pads at locations proximate a site of the interstitial cyst under operative pressure, wherein the plurality of the pads each fit into each other to be positioned within a space within the site of the interstitial cyst and the locations of the flexible pads comprise both interior and exterior material; ]
0.99327314	1777	[ applying at least one power to the flexible pads to generate a force on the flexible pads, wherein the flexible pads are not positioned in a manner such that the force on the flexible pads can be sufficiently applied so as to reduce a stretch of the interstitial cyst; and ]	[ placing a rigid shaft into and through an opening therethrough; ]
0.9999918	1778	[ applying a plurality of electrodes to an interstitial fluid within the interstitial cyst. ]	[ applying at least one power to the flexible pads to generate a force on the flexible pads, wherein the flexible pads are not positioned in a manner such that the force on the flexible pads can be sufficiently applied so as to reduce a stretch of the interstitial cyst; and ]
0.99950624	1779	[ 10), and ]	[ A composition comprising (a) a triope comprising a pyrrolidine ester, a pyrrolidine salt (SEQ ID NO: ]
0.010364888	1780	[ a hydrazone; and ]	[ 10), and ]
0.01032672	1781	[ (b) at least a binder solubilized at least partly in the pyrrolidine ester to which binder is added; wherein the at least partially contained binder solidifies during incubation with the pyrrolidine ester and is further solidified by mixing and de-esterating the pyrrolidine salt (SEQ ID NO: ]	[ a hydrazone; and ]
0.9996873	1782	[ 12) with and de-merging the hydrazone (SEQ ID NO: ]	[ (b) at least a binder solubilized at least partly in the pyrrolidine ester to which binder is added; wherein the at least partially contained binder solidifies during incubation with the pyrrolidine ester and is further solidified by mixing and de-esterating the pyrrolidine salt (SEQ ID NO: ]
0.9999894	1783	[ 2), which together together form a mixture of binder solubilized in the pyrrolidine ester with and with the binder liquid and binder solidified in the pyrrolidine salt-containing hydrazone (SEQ ID NO: 2). ]	[ 12) with and de-merging the hydrazone (SEQ ID NO: ]
0.9754386	1784	[ a chassis that contains at least one operating apparatus therein, ]	[ An apparatus comprising: ]
0.99998724	1785	[ wherein said operating apparatus is configured to provide assistance in a particular field, with some or all of said equipment having first and second main surfaces that are opposed in shape to each other by a top surface, and ]	[ a chassis that contains at least one operating apparatus therein, ]
0.999992	1786	[ wherein each of said main surfaces includes an interior dimension substantially identical to that of the top surface of the main surface of the operating apparatus, wherein said operating apparatus is coupled to said chassis through a first interconnect, wherein said first interconnect also includes a second interconnect; ]	[ wherein said operating apparatus is configured to provide assistance in a particular field, with some or all of said equipment having first and second main surfaces that are opposed in shape to each other by a top surface, and ]
0.9999908	1787	[ a motor assembly that is configured to drive said operating apparatus, and ]	[ wherein each of said main surfaces includes an interior dimension substantially identical to that of the top surface of the main surface of the operating apparatus, wherein said operating apparatus is coupled to said chassis through a first interconnect, wherein said first interconnect also includes a second interconnect; ]
0.99998736	1788	[ the main surface of said plurality of main surfaces being coupled to said motor assembly by a connection means; ]	[ a motor assembly that is configured to drive said operating apparatus, and ]
0.9999912	1789	[ a mounting means for the motor assembly; and ]	[ the main surface of said plurality of main surfaces being coupled to said motor assembly by a connection means; ]
0.99999213	1790	[ a power source for providing operating power to said mounting means while said motor assembly is operating; ]	[ a mounting means for the motor assembly; and ]
0.99895704	1791	[ wherein whereby said base is mounted relative to said chassis. ]	[ a power source for providing operating power to said mounting means while said motor assembly is operating; ]
0.9912451	1792	[ a head including a base, a first teeth contact surface on said base, a generally concave head portion, a generally obtuse tooth contact surface on said base, a first, generally flat top and a generally flat bottom, and ]	[ A robotic dental instrument comprising: ]
0.9999895	1793	[ said base being slidably mounted to said bottom of said head; ]	[ a head including a base, a first teeth contact surface on said base, a generally concave head portion, a generally obtuse tooth contact surface on said base, a first, generally flat top and a generally flat bottom, and ]
0.99992275	1794	[ a proximal plate and a distal plate forming said head and comprising: ]	[ said base being slidably mounted to said bottom of said head; ]
0.98716575	1795	[ a proximal body portion through which a rotatable rotor can move, and ]	[ a proximal plate and a distal plate forming said head and comprising: ]
0.999992	1796	[ a distal body portion through which a rotatable arm can move, said body portion, base, and ]	[ a proximal body portion through which a rotatable rotor can move, and ]
0.9999738	1797	[ top being movably coupled to said distal top portion of said proximal body portion defining a pivot axis, wherein said rotary rotation of said rotor defines a generally inverted axis. ]	[ a distal body portion through which a rotatable arm can move, said body portion, base, and ]
0.9998524	1798	[ (a) the preparation comprises a reaction of the amino acid or amino acid substitution; ]	[ A method for preparing the composition of a pharmaceutical composition comprising an amino acid or amino acid substitution with a amino acid whose concentration within the composition is within a range of 3.3 to 10.0% by weight and a pharmaceutically acceptable salt, wherein said container is hollow and said composition is comprised of at least about 1 cup of solid or liquid calcium phosphate buffered with about 50% by weight of said calcium phosphate, wherein: ]
0.99927443	1799	[ (b) wherein the preparation is a sodium fluoride solution; and ]	[ (a) the preparation comprises a reaction of the amino acid or amino acid substitution; ]
0.99993753	1800	[ (c) the preparation has a pH of in the range of 7.0 to 6.0; ]	[ (b) wherein the preparation is a sodium fluoride solution; and ]
0.9746932	1801	[ wherein the pharmaceutical composition comprises a pharmaceutically acceptable salt. ]	[ (c) the preparation has a pH of in the range of 7.0 to 6.0; ]
0.98857856	1802	[ mixtures thereof. ]	[ A cosmetic composition comprising a mixture of 1-20% by weight of elate, 1-20% by weight of ala-late, and ]
0.999691	1803	[ identifying a tumor in a patient; and ]	[ A method for diagnosing a lung cancer, comprising: ]
0.9999906	1804	[ identifying an effective treatment against the cancer in the patient. ]	[ identifying a tumor in a patient; and ]
0.99989307	1805	[ applying a force to the individual's anatomy; ]	[ A method of delivering nanoparticles to bone in an individual, the method comprising: ]
0.9998178	1806	[ attaching a tissue delivery device to the body via the body; and ]	[ applying a force to the individual's anatomy; ]
0.99999034	1807	[ delivering the nanoparticles at a time responsive to a change in relative positioning of the tissue delivery device at or adjacent the bone based on a change of thickness to protect the bone in response to the applied force. ]	[ attaching a tissue delivery device to the body via the body; and ]
0.99998844	1808	[ providing an energy harvesting device and, in the connection with said device, a guide provided with a housing having a plurality of openings and an end, wherein said guide can communicate with a flow line within the fluid conduit of the device, said light emitting diode has an electrical channel on a surface and can be implanted into the non-invasive delivery administration of the energy harvesting device to transmit light to said energy harvesting device, and ]	[ A method of managing non-invasive delivery administration of a biologic agent to a body of a patient, comprising: ]
0.99964356	1809	[ a power source mounted on the tip of said guide, ]	[ providing an energy harvesting device and, in the connection with said device, a guide provided with a housing having a plurality of openings and an end, wherein said guide can communicate with a flow line within the fluid conduit of the device, said light emitting diode has an electrical channel on a surface and can be implanted into the non-invasive delivery administration of the energy harvesting device to transmit light to said energy harvesting device, and ]
0.9999875	1810	[ wherein said guide can be placed into a tube for insertion of an elongated device having an output connector disposed within an inner surface of said guide, said elongated device further having a support configured for its longitudinally extending distal end for holding said elongated device, ]	[ a power source mounted on the tip of said guide, ]
2.1188847e-05	1811	[ whereby said delivery administration of the biologic agent is in effect conducted within a reduced time or volume, and ]	[ wherein said guide can be placed into a tube for insertion of an elongated device having an output connector disposed within an inner surface of said guide, said elongated device further having a support configured for its longitudinally extending distal end for holding said elongated device, ]
0.99999213	1812	[ upon delivery of said biologic agent directly to the body a change in a state of a body surface of the patient is substantially prevented. ]	[ whereby said delivery administration of the biologic agent is in effect conducted within a reduced time or volume, and ]
0.9999633	1813	[ administering to the subject in an amount effective to treat liver disease, the subject comprising a genetically modified human being. ]	[ A method of treating a defect in liver epithelial barrier formation in a human subject comprising: ]
0.9999918	1814	[ at a plurality of apertures in an interior of the pump, receiving a signal output from a sensor and providing a plurality of oxygenated conditions of the pump; ]	[ A method for controlling oxygenated conditions of an infusion pump, the method comprising: ]
0.99999213	1815	[ after the plurality of oxygenated conditions have been provided, reducing a plurality of electrical pulses transmitted from a first control unit and reflected to an air outlet of an infusion pump; and ]	[ at a plurality of apertures in an interior of the pump, receiving a signal output from a sensor and providing a plurality of oxygenated conditions of the pump; ]
0.99999225	1816	[ after the plurality of oxygenated conditions are provided, decreasing an electrical pulse transmitted from the first control unit and reflected from the air outlet of the pump. ]	[ after the plurality of oxygenated conditions have been provided, reducing a plurality of electrical pulses transmitted from a first control unit and reflected to an air outlet of an infusion pump; and ]
0.9999552	1817	[ a tubular lumen having a main section extending within said vascular vessel, for receiving a user's blood at a first site of the tubular lumen; ]	[ A device for implantation into an external vascular vessel in a patient to thereby inflate the vascular vessel and deliver a therapeutically effective amount of an active agent into the vascular vessel, comprising: ]
0.99986887	1818	[ said lumen adapted to guide blood flow into at least one artery of a patient; ]	[ a tubular lumen having a main section extending within said vascular vessel, for receiving a user's blood at a first site of the tubular lumen; ]
0.39102456	1819	[ first contact means comprising: ]	[ said lumen adapted to guide blood flow into at least one artery of a patient; ]
0.9999634	1820	[ a first contact at both the main and non-linear locations of the main section, the main section, and ]	[ first contact means comprising: ]
0.999941	1821	[ at the non-linear location where blood is administered to a patient; a first anchor for anchoring the lumen to the patient; and ]	[ a first contact at both the main and non-linear locations of the main section, the main section, and ]
0.99999106	1822	[ first means for controlling said first anchor to cause at least one of the first anchoring sites to move towards the patient; ]	[ at the non-linear location where blood is administered to a patient; a first anchor for anchoring the lumen to the patient; and ]
0.99886715	1823	[ lateral contact means comprising: ]	[ first means for controlling said first anchor to cause at least one of the first anchoring sites to move towards the patient; ]
0.45123675	1824	[ a second contact at both the main section and the non-linear location where blood is administered to the patient; ]	[ lateral contact means comprising: ]
0.9996	1825	[ a second anchor for anchoring the lumen to the patient-region. ]	[ a second contact at both the main section and the non-linear location where blood is administered to the patient; ]
0.00041673973	1826	[ a) an image generator comprising the following data; ]	[ A system for monitoring a catheter, comprising: ]
0.999882	1827	[ b) a computer interface configured to receive at the computer interface the data shown in b) of and receive at said computer interface a correction input; ]	[ a) an image generator comprising the following data; ]
0.999845	1828	[ c) an image processor configured to: ]	[ b) a computer interface configured to receive at the computer interface the data shown in b) of and receive at said computer interface a correction input; ]
0.99957174	1829	[ i) evaluate the received correction input to determine wherein said correction input reflects performance data; ]	[ c) an image processor configured to: ]
0.99999213	1830	[ ii) apply the corrected performance data contained in the received correction input to the image, into the image generator, and ]	[ i) evaluate the received correction input to determine wherein said correction input reflects performance data; ]
0.9996655	1831	[ out of the image; and ]	[ ii) apply the corrected performance data contained in the received correction input to the image, into the image generator, and ]
0.01591078	1832	[ iii) compare the image with the received corrected performance data to determine whether the received corrected performance data is at odds with performance of an earlier image, such that the image is determined to belong in a lower calibration setting for the first image, for the second image, and ]	[ out of the image; and ]
0.9999155	1833	[ for the image before or after the correction and contrast detection process step. ]	[ iii) compare the image with the received corrected performance data to determine whether the received corrected performance data is at odds with performance of an earlier image, such that the image is determined to belong in a lower calibration setting for the first image, for the second image, and ]
0.992401	1834	[ a control unit to control a movement of a computer; ]	[ A game device to be for the playing of a simulation of a tournament game comprising: ]
0.99944204	1835	[ at least one player controlling the computer to play a computer game based on at least one of a game point outcome specified by the computer and an average score which is generated by game program, wherein the average score is for a predetermined distance from a center of a track formed by a plurality of characters included in the simulation of the tournament game, wherein the computer is synchronized to control both the running and the standing position of a character within the simulation of the tournament game; and ]	[ a control unit to control a movement of a computer; ]
0.99999225	1836	[ wherein the control unit moves a character to a position in the simulation of the tournament game in which the average score is at least one score higher than an average score over a predetermined period of time. ]	[ at least one player controlling the computer to play a computer game based on at least one of a game point outcome specified by the computer and an average score which is generated by game program, wherein the average score is for a predetermined distance from a center of a track formed by a plurality of characters included in the simulation of the tournament game, wherein the computer is synchronized to control both the running and the standing position of a character within the simulation of the tournament game; and ]
0.99999213	1837	[ evaluating the amount of polyurea in a plurality of body fluids of the subject, wherein said evaluated amount is determined by a ratio of weight per volume of said body fluids; ]	[ A method for determining the degree of an accumulation of polyurea in a subject, comprising: ]
0.999959	1838	[ providing a set of data comprising measurement results of a plurality of blood signals from the subject, wherein said measurement results of each said plurality of blood signals are from a sampling process employing a plurality of test devices; and ]	[ evaluating the amount of polyurea in a plurality of body fluids of the subject, wherein said evaluated amount is determined by a ratio of weight per volume of said body fluids; ]
0.99999213	1839	[ applying a processor to said data to determine, based on the ratio of weight per volume of said body fluids of respective blood signals, whether the accumulation of polyurea is within the measurement results, wherein the processor is configured to automatically determine at least one of whether polyurea in the measured sample is within the predetermined maximum weight per volume, and ]	[ providing a set of data comprising measurement results of a plurality of blood signals from the subject, wherein said measurement results of each said plurality of blood signals are from a sampling process employing a plurality of test devices; and ]
0.81585616	1840	[ a subset thereof. ]	[ applying a processor to said data to determine, based on the ratio of weight per volume of said body fluids of respective blood signals, whether the accumulation of polyurea is within the measurement results, wherein the processor is configured to automatically determine at least one of whether polyurea in the measured sample is within the predetermined maximum weight per volume, and ]
0.9999324	1841	[ a mattress to which said patient has a seat and which is constructed and arranged to be positioned relative to the chassis of said patient in such an arrangement that the patient is present in the bed of said mattress when said patient is held in said patient's seat; and ]	[ A bed for receiving or positioning a patient, the bed including: ]
0.9999784	1842	[ a sliding support surface movably supported on from said at least one bar to be secured in rearward rotation with respect to said pivot on said mattress when the bed is provided as an operating unit for a medical facility, ]	[ a mattress to which said patient has a seat and which is constructed and arranged to be positioned relative to the chassis of said patient in such an arrangement that the patient is present in the bed of said mattress when said patient is held in said patient's seat; and ]
0.9999924	1843	[ wherein said mattress and said sliding support surface may be placed in a first position, and ]	[ a sliding support surface movably supported on from said at least one bar to be secured in rearward rotation with respect to said pivot on said mattress when the bed is provided as an operating unit for a medical facility, ]
0.99999213	1844	[ wherein said mattress and said sliding support surface may be placed in said second position, ]	[ wherein said mattress and said sliding support surface may be placed in a first position, and ]
0.9999919	1845	[ wherein each of said sliding support surface is constructed for support of a bone pad when a medical device is directly mounted to the bone pad. ]	[ wherein said mattress and said sliding support surface may be placed in said second position, ]
0.999992	1846	[ a. determining whether or not at least one medical article in at least one medical device is more dense or less dense than the average weight of the all of the medical articles in the medical device; ]	[ A computer-implemented method for determining the average weight of each of a plurality of medical articles in a medical device, comprising: ]
0.9999924	1847	[ b. forming an average weight matrix of the at least one medical article to represent one of the different densities of the at least one medical article as a function of the at least one medical article's concentration in the average weight matrix at a time, the total quantity of the at least one medical article being greater at any one time than at other times; ]	[ a. determining whether or not at least one medical article in at least one medical device is more dense or less dense than the average weight of the all of the medical articles in the medical device; ]
0.99999225	1848	[ c. calculating an average weights of the at least one medical article at the time by subtracting all parts of the at least one medical article from the total quantities of the at least one medical article or measuring the total quantity of the at least one medical article for each physical state of the at least one medical article by utilizing the average weight matrix; and ]	[ b. forming an average weight matrix of the at least one medical article to represent one of the different densities of the at least one medical article as a function of the at least one medical article's concentration in the average weight matrix at a time, the total quantity of the at least one medical article being greater at any one time than at other times; ]
0.9999924	1849	[ d. combining the measured weight of an average weight matrix of one medical article of an array of medical articles in at least one medical device to form a weighted average, wherein a weighted average of one medical article of the array of medical articles represents a weight of the array measured for the array of medical articles at one specific point in time. ]	[ c. calculating an average weights of the at least one medical article at the time by subtracting all parts of the at least one medical article from the total quantities of the at least one medical article or measuring the total quantity of the at least one medical article for each physical state of the at least one medical article by utilizing the average weight matrix; and ]
0.9998455	1850	[ processing the plurality of images by using multiple, synchronous images that correspond to the respective images; ]	[ A method of reconstructing patient-selected physiological data from a plurality of images obtained at real-time with at least four orthodontic appliances, the method comprising: ]
0.9999758	1851	[ adjusting at least one predetermined anatomical parameter associated with at least one image to correspond to at least one of the plurality of images, wherein the at least one predetermined anatomical parameter is present in at least one image representative of at least one external anatomical region of the at least one image based on at least one of a first plurality of predetermined values for a first parameter of the first parameter or a second plurality of predetermined values for a second parameter of the first parameter, and ]	[ processing the plurality of images by using multiple, synchronous images that correspond to the respective images; ]
0.016140018	1852	[ wherein the compensating effect of a known region or group of regions is applied to a region or group of regions that is not present in a reference region; ]	[ adjusting at least one predetermined anatomical parameter associated with at least one image to correspond to at least one of the plurality of images, wherein the at least one predetermined anatomical parameter is present in at least one image representative of at least one external anatomical region of the at least one image based on at least one of a first plurality of predetermined values for a first parameter of the first parameter or a second plurality of predetermined values for a second parameter of the first parameter, and ]
0.99382234	1853	[ adjusting at least one characteristic of at least one image by using different, different, random parameters of the at least one image corresponding to the at least one instance of the different, different, different parameters that are present in the different, different, random parameters of the at least one image; and ]	[ wherein the compensating effect of a known region or group of regions is applied to a region or group of regions that is not present in a reference region; ]
0.99515885	1854	[ outputting the adjusted, reduced, and ]	[ adjusting at least one characteristic of at least one image by using different, different, random parameters of the at least one image corresponding to the at least one instance of the different, different, different parameters that are present in the different, different, random parameters of the at least one image; and ]
0.99999106	1855	[ adjusted, reduced and adjusted images: ]	[ outputting the adjusted, reduced, and ]
0.99578923	1856	[ wherein the adjustment is sequential, and ]	[ adjusted, reduced and adjusted images: ]
0.9999888	1857	[ at least one of the parameters associated with a characteristic of the adjustment is determined by using an algorithm defined by one or more models structured with data sets so that adaptive optimization of the algorithm using at least one model or multiple model is facilitated. ]	[ wherein the adjustment is sequential, and ]
0.0005293412	1858	[ providing a tissue vector; ]	[ A method for producing an emulsion obtained by a hybridization, the method comprising: ]
0.9999918	1859	[ exposing a tissue vector comprising a first component based on a mixture of a first antigen and a second antigen, such that the first component is in direct contact with blood of the target site; ]	[ providing a tissue vector; ]
0.9999918	1860	[ introducing a heat medium into the tissue vector; and ]	[ exposing a tissue vector comprising a first component based on a mixture of a first antigen and a second antigen, such that the first component is in direct contact with blood of the target site; ]
0.99999225	1861	[ exposing a portion of the thermal medium onto the tissue vector, thereby generating a first emulsion. ]	[ introducing a heat medium into the tissue vector; and ]
0.9999907	1862	[ an applicator frame connecting to said applicator frame from said handlebar, said applicator frame having a generally flat rear surface in vertical orientation with a generally circumferential handle to expose a second side of said rear surface between said adjacent side walls but not from said rear surface to prevent said two sides of said rear surface from folding around or through said applicator frame, a crotch area defined by a fabric frame and defining a curved portion, said crotch area including an inwardly extending portion extending outwardly from and extending distally from said handlebar and disposed on said rear surface, said crotch area conveying at least one latching feature provided in said crotch area to seal a latching system, said crotch being disposed adjacent said rear surface of said applicator assembly and being secured against movement by a front side surface of said applicator assembly. ]	[ An applicator assembly, a handlebar pivot connected to said applicator assembly, and ]
0.99993086	1863	[ a first input comprising a plurality of first electrodes spaced to provide a first region of tissue in one or more regions of said tissue; ]	[ An apparatus for diagnosing a disease in a tissue, said apparatus comprising: ]
0.99999225	1864	[ a second input comprising a second region of tissue in and adapted to interact with the first region of tissue; ]	[ a first input comprising a plurality of first electrodes spaced to provide a first region of tissue in one or more regions of said tissue; ]
0.99997747	1865	[ a first temperature sensor coupled to the first input and having a temperature sensed range, wherein said first temperature sensor provides at least one value indicative of a first temperature; and ]	[ a second input comprising a second region of tissue in and adapted to interact with the first region of tissue; ]
0.9999924	1866	[ a second temperature sensor coupled to the second input and having a temperature sensed range, and ]	[ a first temperature sensor coupled to the first input and having a temperature sensed range, wherein said first temperature sensor provides at least one value indicative of a first temperature; and ]
0.9999913	1867	[ wherein said second temperature sensor provides at least one value indicative of a second temperature. ]	[ a second temperature sensor coupled to the second input and having a temperature sensed range, and ]
0.99999154	1868	[ a cannula having a first end and a second end, such that the cannula may contain an acetylcholine precursor; ]	[ A device for providing an infusion of an acetylcholine precursor to stimulate a heart or a respiration system, the device comprising: ]
0.99999166	1869	[ an infusion guide configured to be inserted within the cannula in a user's arm during an infusion and configured to allow an infusion to convey the acetylcholine precursor; and ]	[ a cannula having a first end and a second end, such that the cannula may contain an acetylcholine precursor; ]
0.99999166	1870	[ a non-inflated catheter, the catheter having a cylindrically oriented first end and a sidewall therebetween, wherein in a test configuration such that the catheter is configured such that upon activation of the needle of the infusion guide, the cylindrically oriented first end of the catheter contacts the cored surface of the surface of the acetylcholine precursor when it is received in the infusion guide, and ]	[ an infusion guide configured to be inserted within the cannula in a user's arm during an infusion and configured to allow an infusion to convey the acetylcholine precursor; and ]
0.99999225	1871	[ wherein in a plurality of test configurations, the infusion guide is configured such that upon activation of the needle of the infusion guide, the first tip of the catheter contacts the sidewall of the catheter when the needle enters the catheter. ]	[ a non-inflated catheter, the catheter having a cylindrically oriented first end and a sidewall therebetween, wherein in a test configuration such that the catheter is configured such that upon activation of the needle of the infusion guide, the cylindrically oriented first end of the catheter contacts the cored surface of the surface of the acetylcholine precursor when it is received in the infusion guide, and ]
0.9915978	1872	[ a frame; ]	[ A portable assembly comprising: ]
0.99919647	1873	[ an elastic member being movable in a plane parallel to the path, the frame being adapted to support a first side of the elastic member and a second side of the elastic member each operatively connected to each other generally perpendicular to the path; and ]	[ a frame; ]
0.99999225	1874	[ a first coupling member being movable in a plane parallel to the path, the first coupling member being arranged to contact a first side of the elastic member when the frame is in an extended position, the first coupling member having an ends extending upwardly between parallel parallel spaced sides adjacent the bottom portion of one of the sides of the frame such that the ends of one side of the frame rest on a ground surface opposite the surfaces of the other sides when the frame is in an extended position on the ground surface. ]	[ an elastic member being movable in a plane parallel to the path, the frame being adapted to support a first side of the elastic member and a second side of the elastic member each operatively connected to each other generally perpendicular to the path; and ]
0.9998447	1875	[ providing an X-ray-based antibody that binds to a target binding site of a pharmaceutically active drug comprising the amino acid sequence deposited under ATCC Accession number PTA-12074. ]	[ A method of screening a drug for effect on a biomarker function, the method comprising: ]
0.99972314	1876	[ i) a plurality of bone implants, and ]	[ A method for improving a quality of surgical preparation and/or therapy of a dental procedure, the method comprisinga) providing a preparation system which includes: ]
0.99984515	1877	[ ii) a dental preparation system; ]	[ i) a plurality of bone implants, and ]
0.99999	1878	[ b) selecting, from said preparation system, a surgeon configured to execute a surgical procedure directed by the preparation system; ]	[ ii) a dental preparation system; ]
0.9999907	1879	[ c) selecting, from said patient, a surgical device configured to insert a surgical instrument into the patient; and ]	[ b) selecting, from said preparation system, a surgeon configured to execute a surgical procedure directed by the preparation system; ]
0.99996936	1880	[ d) adjusting, from said preparation system, said patient's anatomy such that, ]	[ c) selecting, from said patient, a surgical device configured to insert a surgical instrument into the patient; and ]
0.99978095	1881	[ i) the surgeon generates a simulated vascular interface through which the surgical instrument can be inserted, ]	[ d) adjusting, from said preparation system, said patient's anatomy such that, ]
0.99999225	1882	[ ii) the tissue's virtual vascular interface is changed so as to provide a improvement in a quality of surgical preparation through the determination of second tissue characteristics characteristic of the virtual vascular interface in response to the surgical instrument being inserted, is performed by a surgeon of the preparation system, and ]	[ i) the surgeon generates a simulated vascular interface through which the surgical instrument can be inserted, ]
0.9999912	1883	[ iii) wherein the surgical instrument is selected from the groupof devices for surgical manipulation, surgical forceps, incisal tools, and ]	[ ii) the tissue's virtual vascular interface is changed so as to provide a improvement in a quality of surgical preparation through the determination of second tissue characteristics characteristic of the virtual vascular interface in response to the surgical instrument being inserted, is performed by a surgeon of the preparation system, and ]
0.9999912	1884	[ surgical instruments, while the surgical instrument does not have a user interface including a plurality of buttons. ]	[ iii) wherein the surgical instrument is selected from the groupof devices for surgical manipulation, surgical forceps, incisal tools, and ]
0.9999924	1885	[ a flexible support configured to be inserted in a lancet delivery system and to be pulled for lancing of blood vessels in the lancet delivery system of the lancing delivery device; ]	[ A lancing delivery device for a lancet, comprising: ]
0.99999225	1886	[ a lancing delivery shaft configured to lead from the flexible support through the flexible support to a lancing release connector for a lancing connector member to be provided around the flexible support while the flexible support is inserted in the lancet delivery system; ]	[ a flexible support configured to be inserted in a lancet delivery system and to be pulled for lancing of blood vessels in the lancet delivery system of the lancing delivery device; ]
0.99999225	1887	[ an elastic and resistive blade configured to be pivoted in a longitudinal direction about a longitudinal axis of the flexible support after insertion of the flexible support in the lancet delivery system; the blade including a connector and a resilient blade head; and ]	[ a lancing delivery shaft configured to lead from the flexible support through the flexible support to a lancing release connector for a lancing connector member to be provided around the flexible support while the flexible support is inserted in the lancet delivery system; ]
0.99999225	1888	[ control means, which controls the orientation of the flexible support in movement on the blade being moved toward the blade head relative to the blade head head relative to the elastic and resistive blade, to move the flexible support forward beyond or around the blade head, thereby creating a lancing connection of the flexible support with the flexible support body moving outward. ]	[ an elastic and resistive blade configured to be pivoted in a longitudinal direction about a longitudinal axis of the flexible support after insertion of the flexible support in the lancet delivery system; the blade including a connector and a resilient blade head; and ]
0.026320234	1889	[ an insert; and ]	[ An apparatus, comprising: ]
0.99998796	1890	[ a latching means which is connected to the insert to LATCH together; ]	[ an insert; and ]
0.99999213	1891	[ wherein the latching means is releasably coupled to the insert end without external support during insertion and removal of the latching means from the insert and into a recess of said recess. ]	[ a latching means which is connected to the insert to LATCH together; ]
0.00027560946	1892	[ initiating a communication sequence executed by the receiving device through a first communications protocol, wherein said first communication protocol is one embodied by a first communication server and a second communication server; ]	[ A method for enabling intraocular communication between a central monitoring device and an intraocular site of a patient comprising the steps of: ]
0.9848053	1893	[ generating a set of data for the central monitoring device to use in response to a target signal; ]	[ initiating a communication sequence executed by the receiving device through a first communications protocol, wherein said first communication protocol is one embodied by a first communication server and a second communication server; ]
0.99999225	1894	[ generating a set of instructions for the central monitoring device to implement the communication sequence, wherein the set of instructions further include at least one setting that is determined to be sufficient for operation of the communication protocol; ]	[ generating a set of data for the central monitoring device to use in response to a target signal; ]
0.99999213	1895	[ sending a reference signal indicative of the set of instructions contained in the received signals to the central monitoring device to enable processing of the reference signal; ]	[ generating a set of instructions for the central monitoring device to implement the communication sequence, wherein the set of instructions further include at least one setting that is determined to be sufficient for operation of the communication protocol; ]
0.99998844	1896	[ implementing the communication sequence in response to the transmitted reference signal; and ]	[ sending a reference signal indicative of the set of instructions contained in the received signals to the central monitoring device to enable processing of the reference signal; ]
0.99999106	1897	[ allowing the central monitoring device to respond to the reference signal based upon the received set of instructions in response to whether it matches a set of actions that have been predefined in the reference signal. ]	[ implementing the communication sequence in response to the transmitted reference signal; and ]
0.99946517	1898	[ (a) injecting parenterally a solid form of an E10 protein, characterized by the amino acid sequence depicted in SEQ ID NO.: ]	[ A method of diagnosing in pancreatic cancer an environmental factor, comprising: ]
0.99934	1899	[ 2 of SEQ ID NO.: ]	[ (a) injecting parenterally a solid form of an E10 protein, characterized by the amino acid sequence depicted in SEQ ID NO.: ]
0.99958104	1900	[ 38, into a tumor cell; ]	[ 2 of SEQ ID NO.: ]
0.9993223	1901	[ (b) detecting a phase difference between the injecting and the tumor region and detecting an increase in the level of an environmental signal having a characteristic representing a disease state in the tumor as a function of a phase change of the injection; ]	[ 38, into a tumor cell; ]
0.99999225	1902	[ (c) comparing the phase of the decrease of phase change of the injection to the phase of phase difference of the phase difference of injecting during a treatment cycle comprising a patient's intake of environmental factor to identify whether the environmental factor is a potential to cause an adverse response; and ]	[ (b) detecting a phase difference between the injecting and the tumor region and detecting an increase in the level of an environmental signal having a characteristic representing a disease state in the tumor as a function of a phase change of the injection; ]
0.99999213	1903	[ detecting an adverse response associated with the chemical, biological or other environmental factor in a sample as compared to a control. ]	[ (c) comparing the phase of the decrease of phase change of the injection to the phase of phase difference of the phase difference of injecting during a treatment cycle comprising a patient's intake of environmental factor to identify whether the environmental factor is a potential to cause an adverse response; and ]
0.9999343	1904	[ a. loading blood into a vasculature of an artery to be blocked; ]	[ A method for treating an angio-venous occlusion(A) of a vein, for blocking an artery flow through the vein, said method comprising: ]
0.99998844	1905	[ b. providing blood into the vein through through a ventilator; ]	[ a. loading blood into a vasculature of an artery to be blocked; ]
0.99999106	1906	[ c. applying pressure on the vein; ]	[ b. providing blood into the vein through through a ventilator; ]
0.99990547	1907	[ d. a sealing process being performed on the at least one valve; ]	[ c. applying pressure on the vein; ]
0.99999225	1908	[ e. a sealing process being performed on a valve mechanism along a length of the valve to increase sealing in the valve mechanism including a sealing angle of less than 75 degrees on the valve. ]	[ d. a sealing process being performed on the at least one valve; ]
0.99710363	1909	[ optionally a pharmaceutically acceptable carrier in an amount selected for the amount of toxicity the selected compound produces. ]	[ A composition comprising a polyphosphoxylidene nitride (PPNT), or a pharmaceutically acceptable salt thereof, a polyol, a compound of formula I, a base, and ]
0.020307198	1910	[ a body having a first portion and a second portion and having a plurality of channel surfaces, wherein each channel surface includes an inner surface and an outer surface, said plurality of channel surfaces each extending between and coupled to one of said plurality of inner surfaces; ]	[ A water-retaining system comprising: ]
0.9999919	1911	[ a conduit means positioned within said body and disposed to provide additional water-retention channels on an inner surface of one of said plurality of channel surfaces; ]	[ a body having a first portion and a second portion and having a plurality of channel surfaces, wherein each channel surface includes an inner surface and an outer surface, said plurality of channel surfaces each extending between and coupled to one of said plurality of inner surfaces; ]
0.99999213	1912	[ a barrier means deployed within said body, said barrier means separated from at least one of said channel surfaces; and ]	[ a conduit means positioned within said body and disposed to provide additional water-retention channels on an inner surface of one of said plurality of channel surfaces; ]
0.9999919	1913	[ a permeable substrate configured to support water in said barrier means. ]	[ a barrier means deployed within said body, said barrier means separated from at least one of said channel surfaces; and ]
0.999992	1914	[ the tray base is disposed on a rim of the tray base and has an opening; ]	[ A food dispensing tray having a tray base, a first base and a second base, wherein: ]
0.99999225	1915	[ the first base extends from the tray base into the opening of the tray base; ]	[ the tray base is disposed on a rim of the tray base and has an opening; ]
0.9999919	1916	[ the first or second base does not prevent a user from placing the tray into a pre-selected slot of the tray; and ]	[ the first base extends from the tray base into the opening of the tray base; ]
0.0036498206	1917	[ a base slider comprises: ]	[ the first or second base does not prevent a user from placing the tray into a pre-selected slot of the tray; and ]
0.004788429	1918	[ a rigid housing having at least one groove associated with a proximal end and a distal end, the interior groove of the housing being disposed from the distal end of the housing to form a cross-feed channel into the opening of the tray base; and ]	[ a base slider comprises: ]
0.999897	1919	[ a slider cap disposed between the housing and the groove, the slider cap having a central axis to be substantially centered at adjacent grooves in the housing. ]	[ a rigid housing having at least one groove associated with a proximal end and a distal end, the interior groove of the housing being disposed from the distal end of the housing to form a cross-feed channel into the opening of the tray base; and ]
0.999982	1920	[ for each selected electrode in a target surface there being at least one second electrode arranged for contact with at least one surface of the target surface, the first electrode arranged so that the selected electrode is disposed in lateral axis communication with a tissue axis of the tissue sample; ]	[ A method for detecting a presence of a target in a tissue sample, comprising: ]
0.99999225	1921	[ for each selected electrode in the target surface there being at least one third electrode arranged for contact with at least one surface of the target surface, the third electrode arranged so that the selected electrode is disposed in lateral axis communication with a tissue axis of the tissue sample; ]	[ for each selected electrode in a target surface there being at least one second electrode arranged for contact with at least one surface of the target surface, the first electrode arranged so that the selected electrode is disposed in lateral axis communication with a tissue axis of the tissue sample; ]
0.9783689	1922	[ a frequency processing portion for receiving a frequency signal signal indicative of a frequency of electric current to enable a processor of the processor to produce a frequency signal signal; and ]	[ for each selected electrode in the target surface there being at least one third electrode arranged for contact with at least one surface of the target surface, the third electrode arranged so that the selected electrode is disposed in lateral axis communication with a tissue axis of the tissue sample; ]
0.99994576	1923	[ an active detection portion for determining an identity of the target. ]	[ a frequency processing portion for receiving a frequency signal signal indicative of a frequency of electric current to enable a processor of the processor to produce a frequency signal signal; and ]
0.99910945	1924	[ S(R4)wherein-S(R4) represents all members of formula X and all members of formula Y, in which R4 represents the amino acid sequence at least 95% identity, ]	[ A pharmaceutical composition comprisinga) a protein of formula I: ]
0.97748405	1925	[ and ]	[ S(R4)wherein-S(R4) represents all members of formula X and all members of formula Y, in which R4 represents the amino acid sequence at least 95% identity, ]
0.9853587	1926	[ X&#x2032; is R1; wherein X&#x2032; is hydrogen, amino, or a substituted amino group comprising substituents selected from the group consisting of alkyl, aralkyl, alkylsulfinyl, and ]	[ and ]
0.9973763	1927	[ arylsulfinyl. ]	[ X&#x2032; is R1; wherein X&#x2032; is hydrogen, amino, or a substituted amino group comprising substituents selected from the group consisting of alkyl, aralkyl, alkylsulfinyl, and ]
0.999923	1928	[ receiving a first signal, which comprises an electrical energy and whether the first signal is an analog signal and a digital signal; ]	[ A method for converting a first signal sent from a sensor to a second signal transmitted from and receiving at an image transmitting device, comprising: ]
0.9998903	1929	[ storing the stored first signal and a second signal during an audio transmission of digital input signals, said stored first signal and stored second signal being different from a received signal as stored in a memory of the image transmitting device; ]	[ receiving a first signal, which comprises an electrical energy and whether the first signal is an analog signal and a digital signal; ]
0.9999807	1930	[ switching on the transmission of said second signal; ]	[ storing the stored first signal and a second signal during an audio transmission of digital input signals, said stored first signal and stored second signal being different from a received signal as stored in a memory of the image transmitting device; ]
0.99726176	1931	[ extracting a first image, which is based on the difference between the stored second signal and the stored first signal between the stored first signal and the stored second signal, and ]	[ switching on the transmission of said second signal; ]
0.99999213	1932	[ extraction of another image based on the difference between the stored second signal and the stored first signal and the first image; ]	[ extracting a first image, which is based on the difference between the stored second signal and the stored first signal between the stored first signal and the stored second signal, and ]
0.99998546	1933	[ generating a first response, which is based on the difference between the first image and a captured first image; ]	[ extraction of another image based on the difference between the stored second signal and the stored first signal and the first image; ]
0.9999591	1934	[ collecting a second image that reflects an estimated distance from the first image; ]	[ generating a first response, which is based on the difference between the first image and a captured first image; ]
0.0041291458	1935	[ analyzing said first response to generate a first response coefficient; and ]	[ collecting a second image that reflects an estimated distance from the first image; ]
0.999987	1936	[ converting the first response coefficient and subsequent second signal using the third signal if not converted to analog or digital. ]	[ analyzing said first response to generate a first response coefficient; and ]
0.99999225	1937	[ the synergistic effect comprises synergistic reactivity between the amide bond and the at least one adjuvant. ]	[ An adhesive compound, an amide bond and an adjuvant that may be linked so as to yield a synergistic effect corresponding to the functional interaction of the adhesive compound with the adjuvant, wherein: ]
0.9977641	1938	[ 2. ]	[ An isolated nucleic acid molecule comprising one or more nucleotides sequence set forth in SEQ ID NO: ]
0.99998784	1939	[ is adapted to extend from a first body surface to a posterior portion of an underlying body between the first opening and the second opening, the tubular member further comprises a generally tubular structure having a thickness between 0 and 3 wt.g. between said opening and the second opening of 1 to 5 cm. ]	[ An elastomeric tubular, biocompatible, multifunctional therapeutic interface for treating cancer, in which said tubular member comprises a tubular region which defines an outer region comprising a first opening and a second opening, and ]
0.998672	1940	[ delivering to an arm of the patient an electric stimulation device to produce an electric current with a voltage higher than a threshold voltage; ]	[ A method for providing a treatment for a patient for chronic pain, the method comprising: ]
0.9999869	1941	[ administering to the arm heat to generate a heating environment in which a therapeutic portion of the active portion of the treatment is present, wherein the heating environment is designed to heat the therapeutic portion of the active portion of the treatment so that the therapeutic portion of the treatment is heated and rendered so that the therapeutic portion of the treatment is delivered therapeutically; and ]	[ delivering to an arm of the patient an electric stimulation device to produce an electric current with a voltage higher than a threshold voltage; ]
0.9999924	1942	[ maintaining the a therapeutic portion of the therapy within the heat environment for at least one of a period of 30 or 60 minutes. ]	[ administering to the arm heat to generate a heating environment in which a therapeutic portion of the active portion of the treatment is present, wherein the heating environment is designed to heat the therapeutic portion of the active portion of the treatment so that the therapeutic portion of the treatment is heated and rendered so that the therapeutic portion of the treatment is delivered therapeutically; and ]
0.9999057	1943	[ wherein an assembly of threaded elements is at least partially formed from bone material, wherein the assembly has an arm region for pivotably securing the needle to a socket, a needle assembly member which has four ends configured to be operatively attached to the needle assembly in said tool section of the needle assembly, and ]	[ An apparatus for inserting a needle having a plurality of holes therethrough, the needle having a proximal surface and a distal surface; ]
0.99999225	1944	[ a grip assembly having five holes which can be opened in relation to said finger of a user in a direction of an arm and a proximal end located on the end side of the needle assembly, and ]	[ wherein an assembly of threaded elements is at least partially formed from bone material, wherein the assembly has an arm region for pivotably securing the needle to a socket, a needle assembly member which has four ends configured to be operatively attached to the needle assembly in said tool section of the needle assembly, and ]
0.99999225	1945	[ wherein when the needle assembly assembly is assembled, the six hole spaces do not overlap the needle assembly member, wherein the grip assembly is disposed over the needle assembly member, and ]	[ a grip assembly having five holes which can be opened in relation to said finger of a user in a direction of an arm and a proximal end located on the end side of the needle assembly, and ]
0.9999485	1946	[ wherein a tension is caused by tensioning the fingers when moving the sleeve above the needle in both directions when said needle is inserted. ]	[ wherein when the needle assembly assembly is assembled, the six hole spaces do not overlap the needle assembly member, wherein the grip assembly is disposed over the needle assembly member, and ]
0.99997246	1947	[ generating an ultrasound image using a pre-defined ultrasonic waveform for a subject; ]	[ A method for analyzing an ultrasonic image comprising the steps of: ]
0.999992	1948	[ detecting a difference in intensity between the ultrasound image and a corresponding reference image; ]	[ generating an ultrasound image using a pre-defined ultrasonic waveform for a subject; ]
0.9999918	1949	[ generating a reconstruction image using the ultrasound image as a first target region; and ]	[ detecting a difference in intensity between the ultrasound image and a corresponding reference image; ]
0.99999154	1950	[ deriving ultrasonic waveform parameters using signals from the background of the compared ultrasound image using a programmable processor. ]	[ generating a reconstruction image using the ultrasound image as a first target region; and ]
0.9955799	1951	[ creating a computer-assisted method of producing a video record from a video of a scene, said computer-assisted method comprising: ]	[ A method, comprising: ]
0.9978988	1952	[ analyzing a virtual screen and a first virtual video image; ]	[ creating a computer-assisted method of producing a video record from a video of a scene, said computer-assisted method comprising: ]
0.99999213	1953	[ generating images and recording audio from the virtual screen; ]	[ analyzing a virtual screen and a first virtual video image; ]
0.999992	1954	[ converting audio from said virtual screen to an audio frame using a display server wherein said audio frame comprises a first and second audio frames, wherein said audio frames are captured at the same time; and ]	[ generating images and recording audio from the virtual screen; ]
0.99999034	1955	[ capturing at least a portion of the first and second audio frames; and ]	[ converting audio from said virtual screen to an audio frame using a display server wherein said audio frame comprises a first and second audio frames, wherein said audio frames are captured at the same time; and ]
0.99999225	1956	[ comparing the first and second audio frames; ]	[ capturing at least a portion of the first and second audio frames; and ]
0.99582845	1957	[ identifying at least one feature on the virtual screen which is related to sound; ]	[ comparing the first and second audio frames; ]
0.9999924	1958	[ generating identifying information including an identification of the feature on the virtual screen; and ]	[ identifying at least one feature on the virtual screen which is related to sound; ]
0.99999225	1959	[ identifying the at least one feature based at least in part on the identification of the feature on the virtual screen. ]	[ generating identifying information including an identification of the feature on the virtual screen; and ]
0.9988574	1960	[ a body having a first cavity defining a lumen having a cross-sectional face and extending between at least two members; ]	[ An oxygen delivery device wherein a lumen is at a distal end of the device and an outlet at a proximal end of the device, the device comprising: ]
0.9997466	1961	[ a control valve disposed in the lumen; ]	[ a body having a first cavity defining a lumen having a cross-sectional face and extending between at least two members; ]
0.9899159	1962	[ an inflation chamber, with said chamber defined by the body; and ]	[ a control valve disposed in the lumen; ]
0.99845123	1963	[ a valve member, with a lumen defining an outlet port for infusing oxygen, the valve member having a valve body with a lumen defining an inner portion; ]	[ an inflation chamber, with said chamber defined by the body; and ]
0.9999738	1964	[ wherein said control valve is positioned in the body between the first of the opening ports of the cavity and the outlet port of the valve; and ]	[ a valve member, with a lumen defining an outlet port for infusing oxygen, the valve member having a valve body with a lumen defining an inner portion; ]
0.9996923	1965	[ wherein said valve body defines a predetermined positioning region, with said closed end of said valve member being at least partially surrounded by said predetermined positioning region. ]	[ wherein said control valve is positioned in the body between the first of the opening ports of the cavity and the outlet port of the valve; and ]
0.99946314	1966	[ providing a first implant, wherein the first implant comprises a first implant body and a first implanted implant section, respectively, wherein first implant section is configured to be implanted in a region of a vasculature of a patient; ]	[ A method for conducting a micro-vascular surgery, the method comprising: ]
0.99999213	1967	[ providing a second implant, wherein the second implant comprises a second implant body and a second implanted implant section, respectively, wherein second implant section is configured to be implanted in at least one of a first vasculature of the vasculature and a second vasculature of the vasculature. ]	[ providing a first implant, wherein the first implant comprises a first implant body and a first implanted implant section, respectively, wherein first implant section is configured to be implanted in a region of a vasculature of a patient; ]
0.99975175	1968	[ receiving a coil consisting of a plurality of magnets from a coil assembly in which the magnets are generated by a magnetic motor; ]	[ A method of using a magnetic signal device, comprising: ]
0.9996494	1969	[ applying, by a mechanical device, an electric field on the coil, wherein the electric field is applied to prevent an magnetic field from traversing through said coil; ]	[ receiving a coil consisting of a plurality of magnets from a coil assembly in which the magnets are generated by a magnetic motor; ]
0.9997751	1970	[ sensing a plurality of regions surrounding a body selected by said plurality of magnets and an average current in said region varies based on position of different and equal portions of one or more of the magnets for maintaining a desired orientation or orientation and spacing; and ]	[ applying, by a mechanical device, an electric field on the coil, wherein the electric field is applied to prevent an magnetic field from traversing through said coil; ]
0.99999225	1971	[ determining relative orientation (r1,r2,r3), where each region is aligned with said one or more magnets for maintaining the desired orientation or orientation and spacing. ]	[ sensing a plurality of regions surrounding a body selected by said plurality of magnets and an average current in said region varies based on position of different and equal portions of one or more of the magnets for maintaining a desired orientation or orientation and spacing; and ]
0.0009895636	1972	[ a base; ]	[ A device that activates an implantable device in a patient having a medical condition, the device comprising: ]
0.99982834	1973	[ first and second opposing sensors positioned adjacent the base; ]	[ a base; ]
0.99998975	1974	[ one or more processors positioned adjacent the base with theone or more processors being activated to activate the other sensor; and ]	[ first and second opposing sensors positioned adjacent the base; ]
0.9996049	1975	[ a processor configured to calculate a first position corresponding to the first external field of a first patient and a second position corresponding to a second external field of the patient and to selectively activate the sensors by moving the first and second controllers to the acquired first and second positions. ]	[ one or more processors positioned adjacent the base with theone or more processors being activated to activate the other sensor; and ]
0.99996245	1976	[ an elongate distal end, the elongate distal end defined by a first tube extending from the elongate distal end, the first tube having a diameter defining a length of the conduit and a distal end, the proximal end of the first tube having a diameter defining a distal surface thereof; and ]	[ A lumen/spiral interface for a tissue lumen including a sheath disposed adjacent to the tissue lumen and forming a conduit formed therethrough, the interface comprising: ]
0.99999154	1977	[ a transverse connection extending from the distal end to the elongate distal end of the first tube, the transverse connection being configured to interconnect with a proximal end of the shaft, ]	[ an elongate distal end, the elongate distal end defined by a first tube extending from the elongate distal end, the first tube having a diameter defining a length of the conduit and a distal end, the proximal end of the first tube having a diameter defining a distal surface thereof; and ]
0.9999869	1978	[ wherein the shaft defines at least one screw (7) having a proximal end configured to engage the proximal end of an opening in the first tube, wherein the opening defines an aperture therein, ]	[ a transverse connection extending from the distal end to the elongate distal end of the first tube, the transverse connection being configured to interconnect with a proximal end of the shaft, ]
0.99978477	1979	[ including a support (10) including an annular surface (16) configured to slide over the end of the shaft, the support (10) defining a shaft of the shaft extending through the shaft into the flexible portion surrounding the needle (14), a passage (14) for separating the shaft (14) from the transverse connection such that movement of the shaft relative to the shaft (14) results in the shaft extending through the tissue lumen when the tube is inserted in the tissue lumen. ]	[ wherein the shaft defines at least one screw (7) having a proximal end configured to engage the proximal end of an opening in the first tube, wherein the opening defines an aperture therein, ]
0.0066585215	1980	[ providing a continuous control device; ]	[ method of treating an inflammatory bowel Disease in a patient living in a home away from a pharmaceutically available drug therapy, comprising: ]
0.98813695	1981	[ positioning the patient against a wall of the home away from the drug therapy; ]	[ providing a continuous control device; ]
0.99999213	1982	[ moving the patient against the wall of the home with the control device, wherein a level of the home against the wall is dynamically set within a non-linear manner; wherein said non-linear volume of the home is defined in a continuous area and wherein once the control device is positioned against the wall the patient may be positioned within the non-linear area; and ]	[ positioning the patient against a wall of the home away from the drug therapy; ]
0.99998784	1983	[ controlling an amount for activation of a therapy comprising the drug therapy when the patient moves against the wall and upon activation of the drug therapy, ]	[ moving the patient against the wall of the home with the control device, wherein a level of the home against the wall is dynamically set within a non-linear manner; wherein said non-linear volume of the home is defined in a continuous area and wherein once the control device is positioned against the wall the patient may be positioned within the non-linear area; and ]
0.95274377	1984	[ wherein said volume of the home is further defined for a plurality of days. ]	[ controlling an amount for activation of a therapy comprising the drug therapy when the patient moves against the wall and upon activation of the drug therapy, ]
0.99632144	1985	[ administering an effective amount of an anti-inflammatory pharmaceutical composition comprising an effective amount of: 5-20% by weight of iodo-carotenoids comprising 0.01 to 5.0% by mass of the composition with 4-15% by weight of arbutin comprising 0.01 to 5.0% by mass of the composition with 0.5% by mass of beta-carotene, and ]	[ A method of stabilizing an intraluminal structure or a stent, comprising: ]
0.9994771	1986	[ the total weight of the composition being from 0.25 to 2.0% by mass; and ]	[ administering an effective amount of an anti-inflammatory pharmaceutical composition comprising an effective amount of: 5-20% by weight of iodo-carotenoids comprising 0.01 to 5.0% by mass of the composition with 4-15% by weight of arbutin comprising 0.01 to 5.0% by mass of the composition with 0.5% by mass of beta-carotene, and ]
0.12852715	1987	[ iodo-carotenoid. ]	[ the total weight of the composition being from 0.25 to 2.0% by mass; and ]
0.032426357	1988	[ an antenna to receive a broadcast signal to generate an imaging time time image; ]	[ An electrical apparatus that comprises: ]
0.9999912	1989	[ an electric vehicle to initiate a direct-current driven electric propulsion of the electric vehicle to drive a motor in a direction in which the imaging time image is displayed and to move the motor according to an electrical current; ]	[ an antenna to receive a broadcast signal to generate an imaging time time image; ]
0.9999883	1990	[ a generator apparatus to be moved by the electric propulsion generating electrical power at a predetermined rate to transmit a direct current signal based on a direct current signal received from the antenna from the generator and to drive the motor based on the direct current signal; and ]	[ an electric vehicle to initiate a direct-current driven electric propulsion of the electric vehicle to drive a motor in a direction in which the imaging time image is displayed and to move the motor according to an electrical current; ]
0.0005844488	1991	[ an image generation apparatus and a recording apparatus which produces an image obtained by illuminating the image generation apparatus with energy at a predetermined image intensity such that the illumination causes the surrounding light reflected by the illuminating light to form images, the image generation apparatus including a first light source producing emission lines to be reflected, the image generation apparatus generating an image time image for recording on a display, the image time image being stored, upon receipt of the direct current signal, in a memory, the memory containing a record corresponding to the direct current signal. ]	[ a generator apparatus to be moved by the electric propulsion generating electrical power at a predetermined rate to transmit a direct current signal based on a direct current signal received from the antenna from the generator and to drive the motor based on the direct current signal; and ]
0.9999801	1992	[ each having a plurality of rows of columns, wherein each column of each row is individually spaced apart from the column it aligns with in the corresponding row with respect to the surface, and ]	[ A single-spaced columnar microfabrication system comprising a plurality of rows of parallel array units each having a second row and a plurality of collets, and ]
0.99999225	1993	[ wherein each of the second row and a corresponding column of each row are arranged adjacent to the surface at an inclined angle, and ]	[ each having a plurality of rows of columns, wherein each column of each row is individually spaced apart from the column it aligns with in the corresponding row with respect to the surface, and ]
0.99999106	1994	[ wherein the second row has two opposed rows and the column is arranged adjacent to the first row with two opposed columns, ]	[ wherein each of the second row and a corresponding column of each row are arranged adjacent to the surface at an inclined angle, and ]
0.063217014	1995	[ wherein: ]	[ wherein the second row has two opposed rows and the column is arranged adjacent to the first row with two opposed columns, ]
0.9523066	1996	[ each column in each row is substantially parallel to the corresponding section in the corresponding row with respect to the surface; ]	[ wherein: ]
0.98928845	1997	[ the ends of, and ]	[ each column in each row is substantially parallel to the corresponding section in the corresponding row with respect to the surface; ]
0.9788069	1998	[ through each row of columns are substantially parallel with respect to the corresponding section, whereby each of the aligned with the surface by the columns are disposed for mounting on a table; and, ]	[ the ends of, and ]
0.99996555	1999	[ each column has a shape and a planar, symmetrical surface structure. ]	[ through each row of columns are substantially parallel with respect to the corresponding section, whereby each of the aligned with the surface by the columns are disposed for mounting on a table; and, ]
0.9999906	2000	[ wherein said personal information processing system is defined in (a) through (g); ]	[ A non-transitory computer readable storage medium storing a program executable by a processor of a personal information processing system for identifying and obtaining a physiological indication based on an input stream of a physiological data source in response to an automated physiological testing method (ARTS) of a personal information processing system, said program also storing programs for generating a real measurement measurement using said biological physiological data source, and ]
0.038978063	2001	[ wherein: ]	[ wherein said personal information processing system is defined in (a) through (g); ]
0.014811638	2002	[ the program stored in said storage medium is configured with an end point specification form for executing when the end point specification form is made available in a computerized protocol capable of executing while a patient is undergoing a test conducted by said arTS; said program is configured to function as follows: ]	[ wherein: ]
0.9999893	2003	[ the program receives a first set of input streams from said physiological data source comprising user-specified medical events, and ]	[ the program stored in said storage medium is configured with an end point specification form for executing when the end point specification form is made available in a computerized protocol capable of executing while a patient is undergoing a test conducted by said arTS; said program is configured to function as follows: ]
0.9999918	2004	[ inputs for assessing a first selected criteria of the input streams; ]	[ the program receives a first set of input streams from said physiological data source comprising user-specified medical events, and ]
0.99999166	2005	[ the program receives a second set of input streams from said physiological data source comprising second sets of medical events, which are different from the first set of input streams; said second sets of medical events comprise first events included in the first set of input streams and second events included in the second set of input streams; ]	[ inputs for assessing a first selected criteria of the input streams; ]
0.99999154	2006	[ a first selected parameter is used to define a predefined parameter representing the first selected criteria of the input streams, and ]	[ the program receives a second set of input streams from said physiological data source comprising second sets of medical events, which are different from the first set of input streams; said second sets of medical events comprise first events included in the first set of input streams and second events included in the second set of input streams; ]
0.99999225	2007	[ a second selected parameter is used to define a predefined parameter representing the second selected criteria of the input streams; ]	[ a first selected parameter is used to define a predefined parameter representing the first selected criteria of the input streams, and ]
0.004258865	2008	[ the program executes and receives a second set of diagnostic signals indicative of an actual condition of the patient; and ]	[ a second selected parameter is used to define a predefined parameter representing the second selected criteria of the input streams; ]
0.99999225	2009	[ the program outputs a medical-related output that corresponds to said second set of diagnostic signals. ]	[ the program executes and receives a second set of diagnostic signals indicative of an actual condition of the patient; and ]
0.9993205	2010	[ a pumping unit configured to accept and generate a pump flow rate indicative of a fluid flow rate; ]	[ A pump that receives fluids, the pump including: ]
0.99998033	2011	[ an output connection for pumping a part of a fluid including the fluid, wherein the part of the fluid is configured to pass through said pumping unit; and ]	[ a pumping unit configured to accept and generate a pump flow rate indicative of a fluid flow rate; ]
0.99999213	2012	[ a part of the fluid configured to be passed through the output connection of the pump. ]	[ an output connection for pumping a part of a fluid including the fluid, wherein the part of the fluid is configured to pass through said pumping unit; and ]
0.99577856	2013	[ a tubular body having first and second axially opposed portions defining an interior chamber configured for removal of moisture; ]	[ An integrally supported device, comprising: ]
0.99999213	2014	[ a second axially opposed portion extending above, parallel to, or adjacent to the tubular body; ]	[ a tubular body having first and second axially opposed portions defining an interior chamber configured for removal of moisture; ]
0.9999609	2015	[ a pressure generating element, located on a main area of the tubular body, which generates a first power at a first pulse; ]	[ a second axially opposed portion extending above, parallel to, or adjacent to the tubular body; ]
0.99999225	2016	[ a vacuum-generating element, located on a main area of the tubular body, which generates an opposing second pressure at a second pulse based at least in part on the first power; and ]	[ a pressure generating element, located on a main area of the tubular body, which generates a first power at a first pulse; ]
0.021236323	2017	[ a conduit connected to one of the first and second axially opposed portions, ]	[ a vacuum-generating element, located on a main area of the tubular body, which generates an opposing second pressure at a second pulse based at least in part on the first power; and ]
0.96541023	2018	[ wherein the pressure generating element and the vacuum-generating element is configured in the interior chamber to provide power at a first pressure and to provide power at a second pressure different from the first for use as an accessory for a hair care article; ]	[ a conduit connected to one of the first and second axially opposed portions, ]
0.99897647	2019	[ wherein each of the chamber and the conduit comprises a seal containing a moisture-based material, and ]	[ wherein the pressure generating element and the vacuum-generating element is configured in the interior chamber to provide power at a first pressure and to provide power at a second pressure different from the first for use as an accessory for a hair care article; ]
0.9999325	2020	[ wherein the second pressure of the second pulse moves the seal such that a first position in which the seal is free of moisture comprises a position from which temperature reaches ambient temperature to a position from which temperature falls within an outer shell of the air. ]	[ wherein each of the chamber and the conduit comprises a seal containing a moisture-based material, and ]
0.9984333	2021	[ a tip having a length; ]	[ A surgical tool for cutting a curved portion of a body portion toward a point of implantation, the curved portion having a longitudinal axis and a circular shape, the tool comprising: ]
0.999961	2022	[ said tip having a side which rests on the longitudinal axis of the curved portion, such that the tip is movably coupled with the longitudinal axis of the curved portion opposite of the longitudinal axis of the curved portion in an axis-free configuration; and ]	[ a tip having a length; ]
0.9999919	2023	[ an adhesive disposed on the tip in a region abutting the longitudinal axis of the curved portion; ]	[ said tip having a side which rests on the longitudinal axis of the curved portion, such that the tip is movably coupled with the longitudinal axis of the curved portion opposite of the longitudinal axis of the curved portion in an axis-free configuration; and ]
0.99999225	2024	[ wherein in said region between the side of said tip and the longitudinal axis of the curved portion, the adhesive defines a bore with a width that is wider than the longitudinal axis of said curved portion along the longitudinal axis. ]	[ an adhesive disposed on the tip in a region abutting the longitudinal axis of the curved portion; ]
0.9930235	2025	[ one or more water-soluble non-oxidising additives, ]	[ A cosmetic composition comprising: ]
0.99998987	2026	[ one or more water-soluble poly- and hydrogenated unsaturated fatty acids, ]	[ one or more water-soluble non-oxidising additives, ]
0.99998033	2027	[ one or more hydroxylating agents, and ]	[ one or more water-soluble poly- and hydrogenated unsaturated fatty acids, ]
0.9999908	2028	[ one or more emollifying agents wherein the cosmetic composition comprises an amount of the water-soluble non-oxidising additives and each hydroxylating agent to be added substantially equal to 5 g/ml of the water-soluble non-oxidising additives and the hydroxylating agents. ]	[ one or more hydroxylating agents, and ]
0.999992	2029	[ providing a water-soluble medical device having a body temperature of 80&#xb0; ]	[ A method for determining the concentration of a medical compounds of medical device type in water-soluble medical matter, the method comprising: ]
0.9999893	2030	[ C. to be exposed to the water-soluble medical matter for a time sufficient to have the medical device form molecular ions or chemical compounds having binding forces at a surface area ratio of about 2.3: 1 and to be charged with a first medical compound and a second medical compound, wherein the medical device is a cell of a biopsy machine, said method comprising treating the water-soluble medical device with an amount of at least one androgen to have the level of said first and second compound. ]	[ providing a water-soluble medical device having a body temperature of 80&#xb0; ]
0.9999876	2031	[ providing a sampling instrument that includes a blood collection port and an input terminal; ]	[ A method for assessing performance of a patient for an arterial monitoring device, the arterial monitoring device including a blood sample collection instrument and a pulse generator, the method comprising: ]
0.9999919	2032	[ disposing said blood collection port within a section of said blood collection port disposed within a lumen extending outwardly from the port when said instrument is positioned in said section; ]	[ providing a sampling instrument that includes a blood collection port and an input terminal; ]
0.997465	2033	[ acquiring a value of a rate of change within the vein region of the patient's heart that is indicative of a rate of change in fluid circulation across the vein region from the blood collected relative to a predetermined time condition; ]	[ disposing said blood collection port within a section of said blood collection port disposed within a lumen extending outwardly from the port when said instrument is positioned in said section; ]
0.9998511	2034	[ disposing said pulse generator at the arterial monitoring device; ]	[ acquiring a value of a rate of change within the vein region of the patient's heart that is indicative of a rate of change in fluid circulation across the vein region from the blood collected relative to a predetermined time condition; ]
0.99998736	2035	[ operating said pulse generator to generate a output signal based upon a corresponding of the value of the rate of change, said output signal being transmitted to a control device; ]	[ disposing said pulse generator at the arterial monitoring device; ]
0.9999881	2036	[ computing a blood saturation of the patient, said computer processing the blood saturation of the patient to yield a total saturation value that is more than that which would be generated by said rate of change of the sample collection port; and ]	[ operating said pulse generator to generate a output signal based upon a corresponding of the value of the rate of change, said output signal being transmitted to a control device; ]
0.9999918	2037	[ outputting a saturation signal corresponding to said total saturation value of the patient. ]	[ computing a blood saturation of the patient, said computer processing the blood saturation of the patient to yield a total saturation value that is more than that which would be generated by said rate of change of the sample collection port; and ]
0.99999154	2038	[ said flexible base mounted at said outside surface of said catheter. ]	[ A catheter for placement in a person's body, said catheter having an outside surface and an inside surface, said catheter having a flexible base, said catheter having a first coupling surface extending between said first coupling surface and said outside surface, said first coupling surface having a first elongated slot having a generally rectangular shape and having a first elongated hole with four corners, said first aperture extending through said first elongated slot and said first slot, said bendline of said bendline being parallel to the length of said first slot and running around the length of said bendline of said bent slot, and ]
0.9998404	2039	[ a container operatively coupled to a medical service apparatus, the container including: ]	[ A medical care device comprising: ]
0.9999492	2040	[ a top surface, the bottom surface being configured to receive an implantable medical treatment device and the top surface also defining a central aperture, wherein the container includes fluid in fluid communication with the central aperture, wherein the container is configured to receive implanted medical treatment device, wherein the fluid is not transmembrane-receiving fluid and fluid, and ]	[ a container operatively coupled to a medical service apparatus, the container including: ]
0.99999225	2041	[ wherein the container provides a plurality of sealed holes within the central aperture that receive only an implantable medical treatment device. ]	[ a top surface, the bottom surface being configured to receive an implantable medical treatment device and the top surface also defining a central aperture, wherein the container includes fluid in fluid communication with the central aperture, wherein the container is configured to receive implanted medical treatment device, wherein the fluid is not transmembrane-receiving fluid and fluid, and ]
0.9932033	2042	[ receiving an electrical signal from an electrical sensor that is to be received by a digital signal generator, wherein the electrical signal comprises a range at least in part of the range to be monitored within a monitored range; ]	[ A method for reducing or eliminating interference in a digital signal, comprising: ]
0.99999213	2043	[ selecting a predetermined range to receive from the electrical sensor; ]	[ receiving an electrical signal from an electrical sensor that is to be received by a digital signal generator, wherein the electrical signal comprises a range at least in part of the range to be monitored within a monitored range; ]
0.9999924	2044	[ receiving at least a portion of the selected range using the electrical sensor; and ]	[ selecting a predetermined range to receive from the electrical sensor; ]
0.9862605	2045	[ detecting, comparing, and ]	[ receiving at least a portion of the selected range using the electrical sensor; and ]
0.98932207	2046	[ determining differences of one or more parameters in the calculated signal sample from the selected range. ]	[ detecting, comparing, and ]
0.9913892	2047	[ a) a lid attached to a main body portion; ]	[ A bag comprising: ]
0.9999881	2048	[ b) a closed aperture in the lid associated with a closure mechanism; ]	[ a) a lid attached to a main body portion; ]
0.99999094	2049	[ c) a bag material within the closed aperture; ]	[ b) a closed aperture in the lid associated with a closure mechanism; ]
0.99995685	2050	[ d) a base portion carried by the bag; ]	[ c) a bag material within the closed aperture; ]
0.9999918	2051	[ e) a cover member carried by the base portion that includes at least a latching mechanism; ]	[ d) a base portion carried by the bag; ]
0.99983454	2052	[ f) at least one button mounted on the closed aperture of the lid; ]	[ e) a cover member carried by the base portion that includes at least a latching mechanism; ]
0.99979955	2053	[ g) a first button slideable with respect to an operator's hand of the user; ]	[ f) at least one button mounted on the closed aperture of the lid; ]
0.99999225	2054	[ h) a second button rotational with respect to the operator's hand of the user; ]	[ g) a first button slideable with respect to an operator's hand of the user; ]
0.99888617	2055	[ i) a handle attached to the closed aperture of the lid; ]	[ h) a second button rotational with respect to the operator's hand of the user; ]
0.9999187	2056	[ j) at least one handle attachment portion on which the bag is to be attached; and ]	[ i) a handle attached to the closed aperture of the lid; ]
0.99977225	2057	[ k) at least one strap having a plurality of elongate strap loops and a plurality of length-adjustable tie straps. ]	[ j) at least one handle attachment portion on which the bag is to be attached; and ]
0.9975067	2058	[ (i) the amino acid sequence N-10-9-32H1GG or an N-10-9-32H1GG pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable carrier therethrough, and ]	[ A therapeutic composition comprising a pharmaceutical monomer selected from the group consisting of: ]
0.99986863	2059	[ (ii) the pharmaceutically acceptable salt thereof; ]	[ (i) the amino acid sequence N-10-9-32H1GG or an N-10-9-32H1GG pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable carrier therethrough, and ]
0.0015330381	2060	[ wherein upon hydroxylation, the amino acid sequence is present as 1P or 2P. ]	[ (ii) the pharmaceutically acceptable salt thereof; ]
0.9999285	2061	[ a first ultrasound imaging apparatus which ultrasound imaging is configured to generate ultrasonic signals; and ]	[ A diagnostic ultrasound system comprising: ]
0.99999225	2062	[ a second ultrasound imaging apparatus which ultrasound imaging is configured to generate pulses of ultrasound signals, the ultrasonic signals being emitted from an ultrasound imaging unit and wherein each of a plurality of ultrasound ultrasound waves in the collection is formed by producing at least two ultrasonic waves as a plurality of overlapping pulses by a non-linear transformation and, by a linear transformation, to generate consecutive pulses, ]	[ a first ultrasound imaging apparatus which ultrasound imaging is configured to generate ultrasonic signals; and ]
0.99998534	2063	[ wherein a reference beam of ultrasonic signals is transmitted through a boundary region defined by a cavity wall. ]	[ a second ultrasound imaging apparatus which ultrasound imaging is configured to generate pulses of ultrasound signals, the ultrasonic signals being emitted from an ultrasound imaging unit and wherein each of a plurality of ultrasound ultrasound waves in the collection is formed by producing at least two ultrasonic waves as a plurality of overlapping pulses by a non-linear transformation and, by a linear transformation, to generate consecutive pulses, ]
0.99923503	2064	[ an arm having a tip, an underside and an opening on a distal end face of the arm: ]	[ A surgical instrument, comprising: ]
0.9999906	2065	[ a pressure sensor connected to the tip of the arm, the surface of the sensor including a sensor layer having a seal in fluid communication with the underside of the sensor; and ]	[ an arm having a tip, an underside and an opening on a distal end face of the arm: ]
0.9999733	2066	[ a sensor sheet comprising a plurality of sensing layers, whereinthe pressure sensor and the sensor sheet are connected to one another via a coupling, ]	[ a pressure sensor connected to the tip of the arm, the surface of the sensor including a sensor layer having a seal in fluid communication with the underside of the sensor; and ]
0.99998355	2067	[ at least one of the sensing layers has a sensing coating on the side that extends through the sensor layer defining the sealing and having a first outer surface that is between the surface of the first sensor surface and the surface of the layer defined by the seal to provide a first surface for contacting information on an ultrasound image obtained by the ultrasound, ]	[ a sensor sheet comprising a plurality of sensing layers, whereinthe pressure sensor and the sensor sheet are connected to one another via a coupling, ]
0.99999225	2068	[ the layer defined by the seal is disposed inside a peripheral portion of the cavity of the arm for controlling the delivery of light to the side of the upper part of the ultrasound image acquired by the ultrasound, and ]	[ at least one of the sensing layers has a sensing coating on the side that extends through the sensor layer defining the sealing and having a first outer surface that is between the surface of the first sensor surface and the surface of the layer defined by the seal to provide a first surface for contacting information on an ultrasound image obtained by the ultrasound, ]
0.9999894	2069	[ the layer formed by the seal includes a surface where a portion of the first surface intersects with a tissue surface to form a plurality of segments surrounding the perimeter of the cavity. ]	[ the layer defined by the seal is disposed inside a peripheral portion of the cavity of the arm for controlling the delivery of light to the side of the upper part of the ultrasound image acquired by the ultrasound, and ]
0.99998784	2070	[ a cleaning member having a shape that is suitable for holding the insect; ]	[ An insect cleaning apparatus for disinfecting an insect or at least selectively cleaning infected insect, comprising: ]
0.998307	2071	[ a cleaning surface and a plunger which, when the plunger is folded through a gap, is guided towards an infected area- wherein said plunger expands into said slidable space via an opposite surface and the area that is uncovered is disinfected under heat; and ]	[ a cleaning member having a shape that is suitable for holding the insect; ]
0.99999225	2072	[ a heater mechanism for increasing the heat in said slidable space to disinfect the area. ]	[ a cleaning surface and a plunger which, when the plunger is folded through a gap, is guided towards an infected area- wherein said plunger expands into said slidable space via an opposite surface and the area that is uncovered is disinfected under heat; and ]
0.9994912	2073	[ an elongated housing having: a first portion disposed in fluid communication with a biological sample wherein the biological sample is taken from a human body and disposed to contain a volatile and/or the chemical; and ]	[ An apparatus for the capture of a body sample, the apparatus comprising: ]
0.99937195	2074	[ a second portion comprising a substantially same location as the first portion; the second portion comprising a portion fixed to the first portion and wherein the second portion defines a lumen having an opening through which liquid enters from the first portion; and ]	[ an elongated housing having: a first portion disposed in fluid communication with a biological sample wherein the biological sample is taken from a human body and disposed to contain a volatile and/or the chemical; and ]
0.9980269	2075	[ a water-soluble cover disposed within the enclosed lumen and shaped and shaped to receive at least part of the body sample when the enclosure is sealed; and ]	[ a second portion comprising a substantially same location as the first portion; the second portion comprising a portion fixed to the first portion and wherein the second portion defines a lumen having an opening through which liquid enters from the first portion; and ]
0.9999907	2076	[ a pressure regulator sealed within the lumen therein to maintain a pressure that prevents the first portion from changing relative to the second portion when the enclosure is in fluid communication with a biological sample. ]	[ a water-soluble cover disposed within the enclosed lumen and shaped and shaped to receive at least part of the body sample when the enclosure is sealed; and ]
0.039746508	2077	[ an elongated flexible member having a proximal end and a distal end that engages two respective ends of a pair of straps secured to the elongated flexible member such that when the elongated flexible member is in an extended position, longitudinal distance between the distal end and the proximal end is not greater than the distal end of the elongated flexible member; ]	[ A fluid delivery device comprising: ]
0.99999225	2078	[ a guide slot located along a curved area of the elongated flexible member between the proximal end and the distal end of the elongated flexible member; ]	[ an elongated flexible member having a proximal end and a distal end that engages two respective ends of a pair of straps secured to the elongated flexible member such that when the elongated flexible member is in an extended position, longitudinal distance between the distal end and the proximal end is not greater than the distal end of the elongated flexible member; ]
0.99999225	2079	[ an inlet hole situated along a central longitudinal portion of the elongated flexible member, the inlet hole being within a longitudinal opening of the elongated flexible member; and ]	[ a guide slot located along a curved area of the elongated flexible member between the proximal end and the distal end of the elongated flexible member; ]
0.99999225	2080	[ an outlet hole situated along a central longitudinal portion of the elongated flexible member, the outlet hole being within a longitudinal opening of the elongated flexible member; ]	[ an inlet hole situated along a central longitudinal portion of the elongated flexible member, the inlet hole being within a longitudinal opening of the elongated flexible member; and ]
0.9999919	2081	[ wherein the guide slot has an opening to receive at least one of the straps along an inner surface of the guide slot, wherein the length of the elongated flexible member is greater than the length of the pair of straps; and ]	[ an outlet hole situated along a central longitudinal portion of the elongated flexible member, the outlet hole being within a longitudinal opening of the elongated flexible member; ]
0.99999225	2082	[ wherein the guide slot has an inner surface that receives a first end of the strap via an end point in the guide slot and an opposite end of the strap via an inner surface of the guide slot; ]	[ wherein the guide slot has an opening to receive at least one of the straps along an inner surface of the guide slot, wherein the length of the elongated flexible member is greater than the length of the pair of straps; and ]
0.0011781355	2083	[ the elongated flexible member being characterized by having an elastomeric layer comprising fiberous material adjacent a peripheral region of the fiberous layer. ]	[ wherein the guide slot has an inner surface that receives a first end of the strap via an end point in the guide slot and an opposite end of the strap via an inner surface of the guide slot; ]
0.9998578	2084	[ delivering an injection of a therapeutically active amino acid to a site within a region of patient memory that contains both memory regions and a therapeutic agent storage domain and not containing a patient storage domain; ]	[ A therapeutic application method for a human, comprising: ]
0.99999213	2085	[ encoding a therapeutic agent in said memory region of said patient storage domain and the memory region of said patient storage domain is non-physiologicalized; and ]	[ delivering an injection of a therapeutically active amino acid to a site within a region of patient memory that contains both memory regions and a therapeutic agent storage domain and not containing a patient storage domain; ]
0.9999914	2086	[ delivering said administration of said amino acid to said region of said patient memory. ]	[ encoding a therapeutic agent in said memory region of said patient storage domain and the memory region of said patient storage domain is non-physiologicalized; and ]
0.9999918	2087	[ applying a flexible medium to a plurality of pores of the wafer or material; ]	[ A method of manufacturing a flexible dental prosthesis in a wafer or other material, the method comprising: ]
0.9999901	2088	[ cutting a path in the material to allow the material to be fed into the pores; ]	[ applying a flexible medium to a plurality of pores of the wafer or material; ]
0.99999166	2089	[ molding the material into the tubular recess with the path cut; and ]	[ cutting a path in the material to allow the material to be fed into the pores; ]
0.99999225	2090	[ shaping the tubular recess such that a desired thickness of the tubular recess extends through the end of a path-cut hole within the material. ]	[ molding the material into the tubular recess with the path cut; and ]
0.001693895	2091	[ a central core body having a top, a bottom, and ]	[ An artificial leaf comprising: ]
0.999941	2092	[ an inner surface defining an opening in said top; ]	[ a central core body having a top, a bottom, and ]
0.9999893	2093	[ walls extending within said inner surface, said surface including a top surface, a middle surface defining a longitudinal axis extending along said top surface, and ]	[ an inner surface defining an opening in said top; ]
0.99992895	2094	[ a bottom surface defining a first peripheral surface; ]	[ walls extending within said inner surface, said surface including a top surface, a middle surface defining a longitudinal axis extending along said top surface, and ]
0.9694669	2095	[ an outer surface disposed between said walls, said outer surface being substantially smooth and smoothly flatter than said outer surface of said central core body; ]	[ a bottom surface defining a first peripheral surface; ]
0.99999225	2096	[ a cap mounted within said central core body; and ]	[ an outer surface disposed between said walls, said outer surface being substantially smooth and smoothly flatter than said outer surface of said central core body; ]
0.9999924	2097	[ a protective cover disposed adjacent a surface disposed across said external surface of said outer surface of said central core body; ]	[ a cap mounted within said central core body; and ]
0.99999225	2098	[ wherein said outer surface of said cap extends in response to said protective cover being disposed within said interior cavity defined by said central core body, and ]	[ a protective cover disposed adjacent a surface disposed across said external surface of said outer surface of said central core body; ]
0.99999225	2099	[ whereupon said outer surface of said cap is configured so as to be in a first region near to said outer surface of said inner surface, the edge of said protection cover between said outer surface of said central core body and an edge of said protective cover over a perimeter of said protective cover, an edge of said protection cover between said bottom surface of said central core body and an edge of said protective cover over said perimeter of said protective cover, and ]	[ wherein said outer surface of said cap extends in response to said protective cover being disposed within said interior cavity defined by said central core body, and ]
0.99999213	2100	[ a lower surface of said outer surface of said local core of said artificial tree wherein said inner surface of said cap forms a lower surface when placed in a second region over a perimeter of said protective cover, within said interior perimeter of said central core body, wherein said central core body is supported by any of two or more support members placed adjacent one of said walls, said resilient inner surface of said cap being disposed on such respective support members, and ]	[ whereupon said outer surface of said cap is configured so as to be in a first region near to said outer surface of said inner surface, the edge of said protection cover between said outer surface of said central core body and an edge of said protective cover over a perimeter of said protective cover, an edge of said protection cover between said bottom surface of said central core body and an edge of said protective cover over said perimeter of said protective cover, and ]
0.99999166	2101	[ such respective support members being adapted to be oriented so as to releasably engage any of two or more other supports by means of the second region. ]	[ a lower surface of said outer surface of said local core of said artificial tree wherein said inner surface of said cap forms a lower surface when placed in a second region over a perimeter of said protective cover, within said interior perimeter of said central core body, wherein said central core body is supported by any of two or more support members placed adjacent one of said walls, said resilient inner surface of said cap being disposed on such respective support members, and ]
0.99999154	2102	[ operating the device to acquire information related to tissue conditions of the patient, or the location of tissue conditions of the patient, by means of time series signals representative of a plurality of time series signals which are acquired at different times in relation to each other, wherein the implantable diagnostic device includes at least one ultrasonic ultrasonic transducer configured to generate ultrasonic echoes of respective tissue conditions from the respective ultrasound echoes of respective tissue conditions, wherein the information consists of the time series signals representing at least one anatomical location of the patient; and ]	[ A method for operating and monitoring an implantable diagnostic device in a patient, the method comprising: ]
0.9999924	2103	[ producing an ultrasonic echo signal using the material, tissue or tissue region of occurrence of tissue conditions of the patient, wherein the tissue conditions of the patient encompass the anatomical location of the patient and where the time series signals form a spectrum of ultrasonic signals that include signals indicative of multiple distinct tissue conditions. ]	[ operating the device to acquire information related to tissue conditions of the patient, or the location of tissue conditions of the patient, by means of time series signals representative of a plurality of time series signals which are acquired at different times in relation to each other, wherein the implantable diagnostic device includes at least one ultrasonic ultrasonic transducer configured to generate ultrasonic echoes of respective tissue conditions from the respective ultrasound echoes of respective tissue conditions, wherein the information consists of the time series signals representing at least one anatomical location of the patient; and ]
0.01281988	2104	[ a) a first or second polymerized cyclic carbamate glycol doped with a hydroxyalkyl (HE) polyterpene; and ]	[ A synthetic composition for inducing apoptosis, comprising: ]
0.99999225	2105	[ b) at least one agent on at least a portion of the second or additional or successive polymerized cyclic carbamate glycol. ]	[ a) a first or second polymerized cyclic carbamate glycol doped with a hydroxyalkyl (HE) polyterpene; and ]
0.999428	2106	[ a pulse generator to generate a pulse signal (S) at a second pulse location and to provide outputs from a cycle control circuitry (C); and ]	[ A system for increasing output from a cardiac cycle, comprising: ]
0.99998844	2107	[ a controller coupled to the cycle control circuitry and operable to selectively receive first and second results of the cycle control circuitry from the Puffwire unit, the controller comprisinga generator controller operating the puff wire of the controller to generate multiple output signals (S1, S2, S3, S4), wherein each output source output from the generator control circuitry corresponds to at least two sources of outputs from a different outputs source and wherein the cycle control circuitry stores at least one of the results of a plurality of second results. ]	[ a pulse generator to generate a pulse signal (S) at a second pulse location and to provide outputs from a cycle control circuitry (C); and ]
0.9984674	2108	[ 2. ]	[ An isolated polypeptide in a mammalian tissue and comprising the amino acid sequence of SEQ ID NO: ]
0.9795797	2109	[ isolating a sample of biological material or body tissue that has been in contact with a pharmaceutical composition which represents a composition comprising pharmaceutically acceptable carrier layers, wherein the carrier layers comprise a polymer having a maximum cross-linking force of 20, ]	[ A method comprising: ]
0.0064106486	2110	[ 000 N. ]	[ isolating a sample of biological material or body tissue that has been in contact with a pharmaceutical composition which represents a composition comprising pharmaceutically acceptable carrier layers, wherein the carrier layers comprise a polymer having a maximum cross-linking force of 20, ]
0.9999871	2111	[ wherein the second protein fragments are not present in the first protein fragments. ]	[ A tissue graft adapted to be placed into an organ of a patient to be treated by surgical techniques or operations, wherein the tissue graft contains at least one graft material which is capable of supporting a continuous length of bone or tissue at least part of the graft material being coated with protein fragments having specific amino acid residues selected from the group consisting of first and second amino acid proteins, and ]
0.9999722	2112	[ moving the distal arm from an initially opposed relative position to a laterally opposed position, the distal arm comprises a first end and a second end; ]	[ Method for treating a distal arm associated with a neck having a lower surface substantially cylindrically disposed on a body side of said neck, the method comprising the steps of: ]
0.9999906	2113	[ changing the position of a first element on said first end of the distal arm in a longitudinal direction; ]	[ moving the distal arm from an initially opposed relative position to a laterally opposed position, the distal arm comprises a first end and a second end; ]
0.99999225	2114	[ decreasing lateral direction of the first element relative to the distal arm in a forward direction by moving the first element through a first longitudinal path; ]	[ changing the position of a first element on said first end of the distal arm in a longitudinal direction; ]
0.99999213	2115	[ changing the position of a second element on said first end of the distal arm in a second longitudinal direction that passes the first longitudinal path; ]	[ decreasing lateral direction of the first element relative to the distal arm in a forward direction by moving the first element through a first longitudinal path; ]
0.99999225	2116	[ reducing the lateral direction of the second element in a forward direction by moving the second element through a second longitudinal path that passes along a second longitudinal axis from a laterally opposed position to the first longitudinal path; and ]	[ changing the position of a second element on said first end of the distal arm in a second longitudinal direction that passes the first longitudinal path; ]
0.99999213	2117	[ increasing the lateral direction of the second element by providing a first lever in said second longitudinal direction to increase movement of the first element from the initially opposed relative position to the longitudinal relative position and a second lever in said second longitudinal direction to increase movement of the second element from the initially opposed relative position to the longitudinal relative position, while the longitudinal path has a longitudinal axis that is radial and parallel to the first longitudinal path. ]	[ reducing the lateral direction of the second element in a forward direction by moving the second element through a second longitudinal path that passes along a second longitudinal axis from a laterally opposed position to the first longitudinal path; and ]
0.012616558	2118	[ PIP), the method comprising the steps of: ]	[ A method of preparing a compound in an amount effective to modulate the expression of a cancer initiation protein (CIP; ]
0.01849164	2119	[ (a) obtaining a DNA protein; ]	[ PIP), the method comprising the steps of: ]
0.99999106	2120	[ (b) washing the DNA protein in a mixtures of a heavy lysis solution and a light lysis solution to remove particles and prepare a mixture of the heavy lysis solution; ]	[ (a) obtaining a DNA protein; ]
0.99999225	2121	[ (c) incubating the mixture of the heavy lysis solution and the light lysis solution in a reaction solution containing: ]	[ (b) washing the DNA protein in a mixtures of a heavy lysis solution and a light lysis solution to remove particles and prepare a mixture of the heavy lysis solution; ]
0.9986986	2122	[ (i) hydrogen peroxide, optionally in a neutralizing step, and ]	[ (c) incubating the mixture of the heavy lysis solution and the light lysis solution in a reaction solution containing: ]
0.9999827	2123	[ (ii) a water-soluble divalent metal complex, optionally in a non-wetting step, in a position of or in proximity to an oxygen atom of a carbon atom in a part of the mixture of the heavy lysis solution containing hydrogen peroxide; ]	[ (i) hydrogen peroxide, optionally in a neutralizing step, and ]
0.99999094	2124	[ (d) repeating steps (a) to (c) using the combination of the heavy lysis and light lysis of step (c), until a silica compound is obtained, wherein the silica compound is a silica powder or a silicate, said silica mixture comprising about 4 to 100 microns of silica powder/100 microns of silica, and ]	[ (ii) a water-soluble divalent metal complex, optionally in a non-wetting step, in a position of or in proximity to an oxygen atom of a carbon atom in a part of the mixture of the heavy lysis solution containing hydrogen peroxide; ]
0.9999902	2125	[ said silica powder is available at the market or from a laboratory. ]	[ (d) repeating steps (a) to (c) using the combination of the heavy lysis and light lysis of step (c), until a silica compound is obtained, wherein the silica compound is a silica powder or a silicate, said silica mixture comprising about 4 to 100 microns of silica powder/100 microns of silica, and ]
0.99999094	2126	[ a seed; ]	[ A device for delivering a seed, comprising: ]
0.99999	2127	[ a carrier which acquires the seed; ]	[ a seed; ]
0.9996153	2128	[ a carrier distal; ]	[ a carrier which acquires the seed; ]
0.99992657	2129	[ a control device which, when said seed is disposed inside the distal, directs a drive-through of said seed through a nozzle to expel said seed; ]	[ a carrier distal; ]
0.99999213	2130	[ a first needle which, when positioned between the carrier and the distal where the seed is deposited, is attached to a needle in a proximal canal and which is disposed outside the container and outside of said proximal canal, and ]	[ a control device which, when said seed is disposed inside the distal, directs a drive-through of said seed through a nozzle to expel said seed; ]
0.99763894	2131	[ is operatively connected to a drive-through nozzle which is placed in communication with a drive-through system; and ]	[ a first needle which, when positioned between the carrier and the distal where the seed is deposited, is attached to a needle in a proximal canal and which is disposed outside the container and outside of said proximal canal, and ]
0.030987976	2132	[ a delivery device positioned directly next to the distal. ]	[ is operatively connected to a drive-through nozzle which is placed in communication with a drive-through system; and ]
0.99999213	2133	[ providing a flexible body fluid dispensing applicator comprising: ]	[ A method for manufacturing a body fluid dispensing applicator for an intraocular lens for an eye of a patient comprising: ]
0.9994411	2134	[ a flexible tube having a bottom portion and proximal end portions, the bottom portion of the flexible tube being expanded beyond its lumen size as the tube is elongated; ]	[ providing a flexible body fluid dispensing applicator comprising: ]
0.999992	2135	[ an apertured portion extending beneath the bottom portion of the flexible tube and being proximate to one of the bottom portions of the flexible tube when the tube is elongated, the apertured portion and the bottom portion of the flexible tube substantially joining in a straight line between the two adjacent portions of the flexible tube; and ]	[ a flexible tube having a bottom portion and proximal end portions, the bottom portion of the flexible tube being expanded beyond its lumen size as the tube is elongated; ]
0.9999919	2136	[ an apertured end portion of the flexible tube extending below the apertured portion of the flexible tube, the apertured portion of the flexible tube aligned to a first surface of an eyeball, the first surface being the head portion of the eye; ]	[ an apertured portion extending beneath the bottom portion of the flexible tube and being proximate to one of the bottom portions of the flexible tube when the tube is elongated, the apertured portion and the bottom portion of the flexible tube substantially joining in a straight line between the two adjacent portions of the flexible tube; and ]
0.9999825	2137	[ expanding the bottom portion of the flexible tube from a state formed prior to having the tube elongated to a state in which the bottom portion is elongated after the tube has been elongated so that the diameter of the bottom portion of the flexible tube remains relatively constant throughout the expanded state; ]	[ an apertured end portion of the flexible tube extending below the apertured portion of the flexible tube, the apertured portion of the flexible tube aligned to a first surface of an eyeball, the first surface being the head portion of the eye; ]
0.99999213	2138	[ stretching the expanded portion of the flexible tube for a period of time such that the expanded portion of the flexible tube becomes shorter. ]	[ expanding the bottom portion of the flexible tube from a state formed prior to having the tube elongated to a state in which the bottom portion is elongated after the tube has been elongated so that the diameter of the bottom portion of the flexible tube remains relatively constant throughout the expanded state; ]
0.99842286	2139	[ examining a patient's heart using an electrical cardiac pacing device, wherein the electrical cardiac pacing device comprises a single cardiac generator comprising a plurality of cardioinductive pulse generators arranged in circuit interlockable pairs; ]	[ A method for diagnosing and treating a condition associated with an arterial stiffness in a mammal, comprising: ]
0.99898404	2140	[ selecting a phase from one or more different phases; ]	[ examining a patient's heart using an electrical cardiac pacing device, wherein the electrical cardiac pacing device comprises a single cardiac generator comprising a plurality of cardioinductive pulse generators arranged in circuit interlockable pairs; ]
0.99908125	2141	[ generating electrical pulses corresponding to different phase positions of the plurality of cardioinductive pulse generators; and ]	[ selecting a phase from one or more different phases; ]
0.9999739	2142	[ recording the physiological response of the patient in response to receiving the generated electrical pulse and after a predetermined period of time. ]	[ generating electrical pulses corresponding to different phase positions of the plurality of cardioinductive pulse generators; and ]
0.9999902	2143	[ a hair-removal support wherein said hair-removal support is configured to be mounted on a hair-removal head and supported up an individual hair-removal bar; and ]	[ A hair-removal apparatus comprising: ]
0.99999225	2144	[ a locking element assembly having a first electrode portion and a second electrode portion, a locking element having one end surrounded by said hair-removal support, wherein said one end includes a screw-like recess and wherein said one end of said locking element contacts the first end of said locking element which has a second electrode portion, also in which one end is circular, to allow said lock-in force to be provided between the hair-removal bar and the hair-removal head, said locking element being configured to releasably hold at least one portion of an individual hair-removal head. ]	[ a hair-removal support wherein said hair-removal support is configured to be mounted on a hair-removal head and supported up an individual hair-removal bar; and ]
0.007014385	2145	[ a shaft having an unclamped configuration; ]	[ A golf club head, comprising: ]
0.9878735	2146	[ a center section including a central point, a concave edge, a circumferential axis extending outward from the circumferential axis, a midpoint point, and ]	[ a shaft having an unclamped configuration; ]
0.99999213	2147	[ an X-shaped region adjacent the circumferential axis, at least one of the midpoint points extending away from the center section, and ]	[ a center section including a central point, a concave edge, a circumferential axis extending outward from the circumferential axis, a midpoint point, and ]
0.99999213	2148	[ one of the circumferential axis defining an X-shaped cross-section extending below the midpoint point; and ]	[ an X-shaped region adjacent the circumferential axis, at least one of the midpoint points extending away from the center section, and ]
0.99999	2149	[ two side sections extending outward from the center section, each of the two side sections having a second sub-section, wherein the two sub-sections and the second sub-section defining an image line aligned in the circumferential axis. ]	[ one of the circumferential axis defining an X-shaped cross-section extending below the midpoint point; and ]
0.99999225	2150	[ a) at least one handlebar mountable to a motor operated bike; ]	[ An implement guide for use in a combination motor operated bike and handlebar mounted system comprising: ]
0.99999225	2151	[ b) a handlebar stand guide mounted to said handlebar mounted to provide a plurality of positioning areas for support of said at least one handlebar mounted to said motor operated bike; ]	[ a) at least one handlebar mountable to a motor operated bike; ]
0.99999225	2152	[ c) a handlebar handle mountable to said handlebar slidably mountable to said handlebar standing guide; ]	[ b) a handlebar stand guide mounted to said handlebar mounted to provide a plurality of positioning areas for support of said at least one handlebar mounted to said motor operated bike; ]
0.99999225	2153	[ d) at least one handlebar mountable to said saddle slidably, adapted to be folded over without falling over and comprising: ]	[ c) a handlebar handle mountable to said handlebar slidably mountable to said handlebar standing guide; ]
0.9999919	2154	[ i) a first mounting bracket attached to said saddle mounted to said handlebar, ]	[ d) at least one handlebar mountable to said saddle slidably, adapted to be folded over without falling over and comprising: ]
0.9999919	2155	[ ii) a second mounting bracket positioned separate from said first mounting bracket and arranged to be slidably mounted to a non-mounted roller mounted to said saddle, <|span|>iii] comprising: ]	[ i) a first mounting bracket attached to said saddle mounted to said handlebar, ]
0.99999166	2156	[ i) a locking means to keep said saddle mounted to said saddle upon movement of such saddle mounted on said handlebar, the locking means being configured to lock each of the respective mounting bracket and saddle; and ]	[ ii) a second mounting bracket positioned separate from said first mounting bracket and arranged to be slidably mounted to a non-mounted roller mounted to said saddle, <|span|>iii] comprising: ]
0.99999213	2157	[ ii) a cover adapted to cover said saddle when a position of said at least one saddle mounted on said handlebar is in another position, thereby allowing mounting of said second mounting bracket to said saddle; ]	[ i) a locking means to keep said saddle mounted to said saddle upon movement of such saddle mounted on said handlebar, the locking means being configured to lock each of the respective mounting bracket and saddle; and ]
0.99999225	2158	[ e) a cushion support mounted to an inner wall of said saddle slidably removable in order for said saddle to move relative to said saddle based on an outside position of the saddle on said handlebar. ]	[ ii) a cover adapted to cover said saddle when a position of said at least one saddle mounted on said handlebar is in another position, thereby allowing mounting of said second mounting bracket to said saddle; ]
0.9980262	2159	[ isolating a bone marrow stem cell from a human bone marrow sample; ]	[ A method for establishing a blood glucose tolerance measurement, comprising: ]
0.99027634	2160	[ providing a system in a blood glucose testing apparatus, the system comprising: ]	[ isolating a bone marrow stem cell from a human bone marrow sample; ]
0.0041754977	2161	[ a nucleic acid molecule sequence that encoding a soluble IKK-2 inhibitor and a soluble IKK-2 monoclonal antibody that includes an antibody selected from the group consisting of the peptide and the heavy chain oligonucleotide; ]	[ providing a system in a blood glucose testing apparatus, the system comprising: ]
0.99991906	2162	[ a first interferon antigen expressed on a surface of at least one of the nucleic acid molecules, said system further comprising: ]	[ a nucleic acid molecule sequence that encoding a soluble IKK-2 inhibitor and a soluble IKK-2 monoclonal antibody that includes an antibody selected from the group consisting of the peptide and the heavy chain oligonucleotide; ]
0.99998987	2163	[ a second interferon polypeptide and a second antagonist selected from the group consisting of a human antithymocyte colony stimulating factor (hSCF), a c-kit, a human papilloma virus (HPV) antigen-binding domain, and ]	[ a first interferon antigen expressed on a surface of at least one of the nucleic acid molecules, said system further comprising: ]
0.99946386	2164	[ the heavy chain oligonucleotide; ]	[ a second interferon polypeptide and a second antagonist selected from the group consisting of a human antithymocyte colony stimulating factor (hSCF), a c-kit, a human papilloma virus (HPV) antigen-binding domain, and ]
0.9981027	2165	[ a second interferon polypeptide and a third antagonist selected from the group consisting of a human papilloma virus (HPV) antigen-binding domain, a human CD4+ T-cell receptor (CD4), a human IgG antibody , and ]	[ the heavy chain oligonucleotide; ]
0.9999852	2166	[ a human CD8 T cell receptor (CD8T), wherein at least one of the first, second and third antagonists expresses in a human and the is in the heavy chain oligonucleotide. ]	[ a second interferon polypeptide and a third antagonist selected from the group consisting of a human papilloma virus (HPV) antigen-binding domain, a human CD4+ T-cell receptor (CD4), a human IgG antibody , and ]
0.0015942528	2167	[ a base; ]	[ In a method of dispensing a medication, the method comprising the action of a machineable, portable device having: ]
0.9997272	2168	[ a plunger having a protrusion sized substantially to extend substantially into at least a first side of said base therethrough; ]	[ a base; ]
0.99867934	2169	[ a handle having proximal and distal ends, said handle being sized to handle a hand of a patient; ]	[ a plunger having a protrusion sized substantially to extend substantially into at least a first side of said base therethrough; ]
0.9999907	2170	[ an air pressure sensor mounted to the hand of the patient; and ]	[ a handle having proximal and distal ends, said handle being sized to handle a hand of a patient; ]
0.99999106	2171	[ a valve that delivers fluid from the air pressure sensor to fluid-rich fluid adjacent to the air pressure sensor, ]	[ an air pressure sensor mounted to the hand of the patient; and ]
0.9999826	2172	[ the device providing a mechanical coupling between at least a first side of said base and a second side of said base where the operation of the plunger includes a reduction of air through the plunger to reduce pressure from the air pressure sensor. ]	[ a valve that delivers fluid from the air pressure sensor to fluid-rich fluid adjacent to the air pressure sensor, ]
0.9945437	2173	[ a housing; ]	[ A portable diagnostic instrument capable of transmitting ultrasound waveform images of a body part using ultrasound waves for diagnostic positioning of the handheld diagnostic instrument's instrument, the portable diagnostic instrument comprising: ]
0.9995432	2174	[ an ultrasound probe positioned within the housing; ]	[ a housing; ]
0.99977833	2175	[ a frame disposed within the housing; ]	[ an ultrasound probe positioned within the housing; ]
0.99579155	2176	[ a waveguide disposed within the waveguide; and ]	[ a frame disposed within the housing; ]
0.99998343	2177	[ a first switch disposed within the waveguide so that the medical identification and diagnostic indication may be selected when the portable diagnostic instrument is mounted adjacent the frame, the second switch being adjustable such that the first switch is not open during use, the first switch being adapted to be exposed to an ultrasound position that permits transmitting ultrasound waveform images of the body part using said ultrasound waves. ]	[ a waveguide disposed within the waveguide; and ]
0.999959	2178	[ q1 is a unique poker number which is a unique code and whose representation has both alphanumeric and numeric elements; ]	[ A method for processing a game (e.g. hand-sealed poker game) in which a casino player moves cards to a player's hand and the player bets that the player's hand contains at least 10 cards including a player, the following formulae are applied to the game (e.g. hand-sealed poker game): ]
0.99999213	2179	[ po1 is a poker number from which to generate an identification of the player; ]	[ q1 is a unique poker number which is a unique code and whose representation has both alphanumeric and numeric elements; ]
0.999969	2180	[ d is a number representative of a first game sequence: ]	[ po1 is a poker number from which to generate an identification of the player; ]
0.9999924	2181	[ d 1 is a zero, or if a first game sequence the number equal to 0, the first game sequence is played, ]	[ d is a number representative of a first game sequence: ]
0.99999225	2182	[ a second game sequence is also played; ]	[ d 1 is a zero, or if a first game sequence the number equal to 0, the first game sequence is played, ]
0.0004491266	2183	[ s, ]	[ a second game sequence is also played; ]
8.413119e-05	2184	[ and<|span|> r are numbers representative of the first first game sequence, each of which is an element of a second game sequence, or the game, from which to generate the identification, and ]	[ s, ]
0.010170282	2185	[ wherein the position of d, q, r, po1, d1, s, and ]	[ and<|span|> r are numbers representative of the first first game sequence, each of which is an element of a second game sequence, or the game, from which to generate the identification, and ]
0.0028152675	2186	[ r are as determined from the casino table and are represented in a game dealer interface. ]	[ wherein the position of d, q, r, po1, d1, s, and ]
0.9806919	2187	[ a main body having a first end and a second end; ]	[ An implantable implant comprising: ]
0.99994814	2188	[ a sleeve coupled to the body at the first end and disposed in axial contact with an adjacent side of an artery to facilitate placement of the sleeve in the artery; and, ]	[ a main body having a first end and a second end; ]
0.99997187	2189	[ a first fluid catheter connected to the sleeve at a distal end for use as a reservoir for the fluid to be implanted, the first fluid catheter having a blood pressure sensor for detecting a blood pressure during operation of the first fluid catheter, wherein the first fluid catheter is configured to be moved relative to the body thereby for guiding a flow of the fluid from the tube through the body. ]	[ a sleeve coupled to the body at the first end and disposed in axial contact with an adjacent side of an artery to facilitate placement of the sleeve in the artery; and, ]
0.99999225	2190	[ a behavior of the living entity related to the body part said at least one of the one of the one of the one of the one of the body part characteristic and the one of the one of the one of the one of the body part orientation parameter determined by modeling. ]	[ A method for processing a process comprising at least one of: detecting by a processor of at least one of one of a method and condition within a process, or a measurement data structure, of a structure of a living entity associated with the living entity including a body part, a region of engagement of the body part according to the method, a position of the body part in the region of engagement according to the method, and ]
0.9999857	2191	[ applying at least one of a first patient-specific therapeutically effective dose of an effective amount of a nucleic acid sequence comprising sequence SEQ ID NO: 2 directly onto a tissue surface of a first patient before the second patient performs a particular method in order to optimize a first therapeutic process and optimize the second therapeutic process in accordance with a predetermined performance timing of the first patient; and ]	[ A method for improving performance of at least two different medical procedures performed with a therapeutic instrument comprising: ]
0.99999225	2192	[ applying a second therapeutic process of an effective amount of nucleic acid sequences comprising sequence SEQ ID NO: 3 at a later time than the first therapeutic process; ]	[ applying at least one of a first patient-specific therapeutically effective dose of an effective amount of a nucleic acid sequence comprising sequence SEQ ID NO: 2 directly onto a tissue surface of a first patient before the second patient performs a particular method in order to optimize a first therapeutic process and optimize the second therapeutic process in accordance with a predetermined performance timing of the first patient; and ]
0.99989796	2193	[ wherein the procedure, comprising application of the therapeutic instrument is performed in a patient controlled therapeutic environment. ]	[ applying a second therapeutic process of an effective amount of nucleic acid sequences comprising sequence SEQ ID NO: 3 at a later time than the first therapeutic process; ]
0.024393238	2194	[ sensing at a first time when a user uses a touch input device an acoustic impedance; ]	[ A method comprising: ]
0.9999913	2195	[ generating a signal when the acoustic impedance exceeds a predetermined threshold; and ]	[ sensing at a first time when a user uses a touch input device an acoustic impedance; ]
0.99999225	2196	[ outputting the signal when the acoustic impedance falls below the predetermined threshold. ]	[ generating a signal when the acoustic impedance exceeds a predetermined threshold; and ]
0.9999881	2197	[ positioning and securing an ear of a person with one ear at a first base position in place thereon; ]	[ A method for determining the viability of an ear for placement into an ear canal of a healthy person in need of a procedure, which comprises: ]
0.99999154	2198	[ elongating two ears located for insertion into the ear canal of the person, the two ears in proximity to one another; ]	[ positioning and securing an ear of a person with one ear at a first base position in place thereon; ]
0.999992	2199	[ positioning and securing at least one clamp attached to an outer portion of at least one of the two ears, the at least one clamp generally extending laterally and in a proximal-posterior direction with respect to one another; ]	[ elongating two ears located for insertion into the ear canal of the person, the two ears in proximity to one another; ]
0.9999919	2200	[ pushing the ear down through a wall of the ear canal upwardly, onto the at least one of the clamps, to retract the at least one clamp until the at least one clamp is completely retracted; and ]	[ positioning and securing at least one clamp attached to an outer portion of at least one of the two ears, the at least one clamp generally extending laterally and in a proximal-posterior direction with respect to one another; ]
0.99999225	2201	[ sealing the at least one clamp with a suture bag which is held between the one clamp and one corresponding slot as the ear is being retracted. ]	[ pushing the ear down through a wall of the ear canal upwardly, onto the at least one of the clamps, to retract the at least one clamp until the at least one clamp is completely retracted; and ]
